
<html lang="en"     class="pb-page"  data-request-id="6fd4711e-7da1-4e17-85a5-e36665104fb5"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.9b02094;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-10"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Synthesis and Biochemical Evaluation of Noncyclic Nucleotide Exchange Proteins Directly Activated by cAMP 1 (EPAC1) Regulators" /></meta><meta name="dc.Creator" content="Pingyuan  Wang" /></meta><meta name="dc.Creator" content="Urszula  Luchowska-Stańska" /></meta><meta name="dc.Creator" content="Boy  van Basten" /></meta><meta name="dc.Creator" content="Haiying  Chen" /></meta><meta name="dc.Creator" content="Zhiqing  Liu" /></meta><meta name="dc.Creator" content="Jolanta  Wiejak" /></meta><meta name="dc.Creator" content="Padraic  Whelan" /></meta><meta name="dc.Creator" content="David  Morgan" /></meta><meta name="dc.Creator" content="Emma  Lochhead" /></meta><meta name="dc.Creator" content="Graeme  Barker" /></meta><meta name="dc.Creator" content="Holger  Rehmann" /></meta><meta name="dc.Creator" content="Stephen J.  Yarwood" /></meta><meta name="dc.Creator" content="Jia  Zhou" /></meta><meta name="dc.Description" content="Exchange proteins directly activated by cAMP (EPAC) play a central role in various biological functions, and activation of the EPAC1 protein has shown potential benefits for the treatment of variou..." /></meta><meta name="Description" content="Exchange proteins directly activated by cAMP (EPAC) play a central role in various biological functions, and activation of the EPAC1 protein has shown potential benefits for the treatment of variou..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 28, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b02094" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b02094" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b02094" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b02094" /></link>
        
    
    

<title>Synthesis and Biochemical Evaluation of Noncyclic Nucleotide Exchange Proteins Directly Activated by cAMP 1 (EPAC1) Regulators | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b02094" /></meta><meta property="og:title" content="Synthesis and Biochemical Evaluation of Noncyclic Nucleotide Exchange Proteins Directly Activated by cAMP 1 (EPAC1) Regulators" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0026.jpeg" /></meta><meta property="og:description" content="Exchange proteins directly activated by cAMP (EPAC) play a central role in various biological functions, and activation of the EPAC1 protein has shown potential benefits for the treatment of various human diseases. Herein, we report the synthesis and biochemical evaluation of a series of noncyclic nucleotide EPAC1 activators. Several potent EPAC1 binders were identified including 25g, 25q, 25n, 25u, 25e, and 25f, which promote EPAC1 guanine nucleotide exchange factor activity in vitro. These agonists can also activate EPAC1 protein in cells, where they exhibit excellent selectivity toward EPAC over protein kinase A and G protein-coupled receptors. Moreover, 25e, 25f, 25n, and 25u exhibited improved selectivity toward activation of EPAC1 over EPAC2 in cells. Of these, 25u was found to robustly inhibit IL-6-activated signal transducer and activator of transcription 3 (STAT3) and subsequent induction of the pro-inflammatory vascular cell adhesion molecule 1 (VCAM1) cell-adhesion protein. These novel EPAC1 activators may therefore act as useful pharmacological tools for elucidation of EPAC function and promising drug leads for the treatment of relevant human diseases." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="Exchange proteins directly activated by cAMP (EPAC) play a central role in various biological functions, and activation of the EPAC1 protein has shown potential benefits for the treatment of various human diseases. Herein, we report the synthesis and biochemical evaluation of a series of noncyclic nucleotide EPAC1 activators. Several potent EPAC1 binders were identified including 25g, 25q, 25n, 25u, 25e, and 25f, which promote EPAC1 guanine nucleotide exchange factor activity in vitro. These agonists can also activate EPAC1 protein in cells, where they exhibit excellent selectivity toward EPAC over protein kinase A and G protein-coupled receptors. Moreover, 25e, 25f, 25n, and 25u exhibited improved selectivity toward activation of EPAC1 over EPAC2 in cells. Of these, 25u was found to robustly inhibit IL-6-activated signal transducer and activator of transcription 3 (STAT3) and subsequent induction of the pro-inflammatory vascular cell adhesion molecule 1 (VCAM1) cell-adhesion protein. These novel EPAC1 activators may therefore act as useful pharmacological tools for elucidation of EPAC function and promising drug leads for the treatment of relevant human diseases." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0026.jpeg" /></meta><meta name="twitter:title" content="Synthesis and Biochemical Evaluation of Noncyclic Nucleotide Exchange Proteins Directly Activated by cAMP 1 (EPAC1) Regulators" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b02094"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02094">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b02094&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b02094&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b02094&amp;href=/doi/10.1021/acs.jmedchem.9b02094" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 5159-5184</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01961" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b02135" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and Biochemical Evaluation of Noncyclic Nucleotide Exchange Proteins Directly Activated by cAMP 1 (EPAC1) Regulators</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Pingyuan Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pingyuan Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pingyuan++Wang">Pingyuan Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Urszula Luchowska-Stańska</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Urszula Luchowska-Stańska</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Biological Chemistry, Biophysics and Bioengineering, Heriot-Watt University, Riccarton, Edinburgh EH14 4AS, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Urszula++Luchowska-Sta%C5%84ska">Urszula Luchowska-Stańska</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Boy van Basten</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Boy van Basten</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Biological Chemistry, Biophysics and Bioengineering, Heriot-Watt University, Riccarton, Edinburgh EH14 4AS, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Boy++van+Basten">Boy van Basten</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Haiying Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Haiying Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Haiying++Chen">Haiying Chen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhiqing Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhiqing Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhiqing++Liu">Zhiqing Liu</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0266-6677" title="Orcid link">http://orcid.org/0000-0003-0266-6677</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jolanta Wiejak</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jolanta Wiejak</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Biological Chemistry, Biophysics and Bioengineering, Heriot-Watt University, Riccarton, Edinburgh EH14 4AS, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jolanta++Wiejak">Jolanta Wiejak</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Padraic Whelan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Padraic Whelan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Chemical Sciences, Heriot-Watt University, Riccarton, Edinburgh EH14 4AS, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Padraic++Whelan">Padraic Whelan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David Morgan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David Morgan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Chemical Sciences, Heriot-Watt University, Riccarton, Edinburgh EH14 4AS, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David++Morgan">David Morgan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Emma Lochhead</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Emma Lochhead</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Chemical Sciences, Heriot-Watt University, Riccarton, Edinburgh EH14 4AS, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Emma++Lochhead">Emma Lochhead</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Graeme Barker</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Graeme Barker</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Chemical Sciences, Heriot-Watt University, Riccarton, Edinburgh EH14 4AS, U.K.</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#3e594c5f5b535b105c5f4c555b4c7e5649105f5d104b55"><span class="__cf_email__" data-cfemail="6e091c0f0b030b400c0f1c050b1c2e0619400f0d401b05">[email protected]</span></a>. Phone: (0131) 451 8204.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Graeme++Barker">Graeme Barker</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2351-1802" title="Orcid link">http://orcid.org/0000-0002-2351-1802</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Holger Rehmann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Holger Rehmann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular Cancer Research, Centre of Biomedical Genetics and Cancer Genomics Centre, University Medical Centre Utrecht, Utrecht 3584 CX, Netherlands</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Holger++Rehmann">Holger Rehmann</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stephen J. Yarwood</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stephen J. Yarwood</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Biological Chemistry, Biophysics and Bioengineering, Heriot-Watt University, Riccarton, Edinburgh EH14 4AS, U.K.</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#15463b4c7467627a7a71557d623b74763b607e"><span class="__cf_email__" data-cfemail="40136e192132372f2f240028376e21236e352b">[email protected]</span></a>. Phone: (0131) 451 3148.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+J.++Yarwood">Stephen J. Yarwood</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Jia Zhou</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jia Zhou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#016b687b696e744174756c632f646574"><span class="__cf_email__" data-cfemail="4a20233022253f0a3f3e2728642f2e3f">[email protected]</span></a>. Phone: (409) 772-9748. Fax: (409) 772-9648.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jia++Zhou">Jia Zhou</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2811-1090" title="Orcid link">http://orcid.org/0000-0002-2811-1090</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b02094&amp;href=/doi/10.1021%2Facs.jmedchem.9b02094" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 5159–5184</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 28, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>16 December 2019</li><li><span class="item_label"><b>Published</b> online</span>28 April 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 May 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b02094" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02094</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5159%26pageCount%3D26%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPingyuan%2BWang%252C%2BUrszula%2BLuchowska-Sta%25C5%2584ska%252C%2BBoy%2Bvan%2BBasten%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D10%26contentID%3Dacs.jmedchem.9b02094%26title%3DSynthesis%2Band%2BBiochemical%2BEvaluation%2Bof%2BNoncyclic%2BNucleotide%2BExchange%2BProteins%2BDirectly%2BActivated%2Bby%2BcAMP%2B1%2B%2528EPAC1%2529%2BRegulators%26numPages%3D26%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5184%26publicationDate%3DMay%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b02094"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1230</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">3</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b02094" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and Biochemical Evaluation of Noncyclic Nucleotide Exchange Proteins Directly Activated by cAMP 1 (EPAC1) Regulators&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Pingyuan&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Urszula&quot;,&quot;last_name&quot;:&quot;Luchowska-Stańska&quot;},{&quot;first_name&quot;:&quot;Boy&quot;,&quot;last_name&quot;:&quot;van Basten&quot;},{&quot;first_name&quot;:&quot;Haiying&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Zhiqing&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Jolanta&quot;,&quot;last_name&quot;:&quot;Wiejak&quot;},{&quot;first_name&quot;:&quot;Padraic&quot;,&quot;last_name&quot;:&quot;Whelan&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Morgan&quot;},{&quot;first_name&quot;:&quot;Emma&quot;,&quot;last_name&quot;:&quot;Lochhead&quot;},{&quot;first_name&quot;:&quot;Graeme&quot;,&quot;last_name&quot;:&quot;Barker&quot;},{&quot;first_name&quot;:&quot;Holger&quot;,&quot;last_name&quot;:&quot;Rehmann&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;J. Yarwood&quot;},{&quot;first_name&quot;:&quot;Jia&quot;,&quot;last_name&quot;:&quot;Zhou&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;5159-5184&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b02094&quot;},&quot;abstract&quot;:&quot;Exchange proteins directly activated by cAMP (EPAC) play a central role in various biological functions, and activation of the EPAC1 protein has shown potential benefits for the treatment of various human diseases. Herein, we report the synthesis and biochemical evaluation of a series of noncyclic nucleotide EPAC1 activators. Several potent EPAC1 binders were identified including 25g, 25q, 25n, 25u, 25e, and 25f, which promote EPAC1 guanine nucleotide exchange factor activity in vitro. These agonists can also activate EPAC1 protein in cells, where they exhibit excellent selectivity toward EPAC over protein kinase A and G protein-coupled receptors. Moreover, 25e, 25f, 25n, and 25u exhibited improved selectivity toward activation of EPAC1 over EPAC2 in cells. Of these, 25u was found to robustly inhibit IL-6-activated signal transducer and activator of transcription 3 (STAT3) and subsequent induction of the pro-inflammatory vascular cell adhesion molecule 1 (VCAM1) cell-adhesion protein. These novel EPAC1 activa&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02094&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02094" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02094&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02094" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02094&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02094" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b02094&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02094&amp;href=/doi/10.1021/acs.jmedchem.9b02094" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b02094" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b02094" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b02094%26sid%3Dliteratum%253Aachs%26pmid%3D32340447%26genre%3Darticle%26aulast%3DWang%26date%3D2020%26atitle%3DSynthesis%2Band%2BBiochemical%2BEvaluation%2Bof%2BNoncyclic%2BNucleotide%2BExchange%2BProteins%2BDirectly%2BActivated%2Bby%2BcAMP%2B1%2B%2528EPAC1%2529%2BRegulators%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D10%26spage%3D5159%26epage%3D5184%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=291456" title="Hydrocarbons">Hydrocarbons</a>,</li><li><a href="/action/doSearch?ConceptID=292161" title="Modification">Modification</a>,</li><li><a href="/action/doSearch?ConceptID=292529" title="Aromatic compounds">Aromatic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/10" title="Go to Volume 63, Issue 10"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/jmcmar.2020.63.issue-10/20200528/jmcmar.2020.63.issue-10.largecover.jpg" alt="Go to Volume 63, Issue 10"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0026.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Exchange proteins directly activated by cAMP (EPAC) play a central role in various biological functions, and activation of the EPAC1 protein has shown potential benefits for the treatment of various human diseases. Herein, we report the synthesis and biochemical evaluation of a series of noncyclic nucleotide EPAC1 activators. Several potent EPAC1 binders were identified including <b>25g</b>, <b>25q</b>, <b>25n</b>, <b>25u</b>, <b>25e</b>, and <b>25f</b>, which promote EPAC1 guanine nucleotide exchange factor activity <i>in vitro</i>. These agonists can also activate EPAC1 protein in cells, where they exhibit excellent selectivity toward EPAC over protein kinase A and G protein-coupled receptors. Moreover, <b>25e</b>, <b>25f</b>, <b>25n</b>, and <b>25u</b> exhibited improved selectivity toward activation of EPAC1 over EPAC2 in cells. Of these, <b>25u</b> was found to robustly inhibit IL-6-activated signal transducer and activator of transcription 3 (STAT3) and subsequent induction of the pro-inflammatory vascular cell adhesion molecule 1 (VCAM1) cell-adhesion protein. These novel EPAC1 activators may therefore act as useful pharmacological tools for elucidation of EPAC function and promising drug leads for the treatment of relevant human diseases.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15846" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15846" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cyclic adenosine monophosphate (cAMP, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), a well-known prototypical second messenger, is synthesized in cells from adenosine triphosphate (ATP) by adenylate cyclases (ACs).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> cAMP plays its functional roles mainly through activation of three downstream mediators including protein kinase A (PKA),<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2−4)</a> cyclic nucleotide-regulated ion channels,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and exchange proteins directly activated by cAMP (EPACs).<a onclick="showRef(event, 'ref6 ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8 ref9 ref10">(6−10)</a> EPAC proteins are multidomain proteins that act as cAMP-regulated guanine nucleotide exchange factors (GEFs) to catalyze the exchange of guanosine diphosphate (GDP) for guanosine triphosphate (GTP) for the Ras-like small GTPases (Rap1 and Rap2).<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> Two members of the EPAC protein family, EPAC1 and EPAC2, have been identified. EPAC1 and EPAC2 share about 68% sequence homology in human cells.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Both isoforms can be found in different concentrations in mature and developing human tissues. In mice, the expression of EPAC1 is relatively ubiquitous, while the expression of EPAC2 is largely restricted to the central nervous system (CNS), testes, and adrenal glands.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In cells, the EPAC protein adopts an inactive conformation when the cAMP concentration is at a low level. In contrast, EPAC enzyme activity is induced following elevations in intracellular cAMP levels.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Subsequently, active EPAC proteins serve as GEFs for Rap proteins.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Although the delineation of the cAMP-EPAC signaling pathway is relatively new, it has been receiving more and more attention because of its extensive and attractive biological functions within the CNS, endocrine, cardiovascular, and immune systems.<a onclick="showRef(event, 'ref1 ref10 ref16'); return false;" href="javascript:void(0);" class="ref ref1 ref10 ref16">(1,10,16)</a> Accordingly, tremendous efforts have been made to identify small-molecule EPAC modulators as chemical probes and drug candidates over the past two decades.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> In recent years, we have made significant progress in the discovery of efficient noncyclic nucleotide small-molecule EPAC antagonists with drug-like profiles as pharmacological tools and potential drug candidates, and several developed EPAC antagonists are under preclinical studies<a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref21 ref22 ref23 ref24">(17−24)</a> as potential therapeutics for cancer,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> infections,<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> obesity,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> chronic pain,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and CNS diseases.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of cAMP and representative reported EPAC agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Growing evidence demonstrates that EPAC1 protein protects the retina against ischemia/reperfusion-induced neuronal damage<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and promotes neuronal differentiation and neurite proliferation.<a onclick="showRef(event, 'ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34">(32−34)</a> The use of EPAC knockout mouse models also indicates that EPAC proteins have an essential role in learning, memory, and social connection.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> In addition, activation of EPAC1 suppresses inflammation <i>via</i> promoting the expression of the suppressor of cytokine signaling 3 (SOCS3) which blocks the interleukin-6 (IL-6)-induced Janus kinase (JAK)/signal transducer and activator of transcription 3 (STAT3) signaling pathway in vascular endothelial cells (VECs).<a onclick="showRef(event, 'ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38">(36−38)</a> EPAC1 can also exert anti-inflammatory activity by reducing the expression of inflammatory mediators including toll-like receptor 4 (TLR4), high-mobility group box 1 (HMGB1), tumor necrosis factor α (TNFα), and interleukin-1β (IL-1β) in human retinal endothelial cells (RECs).<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39,40)</a> Moreover, EPAC plays a crucial role in cardiac cell protection<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> and energy balance.<a onclick="showRef(event, 'ref28 ref42'); return false;" href="javascript:void(0);" class="ref ref28 ref42">(28,42)</a> Therefore, upregulating the activity of EPAC proteins may also offer an avenue for novel therapeutics, including drug addiction,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> hyperalgesia,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> cardiac and cardiovascular diseases,<a onclick="showRef(event, 'ref41 ref45'); return false;" href="javascript:void(0);" class="ref ref41 ref45">(41,45)</a> and inflammation.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><div class="NLM_p">Currently, most reported EPAC agonists are derived from cAMP (e.g., compounds <b>2</b><a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> and <b>4</b>,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a><a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> However, these cAMP-derived EPAC agonists suffer from off-target side effects or poor pharmacokinetic (PK) profiles, which limit the potential of these cAMP-derived EPAC agonists for further biological applications.<a onclick="showRef(event, 'ref10 ref46'); return false;" href="javascript:void(0);" class="ref ref10 ref46">(10,46)</a> Furthermore, cyclic phosphates afford limited potential for further synthetic modifications, limiting their potential as drug development candidates. Hence, potent and selective noncyclic nucleotide small-molecule EPAC agonists with drug-like properties are urgently needed.</div><div class="NLM_p">We have recently reported the first noncyclic nucleotide small-molecule EPAC1 partial agonist hits identified by screening the commercially available BioAscent Compound Cloud of 120,000 lead-like small molecules using a robust and sensitive fluorescence-based<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> high-throughput screening (HTS) assay.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Among these hits, compound <b>3</b> (I942, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) was identified and characterized as a novel noncyclic nucleotide small-molecule EPAC1 partial agonist with an IC<sub>50</sub> value of about 35 μM.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Moreover, compound <b>3</b> does not induce PKA activity and displays no autofluorescence over a broad range of concentrations. Ligand-observed NMR studies demonstrated that compound <b>3</b> selectively binds to the EPAC1 cAMP binding domain (CNBD). Further studies indicate that compound <b>3</b> promotes the activity of the EPAC1/Rap1 pathway in HEK293T cells and induces the expression of SOCS3 in VECs.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Additionally, compound <b>3</b> suppresses IL-6-stimulated vascular cell adhesion molecule 1 (VCAM1) protein expression <i>in cellulae</i>. Most recently, we reported the EPAC1 partial agonism mechanism of compound <b>3</b> by utilizing nuclear magnetic resonance (NMR) spectroscopy techniques to determine the key interactions between <b>3</b> and EPAC1 protein.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Therefore, compound <b>3</b> has been considered as a suitable hit for further hit-to-lead chemical optimization through rational drug design strategies to improve its binding and activation potencies as well as drug-like properties.</div><div class="NLM_p">Herein, we report our synthesis and pharmacological evaluation efforts using compound <b>3</b> as the lead compound with the aim of identifying novel potent noncyclic nucleotide small-molecule EPAC agonists as pharmacological tools to study the functions of EPAC and as potential drug candidates for the treatment of human diseases. In this work, we concentrated our efforts on the optimization of the naphthyloxy group (<b>P1</b>, highlighted in red, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) and the <i>N</i>-acylsulfonamide linker (<b>P2</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), as well as the <i>m</i>-xylyl group (<b>P3</b>, highlighted in blue, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), for systematic structure–activity relationship (SAR) studies.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Proposed structural modifications on <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21107" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21107" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthetic routes for these newly synthesized EPAC1 partial agonists are outlined in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<named-content content-type="anchor" rid="sch2" type="simple"></named-content><named-content content-type="anchor" rid="sch3" type="simple"></named-content><named-content content-type="anchor" rid="sch4" type="simple"></named-content><a class="ref internalNav" href="#sch5" aria-label="5">5</a>. We initially replaced the <i>m</i>-xylyl group of compound <b>3</b> with the 2,4,6-trimethylbenzene group to obtain the compound <b>9a</b>, and its synthetic procedure is depicted in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The intermediate <b>6</b> was obtained by the reaction of the starting material—2,4,6-trimethylbenzenesulfonyl chloride (<b>5</b>)—with NH<sub>3</sub>·H<sub>2</sub>O in THF. Coupling of intermediate <b>6</b> with commercially available 2-bromoacetyl bromide gave the intermediate <b>7</b>. Compound <b>9a</b> was produced via the substitution reaction of intermediate <b>7</b> with commercially available naphthalen-2-ol (<b>8a</b>) in the presence of K<sub>2</sub>CO<sub>3</sub> in a yield of 68%. Target compounds <b>9b–m</b> were designed by further modifications of compound <b>7</b> through the replacement of the <b>P1</b> moiety with various bicyclic or heterocyclic rings (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). These molecules were synthesized by the reaction of intermediate <b>7</b> with commercially available materials <b>8b–m</b> following a similar synthetic procedure to that of compound <b>9a</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>9a–m</b> with Modification on the <b>P1</b> Moiety<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NH<sub>4</sub>OH<sub>(aq)</sub>, THF, 0 °C to rt, overnight, 94%; (b) 2-bromoacetyl bromide, toluene, reflux, 5 h, 67%; and (c) <b>8a–m</b>, K<sub>2</sub>CO<sub>3</sub>, dry DMF, rt, overnight, 48–81%.</p></p></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>9n–s</b> with Modification on the <b>P1</b> Moiety<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaH, THF, rt, 0.5 h and then MOMCl, THF, rt, 2 h, 58–60%; (b) <i>n</i>-BuLi, THF, −78 °C, 0.5 h and then <i>N</i>-chlorosuccinimide, THF, −78 °C to rt, 16 h, 21–29%; (c) <i>n</i>-BuLi, THF, −78 °C, 0.5 h and then <i>N</i>-fluorobenzenesulfonimide, THF, −78 °C to rt, 16 h, 38%; (d) HCl<sub>(aq)</sub>, MeOH, 50 °C, 2 h, 86–95%; (e) <b>8n–s</b>, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 16 h and then NaOH<sub>(aq)</sub>, MeOH, rt, 3 h, 11–99%; (f) NH<sub>4</sub>OH<sub>(aq)</sub>, THF, rt, 16 h, 93%; and (g) EDCI, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 72 h, 16–88%.</p></p></figure><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>12a–g</b> with Modification on the <b>P2</b> Moiety<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaH, THF, 0 °C to rt, overnight, 40–76%; (b) <i>tert</i>-butyl (2-hydroxyethyl)carbamate or <i>tert</i>-butyl 4-hydroxypiperidine-1-carboxylate, PPh<sub>3</sub>, DEAD, THF, rt, overnight, 81–88%; (c) CF<sub>3</sub>COOH, CH<sub>2</sub>Cl<sub>2</sub>, rt, 5 h, quant; (d) <b>5</b>, NEt<sub>3</sub>, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 8 h, 91–92%; (e) ethyl 2-bromo-2-fluoroacetate, K<sub>2</sub>CO<sub>3</sub>, dry DMF, rt, overnight, 40%; (f) (i) LiOH, THF, H<sub>2</sub>O, rt, overnight; (ii) 4 N HCl, 76%; (g) <b>6</b>, EDCI, DAMP, DMF, rt, overnight, 86%; (h) 2-bromo-2-methylpropanoic acid, acetone, CHCl<sub>3</sub>, NaOH, reflux, 4 h, 22%; (i) EDCI, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 48 h, 8%; (j) 2-chloroethylamine hydrochloride, KOH, 3:1 PhMe/dioxane, reflux, 18 h, 57%; and (k) 2,4-dimethylbenzenesulfonyl chloride, CH<sub>2</sub>Cl<sub>2</sub>, rt, 20 min, 36%.</p></p></figure><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>25a–v</b> with Modification on the <b>P3</b> Moiety<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) methyl 2-bromoacetate, K<sub>2</sub>CO<sub>3</sub>, dry DMF, rt, overnight, 84–87%; (b) (i) LiOH, THF, H<sub>2</sub>O, rt, overnight; (ii) 4 N HCl, 86–88%; (c) substituted benzenesulfonamide, EDCI, DAMP, DMF, rt, overnight, 39–87%; (d) Pd/C, H<sub>2</sub>, MeOH, 50 °C, 3 h, 92–94%; and (e) for <b>25r–t</b>, R<sup>4</sup>B(OH)<sub>2</sub>, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, H<sub>2</sub>O, 110 °C, overnight, 63–79%; for <b>25u</b> and <b>25v</b>, R<sup>4</sup>H, Pd(OAc)<sub>2</sub>, XantPhos, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 100 °C, overnight, 50–72%.</p></p></figure><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compounds <b>25w–ad</b> with Modification on the <b>P3</b> Moiety<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NH<sub>4</sub>OH<sub>(aq)</sub>, THF, rt, 16 h, 51–96%; (b) PhB(OH)<sub>2</sub> or 3-furanylB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, reflux, 16 h, 81–93%; and (c) <b>23</b>, EDCI, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 48 h, 8–77%.</p></p></figure><div class="NLM_p">A smaller range of compound <b>3</b> analogues were designed to explore the <b>P1</b> moiety of compound <b>3</b> while retaining the <i>m</i>-xylyl group. These new molecules were synthesized <i>via</i> a slightly different route (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Halonaphthols <b>8n–p</b> were prepared from the corresponding bromonaphthols <i>via</i> an MOM-protection/lithiation-trapping/deprotection sequence. Then, a range of aryloxyacetic acids <b>10n–s</b> were prepared by the reaction of the corresponding arylalcohol <b>8</b> with ethylbromoacetate and K<sub>2</sub>CO<sub>3</sub> in acetone at reflux for 16 h, followed by a solvent swap to MeOH and hydrolysis using aqueous NaOH to give <b>10n–s</b> in 11–99% yield. The required sulfonylamide was synthesized by the reaction of 2,4-dimethylbenzenesulfonyl chloride <b>11</b> with aqueous ammonia in THF, giving the product in 93% yield. Finally, an EDCI-mediated amide coupling produced target compounds <b>9n–s</b> in 16–88% yield.</div><div class="NLM_p">As depicted in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, compounds <b>12a–g</b> were designed by replacing the <b>P2</b> moiety of compound <b>3</b> with different linkers to investigate the <b>P2</b> role in EPAC1 binding potency. Compounds <b>12a</b> and <b>12b</b> were obtained following a similar synthetic procedure to that of compound <b>9a</b> by the substitution reaction of intermediate <b>7</b> with compounds <b>13</b> and <b>14</b>, respectively. The intermediates <b>15</b> and <b>16</b> were produced <i>via</i> the Mitsunobu coupling reaction with compound <b>8a</b> as the starting reagent. Deprotection of intermediates <b>15</b> and <b>16</b> followed by coupling with <b>5</b> led to compounds <b>12c</b> and <b>12d</b>, respectively. Intermediate <b>17</b> was synthesized from compound <b>8a</b> and ethyl 2-bromo-2-fluoroacetate with K<sub>2</sub>CO<sub>3</sub> as the base. Hydrolysis of intermediate <b>17</b> under basic conditions yielded the key intermediate <b>18</b>, followed by the subsequent coupling with intermediate <b>6</b> leading to the final compound <b>12e</b> in a yield of 86%. <i>m</i>-Xylyl analogues <b>12f</b> and <b>12g</b> were also synthesized for direct comparison to <b>3</b>. Dimethylnaphthoxyacid <b>19</b> was synthesized <i>via</i> treatment of 2-naphthol with chloroform and acetone in the presence of sodium hydroxide, giving <b>19</b> in 22% after reflux for 4 h. Carbodiimide coupling with sulfonamide <b>11</b> then gave <b>12f</b> in 8% yield. Naphthoxyamine <b>20</b> was obtained from 2-naphthol after the reaction with 2-chloroethylamine in the presence of a base (KOH) in 57% yield, after which, the reaction with the required sulfonyl chloride gave <b>12g</b> in 36%.</div><div class="NLM_p">To extend the SARs, we designed another series of compounds with modifications to the <b>P3</b> moiety, as outlined in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. The intermediates <b>21</b> and <b>22</b> were synthesized from the corresponding compounds <b>8a</b> and <b>8e</b> and were further hydrolyzed into intermediates <b>23</b> and <b>24</b>, respectively. Compounds <b>25a–e</b>, <b>25g–h</b>, <b>25i–m</b>, and <b>25o–q</b> were obtained by the reaction of intermediates <b>23</b> and <b>24</b> with various commercially available substituted benzenesulfonamides following a similar preparation procedure to that of compound <b>12e</b>. Hydrogenation of compounds <b>25e</b> and <b>25m</b> produced compounds <b>25f</b> and <b>25n</b>, respectively. Compounds <b>25r–v</b> were prepared from compound <b>25j</b><i>via</i> the C–N coupling reaction under the palladium-catalyzed conditions.</div><div class="NLM_p last">Alternatively, a small range of additional analogues were prepared <i>via</i> a different synthetic route (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>); sulfonamides <b>26–27</b> were prepared from the corresponding sulfonyl chlorides by treatment with aqueous ammonia. Biarylsulfonamides <b>30</b> and <b>31</b> were prepared from a precursor bromosulfonamide <i>via</i> Suzuki–Miyaura coupling. Compounds <b>25w–ad</b> were then synthesized from naphthoxy acid <b>23</b> and the corresponding sulfonamides using carbodiimide coupling.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76504" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76504" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Biochemical Evaluation of EPAC1 Binding and SAR Studies</h3><div class="NLM_p">All the final target compounds have been evaluated for their binding to recombinant forms of either the isolated EPAC1 CNBD or a truncated version of the full-length protein that contains the CNBD but lacks the N-terminal DEP domain (EPAC1-ΔDEP) using a fluorescence-based competition assay,<a onclick="showRef(event, 'ref49 ref53'); return false;" href="javascript:void(0);" class="ref ref49 ref53">(49,53)</a> and screening hit <b>3</b> was used as the reference compound.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> EPAC binders compete with the fluorescent ligand 8-NBD-cAMP (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02094/suppl_file/jm9b02094_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S1)<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> and by displacing it from the protein binding pocket, they reduce its fluorescence. Therefore, relative fluorescence intensity (RFI, described in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>) is used to indicate the affinity of the final target compounds binding with EPAC1 and the results are shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<named-content content-type="anchor" rid="tbl2" type="simple"></named-content><named-content content-type="anchor" rid="tbl3" type="simple"></named-content><a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Hit compounds were subsequently tested for EPAC1 binding in a cell-based model, using EPAC1 immunoprecipitation (IP) with an activation-selective antibody (as described in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Sectio">Experimental Sectio</a>n). Compounds which interacted with EPAC1 in cells (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02094/suppl_file/jm9b02094_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S2) were chosen for further studies. We previously reported a series of 2,4,6-trimethylbenzenesulfonamide derivatives as potent and selective EPAC2 antagonists.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Therefore, compound <b>9a</b> was initially designed by replacing the <i>m</i>-xylyl group of compound <b>3</b> with the 2,4,6-trimethylbenzene group, assuming that it might enhance EPAC1 binding affinity. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, the results indicate that compound <b>9a</b> has a similar affinity for EPAC1 as compound <b>3</b>. Further modification of compound <b>9a</b> by changing the substituted position (<b>9b</b>), adding a nitrogen atom (<b>9c</b>), or appending an acetyl group (<b>9d</b>) onto the naphthalene ring showed no significant improvement on the binding potency compared to compound <b>3</b>. However, compound <b>9e</b>, with a methoxy substitution at the 7-position of the naphthalene ring of <b>9a</b>, exhibited about 1.7-fold improvement in binding potency, when compared to <b>9a</b>. Reduction of the naphthalene ring of <b>9a</b> to the tetrahydronaphthane ring (<b>9f</b>) or dihydroquinolin-2(1<i>H</i>)-one ring (<b>9g</b>) showed slightly decreased binding potency. However, replacement of the <b>P1</b> moiety with various bicyclic or heterocyclic rings (<b>9h–m</b>) resulted in a loss of the EPAC1 binding potency. These results suggest that the substitution position on the naphthalene ring of <b>9a</b> is very important for EPAC1 binding affinity. In addition, adding an electron-donating group to the 7-position on the naphthalene ring of <b>9a</b> benefits the EPAC1 affinity. However, replacing the naphthalene ring of <b>9a</b> with other bicyclic rings and heterocyclic rings was found unfavorable.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. EPAC Binding Affinities of Compounds <b>9a–m</b> with Modifications on the <b>P1</b> Moiety</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0019.gif" alt="" id="GRAPHIC-d7e1389-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0020.gif" alt="" id="gr19" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">The RFI values are the mean ± SEM of at least three independent experiments.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. EPAC1 Binding Activities of <i>m</i>-Xylyl Compounds <b>9n–s</b> with Modifications on the <b>P1</b> Moiety</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0021.gif" alt="" id="GRAPHIC-d7e1412-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0022.gif" alt="" id="gr20" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">The RFI values are the mean ± SEM of at least three independent experiments.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. EPAC1 Binding Activities of Compounds <b>12a–g</b> with Modification on the <b>P2</b> Moiety</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0023.gif" alt="" id="GRAPHIC-d7e1432-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0024.gif" alt="" id="gr21" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">The values are the mean ± SEM of at least three independent experiments.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. EPAC1 Binding Activities of Compounds <b>25a–25ad</b> with Modifications on the <b>P3</b> Moiety</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0025.gif" alt="" id="GRAPHIC-d7e1452-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">RFI (%)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25a</b></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">3,5-dimethylphenyl</td><td class="colsep0 rowsep0" align="left">38 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25b</b></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">2-fluorophenyl</td><td class="colsep0 rowsep0" align="left">69 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25c</b></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">3-fluorophenyl</td><td class="colsep0 rowsep0" align="left">82 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25d</b></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">4-fluorophenyl</td><td class="colsep0 rowsep0" align="left">81 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25e</b></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">3-fluoro-4-nitrophenyl</td><td class="colsep0 rowsep0" align="left">81 ± 8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25f</b></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">3-fluoro-4-aminophenyl</td><td class="colsep0 rowsep0" align="left">-</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25g</b></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">2,4-dimethoxyphenyl</td><td class="colsep0 rowsep0" align="left">23 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25h</b></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">2,5-dimethoxyphenyl</td><td class="colsep0 rowsep0" align="left">72 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25i</b></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">3,4-dimethoxyphenyl</td><td class="colsep0 rowsep0" align="left">50 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25j</b></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">3-bromo-5-methylphenyl</td><td class="colsep0 rowsep0" align="left">58 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25k</b></td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">3-bromo-5-methylphenyl</td><td class="colsep0 rowsep0" align="left">29 ± 8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25l</b></td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">3,5-dichlorophenyl</td><td class="colsep0 rowsep0" align="left">54 ± 6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25m</b></td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">2-methoxy-4-nitrophenyl</td><td class="colsep0 rowsep0" align="left">24 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25n</b></td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">2-methoxy-4-aminophenyl</td><td class="colsep0 rowsep0" align="left">7 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25o</b></td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">2,5-dimethxoylphenyl</td><td class="colsep0 rowsep0" align="left">49 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25p</b></td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">3,4-dimethoxyphenyl</td><td class="colsep0 rowsep0" align="left">23 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25q</b></td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">2-naphthyl</td><td class="colsep0 rowsep0" align="left">14 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25r</b></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">3-(5-fluoropyridin-3-yl)-5-methylphenyl</td><td class="colsep0 rowsep0" align="left">36 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25s</b></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">3-(furan-2-yl)-5-methylphenyl</td><td class="colsep0 rowsep0" align="left">40 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25t</b></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">3-methyl-5-(1-methyl-1<i>H</i>-pyrazol-5-ylphenyl</td><td class="colsep0 rowsep0" align="left">34 ± 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25u</b></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">3-methyl-5-(3-(trifluoromethyl)pyridin-2-yl)aminophenyl</td><td class="colsep0 rowsep0" align="left">56 ± 6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25v</b></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">3-methyl-5-(5-(trifluoromethyl)pyridin-2-yl)aminophenyl</td><td class="colsep0 rowsep0" align="left">20 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25w</b></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">4-methylphenyl</td><td class="colsep0 rowsep0" align="left">44 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25x</b></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">3-nitrophenyl</td><td class="colsep0 rowsep0" align="left">67 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25y</b></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">phenyl</td><td class="colsep0 rowsep0" align="left">49 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25z</b></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">3-methoxyphenyl</td><td class="colsep0 rowsep0" align="left">33 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25aa</b></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">cyclohexyl</td><td class="colsep0 rowsep0" align="left">81 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25ab</b></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">3-(3-furanyl)phenyl</td><td class="colsep0 rowsep0" align="left">53 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25ac</b></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">3-biphenyl</td><td class="colsep0 rowsep0" align="left">35 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25ad</b></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">methyl 3-benzoyl</td><td class="colsep0 rowsep0" align="left">71 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">2,4-dimethylphenyl</td><td class="colsep0 rowsep0" align="left">61 ± 3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">The values are the mean ± SEM of at least three independent experiments. “-” means not detected.</p></div></div></div><div class="NLM_p">A further short series of compounds exploring the <b>P1</b> moiety was prepared and tested for their interaction with the EPAC1 CNBD while maintaining the <i>m</i>-xylyl ring of <b>3</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Thus, chloro- and fluoro-naphthyl analogues <b>9n–p</b>, <b>9q</b>, and <b>3</b> were found to display similar affinity. Finally, we explored ether-linked heterocyclic <b>P1</b> moieties, but unfortunately, indolyl (<b>9r</b>) and indazolyl (<b>9s</b>) analogues did not appear to displace 8-NBD-cAMP from the CNBD binding site.</div><div class="NLM_p">To further explore the SAR of the <b>P2</b> moiety of <b>9a</b>, compounds <b>12a–g</b> were synthesized to probe the impact of a linker on EPAC binding (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Interestingly, all these interventions (with the exception of <b>12e</b>) were found to completely inhibit EPAC binding potency, even in the case of replacing the oxygen atom with its bioisostere sulfur atom (<b>12a</b>). Increased <b>P2</b> steric bulk (<b>12d</b> and <b>12f</b>) as well as a significant reduction in the pKa of the <b>3</b><i>N</i>-acylsulfonamide proton (<b>12c</b>, <b>12d</b>, and <b>12g</b>) resulted in a partial or complete loss of binding activity, in line with our previously postulated binding modes,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> which suggest that the acidic <i>N</i>-acylsulfonamide motif of <b>3</b> occupies a similar volume to cAMP and that the oxymethylene unit threads a narrow solvent channel.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> These findings suggest that significant modifications on the <b>P2</b> moiety of <b>9a</b> are not amenable for EPAC binding enhancement.</div><div class="NLM_p">As listed in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, a series of benzenesulfonamide derivatives with different substitution patterns and electronic properties were synthesized to explore the importance of the <b>P3</b> moiety for EPAC1 binding affinity. Moving the dimethyl group from the 2,4-position to the 3,5-position, an increase of about 1.6-fold in binding potency was observed (<b>25a</b><i>vs</i><b>3</b>). Adding electron-withdrawing groups was not tolerated and decreased the binding potency (<b>3</b><i>vs</i><b>25b</b>, <b>25c</b> and <b>25d</b>), while sterically similar benzenesulfonamide derivatives with electron-donating substitutes were also investigated (<b>3</b><i>vs</i><b>25g</b>, <b>25h</b>, and <b>25i</b>). We found that compound <b>25g</b> was much more potent than the screening hit (<b>3</b>) with an IC<sub>50</sub> of 4.8 μM for EPAC1-CNBD and an IC<sub>50</sub> of 4.9 μM for EPAC1-ΔDEP (aa. 149–881; <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). As shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, adding an electron-donating substitute at the 7-position on the naphthalene ring could improve the binding potency and this conclusion was further validated by comparing <b>25k</b> with <b>25j</b>. Having identified that the electron-donating substitutes at the 7-position on the naphthalene ring and benzenesulfonamide maintain good binding potency, we then designed a series of compounds with electron-donating substitutes on both sides (<b>25k–p</b>), all of which displayed increased binding potency. Compound <b>25n</b> was shown to be the best compound among this series with IC<sub>50</sub> values reaching sub-micromolar binding potency for both the EPAC1-CNBD and EPAC1-ΔDEP (IC<sub>50</sub> = 0.9 μM and IC<sub>50</sub> = 0.6 μM, respectively, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Interestingly, compound <b>25q</b> with naphthalene rings on both sides also displays significantly enhanced binding potency, with EPAC1-CNBD binding potency (IC<sub>50</sub> = 2.2 μM, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>) at the single digit micromolar level and EPAC1-full activity achieved sub-micromolar binding potency (IC<sub>50</sub> = 0.5 μM, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). This result suggests that substituents with larger size (e.g., pyridine ring) on the benzenesulfonamide may be tolerated. For additional SAR studies, we added a heterocyclic or phenyl ring onto the benzene ring of <b>3</b> with or without substitutes leading to compounds <b>25r–v</b>, <b>25ab</b>, and <b>25ac</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). As expected, the binding potency of these compounds increased by adding the heterocyclic ring on the benzene ring of <b>3</b>. Especially, compound <b>25u</b> exhibited about twofold higher binding potency than the lead compound <b>3</b>, with EPAC1-CNBD binding potency (IC<sub>50</sub> = 4.6 μM, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>) at the single digit micromolar level. Altogether, compounds with electron-donating substituents at the benzene ring of <b>3</b> exhibited more favorable binding properties than compounds with electron-withdrawing groups. We also investigated nonaromatic analogues of the <b>3</b><i>m</i>-xylyl ring (<b>25aa</b>); replacement with a cyclohexyl ring resulted in a complete loss of affinity. Meanwhile, an additional electron-donating substituent at the 7-position on the naphthalene ring of <b>3</b> further improved the binding potency. Moreover, compounds which have naphthalene rings on both sides or a heterocyclic ring substituent on the benzene ring showed positive results for the binding potency improvement.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0007.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Relative binding affinity of selected hit compounds, in comparison with hit <b>3</b>, was tested using the 8-NBD-cAMP competition assay. (A) Dose–response curves of the selected compounds (<b>3</b>, <b>25g</b>, <b>25q</b>, and <b>25n</b>) for EPAC1-CNBD binding affinity. (B) Dose–response curves of selected compounds (<b>3</b>, <b>25u</b>, <b>25e</b>, and <b>25f</b>) for EPAC1-CNBD binding affinity. (C) Representative dose–response curves for EPAC1-ΔDEP binding affinity. The data are the mean ± SEM of at least three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. IC<sub>50</sub> Values of Selected EPAC1 Activators for EPAC1-CNBD and EPAC1-ΔDEP</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">EPAC1-CNBD</th><th class="rowsep1 colsep0" colspan="2" align="center">EPAC1-ΔDEP</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">significance in comparison to <b>3</b></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">significance in comparison to <b>3</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b><sup>A/C</sup></td><td class="colsep0 rowsep0" align="left">12.0 ± 1.1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">6.7 ± 1.5</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25g</b></td><td class="colsep0 rowsep0" align="left">4.8 ± 0.4</td><td class="colsep0 rowsep0" align="left">***</td><td class="colsep0 rowsep0" align="left">4.9 ± 1.1</td><td class="colsep0 rowsep0" align="left">ns</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25q</b></td><td class="colsep0 rowsep0" align="left">2.2 ± 0.2</td><td class="colsep0 rowsep0" align="left">***</td><td class="colsep0 rowsep0" align="left">0.5 ± 0.1</td><td class="colsep0 rowsep0" align="left">**</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25n</b></td><td class="colsep0 rowsep0" align="left">0.9 ± 0.1</td><td class="colsep0 rowsep0" align="left">***</td><td class="colsep0 rowsep0" align="left">0.6 ± 0.1</td><td class="colsep0 rowsep0" align="left">**</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b><sup>B</sup></td><td class="colsep0 rowsep0" align="left">9.2 ± 0.7</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25u</b></td><td class="colsep0 rowsep0" align="left">4.6 ± 0.4</td><td class="colsep0 rowsep0" align="left">ns</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25e</b></td><td class="colsep0 rowsep0" align="left">32.5 ± 2.3</td><td class="colsep0 rowsep0" align="left">***</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25f</b></td><td class="colsep0 rowsep0" align="left">-</td><td class="colsep0 rowsep0" align="left">-</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">The values are the mean ± SEM of at least three independent experiments. Significance in comparison to compound <b>3</b> was determined by one-way ANOVA with Tukey posthoc test; **<i>p</i> < 0.01, ***<i>p</i> < 0.001. The data are from two separate experiments, resulting in small variations in the IC<sub>50</sub> values obtained for <b>3</b>, with A/C corresponding to <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A,C and B to <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B. “ND” means not detected, “ns” means not significant, and “-” means its fluorescent properties interfere with the assay at higher compound concentrations; therefore, a proper dose–response curve cannot be obtained.</p></div></div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Potential of Newly Discovered EPAC1 Binders to Activate EPAC1 and EPAC2</h3><div class="NLM_p">Given the improved affinity of <b>25g</b>, <b>25q</b>, and <b>25n</b> for EPAC1 observed in the 8-NBD-cAMP competition assay, we next investigated their ability to activate EPAC1 in <i>in vitro</i> GEF assays (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). The assay is based on a decay of fluorescence caused by EPAC-stimulated dissociation of fluorescent MANT-GDP from Rap1 in the presence of excess nonfluorescent nucleotides. The time dependency of the fluorescence signal can be fitted as single exponential decay and the obtained rate constant (<i>k</i><sub>obs</sub>) is a measure of EPAC activity.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> To monitor agonistic and antagonistic properties of the compounds, EPAC1 activity was measured in the presence of either 500 μM cAMP or 500 μM compound, or 500 μM cAMP and 500 μM compound. This concentration of cAMP is saturating and thus the maximum cAMP-induced EPAC activity is observed. If applied alone, <b>25g</b> and <b>25n</b> induced about 2% of the cAMP activity (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A,B). If applied in combination with cAMP, cAMP-induced activity is reduced (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A,B), indicating that <b>25g</b> and <b>25n</b> interact with the cAMP-binding pocket. If <b>25q</b> was applied at as high as 500 μM, unspecific effects were observed, which likely originated from a combination of protein and compound aggregation. Insufficient solubility in aqueous solution would be in agreement with the hydrophobic nature of the naphthalene group in <b>25q</b>. To further characterize the compounds, the concentration dependency of induced EPAC activity was analyzed (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C). From these data, the concentration of half maximal activity was estimated to be about 5 μM for <b>25g</b>, <b>25n</b>, and <b>25q</b>. In these experiments, it was also shown that <b>25q</b> could be applied to a concentration of up to 100 μM and induces activity to a similar extent as <b>25g</b> and <b>25n</b>. Compound <b>25q</b> is thus an activator of EPAC1 as well.</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0008.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Ability of compounds <b>25g</b>, <b>25n</b>, and <b>25q</b> to promote EPAC1 GEF activity <i>in vitro</i>. The figure shows relative fluorescence from EPAC1 activation assays (on left) and rate constants (<i>k</i><sub>obs</sub>) as bar graphs (on right) with 500 μM cyclic AMP, in the presence or absence of 500 μM <b>25g</b> (A) or <b>25n</b> (B), respectively. (C) Dose dependency of EPAC1 <i>k</i><sub>obs</sub> on the concentration of <b>25n</b> (open circles), <b>25n</b> (closed triangles), or <b>25q</b> (closed squares).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Activation of Cellular EPAC1</h3><div class="NLM_p">We next used cells expressing EPAC1 to determine if compounds <b>25g</b>, <b>25n</b>, and <b>25q</b> can activate cellular EPAC activity, by measuring the nucleotide-loading state of Rap1 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). In these assays, we used a selective binding protein to isolate active, GTP-bound Rap1 from cell extracts, which was demonstrated by western blotting as described in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>. Experiments were carried out in the presence of the EPAC1-selective cAMP analogue <b>2</b> to determine whether <b>25g</b>, <b>25n</b>, and <b>25q</b> acted as agonists or partial agonists in cells. Experiments revealed that compounds <b>25g</b> and <b>25n</b> enhanced, as opposed to inhibited, activation of EPAC1 by compound <b>2</b>, indicating that they are acting as agonists rather than partial agonists in cells (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Together, these results indicate that <b>25g</b>, <b>25n</b>, and <b>25q</b> bind strongly to EPAC1 in binding assays and activate EPAC1 in cells.</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0009.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Ability of compounds <b>25g</b>, <b>25q</b>, and <b>25n</b> to promote cellular EPAC1 activity in the presence of the EPAC1 agonist, compound <b>2</b>. U2OS cells stably transfected with EPAC1 were stimulated with the indicated compounds (as described in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>). Active, GTP-bound Rap1 was pulled down from cell lysates and its levels were visualized by western blotting and quantified densitometrically. Data from at least three independent experiments presented as mean ± SEM with significant increases in Rap1-GTP levels in comparison with cells treated with <b>2</b> being indicated; *<i>p</i> < 0.05 and **<i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Series Expansion and EPAC1 Versus EPAC2 Selectivity</h3><div class="NLM_p">Given the limited ability of compounds <b>25g</b>, <b>25n</b>, and <b>25q</b> to activate EPAC1 in the <i>in vitro</i> GEF assay (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), we decided to use the GEF assay to further screen all newly synthesized analogues at 10 μM to see if we could identify additional activating compounds to expand the series of EPAC1 agonists (<named-content content-type="anchor" rid="fig6" type="simple"></named-content><a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). Using this approach, we identified three additional compounds, <b>25e</b>, <b>25f</b>, and <b>25u</b>, that appeared to promote EPAC1 activity more effectively than <b>25g</b>, <b>25n</b>, and <b>25q</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>) and were unable to activate PKA (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). Having now identified an expanded series of compounds as potential EPAC1 activators, we next compared the ability of <b>25e</b>, <b>25f</b>, <b>25g</b>, <b>25n</b>, and <b>25u</b> to activate EPAC1 and EPAC2 in cellular Rap1 activation assays (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). For these, we used U2OS cells transfected with either EPAC1 or EPAC2. From these assays, we found that all compounds in the series induced Rap1 activation in EPAC1 cells, with compounds <b>25e</b> and <b>25u</b> promoting levels of activation roughly equivalent to the positive control, compound <b>3</b> (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). Densitometry was carried out on all immunoblots and the ratio of EPAC1 to EPAC2 activation was calculated and presented in a bar graph in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>. Results demonstrated that compounds <b>25e</b> and <b>25f</b> exhibited the best selectivity, in terms of their ability to activate EPAC1 over EPAC2.</div><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0010.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. PKA activation results of representative newly discovered EPAC1 agonists. U2OS cells stably transfected with EPAC1 were treated with 100 μM test compounds, cyclic nucleotide EPAC1 agonist <b>2</b> or 10 μM forskolin and rolipram (F/R), cyclic AMP elevating agents, as a positive control. Active, phosphorylated VASP (P-VASP) was visualized using a phosphospecific, anti-VASP antibody. None of the tested compounds promoted VASP phosphorylation in cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0011.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Identification of compounds <b>25e</b>, <b>25f</b>, and <b>25u</b> as EPAC1 activators in an <i>in vitro</i> GEF screen. The figure demonstrates relative fluorescence from EPAC1 activation assays with 10 μM of all synthesized compounds. Selected compounds have been highlighted as indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0012.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Ability of compounds <b>25e</b>, <b>25f</b>, <b>25g</b>, <b>25q</b>, <b>25n</b>, and <b>25u</b> to promote EPAC1 and EPAC2 activity in cells. U2OS cells stably transfected with EPAC1 or EPAC2 were stimulated with the indicated compounds. Cyclic nucleotide EPAC1 and EPAC2 agonist 007 and S-220, respectively (<b>2</b> and <b>4</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), were used as positive controls. Active, GTP-bound Rap1 was pulled down from cell lysates and its levels were visualized by western blotting. Experiments were carried out on at least three separate occasions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig9" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0013.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Immunoblots in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a> were quantified densitometrically and the data from at least three independent experiments are presented here as mean ± SEM with significant increases in Rap1-GTP levels in EPAC1-expressing cells relative to EPAC2-expressing cells being indicated; **<i>p</i> < 0.01. Red bars indicate separate, not additive, percentages of Rap1 activation for EPAC2 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> PKA and GPCR Selectivity</h3><div class="NLM_p last">To investigate the EPAC selectivity of these EPAC agonists, compounds (<b>25e</b>, <b>25f</b>, <b>25g</b>, <b>25n</b>, <b>25q</b>, and <b>25u</b>) were selected for further PKA activation studies, and the results are shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>. PKA activation was assessed by monitoring the phosphorylation state of a downstream PKA effector, vasodilator-stimulated phosphoprotein (VASP). In western blot studies, these six compounds did not induce any PKA activation. This result suggests that our newly designed EPAC agonists have excellent EPAC/PKA selectivity, without potential PKA activation side effects. Additionally, compounds <b>25n</b> and <b>25q</b> were further chosen for the counter screening study of over 40 GPCR targets.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a><i>In vitro</i> functional selectivity profiles of compounds <b>25g</b>, <b>25n</b>, and <b>25q</b> were investigated for their affinity across a broad panel of over 40 GPCR proteins (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02094/suppl_file/jm9b02094_si_001.pdf" class="ext-link">Supporting Information</a>, Table S1), indicating that these EPAC agonists are highly specific and none of them displays the potential off-target effects toward these tested GPCR proteins.</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Regulation of EPAC1-Mediated Cell Signaling</h3><div class="NLM_p">We have previously shown that activation of EPAC1 by compound <b>3</b> in human umbilical vein endothelial cells (HUVECs) inhibits activation of the proinflammatory transcription factor STAT3 by the cytokine IL-6, resulting in the inhibition of monocyte adhesion to the cell surface adhesion molecule VCAM1.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Given their effectiveness as activators of cellular EPAC1 (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>), we next tested the ability of compounds <b>25e</b>, <b>25f</b>, <b>25n</b>, and <b>25u</b> to affect IL-6 signaling in HUVECs. We used western blotting to determine if treatment of HUVECs inhibited IL-6 signaling through the STAT3, ERK, and AKT signaling pathways (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a> and <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>) and any resulting effect on downstream expression of the cell adhesion molecules VCAM1, ICAM1, or SELE (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a> and <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>). Of the <b>4</b> compounds tested, we found that <b>25u</b> was very effective at inhibiting IL-6-activated STAT3 (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a> and <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>) and VCAM1, but not SELE or ICAM1 (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a> and <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>), achieving levels of inhibition greater than compound <b>3</b>. Interestingly, both compound <b>3</b> and <b>25u</b> also promoted AKT, but not ERK, activation in HUVECs. Compounds <b>25e</b>, <b>25f</b>, and <b>25n</b> were found to be largely inactive in HUVECs.</div><figure id="fig10" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0002.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Effects of the selected compounds on IL-6-promoted signaling in HUVECs. HUVECs were preincubated with 100 μM of the indicated compounds for 30 min and then stimulated with IL-6 (5 ng/mL) plus sIL6Rα (25 ng/mL) for 5 h. Cell extracts were then prepared and immunoblotted with antibodies to phosphorylated and nonphosphorylated forms of STAT3, ERK, and AKT, as indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig11" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0003.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Compounds <b>3</b> and <b>25u</b> inhibit IL-6-promoted STAT3 and promote AKT signaling in HUVECs. Densitometric values from three separate immunoblots from <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a> are shown, with significant decreases in STAT3 phosphorylation being indicated; <sup>#</sup><i>p</i> < 0.05 and <sup>##</sup><i>p</i> < 0.01, relative to IL-6-stimulated cells. Significant increases in STAT3 and AKT activation, relative to vehicle-stimulated (veh.) cells, are also indicated; *<i>p</i> < 0.05, **<i>p</i> < 0.01, and ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig12" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0004.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Effects of the selected compounds on IL-6-promoted adhesion molecule expression in HUVECs. HUVECs were preincubated with 100 μM of the indicated compounds for 30 min and then further incubated with IL-6 (5 ng/mL) plus sIL6Rα (25 ng/mL) for 5 h. Cell extracts were then prepared and immunoblotted with antibodies to either VCAM1, ICAM1, or SELE, as indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig13" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0005.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Capability of the selected compounds to inhibit IL-6-promoted VCAM1 induction in HUVECs. Densitometric values from three separate immunoblots from <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a> are shown, with significant decreases in VCAM1 expression being indicated; <sup>#</sup><i>p</i> < 0.05, relative to IL-6-stimulated cells. Significant increases in VCAM1 expression, relative to vehicle-stimulated (veh.) cells, are also indicated; *<i>p</i> < 0.05. Changes that were not statistically significant are indicated (ns).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76056" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76056" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, a series of substituted 2-(naphthalen-2-yloxy)-<i>N</i>-(phenylsulfonyl)acetamide derivatives that exhibit improved binding potency for EPAC1 protein was designed <i>via</i> systematic modifications on different moieties of the hit compound: <b>P1</b>, <b>P2</b>, and <b>P3</b>. Our SAR studies were initiated by replacing the <b>P1</b> moiety with various bicycle rings or adding substitutes on the <b>P1</b> region, indicating that the naphthalene ring is important for EPAC1 binding and an additional electron-donating substitute at the 7-position on naphthalene (<b>P1</b> moiety) can improve the binding. It was found that modifications of the linker (<b>P2</b> moiety) are not tolerable, suggesting that the linker plays a critical role for affinity. Moreover, results of further optimizations on the <b>P3</b> moiety indicate that substituents with electron-donating groups are more favorable than electron-withdrawing groups and replacing the <b>P3</b> moiety with higher π-conjugated systems also leads to increased EPAC1 potency. Compounds <b>25g</b> (<b>PW0381</b>), <b>25n</b> (<b>PW0577</b>), and <b>25q</b> (<b>PW0521</b>) have been identified as the most potent EPAC1 binders in this series, with IC<sub>50</sub> values ranging from low micromolar to sub-micromolar level. Further screening, using the EPAC1 GEF assay, identified three additional active compounds <b>25u</b> (<b>PW0606</b>), <b>25e</b> (<b>PW0624</b>), and <b>25f</b> (<b>PW0625</b>). In U2OS cells, all compounds induce EPAC1 but not EPAC2 or PKA activity. This is remarkable, as the EPAC1 agonistic effect <i>in vitro</i> is in the region of 2% of that of cAMP. This may suggest that in cells, the activation equilibrium of EPAC1 is further modulated, for example, by additional protein interactions. Moreover, compound <b>25u</b> was found to effectively block proinflammatory IL-6 signaling to VCAM1 induction through inhibition of STAT3 activation. In this case, <b>25u</b> was found to be much more active than the known EPAC1 activator, compound <b>3</b> (<b>I942</b>). Taken together, these noncyclic nucleotide small molecule EPAC1 agonists may serve as useful pharmacological tools for the studies of EPAC functions, or in the case of <b>25u</b>, the potential drug leads for the treatment of a wide range of human diseases. Further structural optimization based upon the identified advanced leads and the relevant SAR findings and the <i>in vivo</i> studies of selected EPAC agonists in various human disease models are currently underway.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74881" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74881" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General</h3><div class="NLM_p">All commercially available starting materials and solvents were of reagent grade and used without further purification. Pooled HUVEC and endothelial cell growth medium (EGM) were purchased from Lonza (Basel, Switzerland). Antibodies to EPAC1 (5D3), Rap1, phospho-CREB (Ser 133), STAT3/phospho-STAT3 (Tyr 705), ICAM1, and VCAM1 were obtained from Cell Signaling Technology. (Massachusetts, US). Antibodies to E-selectin (SELE) were from Bio-Techne (Abingdon, UK). The SuperSignal West Pico chemiluminescent substrate was from Fisher Scientific (Loughborough, UK). Secondary antibodies, anti-rabbit-IgG horseradish peroxidase, anti-goat-IgG horseradish peroxidase, and anti-mouse-IgG horseradish peroxidase conjugates were from Sigma-Aldrich Company Ltd. (Dorset, England). Recombinant human IL-6 protein and recombinant human-soluble IL-6 receptor α (sIL6Rα) proteins were purchased from R and D Systems (Abingdon, UK).</div><div class="NLM_p last">Chemical reactions were performed under a nitrogen atmosphere in dry glassware with magnetic stirring. Preparative column chromatography was performed using silica gel 60, particle size 0.063–0.200 mm (70–230 mesh, flash). Analytical TLC was carried out employing silica gel 60 F254 plates (Merck, Darmstadt). Visualization of the developed chromatograms was performed with detection by UV (254 nm). NMR spectra were recorded on a Bruker-600 or AV300 (<sup>1</sup>H, 300 MHz; <sup>13</sup>C, 75.5 MHz) or Bruker AV400 (<sup>1</sup>H, 400 MHz, <sup>13</sup>C, 101 MHz) spectrometer. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded with TMS as an internal reference or referenced to a solvent. Chemical shifts downfield from TMS were expressed in ppm, and <i>J</i> values were given in Hz. High-resolution mass spectra (HRMS) were obtained from a Thermo Fisher LTQ Orbitrap Elite mass spectrometer or from the EPSRC UK National Mass Spectrometry Facility at Swansea University. Parameters include the following: nano ESI spray voltage was 1.8 kV, capillary temperature was 275 °C, and the resolution was 60,000; ionization was achieved by the positive mode. Purity of final compounds was determined by analytical HPLC, which was carried out on a Shimadzu HPLC system (model: CBM-20A LC-20AD SPD-20A UV/vis). HPLC analysis conditions: Waters μBondapak C18 (300 mm × 3.9 mm), flow rate 0.5 mL/min, UV detection at 270 and 254 nm, and linear gradient from 10% acetonitrile in water (0.1% TFA) to 100% acetonitrile (0.1% TFA) in 20 min, followed by 30 min of the last-named solvent. All biologically evaluated compounds are >95% pure. Compounds <b>6</b>, <b>11</b>, <b>16</b>, <b>21</b>, <b>23</b>, <b>27</b>, <b>28</b>, <b>29</b>, and <b>10r</b> were resynthesized in-house following reported synthetic procedures.<a onclick="showRef(event, 'ref56 ref57 ref58 ref59 ref60 ref61 ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref56 ref57 ref58 ref59 ref60 ref61 ref62 ref63">(56−63)</a></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 2-Bromo-<i>N</i>-(Mesitylsulfonyl)acetamide (<b>7</b>)</h3><div class="NLM_p last">Compound <b>6</b> (1.0 g, 5 mmol) was dissolved in 25 mL of dry toluene and stirred at room temperature. Bromoacetyl bromide (1.7 mL, 20 mmol) was added dropwise to the reaction mixture and it was stirred at reflux for 5 h. After 5 h, the reaction mixture was cooled to room temperature and then placed on an ice. The product was crystallized out of toluene and was collected by vacuum filtration and rinsed with cold toluene. Compound <b>7</b> was obtained as a gray solid (1.1 g, 67%). <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>): δ 7.05 (d, <i>J</i> = 0.6 Hz, 2H), 3.81 (s, 2H), 2.69 (s, 6H), 2.33 (s, 3H).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>N</i>-(Mesitylsulfonyl)-2-(naphthalen-2-yloxy)acetamide (<b>9a</b>)</h3><div class="NLM_p last">To a solution of <b>7</b> (64 mg, 0.2 mmol) in dry DMF (1 mL) was added K<sub>2</sub>CO<sub>3</sub> (55 mg, 0.4 mmol) and naphthalen-2-ol (29 mg, 0.2 mmol). The mixture was stirred at room temperature overnight, added with 5 mL of water, and then extracted with EtOAc (10 mL × 3). The combined EtOAc extracts were successively washed with brine and then dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to the residue. This residue was further purified by preparative TLC plates (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 50:1) to produce compound <b>9a</b> as a white solid (49 mg, 68%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 9.14 (s, 1H), 7.82 (d, <i>J</i> = 8.5 Hz, 2H), 7.65 (d, <i>J</i> = 8.0 Hz, 1H), 7.54–7.39 (m, 2H), 7.20 (dd, <i>J</i> = 9.0, 2.6 Hz, 1H), 7.00 (d, <i>J</i> = 2.6 Hz, 1H), 6.91 (s, 2H), 4.59 (s, 2H), 2.61 (s, 6H), 2.32 (s, 3H). <sup>13</sup>C NMR (75 MHz, chloroform-<i>d</i>): δ 166.8, 154.4, 144.0, 140.7, 134.1, 132.1, 132.0, 130.3, 129.7, 127.7, 127.0, 126.8, 124.7, 117.9, 107.6, 67.3, 23.0, 21.1. HRMS (ESI): calcd for C<sub>21</sub>H<sub>21</sub>NO<sub>4</sub>SNa, 406.1089 (M + Na)<sup>+</sup>; found, 406.1068.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>N</i>-(Mesitylsulfonyl)-2-(naphthalen-1-yloxy)acetamide (<b>9b</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>9a</b>, compound <b>9b</b> was obtained as a white solid (48 mg, 67%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 9.07 (s, 1H), 8.27–8.14 (m, 1H), 7.93–7.82 (m, 1H), 7.67–7.52 (m, 3H), 7.34 (t, <i>J</i> = 8.0 Hz, 1H), 6.99 (s, 2H), 6.69 (d, <i>J</i> = 7.7 Hz, 1H), 4.68 (s, 2H), 2.64 (s, 6H), 2.34 (s, 3H). <sup>13</sup>C NMR (75 MHz, chloroform-<i>d</i>): δ 166.8, 152.3, 144.0, 140.7, 134.7, 132.1, 127.9, 127.0, 126.2, 125.4, 125.0, 122.7, 121.0, 105.9, 67.8, 22.67, 21.1. HRMS (ESI): calcd for C<sub>21</sub>H<sub>21</sub>NO<sub>4</sub>SNa, 406.1089 (M + Na)<sup>+</sup>; found, 406.1068.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>N</i>-(Mesitylsulfonyl)-2-(quinolin-7-yloxy)acetamide (<b>9c</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>9a</b>, compound <b>9c</b> was obtained as a white solid (38 mg, 48%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 8.87 (dd, <i>J</i> = 4.5, 1.7 Hz, 1H), 8.12 (dd, <i>J</i> = 8.2, 1.7 Hz, 1H), 7.76 (d, <i>J</i> = 9.0 Hz, 1H), 7.40–7.31 (m, 2H), 7.26 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H), 6.95 (s, 2H), 6.35 (s, 1H), 4.64 (s, 2H), 2.68 (s, 6H), 2.31 (s, 3H). <sup>13</sup>C NMR (75 MHz, chloroform-<i>d</i>): δ 166.3, 157.4, 150.8, 149.1, 144.0, 140.6, 136.0, 132.1, 129.6, 124.4, 119.9, 119.0, 108.9, 67.1, 22.7, 21.1. HRMS (ESI): calcd for C<sub>20</sub>H<sub>20</sub>N<sub>2</sub>O<sub>4</sub>SNa, 407.1041 (M + Na)<sup>+</sup>; found, 407.1025.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 2-((1-Acetylnaphthalen-2-yl)oxy)-<i>N</i>-(mesitylsulfonyl)acetamide (<b>9d</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>9a</b>, compound <b>9d</b> was obtained as a white solid (52 mg, 61%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 10.33 (s, 1H), 7.96–7.85 (m, 2H), 7.73 (dd, <i>J</i> = 8.4, 1.1 Hz, 1H), 7.60 (ddd, <i>J</i> = 8.4, 6.8, 1.4 Hz, 1H), 7.50 (ddd, <i>J</i> = 8.1, 6.8, 1.3 Hz, 1H), 7.15 (d, <i>J</i> = 9.1 Hz, 1H), 6.92 (s, 2H), 4.69 (s, 2H), 2.77 (s, 3H), 2.61 (s, 6H), 2.29 (s, 3H). <sup>13</sup>C NMR (75 MHz, chloroform-<i>d</i>): δ 205.5, 150.4, 143.6, 140.7, 132.4, 131.9, 130.5, 130.0, 129.7, 128.6, 128.3, 126.5, 125.4, 123.7, 113.8, 68.7, 32.9, 22.5, 21.0. HRMS (ESI): calcd for C<sub>23</sub>H<sub>23</sub>NO<sub>5</sub>SNa, 448.1195 (M + Na)<sup>+</sup>; found, 448.1180.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>N</i>-(Mesitylsulfonyl)-2-((7-methoxynaphthalen-2-yl)oxy)acetamide (<b>9e</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>9a</b>, compound <b>9e</b> was obtained as a white solid (46 mg, 56%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 9.06 (s, 1H), 7.72 (t, <i>J</i> = 8.6 Hz, 2H), 7.09 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 7.04 (dd, <i>J</i> = 8.9, 2.6 Hz, 1H), 6.96 (dd, <i>J</i> = 9.4, 2.6 Hz, 2H), 6.92 (s, 2H), 4.58 (s, 2H), 3.92 (s, 3H), 2.61 (s, 6H), 2.31 (s, 3H). <sup>13</sup>C NMR (75 MHz, chloroform-<i>d</i>): δ 166.8, 158.6, 155.0, 143.9, 140.7, 135.6, 132.0, 130.0, 129.2, 125.1, 117.3, 115.1, 107.0, 105.5, 67.3, 55.3, 22.7, 21.0. HRMS (ESI): calcd for C<sub>22</sub>H<sub>23</sub>NO<sub>5</sub>SNa, 436.1195 (M + Na)<sup>+</sup>; found, 436.1175.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>N</i>-(Mesitylsulfonyl)-2-((5,6,7,8-tetrahydronaphthalen-2-yl)oxy)acetamide (<b>9f</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>9a</b>, compound <b>9f</b> was obtained as a white solid (42 mg, 54%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 9.01 (s, 1H), 7.05–6.96 (m, 3H), 6.65 (dd, <i>J</i> = 8.4, 2.8 Hz, 1H), 6.56 (d, <i>J</i> = 2.7 Hz, 1H), 4.43 (s, 2H), 2.72 (d, <i>J</i> = 5.4 Hz, 4H), 2.66 (s, 6H), 2.33 (s, 3H), 1.87–1.74 (m, 4H), 1.58 (s, 4H). <sup>13</sup>C NMR (75 MHz, chloroform-<i>d</i>): δ 167.0, 154.3, 143.9, 140.7, 138.9, 132.0, 131.7, 130.4, 114.5, 112.4, 67.4, 29.6, 28.6, 23.2, 23.0, 22.7, 21.1. HRMS (ESI): calcd for C<sub>21</sub>H<sub>25</sub>NO<sub>4</sub>SNa, 410.1402 (M + Na)<sup>+</sup>; found, 410.1386.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>N</i>-(Mesitylsulfonyl)-2-((2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)oxy)acetamide (<b>9g</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>9a</b>, compound <b>9g</b> was obtained as a white solid (38 mg, 48%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.41 (s, 1H), 9.90 (s, 1H), 7.05 (s, 2H), 6.71 (d, <i>J</i> = 8.3 Hz, 1H), 6.59 (d, <i>J</i> = 7.8 Hz, 2H), 4.56 (s, 2H), 2.80–2.73 (m, 2H), 2.59 (s, 6H), 2.38 (dd, <i>J</i> = 8.5, 6.4 Hz, 2H), 2.27 (s, 3H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.1, 168.2, 153.1, 143.4, 140.1, 133.5, 132.9, 132.0, 125.2, 116.1, 114.4, 113.5, 66.8, 30.7, 25.5, 22.5, 20.9. HRMS (ESI): calcd for C<sub>20</sub>H<sub>22</sub>N<sub>2</sub>O<sub>5</sub>SNa, 425.1147 (M + Na)<sup>+</sup>; found, 425.1134.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 2-((3-Chlorophenyl)amino)-<i>N</i>-(mesitylsulfonyl)acetamide (<b>9h</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>9a</b>, compound <b>9h</b> was obtained as a white solid (41 mg, 56%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 9.24 (s, 1H), 7.11 (t, <i>J</i> = 7.9 Hz, 1H), 6.99 (s, 2H), 6.88–6.81 (m, 1H), 6.47–6.38 (m, 2H), 4.43 (s, 1H), 3.79 (d, <i>J</i> = 3.3 Hz, 2H), 2.57 (s, 6H), 2.34 (s, 3H). <sup>13</sup>C NMR (75 MHz, chloroform-<i>d</i>): δ 169.2, 147.2, 144.0, 140.6, 135.5, 132.1, 131.9, 130.6, 119.9, 113.0, 111.7, 48.7, 22.6, 21.1. HRMS (ESI): calcd for C<sub>17</sub>H<sub>19</sub>ClN<sub>2</sub>O<sub>3</sub>SNa, 389.0703 (M + Na)<sup>+</sup>; found, 389.0688.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>N</i>-(Mesitylsulfonyl)-2-((4-oxo-3,4-dihydroquinazolin-2-yl)thio)acetamide (<b>9i</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>9a</b>, compound <b>9i</b> was obtained as a white solid (33 mg, 79%). <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.10 (dd, <i>J</i> = 8.2, 1.6 Hz, 1H), 7.74 (t, <i>J</i> = 7.6 Hz, 1H), 7.43 (td, <i>J</i> = 6.6, 6.1, 2.9 Hz, 2H), 6.90 (s, 2H), 3.99 (s, 2H), 2.65 (s, 6H), 2.20 (s, 3H). <sup>13</sup>C NMR (75 MHz, methanol-<i>d</i><sub>4</sub>): δ 167.6, 166.6, 148.3, 143.2, 140.1, 134.4, 132.9, 131.4, 125.8, 119.6, 47.3, 47.0, 46.7, 34.0, 21.5, 19.6. HRMS (ESI): calcd for C<sub>19</sub>H<sub>19</sub>N<sub>3</sub>O<sub>4</sub>S<sub>2</sub>Na, 440.0715 (M + Na)<sup>+</sup>; found, 440.0698.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 2-(3,4-Dihydroisoquinolin-2(1<i>H</i>)-yl)-<i>N</i>-(mesitylsulfonyl)acetamide (<b>9j</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>9a</b>, compound <b>9j</b> was obtained as a white solid (35 mg, 82%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 7.23–7.16 (m, 4H), 7.02 (d, <i>J</i> = 8.1 Hz, 3H), 3.73 (s, 2H), 3.20 (s, 2H), 3.00 (t, <i>J</i> = 6.0 Hz, 2H), 2.86 (t, <i>J</i> = 5.9 Hz, 2H), 2.70 (s, 6H), 2.34 (s, 3H). <sup>13</sup>C NMR (75 MHz, chloroform-<i>d</i>): δ 169.0, 143.6, 140.5, 133.0, 132.0, 128.8, 126.8, 126.4, 126.1, 61.3, 56.0, 51.5, 28.8, 22.8, 21.1. HRMS (ESI): calcd for C<sub>20</sub>H<sub>25</sub>N<sub>2</sub>O<sub>3</sub>S, 373.1586 (M + H)<sup>+</sup>; found, 373.1574.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 2-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)-<i>N</i>-(mesitylsulfonyl)acetamide (<b>9k</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>9a</b>, compound <b>9k</b> was obtained as a white solid (38 mg, 81%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 6.99 (s, 2H), 6.64 (s, 1H), 6.50 (s, 1H), 3.89 (s, 3H), 3.87 (s, 3H), 3.67 (s, 2H), 3.18 (s, 2H), 2.87 (dd, <i>J</i> = 10.8, 4.6 Hz, 4H), 2.70 (s, 6H), 2.33 (s, 3H). <sup>13</sup>C NMR (75 MHz, chloroform-<i>d</i>): δ 169.1, 148.1, 147.6, 143.6, 140.4, 132.6, 132.0, 125.0, 124.8, 111.5, 109.3, 61.1, 56.0, 56.0, 55.6, 51.5, 28.2, 22.8, 21.1. HRMS (ESI): calcd for C<sub>22</sub>H<sub>29</sub>N<sub>2</sub>O<sub>5</sub>S, 433.1797 (M + H)<sup>+</sup>; found, 433.1782.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>N</i>-(Mesitylsulfonyl)-2-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-<i>a</i>]pyrazin-7(8<i>H</i>)-yl)acetamide (<b>9l</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>9a</b>, compound <b>9l</b> was obtained as a white solid (146 mg, 70%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 9.85 (s, 1H), 7.00 (s, 2H), 4.24 (t, <i>J</i> = 5.6 Hz, 2H), 4.01 (s, 2H), 3.37 (s, 2H), 3.15–3.04 (m, 2H), 2.67 (s, 6H), 2.33 (s, 3H). <sup>13</sup>C NMR (75 MHz, chloroform-<i>d</i>): δ 167.2, 150.7, 144.1, 140.5, 132.1, 131.9, 77.2, 60.2, 49.5, 49.0, 43.1, 22.8, 21.1. HRMS (ESI): calcd for C<sub>17</sub>H<sub>21</sub>F<sub>3</sub>N<sub>5</sub>O<sub>3</sub>S, 432.1317 (M + H)<sup>+</sup>; found, 432.1304.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>N</i>-(Mesitylsulfonyl)-2-(4-(pyridin-2-yl)piperazin-1-yl)acetamide (<b>9m</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>9a</b>, compound <b>9m</b> was obtained as a white solid (32 mg, 80%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 8.26–8.18 (m, 1H), 7.52 (ddd, <i>J</i> = 9.1, 7.5, 2.0 Hz, 1H), 7.00 (s, 2H), 6.68 (dd, <i>J</i> = 7.6, 4.9 Hz, 2H), 3.62 (t, <i>J</i> = 5.0 Hz, 4H), 3.07 (s, 2H), 2.72 (s, 6H), 2.65 (t, <i>J</i> = 5.0 Hz, 4H), 2.32 (s, 3H). <sup>13</sup>C NMR (75 MHz, chloroform-<i>d</i>): δ 168.6, 159.1, 148.0, 143.7, 140.4, 137.6, 132.4, 132.0, 113.9, 107.2, 61.7, 53.3, 45.2, 22.8, 21.1. HRMS (ESI): calcd for C<sub>20</sub>H<sub>27</sub>N<sub>4</sub>O<sub>3</sub>S, 403.1804 (M + H)<sup>+</sup>; found, 403.1788.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 6-Chloronaphthalen-2-ol (<b>8n</b>)<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></h3><div class="NLM_p">6-Bromonaphthalen-2-ol (1.0 g, 4.5 mmol) in THF (10 mL) was added dropwise to a stirred suspension of NaH (900 mg 22.5 mmol) in THF (10 mL) at room temperature (rt) for 30 min. MOMCl (0.9 mL, 11.3 mmol) was then added, and the solution was stirred at rt for further 2 h. The solution was then quenched sequentially with water (10 mL) and MeOH (10 mL). Et<sub>2</sub>O was added, and the layers were separated. The aqueous layer was extracted with Et<sub>2</sub>O (3 × 20 mL). The organic layers were combined, washed with water (20 mL), brine (20 mL), and NaHCO<sub>3(aq)</sub>, dried (MgSO<sub>4</sub>), and evaporated under reduced pressure to give the crude product. Purification by flash column chromatography on silica with petroleum ether/EtOAc (90:10) as an eluent gave 2-bromo-6-(methoxymethoxy)naphthalene as a white solid (721 mg, 60%); <i>R</i><sub><i>f</i></sub> 0.3 (petroleum ether/EtOAc 90:10); mp 65–67 °C; IR (solid) 2956, 2926, 2852, 2826, 1621, 1586, 1495, 1478, 1464, 1252, 1217, 1196, 1151, 1124, 1076, 1061, 880, 861 cm<sup>–1</sup>; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.93 (d, <i>J</i> = 2.0 Hz, 1H, Ar), 7.67 (d, <i>J</i> = 9.0 Hz, 1H, Ar), 7.61 (d, <i>J</i> = 9.0 Hz, 1H, Ar), 7.50 (dd, <i>J</i> = 9.0, 2.0 Hz, 1H, Ar), 7.37 (d, <i>J</i> = 2.5 Hz, 1H, Ar), 7.23 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H, Ar), 5.29 (s, 2H, CH<sub>2</sub>), 3.52 (s, 3H, CH<sub>3</sub>); <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>): δ 155.5 (C), 133.0 (C), 130.7 (C), 129.8 (CH), 129.8 (CH), 128.8 (CH), 128.7 (CH), 120.2 (CH), 117.7 (C), 110.0 (CH), 94.6 (CH<sub>2</sub>), 56.3 (CH<sub>3</sub>). Spectroscopic data are consistent with those reported in the literature.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></div><div class="NLM_p">Next, <i>n</i>-BuLi (1.4 mL of a 2.5 M solution in hexanes, 3.38 mmol) was added to a stirred solution of 2-bromo-6-(methoxymethoxy)naphthalene (600 mg, 2.25 mmol) in THF (10 mL) at −78 °C for 30 min, and then, a solution of NCS (300 mg, 2.25 mmol) in THF (10 mL) was added and the solution was allowed to warm to rt and stirred for 16 h. The solution was then quenched with water (10 mL). EtOAc (20 mL) was added, and the two layers were separated, extracting the aqueous layer with EtOAc (3 × 20 mL). The combined organic layers were washed with water (20 mL) and brine (20 mL), dried (MgSO<sub>4</sub>), and evaporated under reduced pressure to give the crude product. Purification by flash column chromatography on silica with petroleum ether/EtOAc (99:1) as an eluent gave the product 2-chloro-6-(methoxymethoxy)naphthalene as a white solid (104 mg, 21%), <i>R</i><sub><i>f</i></sub> 0.2 (petroleum ether/EtOAc 99:1); 55–57 °C; IR (solid) 2957, 2903, 2829, 1616, 1589, 1500, 1479, 1464, 1269, 1253, 1218, 1124, 1153, 1074, 991, 962, 956, 908 cm<sup>–1</sup>; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.79 (d, <i>J</i> = 1.5 Hz, 1H, Ar), 7.72–7.69 (m, 2H, Ar), 7.44–7.40 (m, 2H, Ar), 7.29 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H, Ar), 5.33 (s, 2H, CH<sub>2</sub>), 3.57 (s, 3H, CH<sub>3</sub>); <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>): δ 155.3 (C), 132.8 (C), 130.1 (C), 129.7 (C), 2 × 128.6 (CH and CH), 127.3 (CH), 126.4 (CH), 120.1 (CH), 110.0 (CH), 94.6 (CH<sub>2</sub>), 56.2 (CH<sub>3</sub>); LRMS (TOF MS ASAP+) <i>m</i>/<i>z</i>: 222 ([M + H]<sup>+</sup>, 10), 191 ([M – OMe]<sup>+</sup>, 100), 157 ([M – OMe – Cl]<sup>+</sup>, 30); HRMS (TOF MS ASAP+) <i>m</i>/<i>z</i>: C<sub>12</sub>H<sub>11</sub>O<sub>2</sub>Cl ([M + H]<sup>+</sup>) calcd for 222.0448; found, 222.0446.</div><div class="NLM_p last">Next, a solution of 2-chloro-6-(methoxymethoxy)naphthalene <b>3</b> (100 mg, 0.47 mmol) in MeOH (5 mL) was stirred and heated at 50 °C and 6 M HCl (10 drops) was added before stirring for further 2 h. The resulting solution was allowed to cool to rt and then EtOAc (20 mL) and water (10 mL) were added and the layers were separated. The organic layer was washed with water (10 mL) and brine (10 mL), dried (MgSO<sub>4</sub>), and evaporated under reduced pressure to give the crude product. Purification by flash column chromatography on silica eluting with petroleum ether/EtOAc (90:10) gave 6-chloronaphthalen-2-ol <b>8n</b> as a tan solid (77 mg, 92%); <i>R</i><sub><i>f</i></sub> 0.3 (petroleum ether/EtOAc 90:10); 63–66 °C; IR (solid) 3265 (O–H), 2962, 2425, 1627, 1591, 1575, 1559, 1505, 1466, 1442, 1429, 1386, 1348, 1267, 1240, 1201, 1159, 1148, 1127, 1075, 914, 886, 876, 861, 807 cm<sup>–1</sup>; <sup>1</sup>H NMR (300 MHz, acetone-<i>d</i><sub>6</sub>): δ 9.01 (br s, 1H, OH), 7.81 (d, <i>J</i> = 2.0 Hz, 1H, Ar), 7.75 (d, <i>J</i> = 9.0 Hz, 1H, Ar), 7.69 (d, <i>J</i> = 9.0 Hz, 1H, Ar), 7.35 (dd, <i>J</i> = 9.0, 2.0 Hz, 1H, Ar), 7.26–7.17 (m, 2H, Ar); <sup>13</sup>C NMR (75.5 MHz, acetone-<i>d</i><sub>6</sub>): δ 156.5 (C), 134.2 (C), 129.8 (C), 129.6 (CH), 128.9 (CH), 128.65 (C), 127.45 (CH), 127.1 (CH), 120.4 (CH), 109.9 (CH); spectroscopic data are consistent with those reported in the literature.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 2-((6-Chloronaphthalen-2-yl)oxy)acetic Acid (<b>10n</b>)</h3><div class="NLM_p last">A solution of 6-chloronaphthalen-2-ol <b>8n</b> (75 mg, 0.42 mmol), ethyl bromoacetate (56 μL, 0.5 mmol), and K<sub>2</sub>CO<sub>3</sub> (120 mg, 0.84 mmol) in acetone (5 mL) was stirred and heated at reflux for 16 h. The resulting solution was allowed to cool to rt and then filtered and evaporated under reduced pressure. NaOH in MeOH was added to the residue, and the solution was stirred at rt for 3 h. The resulting solution was evaporated under reduced pressure and then acidified with 1 M HCl. Water and EtOAc were added, and the two layers were separated. The aqueous layer was extracted with EtOAc (×3). The combined organic layers were washed with brine, dried (MgSO<sub>4</sub>), and evaporated under reduced pressure to give <b>10n</b> as an off-white solid (89 mg, 89%); 176–178 °C; IR (solid) 2911 (O–H), 2586, 1733 (C═O), 1627, 1594, 1503, 1429, 1407, 1389, 1359, 1345, 1209, 1168, 1081, 881, 822 cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.97 (d, <i>J</i> = 2.0 Hz, 1H, Ar), 7.85 (d, <i>J</i> = 4.0 Hz, 1H, Ar), 7.83 (d, <i>J</i> = 4.0 Hz, 1H, Ar), 7.46 (dd, <i>J</i> = 9.0, 2.0 Hz, 1H, Ar), 7.33 (d, <i>J</i> = 2.5 Hz, 1H, Ar), 7.27 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H, Ar), 4.80 (s, 2H, CH<sub>2</sub>); <sup>13</sup>C NMR (75.5 MHz, DMSO-<i>d</i><sub>6</sub>): δ 169.92 (C), 155.96 (C), 132.49 (C), 129.28 (C), 128.83 (CH), 128.72 (CH), 128.09 (C), 126.84 (CH), 126.13 (CH), 119.67 (CH), 107.12 (CH), 64.5 (CH<sub>2</sub>); LRMS (ESI) <i>m</i>/<i>z</i>: 235 ([M]<sup>+</sup>, 100), 202 ([M – OH]<sup>+</sup>, 10); HRMS (ESI) <i>m</i>/<i>z</i>: C<sub>12</sub>H<sub>9</sub>O<sub>3</sub>Cl ([M]<sup>+</sup>) calcd for 235.0167; found, 235.0170.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 2-((6-Chloronaphthalen-2-yl)oxy)-<i>N</i>-((2,4-dimethylphenyl)sulfonyl)acetamide (<b>9n</b>)</h3><div class="NLM_p last">A solution of <b>10n</b> (46 mg, 0.19 mmol), sulfonamide <b>11</b> (36 mg, 0.19 mmol), EDCI (45 mg, 0.23 mmol), and DMAP (24 mg, 0.19 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was stirred at rt for 72 h. Water was added, and the two layers were separated. The organic layer was washed with 1 M HCl (5 mL × 3), water, and brine, dried (MgSO<sub>4</sub>), and evaporated under reduced pressure to give the crude product. Purification by recrystallization from toluene gave the product <b>9n</b> as a white solid (12 mg, 16%); mp 208–210 °C; IR (solid) 3269 (N–H), 1722 (C═O), 1432, 1410, 1356, 1330, 1196, 1174, 1158, 1140, 1057, 1048, 930, 911 cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.96 (d, <i>J</i> = 2.0 Hz, 1H, Ar), 7.87–7.78 (m, 2H, Ar), 7.71 (d, <i>J</i> = 9.0 Hz, 1H, Ar), 7.47 (dd, <i>J</i> = 9.0, 2.0 Hz, 1H, Ar), 7.25–7.15 (m, 3H, Ar), 7.08 (d, <i>J</i> = 2.5 Hz, 1H, Ar), 4.77 (s, 2H, CH<sub>2</sub>), 2.54 (s, 3H, CH<sub>3</sub>), 2.31 (s, 3H, CH<sub>3</sub>); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 166.8 (C), 155.7 (C), 143.9 (C), 136.8 (C), 134.5 (C), 132.8 (CH), 132.2 (C), 130.3 (CH), 129.3 (C), 128.7 (CH), 128.6 (CH), 128.2 (C), 126.8 (CH), 126.5 (CH), 126.1 (CH), 119.5 (CH), 107.1 (CH), 66.2 (CH<sub>2</sub>), 20.7 (CH<sub>3</sub>), 19.4 (CH<sub>3</sub>); LRMS (TOF MS ASAP+) <i>m</i>/<i>z</i>: 404 ([M + H]<sup>+</sup>, 100), 219 ([M – NHSO<sub>2</sub>C<sub>8</sub>H<sub>9</sub>]<sup>+</sup>, 10); HRMS (TOF MS ASAP+) <i>m</i>/<i>z</i>: C<sub>20</sub>H<sub>19</sub>NO<sub>4</sub>SCl ([M + H]<sup>+</sup>) calcd for 404.0723; found, 404.0722.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 6-Fluoronaphthalen-2-ol (<b>8o</b>)</h3><div class="NLM_p"><i>n</i>-BuLi (0.8 mL of a 2.5 M solution in hexanes, 2.0 mmol) was added to a stirred solution of 2-bromo-6-(methoxymethoxy)naphthalene (prepared during the synthesis of <b>8o</b>, above) (350 mg, 1.3 mmol) in THF (5 mL) at −78 °C for 30 min, and then, a solution of NFSI (410 mg, 1.3 mmol) in THF (5 mL) was added and the solution was allowed to warm to rt and stirred for 16 h. The solution was then quenched with water (10 mL). EtOAc (20 mL) was added, and the two layers were separated, extracting the aqueous layer with EtOAc (3 × 20 mL). The combined organic layers were washed with water (20 mL) and brine (20 mL), dried (MgSO<sub>4</sub>), and evaporated under reduced pressure to give the crude product. Purification by flash column chromatography on silica with petroleum ether/EtOAc (99:1) as an eluent gave 2-fluoro-6-(methoxymethoxy)naphthalene as a white solid (104 mg, 38%), <i>R</i><sub><i>f</i></sub> 0.2 (petroleum ether/EtOAc 99:1); 50–52 °C; IR (solid) 2956, 2936, 2909, 1603, 1579, 1510, 1376, 1360, 1226, 1152, 1078, 993, 960 cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.72–7.66 (m, 2H, Ar), 7.40–7.36 (m, 2H, Ar), 7.25–7.18 (m, 2H, Ar), 5.27 (s, 2H, CH<sub>2</sub>), 3.51 (s, 3H, CH<sub>3</sub>); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 159.7 (d, <i>J</i> = 243.5 Hz, C), 154.7 (d, <i>J</i> = 2.0 Hz, C), 131.5 (C), 130.1 (d, <i>J</i> = 9.0 Hz, C), 129.2 (d, <i>J</i> = 9.0 Hz, CH), 128.7 (d, <i>J</i> = 5.5 Hz, CH), 120.2 (CH), 116.7 (d, <i>J</i> = 25.0 Hz, CH), 110.8 (d, <i>J</i> = 20.5 Hz, CH), 110.4 (CH), 94.8 (CH<sub>2</sub>), 56.1 (CH<sub>3</sub>); <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>): δ −117.8 (td, <i>J</i> = 9.0, 5.5 Hz); LRMS (TOF MS ASAP+) <i>m</i>/<i>z</i>: 206 ([M]<sup>+</sup>, 60), 175 ([M – OMe]<sup>+</sup>, 100); HRMS (TOF MS ASAP+) <i>m</i>/<i>z</i>: C<sub>12</sub>H<sub>11</sub>O<sub>2</sub>F ([M]<sup>+</sup>) calcd for 206.0743; found, 206.0742.</div><div class="NLM_p last">Next, a solution of 2-fluoro-6-(methoxymethoxy)naphthalene (103 mg, 0.5 mmol) in MeOH (5 mL) was stirred and heated at 50 °C and 6 M HCl (10 drops) was added before stirring for further 2 h. The resulting solution was allowed to cool to rt and then EtOAc (20 mL) and water (10 mL) were added and the layers were separated. The organic layer was washed with water (10 mL) and brine (10 mL), dried (MgSO<sub>4</sub>), and evaporated under reduced pressure to give 6-fluoronaphthalen-2-ol <b>8o</b> as a tan solid (77 mg, 95%); 55–57 °C; IR (solid) 3265 (O–H), 1602, 1511, 1453, 1379, 1277, 1223, 1138, 1108, 941 cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, acetone-<i>d</i><sub>6</sub>): δ 8.63 (br s, 1H, OH), 7.77 (d, <i>J</i> = 9.0, 1H, Ar), 7.74 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H, Ar), 7.49 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H, Ar), 7.26 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H, Ar), 7.23 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H, Ar), 7.19 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H, Ar); <sup>13</sup>C NMR (101 MHz, acetone-<i>d</i><sub>6</sub>): δ 159.8 (d, <i>J</i> = 240.0 Hz, C), 155.8 (d, <i>J</i> = 2.5 Hz, C), 133.0 (C), 129.7 (d, <i>J</i> = 8.0 Hz, C), 129.6 (d, <i>J</i> = 5.0 Hz, CH), 129.5 (d, <i>J</i> = 8.5 Hz, CH), 120.5 (CH), 117.0 (d, <i>J</i> = 25.5 Hz, CH), 111.4 (d, <i>J</i> = 20.5 Hz, CH), 110.1 (CH); <sup>19</sup>F NMR (376 MHz, acetone-<i>d</i><sub>6</sub>): δ −120.9 (td, <i>J</i> = 9.5, 6.0 Hz).</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 2-((6-Fluoronaphthalen-2-yl)oxy)acetic Acid (<b>10o</b>)</h3><div class="NLM_p last">A solution of 6-fluoronaphthalen-2-ol <b>8o</b> (69 mg, 0.43 mmol), ethyl bromoacetate (60 μL, 0.52 mmol), and K<sub>2</sub>CO<sub>3</sub> (118 mg, 0.85 mmol) in acetone (5 mL) was stirred and heated at reflux for 16 h. The resulting solution was allowed to cool to rt and then filtered and evaporated under reduced pressure. NaOH in MeOH was added to the residue, and the solution was stirred at rt for 3 h. The resulting solution was evaporated under reduced pressure and then acidified with 1 M HCl. Water and EtOAc were added, and the two layers were separated. The aqueous layer was extracted with EtOAc (15 mL × 3). The combined organic layers were washed with brine, dried (MgSO<sub>4</sub>), and evaporated under reduced pressure to give the product <b>10o</b> as an off-white solid (77 mg, 82%) 159–162 °C; IR (solid) 2915 (O–H), 2853, 2581, 1739 (C═O) 1605, 1513, 1389, 1250, 1226, 1183, 1110, 857 cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, acetone-<i>d</i><sub>6</sub>): δ 7.89–7.82 (m, 2H, Ar), 7.55 (ddd, <i>J</i> = 10.0, 2.5, 0.5 Hz, 1H, Ar), 7.36 (d, <i>J</i> = 2.5 Hz, 1H, Ar), 7.34–7.26 (m, 2H, Ar), 4.85 (s, 2H, CH<sub>2</sub>); <sup>13</sup>C NMR (101 MHz, acetone-<i>d</i><sub>6</sub>): δ 170.0 (C), 160.4 (d, <i>J</i> = 241.5 Hz, C), 156.7 (d, <i>J</i> = 2.0 Hz, C), 132.5 (C), 130.7 (d, <i>J</i> = 9.0 Hz, C), 130.2 (d, <i>J</i> = 9.0 Hz, CH), 129.7 (d, <i>J</i> = 5.0 Hz, CH), 120.7 (CH), 117.2 (d, <i>J</i> = 25.5 Hz, CH), 111.5 (d, <i>J</i> = 21.0 Hz, CH), 108.4 (CH), 65.6 (CH<sub>2</sub>); <sup>19</sup>F NMR (376 MHz, acetone-<i>d</i><sub>6</sub>): δ −119.5 (td, <i>J</i> = 9.5, 5.5 Hz).</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 2-((6-Fluoronaphthalen-2-yl)oxy)-<i>N</i>-((2,4-dimethylphenyl)sulfonyl)acetamide (<b>9o</b>)</h3><div class="NLM_p last">A solution of naphthoxyacetic acid <b>10o</b> (76 mg, 0.35 mmol), sulfonamide <b>11</b> (64 mg, 0.35 mmol), EDCI (79 mg, 0.41 mmol), and DMAP (42 mg, 0.35 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was stirred at rt for 72 h. Water was added, and the two layers were separated. The organic layer was washed with 1 M HCl (×3), water, and brine, dried (MgSO<sub>4</sub>), and evaporated under reduced pressure to give the crude product. Purification by flash column chromatography on silica with petroleum ether/EtOAc (80:20) as an eluent gave the product <b>15</b> as a white solid (57 mg, 43%); <i>R</i><sub><i>f</i></sub> 0.3 (petroleum ether/EtOAc 80:20); mp 185–188 °C; IR (solid) 3269 (N–H), 1721 (C═O), 1585, 1504, 1409, 1330, 1200, 1137, 1049, 933, 860 cm<sup>–1</sup>; <sup>1</sup>H NMR (300 MHz, acetone-<i>d</i><sub>6</sub>): δ 10.92 (br s, 1H, NH), 7.97 (d, <i>J</i> = 8.0 Hz, 1H, Ar), 7.83 (d, <i>J</i> = 9.0 Hz, 1H, Ar), 7.75 (dd, <i>J</i> = 9.0, 5.5 Hz, 1H, Ar), 7.55 (dd, <i>J</i> = 10.0, 2.5 Hz, 1H, Ar), 7.37–7.23 (m, 2H, Ar), 7.23–7.16 (m, 2H, Ar), 7.10 (s, 1H, Ar), 4.77 (s, 2H, CH<sub>2</sub>), 2.50 (s, 3H, CH<sub>3</sub>), 2.35 (s, 3H, CH<sub>3</sub>); <sup>13</sup>C NMR (75.5 MHz, acetone-<i>d</i><sub>6</sub>): δ 167.8 (C), 160.4 (d, <i>J</i> = 241.5 Hz, C), 156.1 (d, <i>J</i> = 2.5 Hz, C), 145.4 (C), 138.4 (C), 133.8 (CH), 132.2 (C), 2 × 132.0 (CH and C), 130.8 (d, <i>J</i> = 9.0 Hz, C), 130.2 (d, <i>J</i> = 9.0 Hz, CH), 129.7 (d, <i>J</i> = 5.5 Hz, CH), 127.4 (CH), 120.6 (CH), 117.2 (d, <i>J</i> = 25.5 Hz, CH), 111.5 (d, <i>J</i> = 20.5 Hz, CH), 108.3 (CH), 68.0 (CH<sub>2</sub>), 21.3 (CH<sub>3</sub>), 20.1 (CH<sub>3</sub>); <sup>19</sup>F NMR (282 MHz, acetone-<i>d</i><sub>6</sub>): δ −119.1 to −119.3 (m); HRMS (ESI): calcd for C<sub>20</sub>H<sub>19</sub>NO<sub>4</sub>NaS, 392.0927 (M – F + Na)<sup>+</sup>; found, 392.0915.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 7-Chloronaphthalen-2-ol (<b>8p</b>)<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></h3><div class="NLM_p">7-Bromonaphthalen-2-ol (1.1 g, 5.1 mmol) in THF (10 mL) was added dropwise to a stirred suspension of NaH (1.0 g 25.4 mmol) in THF (10 mL) at rt for 30 min. MOMCl (1.0 mL, 12.7 mmol) was then added, and the solution was stirred at rt for further 2 h. The solution was then quenched sequentially with water (10 mL) and MeOH (10 mL). Et<sub>2</sub>O was added, and the layers were separated. The aqueous layer was extracted with Et<sub>2</sub>O (3 × 20 mL). The organic layers were combined, washed with water (20 mL), brine (20 mL), and NaHCO<sub>3(aq)</sub>, dried (MgSO<sub>4</sub>), and evaporated under reduced pressure to give the crude product. Purification by flash column chromatography on silica with petroleum ether/EtOAc (95:5) as an eluent gave 2-bromo-7-(methoxymethoxy)naphthalene as a white solid (793 mg, 58%); <i>R</i><sub><i>f</i></sub> 0.2 (petroleum ether/EtOAc 95:5); mp 60–63 °C; IR (solid) 2961, 2906, 1620, 1590, 1498, 1483, 1451, 1213, 1165, 1144, 1125, 1080, 991, 952, 920, 844 cm<sup>–1</sup>; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.90 (d, <i>J</i> = 2 Hz, 1H, Ar), 7.73 (d, <i>J</i> = 9.0 Hz, 1H, Ar), 7.63 (d, <i>J</i> = 8.5 Hz, 1H), 7.42 (dd, <i>J</i> = 8.5, 2.0 Hz, 1H), 7.30 (d, <i>J</i> = 2.5 Hz, 1H), 7.22 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H, Ar), 5.29 (s, 2H, CH<sub>2</sub>), 3.52 (s, 3H, CH<sub>3</sub>); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 156.0 (C), 135.9 (C), 129.6 (CH), 129.4 (CH), 129.2 (CH), 128.0 (C), 127.5 (CH), 120.7 (C), 119.5 (CH), 109.4 (CH), 94.7 (CH<sub>2</sub>), 56.3 (CH<sub>3</sub>); LRMS (TOF MS ASAP+) <i>m</i>/<i>z</i>: 266 ([M + H]<sup>+</sup>, 15), 235 ([M – OMe]<sup>+</sup>, 100), 188 ([M – Br]<sup>+</sup>, 5); HRMS (TOF MS ASAP+) <i>m</i>/<i>z</i>: C<sub>12</sub>H<sub>11</sub>O<sub>2</sub>Br ([M + H]<sup>+</sup>) calcd for 265.9942; found, 265.9948.</div><div class="NLM_p">Then, <i>n</i>-BuLi (0.8 mL of a 2.5 M solution in hexanes, 2.0 mmol) was added to a stirred solution of 2-bromo-7-(methoxymethoxy)naphthalene (350 mg, 1.3 mmol) in THF (5 mL) at −78 °C for 30 min, and then, a solution of NCS (170 mg, 1.3 mmol) in THF (5 mL) was added and the solution was allowed to warm to rt and stirred for 16 h. The solution was then quenched with water (10 mL). EtOAc (20 mL) was added, and the two layers were separated, extracting the aqueous layer with EtOAc (3 × 20 mL). The combined organic layers were washed with water (20 mL) and brine (20 mL), dried (MgSO<sub>4</sub>), and evaporated under reduced pressure to give the crude product. Purification by flash column chromatography on silica with petroleum ether/toluene (90:10) as an eluent gave 2-bromo-7-(methoxymethoxy)naphthalene as a white solid (82 mg, 29%), <i>R</i><sub><i>f</i></sub> 0.2 (petroleum ether/toluene 90:10); 50–53 °C; IR (solid) 2902, 2829, 1623, 1589, 1498, 1407, 1252, 1218, 1153, 1073, 991, 955, 907, 881 cm<sup>–1</sup>; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.75–7.67 (m, 3H, Ar), 7.33–7.27 (m, 2H, Ar), 7.22 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H, Ar), 5.30 (s, 2H, CH<sub>2</sub>), 3.53 (s, 3H, CH<sub>3</sub>); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 156.0 (C), 135.4 (C), 132.4 (C), 129.5 (CH), 129.3 (CH), 127.8 (C), 125.9 (CH), 125.0 (CH), 119.3 (CH), 109.4 (CH), 94.7 (CH<sub>2</sub>), 56.3 (CH<sub>3</sub>); LRMS (TOF MS ASAP+) <i>m</i>/<i>z</i>: 222 ([M]<sup>+</sup>, 15), 191 ([M – OMe]<sup>+</sup>, 100); HRMS (TOF MS ASAP+) <i>m</i>/<i>z</i>: C<sub>12</sub>H<sub>11</sub>O<sub>2</sub>Cl ([M]<sup>+</sup>) calcd for 222.0448; found, 222.0447.</div><div class="NLM_p last">Then, a solution of 2-chloro-7-(methoxymethoxy)naphthalene (82 mg, 0.37 mmol) in MeOH (5 mL) was stirred and heated at 50 °C, and 6 M HCl (10 drops) was added before stirring for further 2 h. The resulting solution was allowed to cool to rt and then EtOAc (20 mL) and water (10 mL) were added and the layers were separated. The organic layer was washed with water (10 mL) and brine (10 mL), dried (MgSO<sub>4</sub>), and evaporated under reduced pressure to give 7-chloronaphthalen-2-ol as a tan solid (56 mg, 86%); 60–63 °C; IR (solid) 3467 (O–H), 3077, 1623, 1598, 1516, 1471, 1458, 1431, 1385, 1349, 1266, 1232, 1175, 1075, 890, 838 cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.72 (d, <i>J</i> = 9.0 Hz, 1H, Ar), 7.69 (d, <i>J</i> = 9.0 Hz, 1H, Ar), 7.65 (d, <i>J</i> = 2.0 Hz, 1H, Ar), 7.26 (dd, <i>J</i> = 9.0, 2.0 Hz, 1H, Ar), 7.10 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H, Ar), 7.06 (d, <i>J</i> = 2.5 Hz, 1H, Ar), 5.39 (br s, 1H, OH); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 154.5 (C), 135.5 (C), 132.6 (C), 129.9 (CH), 129.5 (CH), 127.3 (C), 125.2 (CH), 124.7 (CH), 118.2 (CH), 108.9 (CH). Spectroscopic data consistent with those reported in the literature.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 2-((7-Chloronaphthalen-2-yl)oxy)acetic Acid (<b>10p</b>)</h3><div class="NLM_p last">A solution of 7-chloronaphthalen-2-ol <b>8p</b> (57 mg, 0.32 mmol), ethyl bromoacetate (40 μL, 0.38 mmol), and K<sub>2</sub>CO<sub>3</sub> (90 mg, 0.64 mmol) in acetone (5 mL) was stirred and heated at reflux for 16 h. The resulting solution was allowed to cool to rt and then filtered and evaporated under reduced pressure. NaOH in MeOH was added to the residue, and the solution was stirred at rt for 3 h. The resulting solution was evaporated under reduced pressure and then acidified with 1 M HCl. Water and EtOAc were added, and the two layers were separated. The aqueous layer was extracted with EtOAc (×3). The combined organic layers were washed with brine, dried (MgSO<sub>4</sub>), and evaporated under reduced pressure to give the crude product. Purification by recrystallization from toluene gave the product <b>10p</b> as an off-white solid (29 mg, 39%); 171–174 °C; IR (solid) 2905 (O–H), 2584, 1717 (C═O), 1631, 1505, 1425, 1241, 1213, 1177, 1140, 1080, 1069, 835, 772 cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, acetone-<i>d</i><sub>6</sub>): δ 7.89–7.84 (m, 3H, Ar), 7.34 (dd, <i>J</i> = 9.0, 2.0 Hz, 1H, Ar), 7.31 (d, <i>J</i> = 2.5 Hz, 1H, Ar), 7.25 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H, Ar), 4.86 (s, 2H, CH<sub>2</sub>); <sup>13</sup>C NMR (101 MHz, acetone-<i>d</i><sub>6</sub>): δ 169.9 (C), 158.1 (C), 136.4 (C), 132.8 (C), 130.5 (CH), 130.4 (CH), 128.6 (C), 126.4 (CH), 125.3 (CH), 119.9 (CH), 107.5 (CH), 65.6 (CH<sub>2</sub>); LRMS (ESI) <i>m</i>/<i>z</i>: 235 ([M]<sup>+</sup>, 100); HRMS (ESI) <i>m</i>/<i>z</i>: C<sub>12</sub>H<sub>9</sub>O<sub>3</sub>Cl ([M]<sup>+</sup>) calcd for 235.0167; found, 235.0169.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 2-((7-Chloronaphthalen-2-yl)oxy)-<i>N</i>-((2,4-dimethylphenyl)sulfonyl)acetamide (<b>9p</b>)</h3><div class="NLM_p last">A solution of naphthoxyacetic acid <b>10p</b> (28 mg, 0.12 mmol), sulfonamide <b>11</b> (22 mg, 0.12 mmol), EDCI (27 mg, 0.14 mmol), and DMAP (14 mg, 0.12 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was stirred at rt for 72 h. Water was added, and the two layers were separated. The organic layer was washed with 1 M HCl (×3), water, and brine, dried (MgSO<sub>4</sub>), and evaporated under reduced pressure to give the crude product. Purification by flash column chromatography on silica with petroleum ether/EtOAc (80:20) as an eluent gave the product <b>11</b> as a white solid (10 mg, 21%); <i>R</i><sub><i>f</i></sub> 0.3 (petroleum ether/EtOAc 80:20); mp 175–177 °C (decomposition); IR (solid) 3269 (N–H), 2904, 1721 (C═O), 1626, 1500, 1331, 1197, 1155, 1145, 1075, 1000, 860 cm<sup>–1</sup>; <sup>1</sup>H NMR (300 MHz, acetone-<i>d</i><sub>6</sub>): δ 10.99 (br s, 1H, NH), 7.98 (d, <i>J</i> = 8.0 Hz, 1H, Ar), 7.90–7.82 (m, 2H, Ar), 7.70 (d, <i>J</i> = 2.0 Hz, 1H, Ar), 7.35 (dd, <i>J</i> = 8.5, 2.0 Hz, 1H, Ar), 7.27–7.16 (m, 2H, Ar), 7.13–7.06 (m, 2H, Ar), 4.80 (s, 2H, CH<sub>2</sub>), 2.48 (s, 3H, CH<sub>3</sub>), 2.36 (s, 3H, CH<sub>3</sub>); <sup>13</sup>C NMR (75.5 MHz, acetone-<i>d</i><sub>6</sub>): δ 167.4 (C), 157.4 (C), 145.5 (C), 138.5 (C), 136.1 (CH), 135.5 (C), 133.8 (CH), 132.7 (C), 132.1 (C), 2 × 130.5 (CH and CH), 128.6 (C), 127.4 (CH), 126.3 (CH), 125.5 (CH), 119.9 (CH), 107.4 (CH), 67.9 (CH<sub>2</sub>), 21.3 (CH<sub>3</sub>), 20.1 (CH<sub>3</sub>); LRMS (TOF MS ASAP+) <i>m</i>/<i>z</i>: 404 ([M + H]<sup>+</sup>, 100), 219 ([M – NHSO<sub>2</sub>C<sub>8</sub>H<sub>9</sub>]<sup>+</sup>, 15); HRMS (TOF MS ASAP+) <i>m</i>/<i>z</i>: C<sub>20</sub>H<sub>19</sub>NO<sub>4</sub>SCl ([M + H]<sup>+</sup>) calcd for 404.0723; found, 404.0721.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (Naphthalen-1-yl)oxyacetic Acid (<b>10q</b>)</h3><div class="NLM_p last">A solution of 1-naphthol <b>8q</b> (2.7 g, 25.0 mmol), ethyl bromoacetate (2.8 mL, 25.0 mmol), and K<sub>2</sub>CO<sub>3</sub> (5.8 g, 41.6 mmol) in acetone (38 mL) was stirred and heated at reflux for 16 h. The resulting solution was allowed to cool to rt and then filtered and evaporated under reduced pressure. NaOH in MeOH was added to the residue, and the solution was stirred at rt for 3 h. The resulting solution was evaporated under reduced pressure and then acidified with 1 M HCl. Water and EtOAc were added, and the two layers were separated. The aqueous layer was extracted with EtOAc (30 mL × 3). The combined organic layers were washed with brine, dried (MgSO<sub>4</sub>), and evaporated under reduced pressure to give <b>10q</b> as an off-white solid (3.4 g, 67%), mp 193–196 °C; IR (solid) 2911, 1741, 1703, 1596, 1422, 1240, 1119 cm<sup>–1</sup>; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.27–8.15 (1H, m), 7.93–7.82 (1H, m), 7.59–7.46 (3H, m), 7.40 (1H, dd, <i>J</i> = 8.2, 7.6), 6.88 (1H, dd, <i>J</i> = 7.6, 1.0), 4.88 (2H, s); <sup>13</sup>C NMR (75.5 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.0, 153.2, 134.0, 127.4, 126.5, 126.0, 125.3, 124.8, 121.6, 120.4, 105.3, 64.9.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> <i>N</i>-((2,4-Dimethylphenyl)sulfonyl)-2-(naphthalen-1-yloxy)acetamide (<b>9q</b>)</h3><div class="NLM_p last">A solution of sulfonamide <b>11</b> (183 mg, 0.99 mmol), naphthoxyacetic acid <b>10q</b> (200 mg, 0.99 mmol), EDCI (228 mg, 1.19 mmol), and DMAP (121 mg, 0.99 mmol) in DCM (20 mL) was stirred for 48 h at rt The reaction mixture was diluted with DCM (25 mL) and washed sequentially with 10% HCl (10 mL × 3), water, and brine. The organic phase was dried over MgSO<sub>4</sub>, and the solvent was removed under vacuum to give the crude product. Purification by flash column chromatography on silica with 8:2 petrol/EtOAc as an eluent gave <b>9q</b> (80 mg, 21%) as a white solid, mp 174–177 °C; IR (solid) 3251, 1717, 1598, 1410, 1257, 1159, 1140 cm<sup>–1</sup>; <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 8.22–8.14 (1H, m), 8.09 (1H, d, <i>J</i> = 8.2), 7.90–7.81 (1H, m), 7.61–7.51 (3H, m), 7.31 (1H, t, <i>J</i> = 8.2, 7.7), 7.20 (1H, d, <i>J</i> = 8.2), 7.12–7.06 (1H, m), 6.66 (1H, dd, <i>J</i> = 7.7, 0.8), 4.66 (2H, s), 2.45 (3H, s), 2.40 (3H, s); <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>): δ 166.4, 152.4, 145.5, 137.8, 134.8, 133.4, 133.3, 131.9, 128.1, 127.2, 127.2, 126.4, 125.6, 125.1, 122.9, 121.1, 106.0, 68.0, 21.6, 20.3.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 2-((1<i>H</i>-Indol-5-yl)oxy)-<i>N</i>-((2,4-dimethylphenyl)sulfonyl)acetamide (<b>9r</b>)</h3><div class="NLM_p last">A solution of sulfonamide <b>11</b> (174 mg, 0.94 mmol), naphthoxyacetic acid <b>10r</b> (180 mg, 0.94 mmol), EDCI (216 mg, 1.13 mmol), and DMAP (115 mg, 0.94 mmol) in DCM (9.4 mL) was stirred for 48 h at rt The reaction mixture was diluted with DCM (20 mL) and washed sequentially with 10% HCl (5 mL × 3), water, and brine. The organic phase was dried (MgSO<sub>4</sub>), and the solvent was removed under vacuum to give the crude product. Purification by flash column chromatography on silica with 7:3 petrol/EtOAc as an eluent gave <b>9r</b> (159 mg, 52%) as an orange oil, IR (film) 3417 (N–H str), 3273, 2927, 1727 (C═O str), 1601, 1583, 1480, 1222 cm<sup>–1</sup>; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 9.04 (s, 1H, NH), 8.21 (s, 1H, NH), 8.08 (d, <i>J</i> = 8.0 Hz, 1H, Ar), 7.33 (d, <i>J</i> = 9.0 Hz, 1H, Ar), 7.24 (t, <i>J</i> = 3.0 Hz, 1H, Ar), 7.18 (d, <i>J</i> = 8.0 Hz, 1H, Ar), 7.05 (s, 1H, Ar), 6.98 (d, <i>J</i> = 2.5 Hz, 1H, Ar), 6.68 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H, Ar), 6.47–6.43 (m, 1H, Ar), 4.49 (s, 2H, OC<i>H</i><sub>2</sub>), 2.47 (s, 3H, Me), 2.38 (s, 3H, Me); <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>): δ 166.9 (C), 151.1 (C), 146.2 (C), 137.6 (C), 133.3 (C), 133.2 (C), 131.9 (CH), 130.6 (CH), 128.3 (C), 127.0 (CH), 125.6 (CH), 112.2 (CH), 112.1 (CH), 104.2 (CH), 102.6 (CH), 68.3 (CH<sub>2</sub>), 60.4 (CH<sub>3</sub>), 40.8 (CH<sub>3</sub>). HRMS (ESI): calcd for C<sub>18</sub>H<sub>19</sub>N<sub>2</sub>O<sub>4</sub>S, 359.1060 (M + H)<sup>+</sup>; found, 359.1062.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 1<i>H</i>-Indazol-5-yloxyacetic Acid (<b>10s</b>)</h3><div class="NLM_p last">A solution of 1<i>H</i>-inazol-5-ol (2.8 g, 20.81 mmol), ethyl bromoacetate (2.8 mL, 25.0 mmol), and K<sub>2</sub>CO<sub>3</sub> (5.8 g, 41.61 mmol) in acetone (30 mL) was stirred and heated at reflux for 16 h. The remaining solids were filtered off and washed with acetone, and the filtrate was evaporated under reduced pressure. NaOH<sub>(aq)</sub> (40 mL, 5 M) and MeOH (20 mL) were added, and the resulting solution was stirred at rt for 3 h. Then, the MeOH was removed under reduced pressure, and the remaining aqueous solution was acidified <i>via</i> addition of 6 M HCl<sub>(aq)</sub>. The aqueous solution was extracted with EtOAc (30 mL × 3), and the combined organic layers were washed with brine, dried (MgSO<sub>4</sub>), and evaporated under reduced pressure to give <b>10s</b> (4.1 g, 99%) as a brown solid, mp stable under 300 °C; IR (solid) 3339 (O–H + N–H str), 1706 (C═O), 1611, 1511, 1102 cm<sup>–1</sup>; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.91 (br s, 2H, OH + NH), 7.93 (d, <i>J</i> = 1.0 Hz 1H, Ar), 7.45 (dt, <i>J</i> = 9.0, 1.0 Hz, 1H, Ar), 7.10 (d, <i>J</i> = 2.0 Hz, 1H, Ar), 7.03 (dd, <i>J</i> = 9.0, 2.0 Hz, 1H, Ar), 4.64 (s, 2H, OC<i>H</i><sub>2</sub>); <sup>13</sup>C NMR (75.5 MHz, DMSO-<i>d</i><sub>6</sub>): δ 170.5 (C), 151.8 (C), 135.9 (C), 132.6 (C), 122.8 (CH), 117.9 (CH), 111.1 (CH), 100.9 (CH), 65.3 (CH<sub>2</sub>).</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 2-((1<i>H</i>-Indazol-5-yl)oxy)-<i>N</i>-((2,4-dimethylphenyl)sulfonyl)acetamide (<b>9s</b>)</h3><div class="NLM_p last">A solution of sulfonamide <b>11</b> (335 mg, 1.81 mmol), acid <b>10s</b> (383 mg, 1.99 mmol), EDCI (385 mg, 2.01 mmol), and DMAP (242 mg, 1.98 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was stirred at rt for 48 h. CH<sub>2</sub>Cl<sub>2</sub> (25 mL) was added, and the solution was washed with 1 M HCl<sub>(aq)</sub>, water, and brine and then dried (MgSO<sub>4</sub>) and evaporated under reduced pressure to give <b>9s</b> (520 mg, 88%) as a yellow solid, mp stable under 300 °C; IR (solid) 3360 (N–H str), 3256, 1645 (C═O str), 1564, 1315, 1172. Compound <b>9s</b> proved to be sparingly soluble in all NMR solvents investigated. Based on spectra obtained after extended run times, we are confident that pure <b>9s</b> has indeed been prepared.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> <i>N</i>-(Mesitylsulfonyl)-2-(naphthalen-2-ylthio)acetamide (<b>12a</b>)</h3><div class="NLM_p last">A solution of naphthalene-2-thiol (<b>10</b>) (32 mg, 0.2 mmol) in dry DMF (1 mL) was cooled to 0 °C with an ice bath and then NaH (8 mg, 0.2 mmol) was added to the solution. The mixture was stirred at 0 °C for 30 min, followed by adding <b>7</b> (64 mg, 0.2 mmol), and the added mixture was stirred at room temperature overnight. After the reaction completed, it was quenched with 2 mL of NH<sub>4</sub>Cl (sat. aq.) and 10 mL of water and then extracted with EtOAc (15 mL × 2). The combined EtOAc extracts were successively washed with brine and then dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to the residue. This residue was further purified by preparative TLC plates (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 50:1) to get <b>12a</b> as a white solid (61 mg, 76%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 9.33 (s, 1H), 7.82 (dt, <i>J</i> = 6.6, 2.0 Hz, 1H), 7.75 (d, <i>J</i> = 8.7 Hz, 1H), 7.56–7.46 (m, 3H), 7.38 (d, <i>J</i> = 2.0 Hz, 1H), 7.30–7.25 (m, 1H), 6.63 (s, 2H), 3.72 (s, 2H), 2.39 (s, 6H), 2.19 (s, 3H). <sup>13</sup>C NMR (75 MHz, chloroform-<i>d</i>): δ 166.9, 143.7, 140.6, 133.7, 132.0, 131.8, 131.5, 130.6, 129.2, 127.7, 127.3, 126.8, 126.3, 125.5, 125.3, 37.1, 22.5, 21.0. HRMS (ESI): calcd for C<sub>21</sub>H<sub>21</sub>NO<sub>3</sub>S<sub>2</sub>Na, 422.0861 (M + Na)<sup>+</sup>; found, 422.0848.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> <i>N</i>-(Mesitylsulfonyl)-2-(naphthalen-2-ylamino)acetamide (<b>12b</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>12a</b>, compound <b>12b</b> was obtained as a white solid (31 mg, 40%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 9.37 (s, 1H), 7.72 (dd, <i>J</i> = 11.8, 8.4 Hz, 2H), 7.41 (dd, <i>J</i> = 6.0, 1.5 Hz, 2H), 7.36–7.29 (m, 1H), 6.91 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 6.81 (s, 2H), 6.48 (d, <i>J</i> = 2.4 Hz, 1H), 4.53 (s, 1H), 3.88 (s, 2H), 2.43 (s, 6H), 2.32 (s, 3H). <sup>13</sup>C NMR (75 MHz, chloroform-<i>d</i>): δ 169.8, 143.7, 143.6, 140.6, 134.5, 132.1, 129.6, 128.6, 127.6, 126.5, 126.5, 123.4, 117.5, 105.7, 49.2, 22.5, 21.1. HRMS (ESI): calcd for C<sub>21</sub>H<sub>22</sub>N<sub>2</sub>O<sub>3</sub>SNa, 405.1249 (M + Na)<sup>+</sup>; found, 405.1233.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> <i>tert</i>-Butyl (2-(naphthalen-2-yloxy)ethyl)carbamate (<b>15</b>)</h3><div class="NLM_p last">To a solution of naphthalene-2-ol (<b>8a</b>) (720 mg, 5 mmol), <i>tert</i>-butyl (2-hydroxyethyl)carbamate (1.2 g, 7.5 mmol), and PPh<sub>3</sub> (2 g, 7.5 mmol) in dry THF (10 mL) was dropwise added DEAD (1.2 g, 7.5 mmol) at 0 °C. The mixture was stirred at room temperature for 12 h, added with 10 mL of water, and then extracted with DCM (10 mL × 3). The combined DCM extracts were successively washed with brine and then dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to the residue. This residue was further purified by preparative TLC plates (hexane/EtOAc = 10:1) to yield <b>15</b> as a colorless oil (1.2 g, 81%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 7.77 (qd, <i>J</i> = 7.9, 7.1, 1.2 Hz, 3H), 7.46 (ddd, <i>J</i> = 8.2, 6.8, 1.4 Hz, 1H), 7.36 (ddd, <i>J</i> = 8.1, 6.8, 1.3 Hz, 1H), 7.16 (d, <i>J</i> = 7.9 Hz, 2H), 5.06 (s, 1H), 4.17 (t, <i>J</i> = 5.1 Hz, 2H), 3.63 (q, <i>J</i> = 5.4 Hz, 2H), 1.49 (s, 9H).</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 2,4,6-Trimethyl-<i>N</i>-(2-(naphthalen-2-yloxy)ethyl)benzenesulfonamide (<b>12c</b>)</h3><div class="NLM_p last">A solution of <b>15</b> (287 mg, 1 mmol) in 5 mL of dry DCM was cooled to 0 °C with an ice bath. TFA (0.2 mL) was successively added to the solution at 0 °C. The mixture was stirred at room temperature for 6 h and then concentrated to the residue. The residue was dissolved in dry DCM (10 mL) and was cooled to 0 °C with an ice bath. NEt<sub>3</sub> (505 mg, 5 mmol), DMAP (22 mg, 0.2 mmol), and 2,4,6-trimethylbenzenesulfonyl chloride (<b>5</b>) (329 mg, 1.5 mmol) were successively added to the solution at 0 °C. The mixture was stirred at room temperature for 12 h, added with 20 mL of water, and then extracted with DCM (20 mL × 3). The combined DCM extracts were successively washed with brine and then dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to the residue. This residue was further purified by preparative TLC plates (hexane/EtOAc = 5:1) to yield <b>12c</b> as a white solid (337 mg, 91%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 7.82–7.66 (m, 3H), 7.46 (ddd, <i>J</i> = 8.2, 6.7, 1.3 Hz, 1H), 7.37 (ddd, <i>J</i> = 8.1, 6.8, 1.3 Hz, 1H), 7.06 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 6.98 (d, <i>J</i> = 2.5 Hz, 1H), 6.91 (s, 2H), 5.14 (t, <i>J</i> = 6.2 Hz, 1H), 4.04 (t, <i>J</i> = 5.1 Hz, 2H), 3.46–3.37 (m, 2H), 2.69 (s, 6H), 2.22 (s, 3H). <sup>13</sup>C NMR (75 MHz, chloroform-<i>d</i>): δ 155.9, 142.3, 138.9, 134.3, 133.9, 132.0, 129.5, 129.2, 127.6, 126.8, 126.5, 124.0, 118.3, 106.8, 66.0, 42.2, 22.9, 20.8. HRMS (ESI): calcd for C<sub>21</sub>H<sub>23</sub>NO<sub>3</sub>SNa, 392.1296 (M + Na)<sup>+</sup>; found, 392.1281.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 1-(Mesitylsulfonyl)-4-(naphthalen-2-yloxy)piperidine (<b>12d</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>12c</b>, compound <b>12d</b> was obtained as a white solid (117 mg, 92%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 7.85–7.65 (m, 3H), 7.46 (ddd, <i>J</i> = 8.2, 6.8, 1.3 Hz, 1H), 7.36 (ddd, <i>J</i> = 8.1, 6.8, 1.3 Hz, 1H), 7.15 (d, <i>J</i> = 7.7 Hz, 2H), 6.99 (s, 2H), 4.65 (tt, <i>J</i> = 6.7, 3.4 Hz, 1H), 3.49 (ddd, <i>J</i> = 12.2, 7.4, 3.7 Hz, 2H), 3.25 (ddd, <i>J</i> = 12.1, 6.8, 4.0 Hz, 2H), 2.67 (s, 6H), 2.33 (s, 3H), 2.08 (ddt, <i>J</i> = 12.1, 7.8, 3.6 Hz, 2H), 1.96 (ddt, <i>J</i> = 13.5, 6.7, 3.3 Hz, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 154.8, 142.5, 140.5, 134.4, 131.9, 131.9, 129.7, 129.1, 127.6, 126.7, 126.4, 123.9, 119.5, 109.0, 77.4, 77.0, 76.6, 71.1, 41.1, 29.9, 22.8, 21.0. HRMS (ESI): calcd for C<sub>24</sub>H<sub>27</sub>NO<sub>3</sub>S, 432.1609 (M + H)<sup>+</sup>; found, 432.1595.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Ethyl 2-fluoro-2-(naphthalen-2-yloxy)acetate (<b>17</b>)</h3><div class="NLM_p last">To a solution of ethyl 2-bromo-2-fluoroacetate (1.8 g, 10 mmol) in dry DMF (1 mL) were added K<sub>2</sub>CO<sub>3</sub> (55.2 mg, 0.4 mmol) and naphthalen-2-ol (720 mg, 5 mmol). The mixture was stirred at room temperature overnight, added with 15 mL of water, and then extracted with EtOAc (20 mL × 3). The combined EtOAc extracts were successively washed with brine and then dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to the residue. This residue was further purified by preparative TLC plates (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 100:1) to yield compound <b>17</b> as a white solid (496 mg, 40%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 7.95–7.73 (m, 3H), 7.60–7.41 (m, 3H), 7.33 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 6.12 (d, <i>J</i> = 59.5 Hz, 1H), 4.41 (q, <i>J</i> = 7.1 Hz, 2H), 1.40 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 2-Fluoro-2-(naphthalen-2-yloxy)acetic Acid (<b>18</b>)</h3><div class="NLM_p last">A solution of lithium hydroxide (84 mg, 2.0 mmol) in water (1 mL) was added to the solution of compound <b>17</b> (248 mg, 1.0 mmol) in tetrahydrofuran (3 mL). The mixture was stirred overnight. After removal of the solvent, the residue was diluted with water (2 mL), acidified with 4 N HCl to pH 4–5, and then extracted with EtOAc (15 mL × 2). The combined organic layer was washed with brine (10 mL), dried, filtered, and then evaporated to yield compound <b>18</b> as a white solid in 76% yield. <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 7.95–7.73 (m, 3H), 7.60–7.41 (m, 3H), 7.33 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 6.12 (d, <i>J</i> = 59.5 Hz, 1H), 4.41 (q, <i>J</i> = 7.1 Hz, 2H), 1.40 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 2-Fluoro-<i>N</i>-(mesitylsulfonyl)-2-(naphthalen-2-yloxy)acetamide (<b>12e</b>)</h3><div class="NLM_p last">A solution of <b>5</b> (40 mg, 0.2 mmol) and compound <b>18</b> (44 mg, 0.2 mmol) in 2 mL of dry DMF was cooled to 0 °C with an ice bath. DMAP (49 mg, 0.4 mmol) and EDCI (77 mg, 0.4 mmol) were successively added to the solution at 0 °C. The mixture was stirred at room temperature for 12 h, added with 10 of mL water, and then extracted with DCM (10 mL × 3). The combined DCM extracts were successively washed with 1 N HCl and brine and then dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to the residue. This residue was further purified by preparative TLC plates (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 50:1) to yield compound <b>20</b> as a white solid (69 mg, 86%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 9.05 (s, 1H), 7.96–7.60 (m, 3H), 7.56–7.38 (m, 3H), 7.24 (d, <i>J</i> = 9.1 Hz, 1H), 6.96 (s, 2H), 6.02 (d, <i>J</i> = 60.4 Hz, 1H), 2.72 (s, 6H), 2.31 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 152.7, 140.7, 133.8, 132.0, 130.8, 130.1, 127.7, 127.5, 126.9, 125.5, 118.4, 113.1, 22.7, 21.1. HRMS (ESI): calcd for C<sub>21</sub>H<sub>20</sub>FNO<sub>4</sub>SNa, 424.0995 (M + Na)<sup>+</sup>; found, 424.0984.</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 2-Methyl-2-(2-naphthyloxy)propanoic Acid (<b>19</b>)</h3><div class="NLM_p last">A solution of 2-naphthol (2.0 g, 13.9 mmol) and NaOH (2.8 g, 69.5 mmol) in acetone (13 mL) was stirred and heated at reflux. Then, CHCl<sub>3</sub> (1.1 mL, 13.8 mmol) was added dropwise over 20 min. The resulting solution was stirred and heated at reflux for 4 h and then evaporated under reduced pressure. H<sub>2</sub>O (15 mL) was added, and the solids were filtered off. The filtrate was acidified via addition of 6 M HCl<sub>(aq)</sub> and extracted with CH<sub>2</sub>Cl<sub>2</sub> (15 mL × 3). The combined organic layers were dried (MgSO<sub>4</sub>) and evaporated under reduced pressure to give the crude product. Recrystallization from 5% EtOAc in pentane gave acid 19 (714 mg, 22%) as a tan solid, mp 122–126 °C; IR (solid) 2994, 1705 (C═O str), 1630, 1599, 1435, 1253, 1115 cm<sup>–1</sup>; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.84–7.68 (m, 3H, Ar), 7.46 (ddd, <i>J</i> = 8.0, 7.0, 1.5, 1H, Ar), 7.40 (ddd, <i>J</i> = 8.0, 7.0, 1.5, 1H, Ar), 7.27 (d, <i>J</i> = 2.5 Hz, 1H, Ar), 7.17 (dd, <i>J</i> = 8.5, 2.5, 1H, Ar), 1.68 (s, 6H); <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>): δ 177.5, 152.2, 134.1, 130.3, 129.6, 127.8, 127.3, 126.6, 124.9, 122.0, 115.8, 80.2, 25.3.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> <i>N</i>-((2,4-Dimethylphenyl)sulfonyl)-2-methyl-2-(naphthalen-2-yloxy)propenamide (<b>12f</b>)</h3><div class="NLM_p last">A solution of sulfonamide <b>11</b> (100 mg, 0.54 mmol), acid <b>19</b> (124 mg, 0.54 mmol), EDCI(124 mg, 0.65 mmol), and DMAP (66 mg, 0.54 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (12 mL) was stirred at rt for 48 h. Then, CH<sub>2</sub>Cl<sub>2</sub> (25 mL) was added, and the resulting solution was washed with 10% HCl<sub>(aq)</sub> (3 × 35 mL), water (25 mL), and brine (25 mL) and then dried (MgSO<sub>4</sub>) and evaporated under reduced pressure to give the crude product. Purification by flash column chromatography on silica with 8:2 petrol/EtOAc as an eluent gave the product <b>12f</b> (17 mg, 8%) as a colorless viscous oil, IR (film) 3253 (O–H str), 2925, 1721 (C═O str), 1598, 1465, 1341, 1177, 1099 cm<sup>–1</sup>; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.09 (d, <i>J</i> = 8.0 Hz, 1H, Ar), 7.82–7.77 (m, 1H), 7.75 (d, <i>J</i> = 9.0 Hz, 1H, Ar), 7.48–7.37 (m, 3H, Ar), 7.19 (d, <i>J</i> = 8.0 Hz, 1H, Ar), 7.06 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H, Ar), 6.89 (d, <i>J</i> = 2.5 Hz, 1H, Ar), 6.87 (s, 1H, NH), 2.40 (s, 3H, Me), 2.21 (s, 3H, Me), 1.55 (s, 6H, CMe<sub>2</sub>); <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>): δ 172.7, 151.4, 145.1, 137.7, 133.9, 133.4, 133.2, 131.9, 130.2, 129.9, 127.7, 127.4, 127.1, 126.5, 125.1, 121.4, 114.7, 81.4, 24.5, 21.6, 20.1.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 2-(Naphthalen-2-yloxy)ethan-1-amine (<b>20</b>)<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></h3><div class="NLM_p last">A solution of 1-naphthol (1.0 g 6.94 mmol), 2-chloroethylamine (15.1 g, 130 mmol), and KOH (25.8 g, 460 mmol) in 3:1 PhMe/dioxane (100 mL) was stirred and heated at reflux for 18 h and then cooled to rt and washed with water (5 × 60 mL). The aqueous layers were washed with EtOAc (3 × 40 mL) and the EtOAc, PhMe, and dioxane layers were combined, dried (MgSO<sub>4</sub>), and evaporated under reduced pressure to give <b>20</b> (886 mg, 57%) as a brown oil, IR (film) 3055 (N–H str), 2930, 2866, 1628, 1599, 1509, 1257, 1216, 1179 cm<sup>–1</sup>; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.81–7.68 (m, 3H, Ar), 7.44 (ddd, <i>J</i> = 8.0, 7.0, 1.5 Hz, 1H, Ar), 7.34 (ddd, <i>J</i> = 8.0, 7.0, 1.5 Hz, 1H, Ar), 7.21–7.12 (m, 2H), 4.11 (t, <i>J</i> = 5.0 Hz, 2H, NCH<sub>2</sub>), 3.15 (t, <i>J</i> = 5.0 Hz, 2H, ArC<i>H</i><sub>2</sub>); <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>): δ 157.0, 134.7, 129.5, 129.1, 127.8, 126.9, 126.5, 123.8, 119.0, 106.8, 70.3, 41.7.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 2,4-Dimethyl-<i>N</i>-(2-(naphthalen-2-yloxy)ethyl)benzenesulfonamide (<b>12g</b>)</h3><div class="NLM_p last">A solution of amine <b>20</b> (131 mg, 0.59 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2.5 mL) was added dropwise to a stirred solution of 2,4-dimethylbenzenesulfonyl chloride (100 mg, 0.49 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2.5 mL) at 0 °C. The resulting solution was allowed to warm to rt and stirred at rt for 20 min. Then, water (15 mL) was added, and the layers were separated, extracting the aqueous layer with CH<sub>2</sub>Cl<sub>2</sub> (3 × 10 mL). The combined organic layers were dried (MgSO<sub>4</sub>) and evaporated under reduced pressure to give the crude product. Purification by flash column chromatography on silica with 9:1 petrol/EtOAc as an eluent gave <b>12g</b> (70 mg, 36%) as a yellow oil, IR (film) 3253 (N–H str), 2933, 1719, 1629, 1600, 1236, 1170, 1156 cm<sup>–1</sup>; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.90 (d, <i>J</i> = 8.0 Hz, 1H, Ar), 7.77 (d, <i>J</i> = 8.0 Hz, 1H, Ar), 7.72 (d, <i>J</i> = 9.0 Hz, 1H, Ar), 7.67 (d, <i>J</i> = 8.5 Hz, 1H, Ar), 7.44 (ddd, <i>J</i> = 8.0, 7.0, 1.5 Hz, 2H, Ar), 7.35 (ddd, <i>J</i> = 8.0, 7.0, 1.5 Hz, 1H, Ar), 7.12–6.94 (m, 4H, Ar), 5.15 (t, <i>J</i> = 6.0 Hz, 1H, NH), 4.01 (t, <i>J</i> = 5.5 Hz, 2H, ArC<i>H</i><sub>2</sub>), 3.41 (dt, <i>J</i> = 5.5, 6.0 Hz, NCH<sub>2</sub>), 2.61 (s, 3H, Me), 2.27 (s, 3H, Me); <sup>13</sup>C (75.5 MHz, CDCl<sub>3</sub>): δ 156.0, 143.7, 136.9, 135.1, 134.4, 133.4, 129.7, 129.6, 129.3, 127.8, 126.9, 126.9, 126.6, 124.1, 118.5, 106.9, 66.1, 42.5, 21.3, 20.2.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Methyl 2-((7-methoxynaphthalen-2-yl)oxy)acetate (<b>22</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>17</b>, compound <b>22</b> was obtained as a white solid (3.7 g, 87%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 7.69 (t, <i>J</i> = 8.1 Hz, 2H), 7.16–6.95 (m, 4H), 4.77 (s, 2H), 3.93 (s, 3H), 3.85 (s, 3H).</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 2-((7-Methoxynaphthalen-2-yl)oxy)acetic Acid (<b>24</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>18</b>, compound <b>24</b> was obtained as a white solid (2.0 g, 86%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.01 (s, 1H), 7.74 (dd, <i>J</i> = 8.9, 3.8 Hz, 2H), 7.19 (dd, <i>J</i> = 13.9, 2.6 Hz, 2H), 7.00 (ddd, <i>J</i> = 9.2, 7.0, 2.6 Hz, 2H), 4.77 (s, 2H), 3.85 (s, 3H).</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> <i>N</i>-((3,5-Dimethylphenyl)sulfonyl)-2-(naphthalen-2-yloxy)acetamide (<b>25a</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>12e</b>, compound <b>25a</b> was obtained as a white solid (41 mg, 57%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 9.08 (s, 1H), 7.80 (d, <i>J</i> = 8.6 Hz, 2H), 7.67 (d, <i>J</i> = 9.4 Hz, 3H), 7.52–7.38 (m, 2H), 7.25 (s, 1H), 7.20 (dd, <i>J</i> = 9.0, 2.6 Hz, 1H), 7.01 (d, <i>J</i> = 2.6 Hz, 1H), 4.60 (s, 2H), 2.35 (s, 6H). <sup>13</sup>C NMR (75 MHz, chloroform-<i>d</i>): δ 166.6, 166.2, 154.3, 139.1, 137.8, 136.0, 134.0, 130.2, 129.7, 127.7, 127.0, 126.9, 125.8, 124.7, 117.8, 107.6, 67.2, 21.2. HRMS (ESI): calcd for C<sub>20</sub>H<sub>19</sub>NO<sub>4</sub>SNa, 392.0932 (M + Na)<sup>+</sup>; found, 392.0919.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> <i>N</i>-((2-Fluorophenyl)sulfonyl)-2-(naphthalen-2-yloxy)acetamide (<b>25b</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>12e</b>, compound <b>25b</b> was obtained as a white solid (43 mg, 60%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 8.12 (t, <i>J</i> = 7.5 Hz, 1H), 7.88–7.73 (m, 2H), 7.63 (dd, <i>J</i> = 15.9, 7.4 Hz, 2H), 7.44 (p, <i>J</i> = 7.1 Hz, 2H), 7.31 (t, <i>J</i> = 7.7 Hz, 1H), 7.26–7.18 (m, 1H), 7.04 (d, <i>J</i> = 8.6 Hz, 2H), 4.61 (s, 2H). <sup>13</sup>C NMR (75 MHz, chloroform-<i>d</i>): δ 160.7, 157.3, 154.4, 136.6, 136.4, 134.1, 131.9, 130.2, 129.7, 127.7, 127.0, 126.8, 124.7, 124.5, 124.5, 118.0, 117.2, 116.9, 107.6, 67.3. HRMS (ESI): calcd for C<sub>18</sub>H<sub>14</sub>FNO<sub>4</sub>SNa, 382.0525 (M + Na)<sup>+</sup>; found, 382.0511.</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> <i>N</i>-((3-Fluorophenyl)sulfonyl)-2-(naphthalen-2-yloxy)acetamide (<b>25c</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>12e</b>, compound <b>25c</b> was obtained as a white solid (46 mg, 64%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 9.15 (s, 1H), 7.90–7.85 (m, 1H), 7.81 (dd, <i>J</i> = 9.4, 3.3 Hz, 3H), 7.68 (d, <i>J</i> = 8.1 Hz, 1H), 7.53–7.39 (m, 3H), 7.35 (dt, <i>J</i> = 8.3, 4.2 Hz, 1H), 7.19 (dd, <i>J</i> = 9.0, 2.6 Hz, 1H), 7.03 (d, <i>J</i> = 2.6 Hz, 1H), 4.61 (s, 2H). <sup>13</sup>C NMR (75 MHz, chloroform-<i>d</i>): δ 166.2, 163.8, 160.4, 154.2, 139.9 (d, <i>J</i> = 7.3 Hz), 134.0, 130.8, 130.7, 130.3, 129.8, 127.7, 127.0, 126.9, 124.8, 124.3, 124.2, 121.7, 121.4, 117.7, 116.1, 115.7, 107.7, 67.2. HRMS (ESI): calcd for C<sub>18</sub>H<sub>14</sub>FNO<sub>4</sub>SNa, 382.0525 (M + Na)<sup>+</sup>; found, 382.0511.</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> <i>N</i>-((4-Fluorophenyl)sulfonyl)-2-(naphthalen-2-yloxy)acetamide (<b>25d</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>12e</b>, compound <b>25d</b> was obtained as a white solid (44 mg, 61%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 9.24 (s, 1H), 8.12–8.04 (m, 2H), 7.79 (dd, <i>J</i> = 8.6, 4.1 Hz, 2H), 7.65 (d, <i>J</i> = 8.1 Hz, 1H), 7.51–7.38 (m, 2H), 7.21–7.10 (m, 3H), 6.99 (d, <i>J</i> = 2.6 Hz, 1H), 4.59 (s, 2H). <sup>13</sup>C NMR (75 MHz, chloroform-<i>d</i>): δ 167.7, 166.5, 164.3, 154.2, 134.0, 133.9, 131.6, 131.4, 130.2, 129.7, 127.7, 127.0, 126.9, 124.8, 117.8, 116.5, 116.2, 107.6, 67.2. HRMS (ESI): calcd for C<sub>18</sub>H<sub>14</sub>FNO<sub>4</sub>SNa, 382.0525 (M + Na)<sup>+</sup>; found, 382.0511.</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> <i>N</i>-((3-Fluoro-4-nitrophenyl)sulfonyl)-2-(naphthalen-2-yloxy)acetamide (<b>25e</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>12e</b>, compound <b>25e</b> was obtained as a yellow solid (113 mg, 56%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.11 (d, <i>J</i> = 9.1 Hz, 1H), 7.82 (d, <i>J</i> = 8.6 Hz, 2H), 7.78–7.60 (m, 4H), 7.39 (dt, <i>J</i> = 23.9, 7.1 Hz, 2H), 7.16 (dd, <i>J</i> = 9.0, 2.6 Hz, 1H), 7.09–6.96 (m, 2H), 4.80 (s, 2H). <sup>13</sup>C NMR (75 MHz, DMSO): δ 168.1, 155.7, 145.9, 145.2, 134.2, 132.5, 129.9, 129.2, 127.9, 127.7, 127.0, 126.9, 124.4, 119.8, 118.8, 112.4, 107.4, 66.6. HRMS (ESI): calcd for C<sub>18</sub>H<sub>14</sub>FN<sub>2</sub>O<sub>6</sub>S, 405.0557 (M + H)<sup>+</sup>; found, 405.0537.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> <i>N</i>-((4-Amino-3-fluorophenyl)sulfonyl)-2-(naphthalen-2-yloxy)acetamide (<b>25f</b>)</h3><div class="NLM_p last">A solution of <b>25e</b> (100 mg, 0.27 mmol) in EtOH (10 mL) was treated with Pd/C (10 mg) and purged with H<sub>2</sub> for 10 min. A slightly positive pressure of H<sub>2</sub> was introduced into the flask and the reaction mixture was heated at 60 °C with vigorous stirring for 3 h. After cooling to room temperature, the reaction mixture was filtered through a pad of celite, and the pad was washed with ethyl acetate. The combined filtrates were concentrated in vacuo, and the residue was purified by silica gel chromatography (eluent: 5% MeOH in DCM) to provide the product as a yellow solid (93 mg, 92%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.97 (d, <i>J</i> = 9.0 Hz, 1H), 7.79 (dd, <i>J</i> = 8.5, 4.1 Hz, 2H), 7.70–7.51 (m, 4H), 7.36 (dt, <i>J</i> = 28.5, 7.2 Hz, 2H), 7.12 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 7.05–6.90 (m, 2H), 4.54 (s, 2H), 3.57 (s, 2H). <sup>13</sup>C NMR (75 MHz, DMSO): δ 171.4, 166.6, 156.5, 150.4, 146.1, 134.5, 131.2, 129.5, 128.9, 127.9, 127.0, 126.7, 126.3, 124.0, 119.1, 118.6, 113.4, 107.3, 68.4. HRMS (ESI): calcd for C<sub>18</sub>H<sub>16</sub>FN<sub>2</sub>O<sub>4</sub>S, 375.0815 (M + H)<sup>+</sup>; found, 375.0819.</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> <i>N</i>-((2,4-Dimethoxyphenyl)sulfonyl)-2-(naphthalen-2-yloxy)acetamide (<b>25g</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>12e</b>, compound <b>25g</b> was obtained as a white solid (31 mg, 39%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 9.11 (s, 1H), 8.06 (d, <i>J</i> = 8.9 Hz, 1H), 7.82 (d, <i>J</i> = 8.6 Hz, 2H), 7.63 (d, <i>J</i> = 8.1 Hz, 1H), 7.45 (dt, <i>J</i> = 19.5, 7.2 Hz, 2H), 7.21 (dd, <i>J</i> = 9.0, 2.6 Hz, 1H), 6.98 (d, <i>J</i> = 2.6 Hz, 1H), 6.60 (dd, <i>J</i> = 9.0, 2.2 Hz, 1H), 6.26 (d, <i>J</i> = 2.3 Hz, 1H), 4.61 (s, 2H), 3.86 (s, 3H), 3.47 (s, 3H). <sup>13</sup>C NMR (75 MHz, chloroform-<i>d</i>): δ 166.6, 166.0, 158.3, 154.7, 134.1, 133.8, 130.1, 129.7, 127.7, 127.0, 126.9, 124.7, 118.0, 107.4, 104.6, 99.2, 67.6, 55.9, 55.8. HRMS (ESI): calcd for C<sub>20</sub>H<sub>19</sub>NO<sub>6</sub>SNa, 424.0831 (M + Na)<sup>+</sup>; found, 424.0816.</div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> <i>N</i>-((2,5-Dimethoxyphenyl)sulfonyl)-2-(naphthalen-2-yloxy)acetamide (<b>25h</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>12e</b>, compound <b>25h</b> was obtained as a white solid (64 mg, 80%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 9.17 (s, 1H), 7.83 (d, <i>J</i> = 9.2 Hz, 2H), 7.69–7.60 (m, 2H), 7.46 (dt, <i>J</i> = 19.7, 7.1 Hz, 2H), 7.21 (dd, <i>J</i> = 9.0, 2.6 Hz, 1H), 7.11 (dd, <i>J</i> = 9.0, 3.2 Hz, 1H), 7.00 (d, <i>J</i> = 2.6 Hz, 1H), 6.76 (d, <i>J</i> = 9.1 Hz, 1H), 4.64 (s, 2H), 3.86 (s, 3H), 3.51 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 166.6, 154.6, 153.0, 134.1, 130.2, 129.7, 127.7, 127.0, 126.9, 124.7, 122.6, 117.9, 115.2, 113.6, 107.5, 67.6, 56.4, 56.1. HRMS (ESI): calcd for C<sub>20</sub>H<sub>20</sub>NO<sub>6</sub>S, 402.1011 (M + H)<sup>+</sup>; found, 402.0999.</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> <i>N</i>-((3,4-Dimethoxyphenyl)sulfonyl)-2-(naphthalen-2-yloxy)acetamide (<b>25i</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>12e</b>, compound <b>25i</b> was obtained as a white solid (60 mg, 75%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 9.00 (s, 1H), 7.81 (d, <i>J</i> = 8.5 Hz, 2H), 7.73–7.61 (m, 2H), 7.52 (d, <i>J</i> = 2.2 Hz, 1H), 7.45 (dt, <i>J</i> = 20.0, 7.0 Hz, 2H), 7.19 (dd, <i>J</i> = 9.0, 2.6 Hz, 1H), 6.99 (d, <i>J</i> = 2.6 Hz, 1H), 6.90 (d, <i>J</i> = 8.6 Hz, 1H), 4.60 (s, 2H), 3.95 (s, 3H), 3.87 (s, 3H). 13C NMR (75 MHz, CDCl<sub>3</sub>): δ 166.6, 154.3, 153.9, 148.9, 134.0, 130.2, 129.7, 127.7, 127.0, 126.9, 124.7, 122.9, 117.8, 110.7, 110.3, 107.6, 67.3, 56.2 (2C). HRMS (ESI): calcd for C<sub>20</sub>H<sub>20</sub>NO<sub>6</sub>S, 402.1011 (M + H)<sup>+</sup>; found, 402.0999.</div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> <i>N</i>-((3-Bromo-5-methylphenyl)sulfonyl)-2-(naphthalen-2-yloxy)acetamide (<b>25j</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>12e</b>, compound <b>25j</b> was obtained as a white solid (69 mg, 75%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 9.06 (s, 1H), 8.03 (d, <i>J</i> = 1.9 Hz, 1H), 7.82 (d, <i>J</i> = 8.6 Hz, 3H), 7.68 (d, <i>J</i> = 8.0 Hz, 1H), 7.57 (s, 1H), 7.45 (dt, <i>J</i> = 20.6, 7.1 Hz, 2H), 7.20 (dd, <i>J</i> = 9.0, 2.7 Hz, 1H), 7.03 (d, <i>J</i> = 2.7 Hz, 1H), 4.61 (s, 2H), 2.37 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 154.2, 141.4, 137.9, 134.0, 130.3, 129.7, 128.2, 127.7, 127.5, 127.0, 126.9, 124.8, 122.6, 117.7, 107.7, 67.2, 21.1. HRMS (ESI): calcd for C<sub>19</sub>H<sub>16</sub>BrNO<sub>4</sub>SNa, 455.9876 (M + Na)<sup>+</sup>; found, 455.9872.</div></div><div id="sec5_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> <i>N</i>-((3-Bromo-5-methylphenyl)sulfonyl)-2-((7-methoxynaphthalen-2-yl)oxy)acetamide (<b>25k</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>12e</b>, compound <b>25k</b> was obtained as a white solid (61 mg, 66%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 9.09 (s, 1H), 8.02 (s, 1H), 7.79 (s, 1H), 7.69 (t, <i>J</i> = 9.0 Hz, 2H), 7.56 (s, 1H), 7.12–6.89 (m, 4H), 4.59 (s, 2H), 3.91 (s, 3H), 2.35 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 158.5, 154.8, 141.4, 137.8, 135.5, 129.9, 129.2, 128.2, 127.5, 125.1, 122.5, 117.3, 115.0, 107.0, 105.4, 67.3, 55.3, 21.0. HRMS (ESI): calcd for C<sub>20</sub>H<sub>18</sub>BrNO<sub>5</sub>SNa, 485.9987 (M + Na)<sup>+</sup>; found, 485.9985.</div></div><div id="sec5_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> <i>N</i>-((3,5-Dichlorophenyl)sulfonyl)-2-((7-methoxynaphthalen-2-yl)oxy)acetamide (<b>25l</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>12e</b>, compound <b>25l</b> was obtained as a white solid (67 mg, 76%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 9.11 (s, 1H), 7.96 (d, <i>J</i> = 1.9 Hz, 2H), 7.72 (dd, <i>J</i> = 11.2, 8.9 Hz, 2H), 7.59 (t, <i>J</i> = 1.9 Hz, 1H), 7.16–6.90 (m, 4H), 4.63 (s, 2H), 3.93 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 166.6, 158.6, 154.7, 136.0, 135.5, 134.2, 130.1, 129.3, 126.8, 125.1, 117.5, 114.9, 107.1, 105.3, 67.2, 55.3. HRMS (ESI): calcd for C<sub>19</sub>H<sub>16</sub>Cl<sub>2</sub>NO<sub>5</sub>S, 440.0126 (M + H)<sup>+</sup>; found, 440.0117.</div></div><div id="sec5_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> <i>N</i>-((2-Methoxy-4-nitrophenyl)sulfonyl)-2-((7-methoxynaphthalen-2-yl)oxy)acetamide (<b>25m</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>12e</b>, compound <b>25m</b> was obtained as a white solid (52 mg, 58%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.82 (s, 1H), 8.12 (d, <i>J</i> = 9.3 Hz, 1H), 8.00–7.87 (m, 2H), 7.73 (dd, <i>J</i> = 8.9, 2.2 Hz, 2H), 7.10 (d, <i>J</i> = 2.5 Hz, 1H), 7.06–6.88 (m, 3H), 4.78 (s, 2H), 4.05 (s, 3H), 3.85 (s, 3H). <sup>13</sup>C NMR (75 MHz, DMSO): δ 168.0, 158.3, 157.6, 156.4, 152.2, 135.8, 132.8, 132.3, 129.6, 129.5, 124.5, 116.8, 115.8, 115.4, 108.7, 107.0, 105.7, 66.5, 57.8, 55.6. HRMS (ESI): calcd for C<sub>20</sub>H<sub>19</sub>N<sub>2</sub>O<sub>8</sub>S, 447.0862 (M + H)<sup>+</sup>; found, 447.0857.</div></div><div id="sec5_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> <i>N</i>-((4-Amino-2-methoxyphenyl)sulfonyl)-2-((7-methoxynaphthalen-2-yl)oxy)acetamide (<b>25n</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>25f</b>, compound <b>25n</b> was obtained as a white solid (87 mg, 94%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.90 (s, 1H), 7.71 (d, <i>J</i> = 8.7 Hz, 2H), 7.44 (d, <i>J</i> = 8.8 Hz, 1H), 7.20–6.84 (m, 4H), 6.35–6.00 (m, 4H), 4.69 (s, 2H), 3.82 (d, <i>J</i> = 19.3 Hz, 5H). <sup>13</sup>C NMR (75 MHz, DMSO): δ 167.0, 159.0, 158.3, 156.6, 156.3, 135.8, 133.1, 129.6, 129.5, 124.5, 116.7, 115.9, 112.2, 106.9, 105.6, 105.1, 96.5, 66.4, 56.1, 55.6. HRMS (ESI): calcd for C<sub>20</sub>H<sub>21</sub>N<sub>2</sub>O<sub>6</sub>S, 417.1120 (M + H)<sup>+</sup>; found, 417.1113.</div></div><div id="sec5_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> <i>N</i>-((2,5-Dimethoxyphenyl)sulfonyl)-2-((7-methoxynaphthalen-2-yl)oxy)acetamide (<b>25o</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>12e</b>, compound <b>25o</b> was obtained as a white solid (61 mg, 71%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 9.09 (s, 1H), 7.70 (t, <i>J</i> = 9.1 Hz, 2H), 7.62 (d, <i>J</i> = 2.9 Hz, 1H), 7.06 (qd, <i>J</i> = 9.0, 3.0 Hz, 3H), 6.91 (d, <i>J</i> = 10.8 Hz, 2H), 6.73 (d, <i>J</i> = 9.0 Hz, 1H), 4.60 (s, 2H), 3.90 (s, 3H), 3.84 (s, 3H), 3.49 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 158.5, 155.3, 153.0, 150.7, 135.6, 129.8, 129.1, 125.0, 122.4, 117.3, 115.2, 115.1, 113.6, 106.8, 105.3, 67.6, 56.3, 56.1, 55.3. HRMS (ESI): calcd for C<sub>21</sub>H<sub>22</sub>NO<sub>7</sub>S, 432.1117 (M + H)<sup>+</sup>; found, 432.1116.</div></div><div id="sec5_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> <i>N</i>-((3,4-Dimethoxyphenyl)sulfonyl)-2-((7-methoxynaphthalen-2-yl)oxy)acetamide (<b>25p</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>12e</b>, compound <b>25p</b> was obtained as a white solid (53 mg, 62%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 8.99 (s, 1H), 7.77–7.59 (m, 3H), 7.51 (d, <i>J</i> = 2.3 Hz, 1H), 7.05 (ddd, <i>J</i> = 14.7, 8.8, 2.5 Hz, 2H), 6.97–6.84 (m, 3H), 4.59 (s, 2H), 3.94 (s, 3H), 3.91 (s, 3H), 3.87 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 166.6, 158.6, 154.9, 148.9, 135.5, 129.9, 129.2, 125.0, 122.9, 117.4, 115.1, 110.7, 110.3, 106.9, 105.3, 67.3, 56.2, 55.3. HRMS (ESI): calcd for C<sub>21</sub>H<sub>22</sub>NO<sub>7</sub>S, 402.1011 (M + H)<sup>+</sup>; found, 402.0999.</div></div><div id="sec5_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 2-((7-Methoxynaphthalen-2-yl)oxy)-<i>N</i>-(naphthalen-2-ylsulfonyl)acetamide (<b>25q</b>)</h3><div class="NLM_p last">Following the same synthetic procedure of compound <b>12e</b>, compound <b>25q</b> was obtained as a white solid (54 mg, 64%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 9.05 (s, 1H), 8.75–8.62 (m, 1H), 7.97 (d, <i>J</i> = 8.0 Hz, 1H), 7.93–7.80 (m, 3H), 7.76–7.58 (m, 4H), 7.05 (td, <i>J</i> = 9.3, 2.5 Hz, 2H), 6.87 (dd, <i>J</i> = 9.1, 2.5 Hz, 2H), 4.58 (s, 2H), 3.83 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 166.3, 158.5, 154.8, 135.5, 134.7, 131.8, 130.8, 130.0, 129.7, 129.5, 129.2, 129.2, 127.9, 127.7, 125.1, 122.6, 117.4, 115.1, 106.9, 105.3, 67.3, 55.2. HRMS (ESI): calcd for C<sub>23</sub>H<sub>20</sub>NO<sub>5</sub>S, 422.1062 (M + H)<sup>+</sup>; found, 422.1053.</div></div><div id="sec5_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> <i>N</i>-((3-(5-Fluoropyridin-3-yl)-5-methylphenyl)sulfonyl)-2-(naphthalen-2-yloxy)acetamide (<b>25r</b>)</h3><div class="NLM_p last">To a stirred solution of compound <b>25j</b> (87 mg, 0.2 mmol) in 1,4-dioxane (2 mL) were added (5-fluoropyridin-3-yl)boronic acid (28 mg, 0.2 mmol), K<sub>2</sub>CO<sub>3</sub> (55.2 mg, 0.4 mmol), and [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) (8 mg, 0.01 mmol), and the reaction mixture was heated at 110 °C overnight. After cooling to room temperature, the reaction mixture was filtered through a pad of celite, and the pad was washed with ethyl acetate. The combined filtrates were concentrated in vacuo, and the residue was purified by silica gel chromatography (eluent: 2% ethyl acetate in petroleum ether) to provide the product <b>25r</b> (62 mg, 71%) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.48 (s, 1H), 8.76 (s, 1H), 8.64 (s, 1H), 8.04 (s, 2H), 7.93 (s, 1H), 7.84–7.74 (m, 3H), 7.58 (d, <i>J</i> = 8.0 Hz, 1H), 7.36 (p, <i>J</i> = 7.2 Hz, 2H), 7.15 (d, <i>J</i> = 8.4 Hz, 1H), 7.06 (s, 1H), 4.81 (s, 2H), 2.45 (s, 3H). <sup>13</sup>C NMR (75 MHz, DMSO): δ 168.2, 155.8, 144.5, 144.4, 141.0, 140.5, 137.9, 137.6, 136.9, 136.4, 134.3, 133.6, 129.8, 129.1, 128.0, 127.9, 127.0, 126.8, 124.3, 123.4, 121.9, 121.7, 118.8, 107.4, 66.7, 21.3. HRMS (ESI): calcd for C<sub>24</sub>H<sub>20</sub>FN<sub>2</sub>O<sub>4</sub>S, 451.1128 (M + H)<sup>+</sup>; found, 451.1120.</div></div><div id="sec5_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> <i>N</i>-((3-(Furan-2-yl)-5-methylphenyl)sulfonyl)-2-(naphthalen-2-yloxy)acetamide (<b>25s</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>25r</b>, compound <b>25s</b> was obtained as a white solid (33 mg, 79%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 9.02 (s, 1H), 8.15 (s, 1H), 7.86–7.69 (m, 4H), 7.64 (d, <i>J</i> = 7.9 Hz, 1H), 7.53–7.36 (m, 3H), 7.19 (dd, <i>J</i> = 9.0, 2.6 Hz, 1H), 7.01 (d, <i>J</i> = 2.6 Hz, 1H), 6.75 (d, <i>J</i> = 3.4 Hz, 1H), 6.50 (dd, <i>J</i> = 3.4, 1.8 Hz, 1H), 4.61 (s, 2H), 2.42 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 166.1, 154.2, 151.9, 143.0, 139.8, 138.6, 134.0, 131.8, 130.2, 129.7, 127.7, 127.1, 127.0, 126.9, 124.7, 120.8, 117.7, 111.9, 107.7, 106.9, 67.3, 21.4. HRMS (ESI): calcd for C<sub>23</sub>H<sub>20</sub>NO<sub>5</sub>S, 422.1062 (M + H)<sup>+</sup>; found, 422.1056.</div></div><div id="sec5_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> <i>N</i>-((3-Methyl-5-(1-methyl-1<i>H</i>-pyrazol-5-yl)phenyl)sulfonyl)-2-(naphthalen-2-yloxy)acetamide (<b>25t</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>25r</b>, compound <b>25t</b> was obtained as a white solid (27 mg, 63%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 7.93 (d, <i>J</i> = 28.3 Hz, 2H), 7.75 (s, 2H), 7.50 (q, <i>J</i> = 20.7 Hz, 5H), 7.19 (d, <i>J</i> = 8.8 Hz, 1H), 7.00 (s, 1H), 6.35 (s, 1H), 4.57 (s, 2H), 3.88 (s, 3H), 2.45 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 154.4, 139.9, 138.7, 134.0, 131.6, 130.1, 129.6, 127.6, 126.9, 126.8, 124.6, 117.7, 107.8, 106.7, 37.6, 21.3. HRMS (ESI): calcd for C<sub>23</sub>H<sub>22</sub>N<sub>3</sub>O<sub>4</sub>S, 436.1331 (M + H)<sup>+</sup>; found, 436.1323.</div></div><div id="sec5_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> <i>N</i>-((3-Methyl-5-((3-(trifluoromethyl)pyridin-2-yl)amino)phenyl)sulfonyl)-2-(naphthalen-2-yloxy)acetamide (<b>25u</b>)</h3><div class="NLM_p last">To a stirred solution of compound <b>25j</b> (87 mg, 0.2 mmol) in 1,4-dioxane (2 mL) were added 3-(trifluoromethyl)pyridin-2-amine (32.4 mg, 0.2 mmol), Cs<sub>2</sub>CO<sub>3</sub> (130 mg, 0.4 mmol), XantPhos (11.6 mg, 0.02), and Pd(OAc)<sub>2</sub> (2 mg, 0.01 mmol), and the reaction mixture was heated at 100 °C overnight. After cooling to room temperature, the reaction mixture was filtered through a pad of celite, and the pad was washed with ethyl acetate. The combined filtrates were concentrated in vacuo, and the residue was purified by silica gel chromatography (eluent: 50% ethyl acetate in petroleum ether) to provide the product <b>25u</b> (52 g, 50%) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.43 (s, 1H), 8.42 (d, <i>J</i> = 25.1 Hz, 2H), 8.03 (d, <i>J</i> = 9.9 Hz, 2H), 7.80 (d, <i>J</i> = 8.4 Hz, 2H), 7.66 (d, <i>J</i> = 8.7 Hz, 2H), 7.36 (d, <i>J</i> = 15.0 Hz, 3H), 7.22–6.90 (m, 3H), 4.80 (s, 2H), 2.32 (s, 3H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 167.6, 166.6, 155.8, 152.0, 151.9, 141.3, 139.8, 139.1, 136.8 (d, <i>J</i> = 5.3 Hz), 134.3, 129.8, 129.2, 127.9, 127.6, 127.1, 126.9, 126.0, 124.4, 122.4, 121.9, 118.7, 117.9, 115.9, 110.6 (dd, <i>J</i> = 62.6, 31.3 Hz), 107.5, 66.6, 21.4. HRMS (ESI): calcd for C<sub>25</sub>H<sub>21</sub>F<sub>3</sub>N<sub>3</sub>O<sub>4</sub>S, 516.1205 (M + H)<sup>+</sup>; found, 516.1199.</div></div><div id="sec5_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> <i>N</i>-((3-Methyl-5-((5-(trifluoromethyl)pyridin-2-yl)amino)phenyl)sulfonyl)-2-(naphthalen-2-yloxy)acetamide (<b>25v</b>)</h3><div class="NLM_p last">Following the synthetic procedure of compound <b>25u</b>, compound <b>25v</b> was obtained as a white solid (37 mg, 72%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 8.50 (s, 1H), 7.97 (s, 1H), 7.75 (d, <i>J</i> = 20.6 Hz, 3H), 7.65 (d, <i>J</i> = 9.3 Hz, 2H), 7.56 (s, 1H), 7.49–7.38 (m, 2H), 7.19 (d, <i>J</i> = 8.9 Hz, 1H), 7.01 (s, 1H), 6.84 (d, <i>J</i> = 9.6 Hz, 2H), 4.62 (s, 2H), 2.40 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 154.2, 154.2, 140.6 (2C), 140.1, 134.9, 134.0, 130.3, 129.7, 127.7 (2C), 126.9, 126.1, 124.8, 123.0, 117.7, 116.7, 108.8, 107.7, 67.3, 21.5. HRMS (ESI): calcd for C<sub>25</sub>H<sub>21</sub>F<sub>3</sub>N<sub>3</sub>O<sub>4</sub>S, 516.1205 (M + H)<sup>+</sup>; found, 516.1198.</div></div><div id="sec5_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> 2-(Naphthalen-2-yloxy)-<i>N</i>-tosylacetamide (<b>25w</b>)</h3><div class="NLM_p last">A solution of acid <b>23</b> (200 mg, 0.99 mmol), <i>p</i>-toluenesulfonamide (170 mg, 0.99 mmol), EDCI (228 mg, 1.19 mmol), and DMAP (121 mg, 0.99 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (15 mL) was stirred at rt for 44 h. Then, CH<sub>2</sub>Cl<sub>2</sub> (25 mL) was added, and the resulting solution was washed with 10% HCl<sub>(aq)</sub> (3 × 25 mL), water (25 mL), and brine (25 mL), dried (MgSO<sub>4</sub>), and evaporated under reduced pressure to give the crude product. Recrystallization from MeOH gave <b>25w</b> (205 mg, 58%) as a white solid, mp 165–168 °C; IR (solid) 3310 (N–H str), 1720 (C═O str), 1629, 1418, 1201, 1179, 1159 cm<sup>–1</sup>; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.91 (s, 1H, NH), 7.93 (dt, <i>J</i> = 8.5, 2.0 Hz, 2H, Ar), 7.85–7.77 (m, 2H, Ar), 7.65 (d, <i>J</i> = 8.0, 1H, Ar), 7.48 (ddd, <i>J</i> = 8.0, 7.0, 1.5 Hz, 1H, Ar), 7.41 (ddd, <i>J</i> = 8.0, 7.0, 1.5 Hz, 1H, Ar), 7.29 (d, <i>J</i> = 8.0 Hz, 2H, Ar), 7.18 (dd, <i>J</i> = 9.0, 2.5 Hz, 2H, Ar), 6.99 (d, <i>J</i> = 2.5 Hz, 1H, Ar), 4.58 (s, 2H, OCH<sub>2</sub>), 2.43 (s, 3H, Me); <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>): δ 166.2, 154.4, 145.6, 135.2, 134.2, 130.4, 129.9, 129.8, 128.7, 127.9, 127.2, 127.1, 124.9, 117.9, 107.8, 67.4, 21.9.</div></div><div id="sec5_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> 3-Nitrobenzenesulfonamide (<b>26</b>)</h3><div class="NLM_p last">NH<sub>4</sub>OH<sub>(aq)</sub> (35%, 3 mL) was added dropwise to a stirred solution of 3-nitrobenzenesulfonyl chloride (1.0 g, 4.52 mmol) in THF (3 mL) at 0 °C. The resulting solution was allowed to warm to rt and stirred at rt for 18 h. Water (10 mL) was added, and the resulting solution was extracted with EtOAc (3 × 30 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and evaporated under reduced pressure to give <b>26</b> (875 mg, 96%) as a white solid, mp 164–167 °C; IR (solid) 3341 (N–H str), 3261 (N–H str), 3095, 1606, 1529, 1333, 1184 cm<sup>–1</sup>; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.60 (t, <i>J</i> = 2.0 Hz, 1H, Ar), 8.45 (ddd, <i>J</i> = 8.0, 2.0, 1.0 Hz, 1H, Ar), 8.24 (ddd, <i>J</i> = 8.0, 2.0, 1.0 Hz, 1H, Ar), 7.89 (t, <i>J</i> = 8.0 Hz, 1H, Ar), 7.71 (br s, 2H, NH<sub>2</sub>); <sup>13</sup>C NMR (75.5 MHz, DMSO-<i>d</i><sub>6</sub>): δ 147.7, 145.6, 131.7, 131.1, 126.5, 120.5.</div></div><div id="sec5_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> 2-(Naphthalen-2-yloxy)-<i>N</i>-((3-nitrophenyl)sulfonyl)acetamide (<b>25x</b>)</h3><div class="NLM_p last">A solution of acid <b>23</b> (200 mg, 0.99 mmol), sulfonamide <b>26</b> (200 mg, 0.99 mmol), EDCI (228 mg, 1.19 mmol), and DMAP (121 g, 0.99 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was stirred at rt for 42 h. Then, CH<sub>2</sub>Cl<sub>2</sub> (25 mL) was added, and the resulting solution was washed with 10% HCl<sub>(aq)</sub> (3 × 25 mL), water (25 mL), and brine (25 mL) and then dried (MgSO<sub>4</sub>) and evaporated under reduced pressure to give the crude product. Purification by flash column chromatography on silica with 8:2 CH<sub>2</sub>Cl<sub>2</sub>:MeOH gave <b>25x</b> (167 mg, 44%) as a yellow solid, mp 145–149 °C; IR (solid) 3566 (N–H str), 3522, 3359, 1631, 1597, 1532, 1390, 1352, 1174, 1117; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.54 (t, <i>J</i> = 2.0 Hz, 1H, Ar), 8.29 (ddd, <i>J</i> = 8.0, 2.5, 1.0 Hz, 1H, Ar), 8.20 (dt, <i>J</i> = 8.0, 1.5 Hz, 1H, Ar), 7.83–7.66 (m, 3H, Ar), 7.61 (d, <i>J</i> = 8.0 Hz, 1H, Ar), 7.40 (ddd, <i>J</i> = 8.0, 7.0, 1.5 Hz, 1H, Ar), 7.31 (ddd, <i>J</i> = 8.0, 7.0, 1.5 Hz, 1H, Ar), 7.09 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H, Ar), 7.00 (d, <i>J</i> = 2.5 Hz, 1H, Ar), 4.48 (s, 2H, OCH<sub>2</sub>); <sup>13</sup>C (75.5 MHz, DMSO-<i>d</i><sub>6</sub>): δ 171.7, 156.2, 147.2, 146.1, 134.1, 133.3, 130.1, 129.2, 128.5, 127.6, 126.6, 126.4, 125.7, 123.7, 121.9, 118.7, 107.0, 68.2.</div></div><div id="sec5_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> 2-(Naphthalen-2-yloxy)-<i>N</i>-(phenylsulfonyl)acetamide (<b>25y</b>)</h3><div class="NLM_p last">A solution of benzenesulfonamide <b>27</b> (455 mg, 0.99 mmol), acid <b>23</b> (200 mg, 0.99 mmol), EDCI (228 mg, 1.19 mmol), and DMAP (121 mg, 0.99 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was stirred at rt for 26 h. Then, CH<sub>2</sub>Cl<sub>2</sub> (25 mL) was added, and the resulting solution was washed with 10% HCl<sub>(aq)</sub> (3 × 25 mL), water (25 mL), and brine (25 mL), dried (MgSO<sub>4</sub>), and evaporated under reduced pressure to give the crude product. Recrystallization from MeOH gave <b>25y</b> (146 mg, 43%) as a white solid, mp 174–178 °C; IR (solid) 3312 (N–H str), 1724 (C═O str), 1627, 1602, 1418, 1370, 1187, 1160 cm<sup>–1</sup>; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.95 (s, 1H, NH), 8.11–8.02 (m, 2H, Ar), 7.81 (dd, <i>J</i> = 9.0, 2.5 Hz, 2H, Ar), 7.70–7.60 (m, 2H, Ar), 7.57–7.36 (m, 4H, Ar), 7.18 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H, Ar), 7.01 (d, <i>J</i> = 2.5 Hz 1H, Ar), 4.59 (s, 2H, OCH<sub>2</sub>); <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>): δ 166.2, 154.3, 138.2, 134.4, 134.2, 130.5, 129.9, 129.2, 128.7, 127.9, 127.2, 127.1, 125.0, 117.9, 107.8, 67.4.</div></div><div id="sec5_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> <i>N</i>-((3-methoxyphenyl)sulfonyl)-2-(naphthalen-2-yloxy)acetamide (<b>25z</b>)</h3><div class="NLM_p last">A solution of sulfonamide <b>28</b> (185 mg, 0.99 mmol), acid <b>23</b> (200 mg, 0.99 mmol), EDCI (228 mg, 1.19 mmol), and DMAP (121 mg, 0.99 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was stirred at rt for 26 h. Then, CH<sub>2</sub>Cl<sub>2</sub> (25 mL) was added, and the resulting solution was washed with 10% HCl (3 × 25 mL), water (25 mL), and brine (25 mL), dried (MgSO<sub>4</sub>), and evaporated under reduced pressure to give the crude product. Recrystallization from MeOH gave <b>26z</b> (163 mg, 44%) as a white solid, mp 151–154 °C; IR (solid) 3313 (N–H str), 1730 (C═O str), 1630, 1601, 1582, 1416, 1258, 1187, 1076 cm<sup>–1</sup>; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.97 (s, 1H, NH), 7.85–7.74 (m, 2H, Ar), 7.65 (d, <i>J</i> = 8.0 Hz 1H, Ar), 7.66–7.61 (m, 1H, Ar), 7.57 (dd, <i>J</i> = 2.5, 1.5 Hz, 1H, Ar), 7.47 (ddd, <i>J</i> = 8.0, 7.0, 1.5 Hz, 1H, Ar), 7.41 (ddd, <i>J</i> = 8.0, 7.0, 1.5 Hz, 1H, Ar), 7.40 (dd, <i>J</i> = 8.0, 8.0 Hz, 1H, Ar), 7.18 (dd, <i>J</i> = 6.5, 3.0 Hz, 1H, Ar), 7.16 (ddd, <i>J</i> = 8.5, 2.5, 1.0 Hz, 1H, Ar), 7.00 (d, <i>J</i> = 2.5 Hz, 1H, Ar), 4.60 (s, 2H, OCH<sub>2</sub>), 3.81 (s, 3H, OMe); <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>): δ 166.2, 159.9, 154.3, 139.2, 134.2, 130.4, 130.2, 129.9, 127.9, 127.2, 127.1, 124.9, 121.2, 120.7, 117.9, 112.8, 107.8, 67.4, 55.8.</div></div><div id="sec5_71" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> <i>N</i>-(Cyclohexylsulfonyl)-2-(naphthalen-2-yloxy)acetamide (<b>25aa</b>)</h3><div class="NLM_p last">A solution of cyclohexylsulfonamide <b>29</b> (50 mg, 0.31 mmol), acid <b>23</b> (62 mg, 0.31 mmol), EDCI (71 mg, 0.37 mmol), and DMAP (37 mg, 0.31 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was stirred at rt for 60 h. Then, CH<sub>2</sub>Cl<sub>2</sub> (25 mL) was added, and the resulting solution was washed with 10% HCl<sub>(aq)</sub> (3 × 25 mL), water (25 mL), and brine (25 mL), dried (MgSO<sub>4</sub>), and evaporated under reduced pressure to give the crude product. Purification by flash column chromatography on silica with 8:2 petrol/EtOAc as an eluent gave <b>25aa</b> (36 mg, 34%) as a colorless oil, IR (film) 3236 (N–H str), 2934, 2858, 1716 (C═O str), 1630, 1468, 1418, 1390, 1338, 1217, 1180, 1145 cm<sup>–1</sup>; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.71 (s, 1H, NH), 7.86–7.77 (m, 2H, Ar), 7.74 (dd, <i>J</i> = 8.0, 1.0 Hz, 1H, Ar), 7.48 (ddd, <i>J</i> = 8.0, 7.0, 1.5 Hz, 1H, Ar), 7.40 (ddd, <i>J</i> = 8.0, 7.0, 1.5 Hz, 1H, Ar), 7.20 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H, Ar), 7.13 (d, <i>J</i> = 2.5 Hz, 1H, Ar), 4.69 (s, 2H, OCH<sub>2</sub>), 3.57 (tt, <i>J</i> = 12.0, 3.5 Hz, 1H, SCH), 2.21–2.07 (m, 2H), 1.86 (dt, <i>J</i> = 13.0 3.5 Hz, 2H), 1.73–1.49 (m, 2H), 1.36–1.10 (m, 4H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 167.5 (C), 154.4 (C), 134.2 (C), 130.5 (CH), 129.9 (C), 127.9 (CH), 127.2 (CH), 127.1 (CH), 125.0 (CH), 118.0 (CH), 107.9 (CH), 67.4 (CH<sub>2</sub>), 62.1 (CH), 25.8 (CH<sub>2</sub>), 25.0 (2 × CH<sub>2</sub>).</div></div><div id="sec5_72" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> 3-(Furan-3-yl)benzenesulfonamide (<b>31</b>)</h3><div class="NLM_p last">A solution of 3-bromobenzenesulfonamide (231 mg, 1.0 mmol), furan-3-boronic acid (130 mg, 1.2 mmol), K<sub>2</sub>CO<sub>3</sub> (201 mg, 1.5 mmol), and Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (35 mg, 0.05 mmol) in dioxane (7 mL) and water (0.4 mL) was stirred and heated at reflux for 2 h. Then, the resulting solution was allowed to cool to rt and filtered over a silica plug, washing with EtOAc. The filtrate was evaporated under reduced pressure to give the crude product. Purification by flash column chromatography on silica with 8:2 petrol/EtOAc as an eluent gave 3-(furan-3-yl)benzenesulfonamide <b>31</b> (241 mg, 86%) as a white solid, mp 132–134 °C; IR (solid) 3341 (N–H str), 3259 (N–H str), 1316, 1306, 1157, 1112, 1052, 1013, 904, 872 cm<sup>–1</sup>; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.03 (dd, <i>J</i> = 2.0, 0.5 Hz, 1H, Ar), 7.84–7.79 (m, 2H, Ar), 7.69 (ddd, <i>J</i> = 8.0, 1.5, 1.0 Hz, 1H, Ar), 7.55 (dd, <i>J</i> = 8.0, 0.5 Hz, 1H, Ar), 7.55–7.48 (m, 1H, Ar), 6.73 (dd, <i>J</i> = 2.0, 1.0 Hz, 1H, Ar), 4.79 (s, 2H, NH<sub>2</sub>); <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>): δ 144.4 (CH), 142.7 (C), 139.5 (CH), 134.1 (C), 130.1 (CH), 129.9 (CH), 125.2 (C), 124.8 (CH), 123.8 (CH), 108.7 (CH).</div></div><div id="sec5_73" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> <i>N</i>-3-(Furan-3-yl)phenylsulfonyl-2-(naphthalene-2-yloxy)acetamide (<b>25ab</b>)</h3><div class="NLM_p last">A solution of sulphonamide <b>31</b> (59 mg, 0.28 mmol), acid <b>23</b> (57 mg, 0.28 mmol), EDCI (64 mg, 0.34 mmol), and DMAP (34 mg, 0.28 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was stirred at rt for 72 h. Then, CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added, and the resulting solution was washed with 10% HCl<sub>(aq)</sub> (3 × 5 mL), water (5 mL), and brine (5 mL), dried (MgSO<sub>4</sub>), and evaporated under reduced pressure to give the crude product. Recrystallization from PhMe/hexane gave <b>25ab</b> (10 mg, 9%) as a white solid, mp 156–158 °C; IR (solid) 3247 (N–H str), 1725 (C═O str), 1630, 1601, 1510, 1416, 1353, 1216, 1160, 839, 750 cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.02 (br s, 1H, NH), 8.16 (t, <i>J</i> = 2.0 Hz, 1H, Ar), 7.94 (d, <i>J</i> = 8.0 Hz, 1H, Ar), 7.83–7.76 (m, 3H, Ar), 7.73 (d, <i>J</i> = 8.0 Hz, 1H, Ar), 7.64 (d, <i>J</i> = 8.0 Hz, 1H, Ar), 7.55–7.33 (m, 4H, Ar), 7.18 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H, Ar), 7.00 (d, <i>J</i> = 2.5 Hz, 1H, Ar), 6.71 (d, <i>J</i> = 0.5 Hz, 1H, Ar), 4.60 (s, 2H, CH<sub>2</sub>); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 166.3 (C), 154.3 (C), 144.4 (C), 139.6 (CH), 138.8 (C), 134.1 (C), 134.0 (C), 131.5 (CH), 130.4 (CH), 129.9 (C), 129.7 (CH), 127.9 (CH), 127.2 (CH), 127.1 (CH), 126.8 (CH), 125.6 (CH), 124.9 (2 × CH), 117.9 (CH), 108.7 (CH), 107.8 (CH), 67.4 (CH<sub>2</sub>); HRMS (ESI): calcd for C<sub>22</sub>H<sub>18</sub>NO<sub>5</sub>S, 408.0900 (M + H)<sup>+</sup>; found, 408.0893.</div></div><div id="sec5_74" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> (1,1′-Biphenyl)-3-sulfonamide (<b>30</b>)<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></h3><div class="NLM_p last">A solution of 3-bromobenzenesulfonamide (300 mg, 1.27 mmol), benzeneboronic acid (186 mg, 1.52 mmol), K<sub>2</sub>CO<sub>3</sub> (264 mg, 1.91 mmol), and Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (45 mg, 0.06 mmol) in dioxane (7.5 mL) and water (0.4 mL) was stirred and heated at reflux for 18 h. The resulting solution was allowed to cool to rt, and CH<sub>2</sub>Cl<sub>2</sub> (10 mL) and water (10 mL) were added. The layers were separated, extracting the aqueous layer with CH<sub>2</sub>Cl<sub>2</sub> (7 × 10 mL). The combined organic layers were dried (MgSO<sub>4</sub>) and evaporated under reduced pressure to give the crude product. Purification by flash column chromatography on silica with 7:3 petrol/EtOAc as an eluent gave <b>30</b> (241 mg, 81%) as a white solid, mp 124–126 °C; IR (solid) 3345 (N–H str), 3246 (N–H str), 1564, 1469, 1408, 1327, 1307, 1287, 1158, 1149, 1092, 905, 894 cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.16 (t, <i>J</i> = 2.0 Hz, 1H, Ar), 7.90 (d, <i>J</i> = 8.0 Hz, 1H, Ar), 7.79 (d, <i>J</i> = 8.0 Hz, 1H, Ar), 7.63–7.35 (m, 6H, Ar), 5.06 (s, 2H, NH<sub>2</sub>); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 142.7 (C), 142.6 (C), 139.3 (C), 131.5 (CH), 129.8 (CH), 129.2 (CH), 128.4 (CH), 127.3 (2 × CH), 125.1 (CH).Spectroscopic data are consistent with those reported in the literature.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div></div><div id="sec5_75" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> <i>N</i>-([1,1′-Biphenyl]-3-ylsulfonyl)-2-(naphthalene-2yloxy)acetamide (<b>25ac</b>)</h3><div class="NLM_p last">A solution of sulphonamide <b>30</b> (204 mg, 0.87 mmol), acid <b>23</b> (176 mg, 0.87 mmol), EDCI (203 mg, 1.06 mmol), and DMAP (106 mg, 0.87 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (15 mL) was stirred at rt for 72 h. Then, CH<sub>2</sub>Cl<sub>2</sub> (30 mL) was added, and the resulting solution was washed with 10% HCl<sub>(aq)</sub> (3 × 15 mL), water (15 mL), and brine (15 mL), dried (MgSO<sub>4</sub>), and evaporated under reduced pressure to give the crude product. Purification by flash column chromatography on silica with 7:3 petrol/EtOAc as an eluent gave <b>25ac</b> (49 mg, 13%) as a beige solid, mp 181–182 °C; IR (solid) 3299 (N–H str), 1730 (C═O str), 1628, 1471, 1417, 1354, 1260, 1152, 871, 851, 752 cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.11 (br s, 1H, NH), 8.32 (t, <i>J</i> = 2.0 Hz, 1H, Ar), 8.03 (dt, <i>J</i> = 8.0, 1.5 Hz, 1H, Ar), 7.85 (dt, <i>J</i> = 8.0, 1.5 Hz, 1H, Ar), 7.81–7.72 (m, 3H, Ar), 7.64 (d, <i>J</i> = 8.0 Hz, 1H, Ar), 7.61–7.51 (m, 3H, Ar), 7.51–7.31 (m, 5H, Ar), 7.18 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H, Ar), 7.01 (d, <i>J</i> = 2.5 Hz, 1H, Ar), 4.59 (s, 2H, CH<sub>2</sub>); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 166.3 (C), 154.3 (C), 142.5 (C), 139.0 (C), 138.8 (C), 134.1 (C), 133.0 (CH), 130.4 (CH), 129.9 (C), 129.6 (CH), 129.2 (2 × CH), 128.5 (CH), 127.9 (CH), 127.4 (2 × CH), 127.2 (CH), 127.1 (CH), 127.1 (CH), 127.1 (CH), 124.9 (CH), 117.9 (CH), 107.8 (CH), 67.3 (CH<sub>2</sub>); HRMS (ESI): calcd for C<sub>24</sub>H<sub>20</sub>NO<sub>4</sub>S, 418.1108 (M + H)<sup>+</sup>; found, 418.1109.</div></div><div id="sec5_76" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> Methyl 3-(<i>N</i>-(2-(naphthalene-2-yloxy)acetyl)sulfamoyl)benzoate (<b>25ad</b>)</h3><div class="NLM_p last">A solution of methyl 3-sulfamoylbenzoate (158 mg, 0.73 mmol), acid <b>23</b> (148 mg, 0.73 mmol), EDCI (169 mg, 0.88 mmol), and DMAP (90 mg, 0.73 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (13 mL) was stirred at rt for 72 h. CH<sub>2</sub>Cl<sub>2</sub> (25 mL) was added, and the resulting solution was washed with 10% HCl<sub>(aq)</sub> (3 × 15 mL), water (15 mL), and brine (15 mL), dried (MgSO<sub>4</sub>), and evaporated under reduced pressure to give the crude product. Recrystallization from acetone/hexane gave <b>25ad</b> (103 mg, 35%) as a white solid, mp 104–106 °C; IR (solid) 3278 (N–H str), 3071, 1718 (br, 2 × C═O str), 1629, 1603, 1511, 1422, 1365, 1304, 1275, 1265, 1167, 1131, 1068, 866, 848, 753 cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.68 (t, <i>J</i> = 2.0 Hz, 1H, Ar), 8.27 (t, <i>J</i> = 8.0 Hz, 2H, Ar), 7.77 (d, <i>J</i> = 8.5 Hz, 2H, Ar), 7.67–7.53 (m, 2H, Ar), 7.50–7.28 (m, 2H, Ar), 7.17 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H, Ar), 6.96 (d, <i>J</i> = 2.5 Hz, 1H, Ar), 4.58 (s, 2H, CH<sub>2</sub>), 3.91 (s, 3H, CH<sub>3</sub>); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 166.5 (C), 165.2 (C), 154.3 (C), 138.7 (C), 135.2 (CH), 134.1 (C), 132.8 (CH), 131.4 (C), 130.4 (CH), 129.8 (C), 129.6 (CH), 129.4 (CH), 127.8 (CH), 127.1 (CH), 127.1 (CH), 124.9 (CH), 117.9 (CH), 107.7 (CH), 67.3 (CH<sub>2</sub>), 52.8 (CH<sub>3</sub>); HRMS (ESI): calcd for C<sub>20</sub>H<sub>18</sub>NO<sub>6</sub>S, 400.0849 (M + H)<sup>+</sup>; found, 400.0859.</div></div><div id="sec5_77" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> Recombinant Protein Purification</h3><div class="NLM_p last">Recombinant EPAC1-CNBD (169–318), EPAC2-CNBD (304–453), EPAC1-ΔDEP (149–881), EPAC2-ΔDEP (280–993), and RalGDS-RBD (aa 788–884) cloned into vectors of pGEX series were expressed as glutathione-S transferase (GST) fusion proteins in chemically competent <i>Escherichia coli</i> (<i>E. coli</i>) strain BL21 Star (DE3) One Shot (Invitrogen). Expression and purification procedures were based on previously described methods.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div></div><div id="sec5_78" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> 8-NBD-cAMP Competition Binding Assay</h3><div class="NLM_p last">The previously described fluorescence-based 8-NBD-cAMP competition binding assay was used to screen compound <b>3</b> analogues for binding to the EPAC1-CNBD.<a onclick="showRef(event, 'ref50 ref67'); return false;" href="javascript:void(0);" class="ref ref50 ref67">(50,67)</a> Experiments were carried out in black 96-well plates in assay buffer (50 mM Tris-HCl, pH = 7.5, 50 mM NaCl, 1 mM EDTA, 1 mM DTT). Studied compounds, EPAC1-CNBD, and 8-NBD-cAMP were combined at 10 μM, 0.8 μM, and 62.5 nM concentrations, respectively. Eleven-point dose–response experiments were performed on compound <b>3</b> and analogues were selected to compare their binding to EPAC1-CNBD and EPAC1-ΔDEP. Experiments were carried out in black 96-well plates in assay buffer. Studied compounds, proteins, and 8-NBD-cAMP were combined at 1–100 μM, 0.8 μM, and 62.5 nM concentrations, respectively. Plates were then incubated for 4 h at room temperature, protected from light. Fluorescence intensity was then measured using a FLUOstar Omega microplate reader (BMG LABTECH) at excitation/emission wavelengths of 485/520 nm. RFI = (fluorescence intensity of studied compounds, EPAC1-CNBD/EPAC1-ΔDEP and 8-NBD-cAMP combined at 10 μM, 0.8 μM, and 62.5 nM concentrations)/(fluorescence intensity of EPAC1-CNBD/EPAC1-ΔDEP and 8-NBD-cAMP combined at 0.8 μM and 62.5 nM concentrations) × 100%.</div></div><div id="sec5_79" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> Active EPAC1 IP</h3><div class="NLM_p last">HEK-293T cells transfected to overexpress EPAC1 were cultured in 6-well plates in Dulbecco’s modified Eagle’s medium (DMEM), high glucose, supplemented with 10% (v/v) FBS, 1% (v/v) GlutaMAX, 1% (v/v) penicillin–streptomycin, and 1 mg/mL G418 (to ensure selection of stable transfectants). A total of 90% confluent cells were stimulated for 30 min with either 50 μM compound <b>2</b>, 100 μM studied compounds, or vehicle. After stimulation, cells were washed with ice-cold PBS and lysed in 0.5 mL of RIPA buffer with protease inhibitor cocktail. Lysates were then cleared by centrifugation. To immunoprecipitate active EPAC1, 2 μL of the activation-selective EPAC1 (5D3) mouse mAb was added to the lysates and incubated for 30 min (4 °C, gentle agitation). Following this, 10 μL of protein G magnetic beads was added to each lysate with antibody, followed by 1 h incubation (4 °C, gentle agitation). Protein G magnetic beads were captured from the supernatant using a magnetic separation rack and washed three times with RIPA buffer. Finally, the beads were resuspended in 1 × SDS sample loading buffer (62.5 mM Tris-HCl, pH = 6.8, 2% (w/v) SDS, 10% (v/v) glycerol, 0.01% (w/v) bromophenol blue, and 10 mM DTT) and denatured for 5 min at 95 °C.</div></div><div id="sec5_80" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> GEF Activity Assay</h3><div class="NLM_p last">The EPAC1 <i>in vitro</i> GEF activities, using recombinant EPAC1 (149–881) and Rap1b (1–167), were calculated as previously described.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Briefly, recombinant EPAC1 (149–881) was incubated at 100  nM with recombinant Rap1b (200 nM) preloaded with the fluorescent GDP analogue 2′/3′-O-(<i>N</i>-methylanthraniloyl)guanosine 5-diphosphate (MANT-GDP) in the presence of 20 μM GDP and then the fluorescence intensity was measured at 360/450 nm (ex/em) over time. Multiple reactions were performed at cyclic AMP/compound concentrations varying between 0.1 and 1000 μM and curves were fit as single exponential decay to obtain <i>k</i><sub>obs</sub>. For the single point GEF screen, reactions were carried out in the 96-well plate format.</div></div><div id="sec5_81" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> Active Rap1 Pull-down</h3><div class="NLM_p last">U2OS cells (from Professor Holger Rehmann, University of Utrecht) stably transfected with EPAC1 or EPAC2 were cultured in 6-well plates in DMEM, high glucose, supplemented with 10% (v/v) FBS, 1% (v/v) GlutaMAX, 1% (v/v) penicillin–streptomycin, and 2 mg/L puromycin (to ensure selection of stable transfectants). A total of 80% confluent cells were starved in culture medium with reduced FBS concentration (0.5%) for 16 h and then stimulated for 10 min with either vehicle, 100 μM studied compounds, 50 μM <b>2</b> in the case of U2OS-EPAC1, or 100 μM compound <b>4</b> for U2OS-EPAC2. In the case of experiments testing partial agonism, cells were preincubated with studied compounds for 10 min, and then, compound 2 was added for further 10 min stimulation. Cells were then rinsed with ice-cold PBS and lysed in 0.5 mL of cell lysis buffer (Cell Signaling Technologies) supplemented with 10 mM MgCl<sub>2</sub> and 1 mM PMSF, followed by clearing the lysates by centrifugation. Cell lysates were incubated for 1 h (4 °C, gentle agitation) with 40 μg of GST-RalGDS-RBD immobilized on Glutathione Sepharose 4B (GE Healthcare) to selectively capture GTP-bound Rap1. Later on, the glutathione resin was separated from the supernatant by centrifugation, washed three times with cell lysis buffer and then resuspended in 2 × SDS sample loading buffer and denatured for 5 min at 95 °C.</div></div><div id="sec5_82" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> SDS-PAGE and Western Blotting</h3><div class="NLM_p last">HUVECs were grown in EGM (Lonza) at 37 °C and 5% (v/v) CO<sub>2</sub>. Cells were passaged weekly to a maximum of six passages. Samples were prepared from cells by mixing equal volumes of the cell lysate and 2 × SDS sample loading buffer and denaturing for 5 min at 95 °C, unless indicated otherwise. Protein samples were separated by SDS-PAGE on 10% (v/v) polyacrylamide gels, for pSTAT3/STAT3, pAKT/AKT, pERK/ERK, ICAM1, VCAM1, SELE, and VASP, or on 12.5% (v/v), for Rap1, and then transferred to nitrocellulose membranes. Membranes were then blocked for 1 h at room temperature in 5% (w/v) nonfat dry milk or 5% (w/v) BSA in Trisbuffered saline containing 0.1% (v/v) Tween 20, followed by an overnight incubation with primary antibody diluted in blocking buffer at 4 °C. Subsequently, the membranes were incubated with appropriate horseradish peroxidase-conjugated secondary antibodies for 1 h at room temperature. For signal detection, the SuperSignal West Pico PLUS chemiluminescent substrate (Thermo Scientific) was used. Images were acquired using the Fusion FX7 camera platform (Vilber). Densitometry was performed with ImageJ.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i105"><a href="/doi/suppl/10.1021/acs.jmedchem.9b02094" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04604" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04604" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b02094?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02094</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Chemical structure of 8-NBD-cAMP; ability of the selected compounds to promote EPAC1 activity by EPAC1 IP in cells; summary results of compounds <b>25n</b> and <b>25q</b> counter screening study of over 40 GPCR targets; HPLC copies of example compounds; and <sup>1</sup>H and <sup>13</sup>C NMR spectra copies of all the biologically tested compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02094/suppl_file/jm9b02094_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">CSV file containing SMILES and binding and cellular data for final target compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02094/suppl_file/jm9b02094_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02094/suppl_file/jm9b02094_si_001.pdf">jm9b02094_si_001.pdf (6.64 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02094/suppl_file/jm9b02094_si_002.csv">jm9b02094_si_002.csv (4.01 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b02094" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06030" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06030" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Graeme Barker</span> - <span class="hlFld-Affiliation affiliation">Institute
of Chemical Sciences, Heriot-Watt University, Riccarton, Edinburgh EH14
4AS, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2351-1802" title="Orcid link">http://orcid.org/0000-0002-2351-1802</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2f485d4e4a424a014d4e5d444a5d6f4758014e4c015a44"><span class="__cf_email__" data-cfemail="80e7f2e1e5ede5aee2e1f2ebe5f2c0e8f7aee1e3aef5eb">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen J. Yarwood</span> - <span class="hlFld-Affiliation affiliation">Institute
of Biological Chemistry, Biophysics and Bioengineering, Heriot-Watt University, Riccarton, Edinburgh EH14 4AS, U.K.</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#acff82f5cddedbc3c3c8ecc4db82cdcf82d9c7"><span class="__cf_email__" data-cfemail="f8abd6a1998a8f97979cb8908fd6999bd68d93">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jia Zhou</span> - <span class="hlFld-Affiliation affiliation">Chemical
Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2811-1090" title="Orcid link">http://orcid.org/0000-0002-2811-1090</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#660c0f1c0e09132613120b0448030213"><span class="__cf_email__" data-cfemail="4e24273426213b0e3b3a232c602b2a3b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pingyuan Wang</span> - <span class="hlFld-Affiliation affiliation">Chemical
Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Urszula Luchowska-Stańska</span> - <span class="hlFld-Affiliation affiliation">Institute
of Biological Chemistry, Biophysics and Bioengineering, Heriot-Watt University, Riccarton, Edinburgh EH14 4AS, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Boy van Basten</span> - <span class="hlFld-Affiliation affiliation">Institute
of Biological Chemistry, Biophysics and Bioengineering, Heriot-Watt University, Riccarton, Edinburgh EH14 4AS, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haiying Chen</span> - <span class="hlFld-Affiliation affiliation">Chemical
Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhiqing Liu</span> - <span class="hlFld-Affiliation affiliation">Chemical
Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0266-6677" title="Orcid link">http://orcid.org/0000-0003-0266-6677</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jolanta Wiejak</span> - <span class="hlFld-Affiliation affiliation">Institute
of Biological Chemistry, Biophysics and Bioengineering, Heriot-Watt University, Riccarton, Edinburgh EH14 4AS, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Padraic Whelan</span> - <span class="hlFld-Affiliation affiliation">Institute
of Chemical Sciences, Heriot-Watt University, Riccarton, Edinburgh EH14
4AS, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Morgan</span> - <span class="hlFld-Affiliation affiliation">Institute
of Chemical Sciences, Heriot-Watt University, Riccarton, Edinburgh EH14
4AS, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emma Lochhead</span> - <span class="hlFld-Affiliation affiliation">Institute
of Chemical Sciences, Heriot-Watt University, Riccarton, Edinburgh EH14
4AS, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Holger Rehmann</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Cancer Research, Centre of Biomedical Genetics and Cancer
Genomics Centre, University Medical Centre
Utrecht, Utrecht 3584 CX, Netherlands</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>P.W., U.L.-S, and B.v.B. contributed equally and should be considered as co-first authors.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare no competing financial interest.<br /></br></p></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i107">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74150" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74150" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by UTMB Technology Commercialization Program, John D. Stobo, M.D. Distinguished Chair Endowment Fund, John Sealy Memorial Endowment Fund, and Institute for Translational Sciences (ITS) at UTMB. We also acknowledge Heriot-Watt University (HWU) and the EPSRC for a DTP studentship (D.M.). U.L.-S. is a British Heart Foundation research scholar (grant number FS/17/12/32703) and Boy van Basten is a James-Watt research scholar, funded by HWU. We further acknowledge the Carnegie Trust for funding (funding reference RIG007814) and Dr. David Ellis for NMR services. We want to thank Dr. Lawrence C. Sowers at the Department of Pharmacology as well as Dr. Tianzhi Wang at the NMR core facility of UTMB for the NMR spectroscopy assistance, and Dr. Xuemei Luo at UTMB mass spectrometry core with funding support from the UT system proteomics network for the HRMS analysis. Partial mass spectrometry data were acquired at the EPSRC National Mass Spectrometry Facility at Swansea University. We thank Dr. Amanda Jarvis (University of Edinburgh) for some HRMS results.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">cAMP</td><td class="NLM_def"><p class="first last">cyclic adenosine monophosphate</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">ACs</td><td class="NLM_def"><p class="first last">adenylate cyclases</p></td></tr><tr><td class="NLM_term">PKA</td><td class="NLM_def"><p class="first last">protein kinase A</p></td></tr><tr><td class="NLM_term">EPAC</td><td class="NLM_def"><p class="first last">exchange proteins directly activated by cAMP</p></td></tr><tr><td class="NLM_term">GEF</td><td class="NLM_def"><p class="first last">guanine nucleotide exchange factor</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">GDP</td><td class="NLM_def"><p class="first last">guanosine diphosphate</p></td></tr><tr><td class="NLM_term">GTP</td><td class="NLM_def"><p class="first last">guanosine triphosphate</p></td></tr><tr><td class="NLM_term">TLR4</td><td class="NLM_def"><p class="first last">toll-like receptor 4</p></td></tr><tr><td class="NLM_term">HMGB1</td><td class="NLM_def"><p class="first last">high-mobility group box 1</p></td></tr><tr><td class="NLM_term">TNFα</td><td class="NLM_def"><p class="first last">tumor necrosis factor α</p></td></tr><tr><td class="NLM_term">IL-1β</td><td class="NLM_def"><p class="first last">interleukin-1β</p></td></tr><tr><td class="NLM_term">RECs</td><td class="NLM_def"><p class="first last">retinal endothelial cells</p></td></tr><tr><td class="NLM_term">SOCS3</td><td class="NLM_def"><p class="first last">suppressor of cytokine signaling 3</p></td></tr><tr><td class="NLM_term">VECs</td><td class="NLM_def"><p class="first last">vascular endothelial cells</p></td></tr><tr><td class="NLM_term">IL-6</td><td class="NLM_def"><p class="first last">interleukin 6</p></td></tr><tr><td class="NLM_term">JAK</td><td class="NLM_def"><p class="first last">Janus kinase</p></td></tr><tr><td class="NLM_term">STAT3</td><td class="NLM_def"><p class="first last">signal transducer and activator of transcription 3</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screening</p></td></tr><tr><td class="NLM_term">VCAM1</td><td class="NLM_def"><p class="first last">vascular cell adhesion molecule 1</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">MOMCl</td><td class="NLM_def"><p class="first last">chloromethyl methyl ether</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyl carbamate</p></td></tr><tr><td class="NLM_term">DEAD</td><td class="NLM_def"><p class="first last">diethyl azodicarboxylate</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-dimethylaminopyridine</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-ethyl-(3-dimethylaminopropyl)carbonyldiimide hydrochloride</p></td></tr><tr><td class="NLM_term">Pd(dppf)Cl<sub>2</sub></td><td class="NLM_def"><p class="first last">1′1-bis(diphenylphosphino)fewocene palladium(II)chloride</p></td></tr><tr><td class="NLM_term">XantPhos</td><td class="NLM_def"><p class="first last">4,5-bis(diphenylphosphino)-9,9-dimethylxanthene</p></td></tr><tr><td class="NLM_term">RFI</td><td class="NLM_def"><p class="first last">relative fluorescence intensity</p></td></tr><tr><td class="NLM_term">CNBD</td><td class="NLM_def"><p class="first last">cAMP binding domain</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G protein-coupled receptor</p></td></tr><tr><td class="NLM_term">TNFα</td><td class="NLM_def"><p class="first last">tumor necrosis factor-alpha</p></td></tr><tr><td class="NLM_term">HUVECs</td><td class="NLM_def"><p class="first last">human umbilical vein endothelial cells</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin-layer chromatography</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">UV</td><td class="NLM_def"><p class="first last">ultraviolet</p></td></tr><tr><td class="NLM_term">TMS</td><td class="NLM_def"><p class="first last">tetramethylsilane</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high-resolution mass spectra</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i109">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11214" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11214" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 67 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robichaux, W. G.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span> <span> </span><span class="NLM_article-title">Intracellular cAMP sensor EPAC: physiology, pathophysiology, and therapeutics development</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">919</span>– <span class="NLM_lpage">1053</span>, <span class="refDoi"> DOI: 10.1152/physrev.00025.2017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1152%2Fphysrev.00025.2017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=29537337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvFeksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2018&pages=919-1053&author=W.+G.+Robichauxauthor=X.+Cheng&title=Intracellular+cAMP+sensor+EPAC%3A+physiology%2C+pathophysiology%2C+and+therapeutics+development&doi=10.1152%2Fphysrev.00025.2017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular cAMP sensor EPAC: physiology, pathophysiology, and therapeutics development</span></div><div class="casAuthors">Robichaux, William G., III; Cheng, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">919-1053</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">1522-1210</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">This review focuses on one family of the known cAMP receptors, the exchange proteins directly activated by cAMP (EPACs), also known as the cAMP-regulated guanine nucleotide exchange factors (cAMP-GEFs).  Although EPAC proteins are fairly new addns. to the growing list of cAMP effectors, and relatively "young" in the cAMP discovery timeline, the significance of an EPAC presence in different cell systems is extraordinary.  The study of EPACs has considerably expanded the diversity and adaptive nature of cAMP signaling assocd. with numerous physiol. and pathophysiol. responses.  This review comprehensively covers EPAC protein functions at the mol., cellular, physiol., and pathophysiol. levels; and in turn, the applications of employing EPAC-based biosensors as detection tools for dissecting cAMP signaling and the implications for targeting EPAC proteins for therapeutic development are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEXxHMBR_kU7Vg90H21EOLACvtfcHk0lhZJ8eAPYborg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvFeksb4%253D&md5=fa74e7dabdae8d04288b9fe4a68b647a</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00025.2017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00025.2017%26sid%3Dliteratum%253Aachs%26aulast%3DRobichaux%26aufirst%3DW.%2BG.%26aulast%3DCheng%26aufirst%3DX.%26atitle%3DIntracellular%2520cAMP%2520sensor%2520EPAC%253A%2520physiology%252C%2520pathophysiology%252C%2520and%2520therapeutics%2520development%26jtitle%3DPhysiol.%2520Rev.%26date%3D2018%26volume%3D98%26spage%3D919%26epage%3D1053%26doi%3D10.1152%2Fphysrev.00025.2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span> <span> </span><span class="NLM_article-title">Protein kinases--the major drug targets of the twenty-first century?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1038/nrd773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1038%2Fnrd773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=12120282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD38XivVGmtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=309-315&author=P.+Cohen&title=Protein+kinases%2D%2Dthe+major+drug+targets+of+the+twenty-first+century%3F&doi=10.1038%2Fnrd773"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Timeline: Protein kinases - the major drug targets of the twenty-first century?</span></div><div class="casAuthors">Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">309-315</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein phosphorylation regulates most aspects of cell life, whereas abnormal phosphorylation is a cause or consequence of disease.  A growing interest in developing orally active protein-kinase inhibitors has recently culminated in the approval of the first of these drugs for clin. use.  Protein kinases have now become the second most important group of drug targets, after G-protein-coupled receptors.  Here, I give a personal view of some of the most important advances that have shaped this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRd_GqiGAWaLVg90H21EOLACvtfcHk0lh5DmrNxcCAEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XivVGmtr8%253D&md5=67d2fbc11a55b5980ee0692f7bc13cc9</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd773%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DProtein%2520kinases--the%2520major%2520drug%2520targets%2520of%2520the%2520twenty-first%2520century%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2002%26volume%3D1%26spage%3D309%26epage%3D315%26doi%3D10.1038%2Fnrd773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steichen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keshwani, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornev, A. P.</span></span> <span> </span><span class="NLM_article-title">PKA: lessons learned after twenty years</span>. <i>Biochim. Biophys. Acta</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1834</i></span>,  <span class="NLM_fpage">1271</span>– <span class="NLM_lpage">1278</span>, <span class="refDoi"> DOI: 10.1016/j.bbapap.2013.03.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2Fj.bbapap.2013.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=23535202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvVertL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1834&publication_year=2013&pages=1271-1278&author=S.+S.+Taylorauthor=P.+Zhangauthor=J.+M.+Steichenauthor=M.+M.+Keshwaniauthor=A.+P.+Kornev&title=PKA%3A+lessons+learned+after+twenty+years&doi=10.1016%2Fj.bbapap.2013.03.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">PKA: Lessons learned after twenty years</span></div><div class="casAuthors">Taylor, Susan S.; Zhang, Ping; Steichen, Jon M.; Keshwani, Malik M.; Kornev, Alexandr P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1834</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1271-1278</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  The first protein kinase structure, solved in 1991, revealed the fold that is shared by all members of the eukaryotic protein kinase superfamily and showed how the conserved sequence motifs cluster mostly around the active site.  This structure of the PKA catalytic (C) subunit showed also how a single phosphate integrated the entire mol.  Since then the EPKs have become a major drug target, second only to the G-protein coupled receptors.  Although PKA provided a mechanistic understanding of catalysis that continues to serve as a prototype for the family, by comparing many active and inactive kinases we subsequently discovered a hydrophobic spine architecture that is a characteristic feature of all active kinases.  The ways in which the regulatory spine is dynamically assembled is the defining feature of each protein kinase.  Protein kinases have thus evolved to be mol. switches, like the G-proteins, and unlike metabolic enzymes which have evolved to be efficient catalysis.  PKA also shows how the dynamic tails surround the core and serve as essential regulatory elements.  The phosphorylation sites in PKA, introduced both co- and post-translationally, are very stable.  The resulting C-subunit is then packaged as an inhibited holoenzyme with cAMP-binding regulatory (R) subunits so that PKA activity is regulated exclusively by cAMP, not by the dynamic turnover of an activation loop phosphate.  We could not understand activation and inhibition without seeing structures of R:C complexes; however, to appreciate the structural uniqueness of each R2:C2 holoenzyme required solving structures of tetrameric holoenzymes.  It is these tetrameric holoenzymes that are localized to discrete sites in the cell, typically by A Kinase Anchoring Proteins where they create discrete foci for PKA signaling.  Understanding these dynamic macromol. complexes is the challenge that we now face.  This article is part of a Special Issue entitled: Inhibitors of Protein Kinases (2012).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdclEBqYAub7Vg90H21EOLACvtfcHk0lh5DmrNxcCAEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvVertL0%253D&md5=9250d05df946ebf658ceda343a89bc28</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2013.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2013.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DSteichen%26aufirst%3DJ.%2BM.%26aulast%3DKeshwani%26aufirst%3DM.%2BM.%26aulast%3DKornev%26aufirst%3DA.%2BP.%26atitle%3DPKA%253A%2520lessons%2520learned%2520after%2520twenty%2520years%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2013%26volume%3D1834%26spage%3D1271%26epage%3D1278%26doi%3D10.1016%2Fj.bbapap.2013.03.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Torres-Quesada, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayrhofer, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefan, E.</span></span> <span> </span><span class="NLM_article-title">The many faces of compartmentalized PKA signalosomes</span>. <i>Cell. Signal.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2017.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2Fj.cellsig.2017.05.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=28528970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC2sXot1egurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=1-11&author=O.+Torres-Quesadaauthor=J.+E.+Mayrhoferauthor=E.+Stefan&title=The+many+faces+of+compartmentalized+PKA+signalosomes&doi=10.1016%2Fj.cellsig.2017.05.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The many faces of compartmentalized PKA signalosomes</span></div><div class="casAuthors">Torres-Quesada, Omar; Mayrhofer, Johanna E.; Stefan, Eduard</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Cellular signal transmission requires the dynamic formation of spatiotemporally controlled mol. interactions.  At the cell surface information is received by receptor complexes and relayed through intracellular signaling platforms which organize the actions of functionally interacting signaling enzymes and substrates.  The list of hormone or neurotransmitter pathways that utilize the ubiquitous cAMP-sensing protein kinase A (PKA) system is expansive.  This requires that the specificity, duration, and intensity of PKA responses are spatially and temporally restricted.  Hereby, scaffolding proteins take the center stage for ensuring proper signal transmission.  They unite second messenger sensors, activators, effectors, and kinase substrates within cellular micro-domains to precisely control and route signal propagation.  A-kinase anchoring proteins (AKAPs) organize such subcellular signalosomes by tethering the PKA holoenzyme to distinct cell compartments.  AKAPs differ in their modular organization showing pathway specific arrangements of interaction motifs or domains.  This enables the cell- and compartment- guided assembly of signalosomes with unique enzyme compn. and function.  The AKAP-mediated clustering of cAMP and other second messenger sensing and interacting signaling components along with functional successive enzymes facilitates the rapid and precise dissemination of incoming signals.  This review article delineates examples for different means of PKA regulation and for snapshots of compartmentalized PKA signalosomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG5NcBVwB2w7Vg90H21EOLACvtfcHk0lgDrxZU4EKTXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXot1egurk%253D&md5=3f2ebf4506b00487cbbf2dcb341af43c</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2017.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2017.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DTorres-Quesada%26aufirst%3DO.%26aulast%3DMayrhofer%26aufirst%3DJ.%2BE.%26aulast%3DStefan%26aufirst%3DE.%26atitle%3DThe%2520many%2520faces%2520of%2520compartmentalized%2520PKA%2520signalosomes%26jtitle%3DCell.%2520Signal.%26date%3D2017%26volume%3D37%26spage%3D1%26epage%3D11%26doi%3D10.1016%2Fj.cellsig.2017.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biel, M.</span></span> <span> </span><span class="NLM_article-title">Cyclic nucleotide-regulated cation channels</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">9017</span>– <span class="NLM_lpage">9021</span>, <span class="refDoi"> DOI: 10.1074/jbc.r800075200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1074%2Fjbc.R800075200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=19054768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjs1ynur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=9017-9021&author=M.+Biel&title=Cyclic+nucleotide-regulated+cation+channels&doi=10.1074%2Fjbc.r800075200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic Nucleotide-regulated Cation Channels</span></div><div class="casAuthors">Biel, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">9017-9021</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  Cyclic nucleotide-regulated cation channels are ion channels whose activation is regulated by the direct binding of cAMP or cGMP to the channel protein.  Two structurally related families of channels regulated by cyclic nucleotides have been identified, the cyclic nucleotide-gated channels and the hyperpolarization-activated cyclic nucleotide-gated channels.  Cyclic nucleotide-gated channels play a key role in visual and olfactory transduction.  Hyperpolarization-activated cyclic nucleotide-gated channels are present in the conduction system of the heart and are involved in the control of cardiac automaticity.  Moreover, these channels are widely expressed in central and peripheral neurons, where they control a variety of fundamental processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiWwEkcIv2MLVg90H21EOLACvtfcHk0lgDrxZU4EKTXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjs1ynur8%253D&md5=a4fa7ded9c03be2429a30d2fbf1e45fa</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R800075200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R800075200%26sid%3Dliteratum%253Aachs%26aulast%3DBiel%26aufirst%3DM.%26atitle%3DCyclic%2520nucleotide-regulated%2520cation%2520channels%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D9017%26epage%3D9021%26doi%3D10.1074%2Fjbc.r800075200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bos, J. L.</span></span> <span> </span><span class="NLM_article-title">Epac: a new cAMP target and new avenues in cAMP research</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">733</span>– <span class="NLM_lpage">738</span>, <span class="refDoi"> DOI: 10.1038/nrm1197</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1038%2Fnrm1197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=14506476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsVKqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=733-738&author=J.+L.+Bos&title=Epac%3A+a+new+cAMP+target+and+new+avenues+in+cAMP+research&doi=10.1038%2Fnrm1197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Opinion: Epac: a new cAMP target and new avenues in cAMP research</span></div><div class="casAuthors">Bos, Johannes L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">733-738</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Five years ago, Epac - a guanine nucleotide exchange factor for the Ras-like small GTPases Rap1 and Rap2 - was found to be a new target of cAMP, which opened up new avenues for cAMP research.  Structural anal. of the cAMP-binding domains of Epac2 has identified a unifying mechanism for how cAMP activates proteins, and the design and synthesis of an Epac-specific cAMP analog has paved the way for future discoveries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMTh0k8Iy-8LVg90H21EOLACvtfcHk0lhhgB0Gnhuz5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsVKqsLw%253D&md5=14be0f1922a69532b14fe2b4d3b079c5</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrm1197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1197%26sid%3Dliteratum%253Aachs%26aulast%3DBos%26aufirst%3DJ.%2BL.%26atitle%3DEpac%253A%2520a%2520new%2520cAMP%2520target%2520and%2520new%2520avenues%2520in%2520cAMP%2520research%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2003%26volume%3D4%26spage%3D733%26epage%3D738%26doi%3D10.1038%2Fnrm1197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsalkova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, F.</span></span> <span> </span><span class="NLM_article-title">Epac and PKA: a tale of two intracellular cAMP receptors</span>. <i>Acta Biochim. Biophys. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">651</span>– <span class="NLM_lpage">662</span>, <span class="refDoi"> DOI: 10.1111/j.1745-7270.2008.00438.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1111%2Fj.1745-7270.2008.00438.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=18604457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpvF2qsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2008&pages=651-662&author=X.+Chengauthor=Z.+Jiauthor=T.+Tsalkovaauthor=F.+Mei&title=Epac+and+PKA%3A+a+tale+of+two+intracellular+cAMP+receptors&doi=10.1111%2Fj.1745-7270.2008.00438.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Epac and PKA: a tale of two intracellular cAMP receptors</span></div><div class="casAuthors">Cheng, Xiaodong; Ji, Zhenyu; Tsalkova, Tamara; Mei, Fang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Biochimica et Biophysica Sinica</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">651-662</span>CODEN:
                <span class="NLM_cas:coden">ABBSC2</span>;
        ISSN:<span class="NLM_cas:issn">1672-9145</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The cAMP-mediated signaling pathways regulate a multitude of important biol. processes under both physiol. and pathol. conditions, including diabetes, heart failure, and cancer.  In eukaryotic cells, the effects of cAMP are mediated by 2 ubiquitously expressed intracellular cAMP receptors, the classic cAMP-dependent protein kinase A (PKA) and the recently discovered exchange protein activated by cAMP (Epac), a cAMP-regulated guanine nucleotide exchange factor.  Like PKA, Epac contains an evolutionally conserved cAMP-binding domain that acts as a mol. switch for sensing intracellular 2nd messenger cAMP levels to control diverse biol. functions.  The existence of 2 families of cAMP effectors provides a mechanism for a more precise and integrated control of the cAMP signaling pathways in a spatial and temporal manner.  Depending upon the specific cellular environments as well as their relative abundance, distribution and localization, Epac and PKA may act independently, converge synergistically, or oppose each other in regulating a specific cellular function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBLmBPtSLObrVg90H21EOLACvtfcHk0lg_nN1L_HzlyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpvF2qsL0%253D&md5=e607e382cff805e63fa1556dc7604558</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fj.1745-7270.2008.00438.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1745-7270.2008.00438.x%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DJi%26aufirst%3DZ.%26aulast%3DTsalkova%26aufirst%3DT.%26aulast%3DMei%26aufirst%3DF.%26atitle%3DEpac%2520and%2520PKA%253A%2520a%2520tale%2520of%2520two%2520intracellular%2520cAMP%2520receptors%26jtitle%3DActa%2520Biochim.%2520Biophys.%2520Sin.%26date%3D2008%26volume%3D40%26spage%3D651%26epage%3D662%26doi%3D10.1111%2Fj.1745-7270.2008.00438.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wild, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the discovery of small molecules targeting exchange proteins directly activated by cAMP (EPAC)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">3651</span>– <span class="NLM_lpage">3665</span>, <span class="refDoi"> DOI: 10.1021/jm401425e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401425e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVShsL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3651-3665&author=H.+Chenauthor=C.+Wildauthor=X.+Zhouauthor=N.+Yeauthor=X.+Chengauthor=J.+Zhou&title=Recent+advances+in+the+discovery+of+small+molecules+targeting+exchange+proteins+directly+activated+by+cAMP+%28EPAC%29&doi=10.1021%2Fjm401425e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances in the Discovery of Small Molecules Targeting Exchange Proteins Directly Activated by cAMP (EPAC)</span></div><div class="casAuthors">Chen, Haijun; Wild, Christopher; Zhou, Xiaobin; Ye, Na; Cheng, Xiaodong; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3651-3665</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  3',5'-Cyclic adenosine monophosphate (cAMP) is a pivotal second messenger that regulates numerous biol. processes under physiol. and pathol. conditions, including cancer, diabetes, heart failure, inflammation, and neurol. disorders.  In the past, all effects of cAMP were initially believed to be mediated by protein kinase A (PKA) and cyclic nucleotide-regulated ion channels.  Since the discovery of exchange proteins directly activated by cAMP (EPACs) in 1998, accumulating evidence has demonstrated that the net cellular effects of cAMP are also regulated by EPAC.  The pursuit of the biol. functions of EPAC has benefited from the development and applications of a growing no. of pharmacol. probes targeting EPACs.  In this review, we seek to provide a concise update on recent advances in the development of chem. entities including various membrane-permeable analogs of cAMP and newly discovered EPAC-specific ligands from high throughput assays and hit-to-lead optimizations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ5iSmjJ-WXLVg90H21EOLACvtfcHk0lgibF6Y_7RmKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVShsL7K&md5=d95ba49c7415288ae57f49e5fc00041e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm401425e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401425e%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DWild%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DN.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DRecent%2520advances%2520in%2520the%2520discovery%2520of%2520small%2520molecules%2520targeting%2520exchange%2520proteins%2520directly%2520activated%2520by%2520cAMP%2520%2528EPAC%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3651%26epage%3D3665%26doi%3D10.1021%2Fjm401425e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parnell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarwood, S. J.</span></span> <span> </span><span class="NLM_article-title">The future of EPAC-targeted therapies: agonism versus antagonism</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">214</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2015.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2Fj.tips.2015.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=25744542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjt1ShsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=203-214&author=E.+Parnellauthor=T.+M.+Palmerauthor=S.+J.+Yarwood&title=The+future+of+EPAC-targeted+therapies%3A+agonism+versus+antagonism&doi=10.1016%2Fj.tips.2015.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The future of EPAC-targeted therapies: agonism versus antagonism</span></div><div class="casAuthors">Parnell, Euan; Palmer, Timothy M.; Yarwood, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">203-214</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Pharmaceutical manipulation of cAMP levels exerts beneficial effects through the regulation of the exchange protein activated by cAMP (EPAC) and protein kinase A (PKA) signaling routes.  Recent attention has turned to the specific regulation of EPAC isoforms (EPAC1 and EPAC2) as a more targeted approach to cAMP-based therapies.  For example, EPAC2-selective agonists could promote insulin secretion from pancreatic β cells, whereas EPAC1-selective agonists may be useful in the treatment of vascular inflammation.  By contrast, EPAC1 and EPAC2 antagonists could both be useful in the treatment of heart failure.  Here we discuss whether the best way forward is to design EPAC-selective agonists or antagonists and the current strategies being used to develop isoform-selective, small-mol. regulators of EPAC1 and EPAC2 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFYdzaBCR8SLVg90H21EOLACvtfcHk0lgibF6Y_7RmKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjt1ShsL0%253D&md5=e130a5389a31f057585fb32456ddbcef</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2015.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2015.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DParnell%26aufirst%3DE.%26aulast%3DPalmer%26aufirst%3DT.%2BM.%26aulast%3DYarwood%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520future%2520of%2520EPAC-targeted%2520therapies%253A%2520agonism%2520versus%2520antagonism%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D36%26spage%3D203%26epage%3D214%26doi%3D10.1016%2Fj.tips.2015.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Exchange proteins directly activated by cAMP (EPACs): emerging therapeutic targets</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1633</span>– <span class="NLM_lpage">1639</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.02.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2Fj.bmcl.2017.02.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=28283242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktVCgu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=1633-1639&author=P.+Wangauthor=Z.+Liuauthor=H.+Chenauthor=N.+Yeauthor=X.+Chengauthor=J.+Zhou&title=Exchange+proteins+directly+activated+by+cAMP+%28EPACs%29%3A+emerging+therapeutic+targets&doi=10.1016%2Fj.bmcl.2017.02.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Exchange proteins directly activated by cAMP (EPACs): Emerging therapeutic targets</span></div><div class="casAuthors">Wang, Pingyuan; Liu, Zhiqing; Chen, Haiying; Ye, Na; Cheng, Xiaodong; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1633-1639</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Exchange proteins directly activated by cAMP (EPACs) are crit. cAMP-dependent signaling pathway mediators.  The discovery of EPAC proteins has significantly facilitated understanding on cAMP-dependent signaling pathway and efforts along this line open new avenues for developing novel therapeutics for cancer, diabetes, heart failure, inflammation, infections, neurol. disorders and other human diseases.  Over the past decade, important progress has been made in the identification of EPAC agonists, antagonists and their biol. and pharmacol. applications.  In this review, we briefly summarize recently reported novel functions of EPACs and the discovery of their small mol. modulators.  The challenges and future perspectives are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAQYamb6TbpLVg90H21EOLACvtfcHk0liQ1MzUUuP2cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktVCgu7Y%253D&md5=0eb3514d37d9fe2813f16e03d1a528f2</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.02.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.02.065%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DYe%26aufirst%3DN.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DExchange%2520proteins%2520directly%2520activated%2520by%2520cAMP%2520%2528EPACs%2529%253A%2520emerging%2520therapeutic%2520targets%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D1633%26epage%3D1639%26doi%3D10.1016%2Fj.bmcl.2017.02.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Rooij, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwartkruis, F. J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verheijen, M. H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cool, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nijman, S. M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittinghofer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bos, J. L.</span></span> <span> </span><span class="NLM_article-title">Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>396</i></span>,  <span class="NLM_fpage">474</span>– <span class="NLM_lpage">477</span>, <span class="refDoi"> DOI: 10.1038/24884</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1038%2F24884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=9853756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADyaK1cXotVSitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=396&publication_year=1998&pages=474-477&author=J.+de%0ARooijauthor=F.+J.+T.+Zwartkruisauthor=M.+H.+G.+Verheijenauthor=R.+H.+Coolauthor=S.+M.+B.+Nijmanauthor=A.+Wittinghoferauthor=J.+L.+Bos&title=Epac+is+a+Rap1+guanine-nucleotide-exchange+factor+directly+activated+by+cyclic+AMP&doi=10.1038%2F24884"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP</span></div><div class="casAuthors">De Rooij, Johan; Zwartkruis, Fried J. T.; Verhaijen, Mark H. G.; Cool, Robbert H.; Nijman, Sebastian M. B.; Wittinghofer, Alfred; Bos, Johannes L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">396</span>
        (<span class="NLM_cas:issue">6710</span>),
    <span class="NLM_cas:pages">474-477</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Rap1 is a small, Ras-like GTPase that was first identified as a protein that could suppress the oncogenic transformation of cells by Ras.  Rap1 is activated by several extracellular stimuli and may be involved in cellular processes such as cell proliferation, cell differentiation, T-cell anergy and platelet activation.  At least three different second messengers, namely diacylglycerol, calcium and cAMP, are able to activate Rap1 by promoting its release of the guanine nucleotide GDP and its binding to GTP.  Here we report that activation of Rap1 by forskolin and cAMP occurs independently of protein kinase A (also known as cAMP-activated protein kinase).  We have cloned the gene encoding a guanine-nucleotide-exchange factor (GEF) which we have named Epac (exchange protein directly activated by cAMP).  This protein contains a cAMP-binding site and a domain that is homologous to domains of known GEFs for Ras and Rap1.  Epac binds cAMP in vitro and exhibits in vivo and in vitro GEF activity towards Rap1.  CAMP strongly induces the GEF activity of Epac towards Rap1 both in vivo and in vitro.  We conclude that Epac is a GEF for Rap1 that is regulated directly by cAMP and that Epac is a new target protein for cAMP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ96rDUUrIc7Vg90H21EOLACvtfcHk0liQ1MzUUuP2cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXotVSitbs%253D&md5=8f4a50b23d8bfc344c0c9947175b89a5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2F24884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F24884%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BRooij%26aufirst%3DJ.%26aulast%3DZwartkruis%26aufirst%3DF.%2BJ.%2BT.%26aulast%3DVerheijen%26aufirst%3DM.%2BH.%2BG.%26aulast%3DCool%26aufirst%3DR.%2BH.%26aulast%3DNijman%26aufirst%3DS.%2BM.%2BB.%26aulast%3DWittinghofer%26aufirst%3DA.%26aulast%3DBos%26aufirst%3DJ.%2BL.%26atitle%3DEpac%2520is%2520a%2520Rap1%2520guanine-nucleotide-exchange%2520factor%2520directly%2520activated%2520by%2520cyclic%2520AMP%26jtitle%3DNature%26date%3D1998%26volume%3D396%26spage%3D474%26epage%3D477%26doi%3D10.1038%2F24884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springett, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mochizuki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakaya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Housman, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graybiel, A. M.</span></span> <span> </span><span class="NLM_article-title">A family of cAMP-binding proteins that directly activate Rap1</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">2275</span>– <span class="NLM_lpage">2279</span>, <span class="refDoi"> DOI: 10.1126/science.282.5397.2275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1126%2Fscience.282.5397.2275" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=9856955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADyaK1cXotFGjt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=1998&pages=2275-2279&author=H.+Kawasakiauthor=G.+M.+Springettauthor=N.+Mochizukiauthor=S.+Tokiauthor=M.+Nakayaauthor=M.+Matsudaauthor=D.+E.+Housmanauthor=A.+M.+Graybiel&title=A+family+of+cAMP-binding+proteins+that+directly+activate+Rap1&doi=10.1126%2Fscience.282.5397.2275"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A family of cAMP-binding proteins that directly activate Rap1</span></div><div class="casAuthors">Kawasaki, Hiroaki; Springett, Gregory M.; Mochizuki, Naoki; Toki, Shinichiro; Nakaya, Mie; Matsuda, Michiyuki; Housman, David E.; Graybiel, Ann M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">5397</span>),
    <span class="NLM_cas:pages">2275-2279</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">CAMP (3',5' cAMP) is a second messenger that in eukaryotic cells induces physiol. responses ranging from growth, differentiation, and gene expression to secretion and neurotransmission.  Most of these effects have been attributed to the binding of cAMP to cAMP-dependent protein kinase A (PKA).  Here, a family of cAMP-binding proteins that are differentially distributed in the mammalian brain and body organs and that exhibit both cAMP-binding and guanine nucleotide exchange factor (GEF) domains is reported.  These cAMP-regulated GEFs (cAMP-GEFs) bind cAMP and selectively activate the Ras superfamily guanine nucleotide binding protein Rap1A in a cAMP-dependent but PKA-independent manner.  Our findings suggest the need to reformulate concepts of cAMP-mediated signaling to include direct coupling to Ras superfamily signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-_6RlErjnO7Vg90H21EOLACvtfcHk0lhNlDL8Q05sIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXotFGjt7c%253D&md5=405913633acf0d725dce8ff974a99a07</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.282.5397.2275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.282.5397.2275%26sid%3Dliteratum%253Aachs%26aulast%3DKawasaki%26aufirst%3DH.%26aulast%3DSpringett%26aufirst%3DG.%2BM.%26aulast%3DMochizuki%26aufirst%3DN.%26aulast%3DToki%26aufirst%3DS.%26aulast%3DNakaya%26aufirst%3DM.%26aulast%3DMatsuda%26aufirst%3DM.%26aulast%3DHousman%26aufirst%3DD.%2BE.%26aulast%3DGraybiel%26aufirst%3DA.%2BM.%26atitle%3DA%2520family%2520of%2520cAMP-binding%2520proteins%2520that%2520directly%2520activate%2520Rap1%26jtitle%3DScience%26date%3D1998%26volume%3D282%26spage%3D2275%26epage%3D2279%26doi%3D10.1126%2Fscience.282.5397.2275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span> <span> </span><span class="NLM_article-title">Exchange protein directly activated by cAMP encoded by the mammalian rapgef3 gene: structure, function and therapeutics</span>. <i>Gene</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>570</i></span>,  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">167</span>, <span class="refDoi"> DOI: 10.1016/j.gene.2015.06.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2Fj.gene.2015.06.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=26119090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVOlsbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=570&publication_year=2015&pages=157-167&author=U.+Banerjeeauthor=X.+Cheng&title=Exchange+protein+directly+activated+by+cAMP+encoded+by+the+mammalian+rapgef3+gene%3A+structure%2C+function+and+therapeutics&doi=10.1016%2Fj.gene.2015.06.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Exchange protein directly activated by cAMP encoded by the mammalian rapgef3 gene: Structure, function and therapeutics</span></div><div class="casAuthors">Banerjee, Upasana; Cheng, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Gene</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">570</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-167</span>CODEN:
                <span class="NLM_cas:coden">GENED6</span>;
        ISSN:<span class="NLM_cas:issn">0378-1119</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Mammalian exchange protein directly activated by cAMP isoform 1 (EPAC1), encoded by the RAPGEF3 gene, is one of the two-membered family of cAMP sensors that mediate the intracellular functions of cAMP by acting as guanine nucleotide exchange factors for the Ras-like Rap small GTPases.  Extensive studies have revealed that EPAC1-mediated cAMP signaling is highly coordinated spatiotemporally through the formation of dynamic signalosomes by interacting with a diverse array of cellular partners.  Recent functional analyses of genetically engineered mouse models further suggest that EPAC1 functions as an important stress response switch and is involved in pathophysiol. conditions of cardiac stresses, chronic pain, cancer and infectious diseases.  These findings, coupled with the development of EPAC specific small mol. modulators, validate EPAC1 as a promising target for therapeutic interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9EhUcwEva9rVg90H21EOLACvtfcHk0li5OaXwiltvXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOlsbjE&md5=3eb0d8b5cb162a14b317b57fab891f31</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.gene.2015.06.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gene.2015.06.063%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DU.%26aulast%3DCheng%26aufirst%3DX.%26atitle%3DExchange%2520protein%2520directly%2520activated%2520by%2520cAMP%2520encoded%2520by%2520the%2520mammalian%2520rapgef3%2520gene%253A%2520structure%252C%2520function%2520and%2520therapeutics%26jtitle%3DGene%26date%3D2015%26volume%3D570%26spage%3D157%26epage%3D167%26doi%3D10.1016%2Fj.gene.2015.06.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rehmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knipscheer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittinghofer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bos, J. L.</span></span> <span> </span><span class="NLM_article-title">Structure of the cyclic-AMP-responsive exchange factor Epac2 in its auto-inhibited state</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>439</i></span>,  <span class="NLM_fpage">625</span>– <span class="NLM_lpage">628</span>, <span class="refDoi"> DOI: 10.1038/nature04468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1038%2Fnature04468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=16452984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsVCgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=439&publication_year=2006&pages=625-628&author=H.+Rehmannauthor=J.+Dasauthor=P.+Knipscheerauthor=A.+Wittinghoferauthor=J.+L.+Bos&title=Structure+of+the+cyclic-AMP-responsive+exchange+factor+Epac2+in+its+auto-inhibited+state&doi=10.1038%2Fnature04468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the cyclic-AMP-responsive exchange factor Epac2 in its auto-inhibited state</span></div><div class="casAuthors">Rehmann, Holger; Das, Joost; Knipscheer, Puck; Wittinghofer, Alfred; Bos, Johannes L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">439</span>
        (<span class="NLM_cas:issue">7076</span>),
    <span class="NLM_cas:pages">625-628</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Epac proteins (exchange proteins directly activated by cAMP) are guanine-nucleotide-exchange factors (GEFs) for the small GTP-binding proteins Rap1 and Rap2 that are directly regulated by the second messenger cAMP and function in the control of diverse cellular processes, including cell adhesion and insulin secretion.  Here we report the three-dimensional structure of full-length Epac2, a 110-kDa protein that contains an amino-terminal regulatory region with two cyclic-nucleotide-binding domains and a carboxy-terminal catalytic region.  The structure was solved in the absence of cAMP and shows the auto-inhibited state of Epac.  The regulatory region is positioned with respect to the catalytic region by a rigid, tripartite β-sheet-like structure we refer to as the 'switchboard' and an ionic interaction we call the 'ionic latch'.  As a consequence of this arrangement, the access of Rap to the catalytic site is sterically blocked.  Mutational anal. suggests a model for cAMP-induced Epac activation with rigid body movement of the regulatory region, the features of which are universally conserved in cAMP-regulated proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK0sBmjrW9krVg90H21EOLACvtfcHk0li5OaXwiltvXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsVCgsQ%253D%253D&md5=1b021d7751d7add16f50026dfe7cecc8</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnature04468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04468%26sid%3Dliteratum%253Aachs%26aulast%3DRehmann%26aufirst%3DH.%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DKnipscheer%26aufirst%3DP.%26aulast%3DWittinghofer%26aufirst%3DA.%26aulast%3DBos%26aufirst%3DJ.%2BL.%26atitle%3DStructure%2520of%2520the%2520cyclic-AMP-responsive%2520exchange%2520factor%2520Epac2%2520in%2520its%2520auto-inhibited%2520state%26jtitle%3DNature%26date%3D2006%26volume%3D439%26spage%3D625%26epage%3D628%26doi%3D10.1038%2Fnature04468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rehmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arias-Palomo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadders, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwede, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llorca, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bos, J. L.</span></span> <span> </span><span class="NLM_article-title">Structure of Epac2 in complex with a cyclic AMP analogue and RAP1B</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>455</i></span>,  <span class="NLM_fpage">124</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.1038/nature07187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1038%2Fnature07187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=18660803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVKrsbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2008&pages=124-127&author=H.+Rehmannauthor=E.+Arias-Palomoauthor=M.+A.+Haddersauthor=F.+Schwedeauthor=O.+Llorcaauthor=J.+L.+Bos&title=Structure+of+Epac2+in+complex+with+a+cyclic+AMP+analogue+and+RAP1B&doi=10.1038%2Fnature07187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of Epac2 in complex with a cyclic AMP analogue and RAP1B</span></div><div class="casAuthors">Rehmann, Holger; Arias-Palomo, Ernesto; Hadders, Michael A.; Schwede, Frank; Llorca, Oscar; Bos, Johannes L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">455</span>
        (<span class="NLM_cas:issue">7209</span>),
    <span class="NLM_cas:pages">124-127</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Epac proteins are activated by binding of the second messenger cAMP and then act as guanine nucleotide exchange factors for Rap proteins.  The Epac proteins are involved in the regulation of cell adhesion and insulin secretion.  Here we have detd. the structure of Epac2 in complex with a cAMP analog (Sp-cAMPS) and RAP1B by X-ray crystallog. and single particle electron microscopy.  The structure represents the cAMP activated state of the Epac2 protein with the RAP1B protein trapped in the course of the exchange reaction.  Comparison with the inactive conformation reveals that cAMP binding causes conformational changes that allow the cyclic nucleotide binding domain to swing from a position blocking the Rap binding site towards a docking site at the Ras exchange motif domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcepqP8Xn6hbVg90H21EOLACvtfcHk0lg3wcskASegNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVKrsbvF&md5=b950409923a86ea5df583065a2dd3dc9</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnature07187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07187%26sid%3Dliteratum%253Aachs%26aulast%3DRehmann%26aufirst%3DH.%26aulast%3DArias-Palomo%26aufirst%3DE.%26aulast%3DHadders%26aufirst%3DM.%2BA.%26aulast%3DSchwede%26aufirst%3DF.%26aulast%3DLlorca%26aufirst%3DO.%26aulast%3DBos%26aufirst%3DJ.%2BL.%26atitle%3DStructure%2520of%2520Epac2%2520in%2520complex%2520with%2520a%2520cyclic%2520AMP%2520analogue%2520and%2520RAP1B%26jtitle%3DNature%26date%3D2008%26volume%3D455%26spage%3D124%26epage%3D127%26doi%3D10.1038%2Fnature07187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laudette, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lezoualc’h, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, M.</span></span> <span> </span><span class="NLM_article-title">Epac function and cAMP scaffolds in the heart and lung</span>. <i>J. Cardiovasc. Dev. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">9</span>, <span class="refDoi"> DOI: 10.3390/jcdd5010009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.3390%2Fjcdd5010009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2018&pages=9&author=M.+Laudetteauthor=H.+Zuoauthor=F.+Lezoualc%E2%80%99hauthor=M.+Schmidt&title=Epac+function+and+cAMP+scaffolds+in+the+heart+and+lung&doi=10.3390%2Fjcdd5010009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.3390%2Fjcdd5010009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fjcdd5010009%26sid%3Dliteratum%253Aachs%26aulast%3DLaudette%26aufirst%3DM.%26aulast%3DZuo%26aufirst%3DH.%26aulast%3DLezoualc%25E2%2580%2599h%26aufirst%3DF.%26aulast%3DSchmidt%26aufirst%3DM.%26atitle%3DEpac%2520function%2520and%2520cAMP%2520scaffolds%2520in%2520the%2520heart%2520and%2520lung%26jtitle%3DJ.%2520Cardiovasc.%2520Dev.%2520Dis.%26date%3D2018%26volume%3D5%26spage%3D9%26doi%3D10.3390%2Fjcdd5010009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Identification of novel 2-(benzo[d]isoxazol-3-yl)-2-oxo-N-phenylacetohydrazonoyl cyanide analoguesas potent EPAC antagonists</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">62</span>– <span class="NLM_lpage">71</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2Fj.ejmech.2017.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=28399451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFWnt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2017&pages=62-71&author=N.+Yeauthor=Y.+Zhuauthor=Z.+Liuauthor=F.+C.+Meiauthor=H.+Chenauthor=P.+Wangauthor=X.+Chengauthor=J.+Zhou&title=Identification+of+novel+2-%28benzo%5Bd%5Disoxazol-3-yl%29-2-oxo-N-phenylacetohydrazonoyl+cyanide+analoguesas+potent+EPAC+antagonists&doi=10.1016%2Fj.ejmech.2017.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel 2-(benzo[d]isoxazol-3-yl)-2-oxo-N-phenylacetohydrazonoyl cyanide analogues as potent EPAC antagonists</span></div><div class="casAuthors">Ye, Na; Zhu, Yingmin; Liu, Zhiqing; Mei, Fang C.; Chen, Haiying; Wang, Pingyuan; Cheng, Xiaodong; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">62-71</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Two series of novel EPAC antagonists are designed, synthesized and evaluated in an effort to develop diversified analogs based on the scaffold of the previously identified high-throughput (HTS) hit (1, ESI-09).  Further SAR studies reveal that the isoxazole ring A of ESI-09 can tolerate chem. modifications with either introduction of flexible electron-donating substitutions or structurally restrictedly fusing with a Ph ring, leading to identification of several more potent and diversified EPAC antagonists (e.g., 10 (NY0617), 14 (NY0460), 26 (NY0725), 32 (NY0561), and 33 (NY0562)), I-V resp., with low micromolar inhibitory activities.  Mol. docking studies on compds. I and V indicate that these two series of compds. bind at a similar site with substantially different interactions with the EPAC proteins.  The findings may serve as good starting points for the development of more potent EPAC antagonists as valuable pharmacol. probes or potential drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4LT4pJFMIhLVg90H21EOLACvtfcHk0lgQczYreHlMxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFWnt7c%253D&md5=845a7194ecb3ae6a54f3bcc80d310fba</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DN.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DMei%26aufirst%3DF.%2BC.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520novel%25202-%2528benzo%255Bd%255Disoxazol-3-yl%2529-2-oxo-N-phenylacetohydrazonoyl%2520cyanide%2520analoguesas%2520potent%2520EPAC%2520antagonists%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D134%26spage%3D62%26epage%3D71%26doi%3D10.1016%2Fj.ejmech.2017.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of 2-substituted phenyl-N-phenyl-2-oxoacetohydrazonoyl cyanides as novel antagonists of exchange proteins directly activated by cAMP (EPACs)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">5163</span>– <span class="NLM_lpage">5166</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.10.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2Fj.bmcl.2017.10.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=29100797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslKnsrzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=5163-5166&author=Z.+Liuauthor=Y.+Zhuauthor=H.+Chenauthor=P.+Wangauthor=F.+C.+Meiauthor=N.+Yeauthor=X.+Chengauthor=J.+Zhou&title=Structure-activity+relationships+of+2-substituted+phenyl-N-phenyl-2-oxoacetohydrazonoyl+cyanides+as+novel+antagonists+of+exchange+proteins+directly+activated+by+cAMP+%28EPACs%29&doi=10.1016%2Fj.bmcl.2017.10.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of 2-substituted phenyl-N-phenyl-2-oxoacetohydrazonoyl cyanides as novel antagonists of exchange proteins directly activated by cAMP (EPACs)</span></div><div class="casAuthors">Liu, Zhiqing; Zhu, Yingmin; Chen, Haiying; Wang, Pingyuan; Mei, Fang C.; Ye, Na; Cheng, Xiaodong; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5163-5166</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Exchange proteins directly activated by cAMP (EPACs) are crit. cAMP-dependent signaling pathway mediators that play important roles in cancer, diabetes, heart failure, inflammations, infections, neurol. disorders and other human diseases.  EPAC specific modulators are urgently needed to explore EPAC's physiol. function, mechanism of action and therapeutic applications.  On the basis of a previously identified EPAC specific inhibitor hit ESI-09, herein we have designed and synthesized a novel series of 2-substituted phenyl-N-phenyl-2-oxoacetohydrazonoyl cyanides as potent EPAC inhibitors.  Compd. 31 (ZL0524) has been discovered as the most potent EPAC inhibitor with IC50 values of 3.6 μM and 1.2 μM against EPAC1 and EPAC2, resp.  Mol. docking of 31 onto an active EPAC2 structure predicts that 31 occupies the hydrophobic pocket in cAMP binding domain (CBD) and also opens up new space leading to the solvent region.  These findings provide inspirations for discovering next generation of EPAC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRFzj5oCxdF7Vg90H21EOLACvtfcHk0lgQczYreHlMxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslKnsrzK&md5=73b37d93a7a5473b909c776f5bc04807</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.10.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.10.056%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DMei%26aufirst%3DF.%2BC.%26aulast%3DYe%26aufirst%3DN.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DStructure-activity%2520relationships%2520of%25202-substituted%2520phenyl-N-phenyl-2-oxoacetohydrazonoyl%2520cyanides%2520as%2520novel%2520antagonists%2520of%2520exchange%2520proteins%2520directly%2520activated%2520by%2520cAMP%2520%2528EPACs%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D5163%26epage%3D5166%26doi%3D10.1016%2Fj.bmcl.2017.10.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wild, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Na, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ynalvez, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Functionalized N,N-diphenylamines as potent and selective EPAC2 inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">460</span>– <span class="NLM_lpage">464</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00477</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00477" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvFClsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=460-464&author=C.+T.+Wildauthor=Y.+Zhuauthor=Y.+Naauthor=F.+Meiauthor=M.+A.+Ynalvezauthor=H.+Chenauthor=X.+Chengauthor=J.+Zhou&title=Functionalized+N%2CN-diphenylamines+as+potent+and+selective+EPAC2+inhibitors&doi=10.1021%2Facsmedchemlett.5b00477"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Functionalized N,N-Diphenylamines as Potent and Selective EPAC2 Inhibitors</span></div><div class="casAuthors">Wild, Christopher T.; Zhu, Yingmin; Na, Ye; Mei, Fang; Ynalvez, Marcus A.; Chen, Haiying; Cheng, Xiaodong; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">460-464</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N,N-Diphenylamines were discovered as potent and selective EPAC2 inhibitors.  A study was conducted to det. the structure-activity relationships in a series of inhibitors of which several compds. displayed submicromolar potencies.  Selectivity over the related EPAC1 protein was also demonstrated.  Computational modeling reveals an allosteric site that is distinct from the cAMP binding domain shared by both EPAC isoforms, providing a theory with regards to subtype selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7mW7XnsgOf7Vg90H21EOLACvtfcHk0ljBh4sso8CXPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvFClsLk%253D&md5=8452ff014caf43ddb96b908b5ba2b3bf</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00477%26sid%3Dliteratum%253Aachs%26aulast%3DWild%26aufirst%3DC.%2BT.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DNa%26aufirst%3DY.%26aulast%3DMei%26aufirst%3DF.%26aulast%3DYnalvez%26aufirst%3DM.%2BA.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DFunctionalized%2520N%252CN-diphenylamines%2520as%2520potent%2520and%2520selective%2520EPAC2%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D460%26epage%3D464%26doi%3D10.1021%2Facsmedchemlett.5b00477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boulton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melacini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span> <span> </span><span class="NLM_article-title">Biochemical and pharmacological characterizations of ESI-09 based EPAC inhibitors: defining the ESI-09 “therapeutic window”</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">9344</span>, <span class="refDoi"> DOI: 10.1038/srep09344</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1038%2Fsrep09344" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=25791905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFKkurnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=9344&author=Y.+Zhuauthor=H.+Chenauthor=S.+Boultonauthor=F.+Meiauthor=N.+Yeauthor=G.+Melaciniauthor=J.+Zhouauthor=X.+Cheng&title=Biochemical+and+pharmacological+characterizations+of+ESI-09+based+EPAC+inhibitors%3A+defining+the+ESI-09+%E2%80%9Ctherapeutic+window%E2%80%9D&doi=10.1038%2Fsrep09344"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and Pharmacological Characterizations of ESI-09 Based EPAC Inhibitors: Defining the ESI-09 "Therapeutic Window"</span></div><div class="casAuthors">Zhu, Yingmin; Chen, Haijun; Boulton, Stephen; Mei, Fang; Ye, Na; Melacini, Giuseppe; Zhou, Jia; Cheng, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9344</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The cAMP signaling cascade is one of the most frequently targeted pathways for the development of pharmaceutics.  A plethora of recent genetic and pharmacol. studies suggest that exchange proteins directly activated by cAMP (EPACs) are implicated in multiple pathologies.  Selective EPAC inhibitors have been recently developed.  One specific inhibitor, ESI-09, has been shown to block EPAC activity and functions, as well as to recapitulate genetic phenotypes of EPAC knockout mice when applied in vivo.  However, a recent study raised concern that ESI-09 might act as a non-specific protein denaturant.  Herein, we present a detailed biochem. and pharmacol. characterization, as well as a structure-activity relationship (SAR) anal. of ESI-09.  Our studies show that ESI-09 dose-dependently inhibits activity of both EPAC1 and EPAC2 with apparent IC50 values well below the concns. shown to induce "protein denaturation".  Moreover, the ESI-09's action towards EPAC proteins is highly sensitive to minor modifications of the 3-chlorophenyl moiety.  Taken together, these results demonstrate that ESI-09 indeed acts as an EPAC specific antagonist and does not significantly destabilize/denature proteins at pharmacol. effective concns.  This conclusion is further supported by NMR data showing that ESI-09 induces residue-dependent chem. shift changes at low concns., while preserving well dispersed peaks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOTzhJMkgGxLVg90H21EOLACvtfcHk0ljBh4sso8CXPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFKkurnF&md5=2890d652223a1f96411a11dd4d11ddc8</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fsrep09344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep09344%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DBoulton%26aufirst%3DS.%26aulast%3DMei%26aufirst%3DF.%26aulast%3DYe%26aufirst%3DN.%26aulast%3DMelacini%26aufirst%3DG.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DX.%26atitle%3DBiochemical%2520and%2520pharmacological%2520characterizations%2520of%2520ESI-09%2520based%2520EPAC%2520inhibitors%253A%2520defining%2520the%2520ESI-09%2520%25E2%2580%259Ctherapeutic%2520window%25E2%2580%259D%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D9344%26doi%3D10.1038%2Fsrep09344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wild, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship studies of substituted 2-(isoxazol-3-yl)-2-oxo-N′-phenyl-acetohydrazonoyl cyanide analogues: identification of potent exchange proteins directly activated by cAMP (EPAC) antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6033</span>– <span class="NLM_lpage">6047</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00635</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00635" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFejtb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6033-6047&author=N.+Yeauthor=Y.+Zhuauthor=H.+Chenauthor=Z.+Liuauthor=F.+C.+Meiauthor=C.+Wildauthor=H.+Chenauthor=X.+Chengauthor=J.+Zhou&title=Structure-activity+relationship+studies+of+substituted+2-%28isoxazol-3-yl%29-2-oxo-N%E2%80%B2-phenyl-acetohydrazonoyl+cyanide+analogues%3A+identification+of+potent+exchange+proteins+directly+activated+by+cAMP+%28EPAC%29+antagonists&doi=10.1021%2Facs.jmedchem.5b00635"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship Studies of Substituted 2-(Isoxazol-3-yl)-2-oxo-N'-phenyl-acetohydrazonoyl Cyanide Analogues: Identification of Potent Exchange Proteins Directly Activated by cAMP (EPAC) Antagonists</span></div><div class="casAuthors">Ye, Na; Zhu, Yingmin; Chen, Haijun; Liu, Zhiqing; Mei, Fang C.; Wild, Christopher; Chen, Haiying; Cheng, Xiaodong; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6033-6047</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Exchange proteins directly activated by cAMP (EPAC) as guanine nucleotide exchange factors mediate the effects of the pivotal second messenger cAMP, thereby regulating a wide variety of intracellular physiol. and pathophysiol. processes.  A series of novel 2-(isoxazol-3-yl)-2-oxo-N'-phenyl-acetohydrazonoyl cyanide EPAC antagonists was synthesized and evaluated in an effort to optimize properties of the previously identified high-throughput (HTS) hit 1 (I, ESI-09).  Structure-activity relationship (SAR) anal. led to the discovery of several more active EPAC antagonists [e.g., 22 (HJC0726), 35 (NY0123), and 47 (NY0173); II, III and IV, resp.] with low micromolar inhibitory activity.  These inhibitors may serve as valuable pharmacol. probes to facilitate our efforts in elucidating the biol. functions of EPAC and developing potential novel therapeutics against human diseases.  Our SAR results have also revealed that further modification at the 3-, 4-, and 5-positions of the Ph ring as well as the 5-position of the isoxazole moiety may allow for the development of more potent EPAC antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjca_eNfQUiLVg90H21EOLACvtfcHk0ljBh4sso8CXPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFejtb7M&md5=a78aa852f1a4cc206a83fe5c72cdeca8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00635%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DN.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DMei%26aufirst%3DF.%2BC.%26aulast%3DWild%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DStructure-activity%2520relationship%2520studies%2520of%2520substituted%25202-%2528isoxazol-3-yl%2529-2-oxo-N%25E2%2580%25B2-phenyl-acetohydrazonoyl%2520cyanide%2520analogues%253A%2520identification%2520of%2520potent%2520exchange%2520proteins%2520directly%2520activated%2520by%2520cAMP%2520%2528EPAC%2529%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6033%26epage%3D6047%26doi%3D10.1021%2Facs.jmedchem.5b00635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsalkova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chepurny, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holz, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of small molecules as potent and specific EPAC2 antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">952</span>– <span class="NLM_lpage">962</span>, <span class="refDoi"> DOI: 10.1021/jm3014162</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3014162" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVartA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=952-962&author=H.+Chenauthor=T.+Tsalkovaauthor=O.+G.+Chepurnyauthor=F.+C.+Meiauthor=G.+G.+Holzauthor=X.+Chengauthor=J.+Zhou&title=Identification+and+characterization+of+small+molecules+as+potent+and+specific+EPAC2+antagonists&doi=10.1021%2Fjm3014162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Characterization of Small Molecules as Potent and Specific EPAC2 Antagonists</span></div><div class="casAuthors">Chen, Haijun; Tsalkova, Tamara; Chepurny, Oleg G.; Mei, Fang C.; Holz, George G.; Cheng, Xiaodong; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">952-962</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">EPAC1 and EPAC2, two isoforms of exchange proteins directly activated by cAMP (EPAC), respond to the second messenger cAMP and regulate a wide variety of intracellular processes under physiol. and pathophysiol. circumstances.  Herein, we report the chem. design, synthesis, and pharmacol. characterization of three different scaffolds (diarylsulfones, N,N-diarylamines, and arylsulfonamides) as highly potent and selective antagonists of EPAC2.  Several selective EPAC2 antagonists have been identified including 20i (HJC0350, I), which has an apparent IC50 of 0.3 μM for competing with 8-NBD-cAMP binding of EPAC2 and is about 133-fold more potent than cAMP.  Compds. 1 (ESI-05), 14c (HJC0338), and 20i, selected from each series, have exhibited no inhibition of EPAC1-mediated Rap1-GDP exchange activity at 25 μM, indicating that they are EPAC2-specific antagonists.  Moreover, live-cell imaging studies using EPAC1, EPAC2, or PKA FRET sensor also demonstrate that 20i functions as an EPAC2 specific antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrumM4DblVhxLVg90H21EOLACvtfcHk0li_Ao-HCqf4WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVartA%253D%253D&md5=5f100066fb30778ba2793a8543d4b89a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm3014162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3014162%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DTsalkova%26aufirst%3DT.%26aulast%3DChepurny%26aufirst%3DO.%2BG.%26aulast%3DMei%26aufirst%3DF.%2BC.%26aulast%3DHolz%26aufirst%3DG.%2BG.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520small%2520molecules%2520as%2520potent%2520and%2520specific%2520EPAC2%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D952%26epage%3D962%26doi%3D10.1021%2Fjm3014162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wild, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Efficient synthesis of ESI-09, a novel non-cyclic nucleotide EPAC antagonist</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1546</span>– <span class="NLM_lpage">1549</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2013.01.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2Fj.tetlet.2013.01.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=23459418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFSms7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=1546-1549&author=H.+Chenauthor=C.+Dingauthor=C.+Wildauthor=H.+Liuauthor=T.+Wangauthor=M.+A.+Whiteauthor=X.+Chengauthor=J.+Zhou&title=Efficient+synthesis+of+ESI-09%2C+a+novel+non-cyclic+nucleotide+EPAC+antagonist&doi=10.1016%2Fj.tetlet.2013.01.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient synthesis of ESI-09, a novel non-cyclic nucleotide EPAC antagonist</span></div><div class="casAuthors">Chen, Haijun; Ding, Chunyong; Wild, Christopher; Liu, Huiling; Wang, Tianzhi; White, Mark A.; Cheng, Xiaodong; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1546-1549</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A concise and efficient synthetic approach to producing a novel non-cyclic nucleotide EPAC antagonist ESI-09 I and its new analogs is reported.  Key features of the synthesis include a mild and reliable one-pot procedure for an isoxazole synthon, as well as a modified one-pot protocol for the cyanomethyl ketone key intermediate.  The synthesis requires inexpensive starting materials and only three linear steps for the completion in a total yield of 53%.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqanZAe4EAqgbVg90H21EOLACvtfcHk0li_Ao-HCqf4WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFSms7o%253D&md5=07ac251997639c928670452ce05f3fa5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2013.01.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2013.01.024%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DDing%26aufirst%3DC.%26aulast%3DWild%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DWhite%26aufirst%3DM.%2BA.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DEfficient%2520synthesis%2520of%2520ESI-09%252C%2520a%2520novel%2520non-cyclic%2520nucleotide%2520EPAC%2520antagonist%26jtitle%3DTetrahedron%2520Lett.%26date%3D2013%26volume%3D54%26spage%3D1546%26epage%3D1549%26doi%3D10.1016%2Fj.tetlet.2013.01.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsalkova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">5-Cyano-6-oxo-1,6-dihydro-pyrimidines as potent antagonists targeting exchange proteins directly activated by cAMP</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">4038</span>– <span class="NLM_lpage">4043</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.04.082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2Fj.bmcl.2012.04.082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=22607683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC38XntlWitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=4038-4043&author=H.+Chenauthor=T.+Tsalkovaauthor=F.+C.+Meiauthor=Y.+Huauthor=X.+Chengauthor=J.+Zhou&title=5-Cyano-6-oxo-1%2C6-dihydro-pyrimidines+as+potent+antagonists+targeting+exchange+proteins+directly+activated+by+cAMP&doi=10.1016%2Fj.bmcl.2012.04.082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">5-Cyano-6-oxo-1,6-dihydropyrimidines as potent antagonists targeting exchange proteins directly activated by cAMP</span></div><div class="casAuthors">Chen, Haijun; Tsalkova, Tamara; Mei, Fang C.; Hu, Yaohua; Cheng, Xiaodong; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4038-4043</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Exchange proteins directly activated by cAMP (Epac) are a family of guanine nucleotide exchange factors that regulate a wide variety of intracellular processes in response to second messenger cAMP.  To explore the structural determinants for Epac antagonist properties of high throughput screening hit ESI-08 [I, R1 = cyclohexyl, R2 = 2-Me], a series of 5-cyano-6-oxo-1,6-dihydropyrimidine analogs have been synthesized and evaluated for their activities for Epac inhibition.  Structure-activity relationship anal. led to the identification of three more potent Epac antagonists I [R1 = cyclohexyl, R2 = 3-Me; R1 = cyclopropyl, cyclopentyl, R2 = 2-Me].  These inhibitors may serve as valuable pharmacol. probes for further elucidation of the physiol. functions and mechanisms of Epac regulation.  The SAR results and mol. docking studies have also revealed that further optimization of the moieties at the C-6 position of pyrimidine scaffold may allow us to discover more potent Epac-specific antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDSgY2kI6j37Vg90H21EOLACvtfcHk0li_Ao-HCqf4WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntlWitLs%253D&md5=fca04e55dfa3e5ea2068a686594a2b21</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.04.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.04.082%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DTsalkova%26aufirst%3DT.%26aulast%3DMei%26aufirst%3DF.%2BC.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3D5-Cyano-6-oxo-1%252C6-dihydro-pyrimidines%2520as%2520potent%2520antagonists%2520targeting%2520exchange%2520proteins%2520directly%2520activated%2520by%2520cAMP%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D4038%26epage%3D4043%26doi%3D10.1016%2Fj.bmcl.2012.04.082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jash, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Husain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehrawat, S.</span></span> <span> </span><span class="NLM_article-title">Insights into exchange factor directly activated by cAMP (EPAC) as potential target for cancer treatment</span>. <i>Mol. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>447</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1007/s11010-018-3294-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1007%2Fs11010-018-3294-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=29417338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVKjtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=447&publication_year=2018&pages=77-92&author=N.+Kumarauthor=P.+Prasadauthor=E.+Jashauthor=M.+Sainiauthor=A.+Husainauthor=A.+Goldmanauthor=S.+Sehrawat&title=Insights+into+exchange+factor+directly+activated+by+cAMP+%28EPAC%29+as+potential+target+for+cancer+treatment&doi=10.1007%2Fs11010-018-3294-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into exchange factor directly activated by cAMP (EPAC) as potential target for cancer treatment</span></div><div class="casAuthors">Kumar, Naveen; Prasad, Peeyush; Jash, Eshna; Saini, Megha; Husain, Amjad; Goldman, Aaron; Sehrawat, Seema</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">447</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">77-92</span>CODEN:
                <span class="NLM_cas:coden">MCBIB8</span>;
        ISSN:<span class="NLM_cas:issn">0300-8177</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Cancer remains a global health problem and approx. 1.7 million new cancer cases are diagnosed every year worldwide.  Although diverse mols. are currently being explored as targets for cancer therapy the tumor treatment and therapy is highly tricky.  Secondary messengers are important for hormone-mediated signaling pathway.  CAMP (cAMP), a secondary messenger responsible for various physiol. processes regulates cell metab. by activating Protein kinase A (PKA) and by targeting exchange protein directly activated by cAMP (EPAC).  EPAC is present in two isoforms EPAC1 and EPAC2, which exhibit different tissue distribution and is involved in GDP/GTP exchange along with activating Rap1- and Rap2-mediated signaling pathways.  EPAC is also known for its dual role in cancer as pro- and anti-proliferative in addn. to metastasis.  Results after perturbing EPAC activity suggests its involvement in cancer cell migration, proliferation, and cytoskeleton remodeling which makes it a potential therapeutic target for cancer treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6OYVC-iV_EbVg90H21EOLACvtfcHk0lg2LyW-BEID_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVKjtLc%253D&md5=7e4452e324d5dd9ab3b6ff26cba30f08</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs11010-018-3294-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11010-018-3294-z%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DN.%26aulast%3DPrasad%26aufirst%3DP.%26aulast%3DJash%26aufirst%3DE.%26aulast%3DSaini%26aufirst%3DM.%26aulast%3DHusain%26aufirst%3DA.%26aulast%3DGoldman%26aufirst%3DA.%26aulast%3DSehrawat%26aufirst%3DS.%26atitle%3DInsights%2520into%2520exchange%2520factor%2520directly%2520activated%2520by%2520cAMP%2520%2528EPAC%2529%2520as%2520potential%2520target%2520for%2520cancer%2520treatment%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2018%26volume%3D447%26spage%3D77%26epage%3D92%26doi%3D10.1007%2Fs11010-018-3294-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelite, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakamiya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ksiazek, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boor, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouyer, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popov, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span> <span> </span><span class="NLM_article-title">Exchange protein directly activated by cAMP plays a critical role in bacterial invasion during fatal rickettsioses</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">19615</span>– <span class="NLM_lpage">19620</span>, <span class="refDoi"> DOI: 10.1073/pnas.1314400110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1073%2Fpnas.1314400110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=24218580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFemurbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=19615-19620&author=B.+Gongauthor=T.+Sheliteauthor=F.+C.+Meiauthor=T.+Haauthor=Y.+Huauthor=G.+Xuauthor=Q.+Changauthor=M.+Wakamiyaauthor=T.+G.+Ksiazekauthor=P.+J.+Boorauthor=D.+H.+Bouyerauthor=V.+L.+Popovauthor=J.+Chenauthor=D.+H.+Walkerauthor=X.+Cheng&title=Exchange+protein+directly+activated+by+cAMP+plays+a+critical+role+in+bacterial+invasion+during+fatal+rickettsioses&doi=10.1073%2Fpnas.1314400110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Exchange protein directly activated by cAMP plays a critical role in bacterial invasion during fatal rickettsioses</span></div><div class="casAuthors">Gong, Bin; Shelite, Thomas; Mei, Fang C.; Ha, Tuha; Hu, Yaohua; Xu, Guang; Chang, Qing; Wakamiya, Maki; Ksiazek, Thomas G.; Boor, Paul J.; Bouyer, Donald H.; Popov, Vsevolod L.; Chen, Ju; Walker, David H.; Cheng, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">19615-19620,S19615/1-S19615/2</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Rickettsiae are responsible for some of the most devastating human infections.  A high infectivity and severe illness after inhalation make some rickettsiae bioterrorism threats.  We report that deletion of the exchange protein directly activated by cAMP (Epac) gene, Epac1, in mice protects them from an ordinarily LD of rickettsiae.  Inhibition of Epac1 suppresses bacterial adhesion and invasion.  Most importantly, pharmacol. inhibition of Epac1 in vivo using an Epac-specific small-mol. inhibitor, ESI-09, completely recapitulates the Epac1 knockout phenotype.  ESI-09 treatment dramatically decreases the morbidity and mortality assocd. with fatal spotted fever rickettsiosis.  Our results demonstrate that Epac1-mediated signaling represents a mechanism for host-pathogen interactions and that Epac1 is a potential target for the prevention and treatment of fatal rickettsioses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPljIAdEy6oLVg90H21EOLACvtfcHk0lg2LyW-BEID_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFemurbE&md5=3e248192593f73aa2b2536787e1a6f09</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1314400110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1314400110%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DB.%26aulast%3DShelite%26aufirst%3DT.%26aulast%3DMei%26aufirst%3DF.%2BC.%26aulast%3DHa%26aufirst%3DT.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DChang%26aufirst%3DQ.%26aulast%3DWakamiya%26aufirst%3DM.%26aulast%3DKsiazek%26aufirst%3DT.%2BG.%26aulast%3DBoor%26aufirst%3DP.%2BJ.%26aulast%3DBouyer%26aufirst%3DD.%2BH.%26aulast%3DPopov%26aufirst%3DV.%2BL.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWalker%26aufirst%3DD.%2BH.%26aulast%3DCheng%26aufirst%3DX.%26atitle%3DExchange%2520protein%2520directly%2520activated%2520by%2520cAMP%2520plays%2520a%2520critical%2520role%2520in%2520bacterial%2520invasion%2520during%2520fatal%2520rickettsioses%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2013%26volume%3D110%26spage%3D19615%26epage%3D19620%26doi%3D10.1073%2Fpnas.1314400110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, E.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garofalo, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, X.</span></span> <span> </span><span class="NLM_article-title">Exchange proteins directly activated by cAMP and their roles in respiratory syncytial virus infection</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">e01200</span>– <span class="NLM_lpage">e01218</span>, <span class="refDoi"> DOI: 10.1128/jvi.01200-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1128%2FJVI.01200-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=30185593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvFemsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2018&pages=e01200-e01218&author=E.-J.+Choiauthor=Y.+Renauthor=Y.+Chenauthor=S.+Liuauthor=W.+Wuauthor=J.+Renauthor=P.+Wangauthor=R.+P.+Garofaloauthor=J.+Zhouauthor=X.+Bao&title=Exchange+proteins+directly+activated+by+cAMP+and+their+roles+in+respiratory+syncytial+virus+infection&doi=10.1128%2Fjvi.01200-18"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Exchange proteins directly activated by cAMP and their roles in respiratory syncytial virus infection</span></div><div class="casAuthors">Choi, Eun-Jin; Ren, Yuping; Chen, Yu; Liu, Shengxuan; Wu, Wenzhe; Ren, Junping; Wang, Pingyuan; Garofalo, Roberto P.; Zhou, Jia; Bao, Xiaoyong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">e01200-18/1-e01200-18/17</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">1098-5514</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Respiratory syncytial virus (RSV) is the leading cause of respiratory infection in young children and high-risk adults.  However, a specific treatment for this viral infection is not currently available.  In this study, we discovered that an exchange protein directly activated by cAMP (EPAC) can serve as a potential therapeutic target for RSV.  In both lower and upper epithelial cells, treatment with EPAC inhibitor (ESI-09), but not protein kinase A inhibitor (H89), significantly inhibits RSV replication and proinflammatory cytokine/chemokine induction.  In addn., RSV-activated transcriptional factors belonging to the NF-κB and IRF families are also suppressed by ESI-09.  Through isoform-specific gene knockdown, we found that EPAC2, but not EPAC1, plays a dominant role in controlling RSV replication and virus-induced host responses.  Expts. using both EPAC2 knockout and EPAC2-specific inhibitor support such roles of EPAC2.  Therefore, EPAC2 is a promising therapeutic target to regulate RSV replication and assocd. inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMrHTgdhc0orVg90H21EOLACvtfcHk0ljzvgrjHiKUNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvFemsbk%253D&md5=7566d42c9692310026ff73dcd2104505</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1128%2FJVI.01200-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01200-18%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DE.-J.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DGarofalo%26aufirst%3DR.%2BP.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DBao%26aufirst%3DX.%26atitle%3DExchange%2520proteins%2520directly%2520activated%2520by%2520cAMP%2520and%2520their%2520roles%2520in%2520respiratory%2520syncytial%2520virus%2520infection%26jtitle%3DJ.%2520Virol.%26date%3D2018%26volume%3D92%26spage%3De01200%26epage%3De01218%26doi%3D10.1128%2Fjvi.01200-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lao, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrikeev, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutz, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineley, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motamedi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hommel, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span> <span> </span><span class="NLM_article-title">Enhanced leptin sensitivity, reduced adiposity, and improved glucose homeostasis in mice lacking exchange protein directly activated by cyclic AMP isoform 1</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">918</span>– <span class="NLM_lpage">926</span>, <span class="refDoi"> DOI: 10.1128/mcb.01227-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1128%2FMCB.01227-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=23263987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltV2hsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=918-926&author=J.+Yanauthor=F.+C.+Meiauthor=H.+Chengauthor=D.+H.+Laoauthor=Y.+Huauthor=J.+Weiauthor=I.+Patrikeevauthor=D.+Haoauthor=S.+J.+Stutzauthor=K.+T.+Dineleyauthor=M.+Motamediauthor=J.+D.+Hommelauthor=K.+A.+Cunninghamauthor=J.+Chenauthor=X.+Cheng&title=Enhanced+leptin+sensitivity%2C+reduced+adiposity%2C+and+improved+glucose+homeostasis+in+mice+lacking+exchange+protein+directly+activated+by+cyclic+AMP+isoform+1&doi=10.1128%2Fmcb.01227-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced leptin sensitivity, reduced adiposity, and improved glucose homeostasis in mice lacking exchange protein directly activated by cyclic AMP isoform 1</span></div><div class="casAuthors">Yan, Jingbo; Mei, Fang C.; Cheng, Hongqiang; Lao, Dieu Hung; Hu, Yaohua; Wei, Jingna; Patrikeev, Igor; Hao, Dapeng; Stutz, Sonja J.; Dineley, Kelly T.; Motamedi, Massoud; Hommel, Jonathan D.; Cunningham, Kathryn A.; Chen, Ju; Cheng, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">918-926</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The prototypic second messenger cAMP (cAMP) is essential for controlling cellular metab., including glucose and lipid homeostasis.  In mammals, the majority of cAMP functions are mediated by cAMP-dependent protein kinase (PKA) and exchange proteins directly activated by cAMP (Epacs).  To explore the physiol. functions of Epac1, we generated Epac1 knockout mice.  Here we report that Epac1 null mutants have reduced white adipose tissue and reduced plasma leptin levels but display heightened leptin sensitivity.  Epac1-deficient mice are more resistant to high-fat diet-induced obesity, hyperleptinemia, and glucose intolerance.  Furthermore, pharmacol. inhibition of Epac by use of an Epac-specific inhibitor reduces plasma leptin levels in vivo and enhances leptin signaling in organotypic hypothalamic slices.  Taken together, our results demonstrate that Epac1 plays an important role in regulating adiposity and energy balance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLNMbsPjnHWrVg90H21EOLACvtfcHk0ljzvgrjHiKUNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltV2hsrY%253D&md5=14e0b6ce132544c477773ba6fb29f4eb</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1128%2FMCB.01227-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01227-12%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DMei%26aufirst%3DF.%2BC.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DLao%26aufirst%3DD.%2BH.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DPatrikeev%26aufirst%3DI.%26aulast%3DHao%26aufirst%3DD.%26aulast%3DStutz%26aufirst%3DS.%2BJ.%26aulast%3DDineley%26aufirst%3DK.%2BT.%26aulast%3DMotamedi%26aufirst%3DM.%26aulast%3DHommel%26aufirst%3DJ.%2BD.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DX.%26atitle%3DEnhanced%2520leptin%2520sensitivity%252C%2520reduced%2520adiposity%252C%2520and%2520improved%2520glucose%2520homeostasis%2520in%2520mice%2520lacking%2520exchange%2520protein%2520directly%2520activated%2520by%2520cyclic%2520AMP%2520isoform%25201%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2013%26volume%3D33%26spage%3D918%26epage%3D926%26doi%3D10.1128%2Fmcb.01227-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heijnen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Velthoven, C. T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willemen, H. L. D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sood, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vroon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eijkelkamp, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kavelaars, A.</span></span> <span> </span><span class="NLM_article-title">Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">5023</span>– <span class="NLM_lpage">5034</span>, <span class="refDoi"> DOI: 10.1172/jci66241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1172%2FJCI66241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=24231349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFSqtbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2013&pages=5023-5034&author=H.+Wangauthor=C.+J.+Heijnenauthor=C.+T.+J.+van+Velthovenauthor=H.+L.+D.+M.+Willemenauthor=Y.+Ishikawaauthor=X.+Zhangauthor=A.+K.+Soodauthor=A.+Vroonauthor=N.+Eijkelkampauthor=A.+Kavelaars&title=Balancing+GRK2+and+EPAC1+levels+prevents+and+relieves+chronic+pain&doi=10.1172%2Fjci66241"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain</span></div><div class="casAuthors">Wang, Huijing; Heijnen, Cobi J.; van Velthoven, Cindy T. J.; Willemen, Hanneke L. D. M.; Ishikawa, Yoshihiro; Zhang, Xinna; Sood, Anil K.; Vroon, Anne; Eijkelkamp, Niels; Kavelaars, Annemieke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5023-5034</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Chronic pain is a major clin. problem, yet the mechanisms underlying the transition from acute to chronic pain remain poorly understood.  In mice, reduced expression of GPCR kinase 2 (GRK2) in nociceptors promotes cAMP signaling to the guanine nucleotide exchange factor EPAC1 and prolongs the PGE2-induced increase in pain sensitivity (hyperalgesia).  Here we hypothesized that redn. of GRK2 or increased EPAC1 in dorsal root ganglion (DRG) neurons would promote the transition to chronic pain.  We used 2 mouse models of hyperalgesic priming in which the transition from acute to chronic PGE2-induced hyperalgesia occurs.  Hyperalgesic priming with carrageenan induced a sustained decrease in nociceptor GRK2, whereas priming with the PKCε agonist ΨεRACK increased DRG EPAC1.  When either GRK2 was increased in vivo by viral-based gene transfer or EPAC1 was decreased in vivo, as was the case for mice heterozygous for Epac1 or mice treated with Epac1 antisense oligodeoxynucleotides, chronic PGE2-induced hyperalgesia development was prevented in the 2 priming models.  Using the CFA model of chronic inflammatory pain, we found that increasing GRK2 or decreasing EPAC1 inhibited chronic hyperalgesia.  Our data suggest that therapies targeted at balancing nociceptor GRK2 and EPAC1 levels have promise for the prevention and treatment of chronic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6YyieKoSJGrVg90H21EOLACvtfcHk0liLiTVJAZdNXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFSqtbbL&md5=5945273ca2a1efe39d5360f26a6a64d0</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1172%2FJCI66241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI66241%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DHeijnen%26aufirst%3DC.%2BJ.%26aulast%3Dvan%2BVelthoven%26aufirst%3DC.%2BT.%2BJ.%26aulast%3DWillemen%26aufirst%3DH.%2BL.%2BD.%2BM.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DSood%26aufirst%3DA.%2BK.%26aulast%3DVroon%26aufirst%3DA.%26aulast%3DEijkelkamp%26aufirst%3DN.%26aulast%3DKavelaars%26aufirst%3DA.%26atitle%3DBalancing%2520GRK2%2520and%2520EPAC1%2520levels%2520prevents%2520and%2520relieves%2520chronic%2520pain%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2013%26volume%3D123%26spage%3D5023%26epage%3D5034%26doi%3D10.1172%2Fjci66241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, P. K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsim, K. W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">So, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, L. C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, S. K.</span></span> <span> </span><span class="NLM_article-title">Anxiety and depression with neurogenesis defects in exchange protein directly activated by cAMP 2-deficient mice are ameliorated by a selective serotonin reuptake inhibitor, Prozac</span>. <i>Transl. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e881</span>, <span class="refDoi"> DOI: 10.1038/tp.2016.129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1038%2Ftp.2016.129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=27598965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOht7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=e881&author=L.+Zhouauthor=S.+L.+Maauthor=P.+K.+K.+Yeungauthor=Y.+H.+Wongauthor=K.+W.+K.+Tsimauthor=K.+F.+Soauthor=L.+C.+W.+Lamauthor=S.+K.+Chung&title=Anxiety+and+depression+with+neurogenesis+defects+in+exchange+protein+directly+activated+by+cAMP+2-deficient+mice+are+ameliorated+by+a+selective+serotonin+reuptake+inhibitor%2C+Prozac&doi=10.1038%2Ftp.2016.129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Anxiety and depression with neurogenesis defects in exchange protein directly activated by cAMP 2-deficient mice are ameliorated by a selective serotonin reuptake inhibitor, Prozac</span></div><div class="casAuthors">Zhou, L.; Ma, S. L.; Yeung, P. K. K.; Wong, Y. H.; Tsim, K. W. K.; So, K. F.; Lam, L. C. W.; Chung, S. K.</div><div class="citationInfo"><span class="NLM_cas:title">Translational Psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e881</span>CODEN:
                <span class="NLM_cas:coden">TPRSCF</span>;
        ISSN:<span class="NLM_cas:issn">2158-3188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Intracellular cAMP and serotonin are important modulators of anxiety and depression.  Fluoxetine, a selective serotonin reuptake inhibitor (SSRI) also known as Prozac, is widely used against depression, potentially by activating cAMP response element-binding protein (CREB) and increasing brain-derived neurotrophic factor (BDNF) through protein kinase A (PKA).  However, the role of Epac1 and Epac2 (Rap guanine nucleotide exchange factors, RAPGEF3 and RAPGEF4, resp.) as potential downstream targets of SSRI/cAMP in mood regulations is not yet clear.  Here, we investigated the phenotypes of Epac1 (Epac1-/-) or Epac2 (Epac2-/-) knockout mice by comparing them with their wild-type counterparts.  Surprisingly, Epac2-/- mice exhibited a wide range of mood disorders, including anxiety and depression with learning and memory deficits in contextual and cued fear-conditioning tests without affecting Epac1 expression or PKA activity.  Interestingly, rs17746510, one of the three single-nucleotide polymorphisms (SNPs) in RAPGEF4 assocd. with cognitive decline in Chinese Alzheimer's disease (AD) patients, was significantly correlated with apathy and mood disturbance, whereas no significant assocn. was obsd. between RAPGEF3 SNPs and the risk of AD or neuropsychiatric inventory scores.  To further det. the detailed role of Epac2 in SSRI/serotonin/cAMP-involved mood disorders, we treated Epac2-/- mice with a SSRI, Prozac.  The alteration in open field behavior and impaired hippocampal cell proliferation in Epac2-/- mice were alleviated by Prozac.  Taken together, Epac2 gene polymorphism is a putative risk factor for mood disorders in AD patients in part by affecting the hippocampal neurogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR4XSTp0T6-bVg90H21EOLACvtfcHk0liLiTVJAZdNXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOht7jO&md5=2a9e4565d993f4cf617b66db8e2417bb</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Ftp.2016.129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Ftp.2016.129%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DMa%26aufirst%3DS.%2BL.%26aulast%3DYeung%26aufirst%3DP.%2BK.%2BK.%26aulast%3DWong%26aufirst%3DY.%2BH.%26aulast%3DTsim%26aufirst%3DK.%2BW.%2BK.%26aulast%3DSo%26aufirst%3DK.%2BF.%26aulast%3DLam%26aufirst%3DL.%2BC.%2BW.%26aulast%3DChung%26aufirst%3DS.%2BK.%26atitle%3DAnxiety%2520and%2520depression%2520with%2520neurogenesis%2520defects%2520in%2520exchange%2520protein%2520directly%2520activated%2520by%2520cAMP%25202-deficient%2520mice%2520are%2520ameliorated%2520by%2520a%2520selective%2520serotonin%2520reuptake%2520inhibitor%252C%2520Prozac%26jtitle%3DTransl.%2520Psychiatry%26date%3D2016%26volume%3D6%26spage%3De881%26doi%3D10.1038%2Ftp.2016.129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinle, J. J.</span></span> <span> </span><span class="NLM_article-title">Epac1 and glycyrrhizin both inhibit HMGB1 levels to reduce diabetes-induced neuronal and vascular damage in the mouse retina</span>. <i>J. Clin. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">772</span>, <span class="refDoi"> DOI: 10.3390/jcm8060772</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.3390%2Fjcm8060772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjslGntL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=772&author=L.+Liuauthor=Y.+Jiangauthor=J.+J.+Steinle&title=Epac1+and+glycyrrhizin+both+inhibit+HMGB1+levels+to+reduce+diabetes-induced+neuronal+and+vascular+damage+in+the+mouse+retina&doi=10.3390%2Fjcm8060772"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Epac1 and glycyrrhizin both inhibit HMGB1 levels to reduce diabetes-induced neuronal and vascular damage in the mouse retina</span></div><div class="casAuthors">Liu, Li; Jiang, Youde; Steinle, Jena J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">772</span>CODEN:
                <span class="NLM_cas:coden">JCMOHK</span>;
        ISSN:<span class="NLM_cas:issn">2077-0383</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The role of high mobility group box 1 (HMGB1) in acute diabetic retinal damage has been demonstrated.  We recently reported that glycyrrhizin, a HMGB1 inhibitor, protected the diabetic retina against neuronal, vascular, and permeability changes.  In this study, we wanted to investigate the role of exchange protein for cAMP 1 (Epac1) on HMGB1 and the actions of glycyrrhizin.  Using endothelial cell specific knockout mice for Epac1, we made some mice diabetic using streptozotocin, and treated some with glycyrrhizin for up to 6 mo.  We measured permeability, neuronal, and vascular changes in the Epac1 floxed and knockout mice.  We also investigated whether Epac1 and glycyrrhizin work synergistically to reduce the retinal inflammatory mediators, tumor necrosis factor alpha (TNFα) and interleukin-1-beta (IL1β), as well as sirtuin 1 (SIRT1) levels.  Epac1 and glycyrrhizin reduced inflammatory mediators with synergistic actions.  Glycyrrhizin also increased SIRT1 levels in the Epac1 mice.  Overall, these studies demonstrate that glycyrrhizin and Epac1 can work together to protect the retina.  Finally, glycyrrhizin may regulate HMGB1 through increased SIRT1 actions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMmb-6C3qNprVg90H21EOLACvtfcHk0liLiTVJAZdNXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjslGntL0%253D&md5=69a8f9c59e1a8c9f17d417a097ca34bf</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.3390%2Fjcm8060772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fjcm8060772%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DSteinle%26aufirst%3DJ.%2BJ.%26atitle%3DEpac1%2520and%2520glycyrrhizin%2520both%2520inhibit%2520HMGB1%2520levels%2520to%2520reduce%2520diabetes-induced%2520neuronal%2520and%2520vascular%2520damage%2520in%2520the%2520mouse%2520retina%26jtitle%3DJ.%2520Clin.%2520Med.%26date%3D2019%26volume%3D8%26spage%3D772%26doi%3D10.3390%2Fjcm8060772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selheim, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Rooij, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dremier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwede, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dao, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maenhaut, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bos, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genieser, H.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Døskeland, S. O.</span></span> <span> </span><span class="NLM_article-title">cAMP Analog Mapping of Epac1 and cAMP Kinase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">35394</span>– <span class="NLM_lpage">35402</span>, <span class="refDoi"> DOI: 10.1074/jbc.m302179200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1074%2Fjbc.M302179200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=12819211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVWqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=35394-35402&author=A.+E.+Christensenauthor=F.+Selheimauthor=J.+de+Rooijauthor=S.+Dremierauthor=F.+Schwedeauthor=K.+K.+Daoauthor=A.+Martinezauthor=C.+Maenhautauthor=J.+L.+Bosauthor=H.-G.+Genieserauthor=S.+O.+D%C3%B8skeland&title=cAMP+Analog+Mapping+of+Epac1+and+cAMP+Kinase&doi=10.1074%2Fjbc.m302179200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">cAMP analog mapping of Epac1 and cAMP kinase: discriminating analogs demonstrate that Epac and camp kinase act synergistically to promote PC-12 cell neurite extension</span></div><div class="casAuthors">Christensen, Anne E.; Selheim, Frode; de Rooij, Johan; Dremier, Sarah; Schwede, Frank; Dao, Khanh K.; Martinez, Aurora; Maenhaut, Carine; Bos, Johannes L.; Genieser, H.-G.; Doskeland, Stein O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">35394-35402</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Little is known about the relative role of cAMP-dependent protein kinase (cAPK) and guanine exchange factor directly activated by cAMP (Epac) as mediators of cAMP action.  The authors tested cAMP analogs for ability to selectively activate Epac1 or cAPK and discriminate between the binding sites of Epac and of cAPKI and cAPKII.  The authors found that commonly used cAMP analogs, like 8-Br-cAMP and 8-pCPT-cAMP, activate Epac and cAPK equally as well as cAMP, i.e., were full agonists.  In contrast, 6-modified cAMP analogs, like N6-benzoyl-cAMP, were inefficient Epac activators and full cAPK activators.  Analogs modified in the 2'-position of the ribose induced stronger Epac1 activation than cAMP but were only partial agonists for cAPK.  2'-O-Alkyl substitution of cAMP improved Epac/cAPK binding selectivity 10-100-fold.  Phenylthio substituents in position 8, particularly with MeO- or Cl- in p-position, enhanced the Epac/cAPK selectivity even more.  The combination of 8-pCPT- and 2'-O-Me substitutions improved the Epac/cAPK binding selectivity about three orders of magnitude.  The cAPK selectivity of 6-substituted cAMP analogs, the preferential inhibition of cAPK by moderate concns. of Rp-cAMPS analogs, and the Epac selectivity of 8-pCPT-2'-O-methyl-cAMP was also demonstrated in intact cells.  Using these compds. to selectively modulate Epac and cAPK in PC-12 cells, the authors obsd. that analogs selectively activating Epac synergized strongly with cAPK specific analogs to induce neurite outgrowth.  The authors therefore conclude that cAMP-induced neurite outgrowth is mediated by both Epac and cAPK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHPaVWQFVD0LVg90H21EOLACvtfcHk0lgfMtKh16b72A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVWqu7s%253D&md5=faa0d4654ad4b49892fd373ba1543aa4</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M302179200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M302179200%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DA.%2BE.%26aulast%3DSelheim%26aufirst%3DF.%26aulast%3Dde%2BRooij%26aufirst%3DJ.%26aulast%3DDremier%26aufirst%3DS.%26aulast%3DSchwede%26aufirst%3DF.%26aulast%3DDao%26aufirst%3DK.%2BK.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DMaenhaut%26aufirst%3DC.%26aulast%3DBos%26aufirst%3DJ.%2BL.%26aulast%3DGenieser%26aufirst%3DH.-G.%26aulast%3DD%25C3%25B8skeland%26aufirst%3DS.%2BO.%26atitle%3DcAMP%2520Analog%2520Mapping%2520of%2520Epac1%2520and%2520cAMP%2520Kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D35394%26epage%3D35402%26doi%3D10.1074%2Fjbc.m302179200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kiermayer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biondi, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plotz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haupenthal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeuzem, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piiper, A.</span></span> <span> </span><span class="NLM_article-title">Epac activation converts cAMP from a proliferative into a differentiation signal in PC12 cells</span>. <i>Mol. Biol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">5639</span>– <span class="NLM_lpage">5648</span>, <span class="refDoi"> DOI: 10.1091/mbc.e05-05-0432</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1091%2Fmbc.e05-05-0432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=16207818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht12gsLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=5639-5648&author=S.+Kiermayerauthor=R.+M.+Biondiauthor=J.+Imigauthor=G.+Plotzauthor=J.+Haupenthalauthor=S.+Zeuzemauthor=A.+Piiper&title=Epac+activation+converts+cAMP+from+a+proliferative+into+a+differentiation+signal+in+PC12+cells&doi=10.1091%2Fmbc.e05-05-0432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Epac activation converts cAMP from a proliferative into a differentiation signal in PC12 cells</span></div><div class="casAuthors">Kiermayer, Simone; Biondi, Ricardo M.; Imig, Jochen; Plotz, Guido; Haupenthal, Joerg; Zeuzem, Stefan; Piiper, Albrecht</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5639-5648</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1059-1524</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">Elevation of the intracellular cAMP concn. ([cAMP]i) regulates metab., cell proliferation, and differentiation and plays roles in memory formation and neoplastic growth.  CAMP mediates its effects mainly through activation of protein kinase A (PKA) as well as Epac1 and Epac2, exchange factors activating the small GTPases Rap1 and Rap2.  However, how cAMP utilizes these effectors to induce distinct biol. responses is unknown.  We here studied the specific roles of PKA and Epac in neuroendocrine PC12 cells.  In these cells, elevation of [cAMP]i activates extracellular signal-regulated kinase (ERK) 1/2 and induces low-degree neurite outgrowth.  The present study showed that specific stimulation of PKA triggered ERK1/2 activation that was considerably more transient than that obsd. upon simultaneous activation of both PKA and Epac.  Unexpectedly, the PKA-specific cAMP analog induced cell proliferation rather than neurite outgrowth.  The proliferative signaling pathway activated by the PKA-specific cAMP analog involved activation of the epidermal growth factor receptor and ERK1/2.  Activation of Epac appeared to extend the duration of PKA-dependent ERK1/2 activation and converted cAMP from a proliferative into an anti-proliferative, neurite outgrowth-promoting signal.  Thus, the present study showed that the outcome of cAMP signaling can depend heavily on the set of cAMP effectors activated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9sMlx_okjoLVg90H21EOLACvtfcHk0lgfMtKh16b72A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht12gsLnL&md5=197efc52d627e9dae346c719836535b2</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1091%2Fmbc.e05-05-0432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.e05-05-0432%26sid%3Dliteratum%253Aachs%26aulast%3DKiermayer%26aufirst%3DS.%26aulast%3DBiondi%26aufirst%3DR.%2BM.%26aulast%3DImig%26aufirst%3DJ.%26aulast%3DPlotz%26aufirst%3DG.%26aulast%3DHaupenthal%26aufirst%3DJ.%26aulast%3DZeuzem%26aufirst%3DS.%26aulast%3DPiiper%26aufirst%3DA.%26atitle%3DEpac%2520activation%2520converts%2520cAMP%2520from%2520a%2520proliferative%2520into%2520a%2520differentiation%2520signal%2520in%2520PC12%2520cells%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2005%26volume%3D16%26spage%3D5639%26epage%3D5648%26doi%3D10.1091%2Fmbc.e05-05-0432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emery, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiden, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiden, L. E.</span></span> <span> </span><span class="NLM_article-title">Separate cyclic AMP sensors for neuritogenesis, growth arrest, and survival of neuroendocrine cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">10126</span>– <span class="NLM_lpage">10139</span>, <span class="refDoi"> DOI: 10.1074/jbc.m113.529321</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1074%2Fjbc.M113.529321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=24567337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1ajtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=10126-10139&author=A.+C.+Emeryauthor=M.+V.+Eidenauthor=L.+E.+Eiden&title=Separate+cyclic+AMP+sensors+for+neuritogenesis%2C+growth+arrest%2C+and+survival+of+neuroendocrine+cells&doi=10.1074%2Fjbc.m113.529321"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Separate Cyclic AMP Sensors for Neuritogenesis, Growth Arrest, and Survival of Neuroendocrine Cells</span></div><div class="casAuthors">Emery, Andrew C.; Eiden, Maribeth V.; Eiden, Lee E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">10126-10139</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Dividing neuroendocrine cells differentiate into a neuronal-like phenotype in response to ligands activating G protein-coupled receptors, leading to the elevation of the second messenger cAMP.  Growth factors that act at receptor tyrosine kinases, such as nerve growth factor, also cause differentiation.  We report here that two aspects of cAMP-induced differentiation, neurite extension and growth arrest, are dissociable at the level of the sensors conveying the cAMP signal in PC12 and NS-1 cells.  Following cAMP elevation, neuritogenic cAMP sensor/Rapgef2 is activated for signaling to ERK to mediate neuritogenesis, whereas Epac2 is activated for signaling to the MAP kinase p38 to mediate growth arrest.  Neither action of cAMP requires transactivation of TrkA, the receptor for NGF.  In fact, the differentiating effects of NGF do not require activation of any of the cAMP sensors protein kinase A, Epac, or neuritogenic cAMP sensor/Rapgef2 but, rather, depend on ERK and p38 activation via completely independent signaling pathways.  Hence, cAMP- and NGF-dependent signaling for differentiation are also completely insulated from each other.  CAMP and NGF also protect NS-1 cells from serum withdrawal-induced cell death, again by two wholly sep. signaling mechanisms, PKA-dependent for cAMP and PKA-independent for NGF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa0ljabRDxHbVg90H21EOLACvtfcHk0lgfMtKh16b72A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1ajtrg%253D&md5=be4c801691d66374fc0c44b9af510b30</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.529321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.529321%26sid%3Dliteratum%253Aachs%26aulast%3DEmery%26aufirst%3DA.%2BC.%26aulast%3DEiden%26aufirst%3DM.%2BV.%26aulast%3DEiden%26aufirst%3DL.%2BE.%26atitle%3DSeparate%2520cyclic%2520AMP%2520sensors%2520for%2520neuritogenesis%252C%2520growth%2520arrest%252C%2520and%2520survival%2520of%2520neuroendocrine%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D10126%26epage%3D10139%26doi%3D10.1074%2Fjbc.m113.529321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petralia, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span> <span> </span><span class="NLM_article-title">EPAC null mutation impairs learning and social interactions via aberrant regulation of miR-124 and Zif268 translation</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">774</span>– <span class="NLM_lpage">788</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2012.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2Fj.neuron.2012.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=22365550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtV2ktLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2012&pages=774-788&author=Y.+Yangauthor=X.+Shuauthor=D.+Liuauthor=Y.+Shangauthor=Y.+Wuauthor=L.+Peiauthor=X.+Xuauthor=Q.+Tianauthor=J.+Zhangauthor=K.+Qianauthor=Y.-X.+Wangauthor=R.+S.+Petraliaauthor=W.+Tuauthor=L.-Q.+Zhuauthor=J.-Z.+Wangauthor=Y.+Lu&title=EPAC+null+mutation+impairs+learning+and+social+interactions+via+aberrant+regulation+of+miR-124+and+Zif268+translation&doi=10.1016%2Fj.neuron.2012.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">EPAC Null Mutation Impairs Learning and Social Interactions via Aberrant Regulation of miR-124 and Zif268 Translation</span></div><div class="casAuthors">Yang, Ying; Shu, Xiaogang; Liu, Dan; Shang, You; Wu, Yan; Pei, Lei; Xu, Xin; Tian, Qing; Zhang, Jian; Qian, Kun; Wang, Ya-Xian; Petralia, Ronald S.; Tu, Weihong; Zhu, Ling-Qiang; Wang, Jian-Zhi; Lu, Youming</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">774-788</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">EPAC proteins are the guanine nucleotide exchange factors that act as the intracellular receptors for cAMP.  Two variants of EPAC genes including EPAC1 and EPAC2 are cloned and are widely expressed throughout the brain.  But, their functions in the brain remain unknown.  Here, we genetically delete EPAC1 (EPAC1-/-), EPAC2 (EPAC2-/-), or both EPAC1 and EPAC2 genes (EPAC-/-) in the forebrain of mice.  We show that EPAC null mutation impairs long-term potentiation (LTP) and that this impairment is paralleled with the severe deficits in spatial learning and social interactions and is mediated in a direct manner by miR-124 transcription and Zif268 translation.  Knockdown of miR-124 restores Zif268 and hence reverses all aspects of the EPAC-/- phenotypes, whereas expression of miR-124 or knockdown of Zif268 reproduces the effects of EPAC null mutation.  Thus, EPAC proteins control miR-124 transcription in the brain for processing spatial learning and social interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS3xT7TZPA37Vg90H21EOLACvtfcHk0lgfNl_27SUKLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtV2ktLw%253D&md5=03fd3bd2a6401a5f3c6e36916d9b3a4b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2012.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2012.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DShu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DShang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DPei%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DTian%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DY.-X.%26aulast%3DPetralia%26aufirst%3DR.%2BS.%26aulast%3DTu%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DL.-Q.%26aulast%3DWang%26aufirst%3DJ.-Z.%26aulast%3DLu%26aufirst%3DY.%26atitle%3DEPAC%2520null%2520mutation%2520impairs%2520learning%2520and%2520social%2520interactions%2520via%2520aberrant%2520regulation%2520of%2520miR-124%2520and%2520Zif268%2520translation%26jtitle%3DNeuron%26date%3D2012%26volume%3D73%26spage%3D774%26epage%3D788%26doi%3D10.1016%2Fj.neuron.2012.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yarwood, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borland, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sands, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, T. M.</span></span> <span> </span><span class="NLM_article-title">Identification of CCAAT/enhancer-binding proteins as exchange protein activated by cAMP-activated transcription factors that mediate the induction of the SOCS-3 gene</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">6843</span>– <span class="NLM_lpage">6853</span>, <span class="refDoi"> DOI: 10.1074/jbc.m710342200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1074%2Fjbc.M710342200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=18195020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivFyjtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=6843-6853&author=S.+J.+Yarwoodauthor=G.+Borlandauthor=W.+A.+Sandsauthor=T.+M.+Palmer&title=Identification+of+CCAAT%2Fenhancer-binding+proteins+as+exchange+protein+activated+by+cAMP-activated+transcription+factors+that+mediate+the+induction+of+the+SOCS-3+gene&doi=10.1074%2Fjbc.m710342200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of CCAAT/Enhancer-binding Proteins as Exchange Protein Activated by cAMP-activated Transcription Factors That Mediate the Induction of the SOCS-3 Gene</span></div><div class="casAuthors">Yarwood, Stephen J.; Borland, Gillian; Sands, William A.; Palmer, Timothy M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6843-6853</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The prototypical second messenger cAMP is a key regulator of immune and inflammatory responses.  Its ability to inhibit interleukin (IL)-6 responses is due to induction of suppressor of cytokine signaling-3 (SOCS-3), a neg. regulator of IL-6 receptor signaling.  We have detd. previously that SOCS-3 induction by cAMP occurs independently of cAMP-dependent protein kinase, instead requiring the recently identified cAMP sensor exchange protein activated by cAMP 1 (EPAC1).  Here we present evidence to suggest that the C/EBP family of transcription factors link EPAC1 activation to SOCS-3 induction.  Firstly, selective activation of EPAC in human umbilical vein endothelial cells increased C/EBP DNA binding activity and recruitment of C/EBPβ to the SOCS-3 promoter.  Secondly, knockdown of C/EBPβ and -δ isoforms abolished both SOCS-3 induction and inhibition of IL-6 signaling in response to cAMP.  Thirdly, overexpression of C/EBPα, -β, or -δ potentiated EPAC-mediated accumulation of SOCS-3.  Finally, these effects were not restricted to human umbilical vein endothelial cells, because similar phenomena were obsd. in murine embryonic fibroblasts in which C/EBPβ or δ had been deleted.  In summary, our findings constitute the first description of an EPAC-C/EBP pathway that can control cAMP-mediated changes in gene expression independently of protein kinase A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp938IwfsNVkLVg90H21EOLACvtfcHk0lgfNl_27SUKLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivFyjtrk%253D&md5=1afd4aaeea00999b360628a06e16bf54</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M710342200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M710342200%26sid%3Dliteratum%253Aachs%26aulast%3DYarwood%26aufirst%3DS.%2BJ.%26aulast%3DBorland%26aufirst%3DG.%26aulast%3DSands%26aufirst%3DW.%2BA.%26aulast%3DPalmer%26aufirst%3DT.%2BM.%26atitle%3DIdentification%2520of%2520CCAAT%252Fenhancer-binding%2520proteins%2520as%2520exchange%2520protein%2520activated%2520by%2520cAMP-activated%2520transcription%2520factors%2520that%2520mediate%2520the%2520induction%2520of%2520the%2520SOCS-3%2520gene%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D6843%26epage%3D6853%26doi%3D10.1074%2Fjbc.m710342200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parnell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terrin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaccolo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarwood, S. J.</span></span> <span> </span><span class="NLM_article-title">Regulation of the inflammatory response of vascular endothelial cells by EPAC1</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>166</i></span>,  <span class="NLM_fpage">434</span>– <span class="NLM_lpage">446</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2011.01808.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1111%2Fj.1476-5381.2011.01808.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=22145651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVaqtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2012&pages=434-446&author=E.+Parnellauthor=B.+O.+Smithauthor=T.+M.+Palmerauthor=A.+Terrinauthor=M.+Zaccoloauthor=S.+J.+Yarwood&title=Regulation+of+the+inflammatory+response+of+vascular+endothelial+cells+by+EPAC1&doi=10.1111%2Fj.1476-5381.2011.01808.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of the inflammatory response of vascular endothelial cells by EPAC1</span></div><div class="casAuthors">Parnell, Euan; Smith, Brian O.; Palmer, Timothy M.; Terrin, Anna; Zaccolo, Manuela; Yarwood, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">434-446</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Life-threatening diseases of the cardiovascular system, like atherosclerosis, are exacerbated by unwanted inflammation within the structures of large blood vessels.  This inflammation involves increased permeability of the vascular endothelial cells (VECs) that form the lining of blood vessels, leading to exaggerated extravasation of blood components and accumulation of fluid in the extravascular space.  This results in tissue dysfunction and increased secretion of chemokines that attract leukocytes and monocytes to the inflamed endothelium.  CAMP is synthesized in VECs in response to endogenous Gs-coupled receptors and is known to limit cytokine action and reduce endothelial hyperpermeability induced by multiple pro-inflammatory stimuli.  The mechanisms underlying this anti-inflammatory action of cAMP are now being elucidated and it is becoming clear that the cAMP sensor, exchange protein activated by cAMP (EPAC1), appears to play a key role in suppressing unwanted inflammation.  EPAC1 mediates at least three anti-inflammatory pathways in VECs by down-regulating inflammatory signalling through the induction of the suppressors of cytokine signalling 3 (SOCS-3) gene, limiting integrin-dependent vascular permeability and enhancing endothelial barrier function through the stabilization of VE-cadherin junctions.  Given that manipulation of cellular cAMP levels currently forms the basis of many effective pharmaceuticals and that EPAC1 is involved in multiple anti-inflammatory protective processes in VECs, does this make EPAC1 an attractive target for the development of activators capable of eliciting a coordinated program of "protection" against the development of endothelial dysfunction.  Here we discuss whether EPAC1 represents an attractive therapeutic target for limiting endothelial dysfunction assocd. with cardiovascular diseases like atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn3b9FSN5J0bVg90H21EOLACvtfcHk0lgfNl_27SUKLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVaqtL8%253D&md5=dd51d27c2c5ff3f0e7316b1d7fcb2df6</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01808.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01808.x%26sid%3Dliteratum%253Aachs%26aulast%3DParnell%26aufirst%3DE.%26aulast%3DSmith%26aufirst%3DB.%2BO.%26aulast%3DPalmer%26aufirst%3DT.%2BM.%26aulast%3DTerrin%26aufirst%3DA.%26aulast%3DZaccolo%26aufirst%3DM.%26aulast%3DYarwood%26aufirst%3DS.%2BJ.%26atitle%3DRegulation%2520of%2520the%2520inflammatory%2520response%2520of%2520vascular%2520endothelial%2520cells%2520by%2520EPAC1%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D166%26spage%3D434%26epage%3D446%26doi%3D10.1111%2Fj.1476-5381.2011.01808.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borland, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarwood, S. J.</span></span> <span> </span><span class="NLM_article-title">EPAC proteins transduce diverse cellular actions of cAMP</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>158</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2008.00087.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1111%2Fj.1476-5381.2008.00087.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=19210747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVKmu7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2009&pages=70-86&author=G.+Borlandauthor=B.+O.+Smithauthor=S.+J.+Yarwood&title=EPAC+proteins+transduce+diverse+cellular+actions+of+cAMP&doi=10.1111%2Fj.1476-5381.2008.00087.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">EPAC Proteins Transduce Diverse Cellular Actions of cAMP</span></div><div class="casAuthors">Borland, Gillian; Smith, Brian O.; Yarwood, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">70-86</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  It has now been over 10 years since efforts to completely understand the signaling actions of cAMP (3'-5'-cAMP) led to the discovery of exchange protein directly activated by cAMP (EPAC) proteins.  In the current review the authors will highlight important advances in the understanding of EPAC structure and function and demonstrate that EPAC proteins mediate multiple actions of cAMP in cells, revealing future targets for pharmaceutical intervention.  It has been known for some time that drugs that elevate intracellular cAMP levels have proven therapeutic benefit for diseases ranging from depression to inflammation.  The challenge now is to det. which of these pos. actions of cAMP involve activation of EPAC-regulated signal transduction pathways.  EPACs are specific guanine nucleotide exchange factors for the Ras GTPase homologs, Rap1 and Rap2, which they activate independently of the classical routes for cAMP signaling, cyclic nucleotide-gated ion channels and protein kinase A.  Rather, EPAC activation is triggered by internal conformational changes induced by direct interaction with cAMP.  Leading from this has been the development of EPAC-specific agonists, which has helped to delineate numerous cellular actions of cAMP that rely on subsequent activation of EPAC.  These include regulation of exocytosis and the control of cell adhesion, growth, division and differentiation.  Recent work also implicates EPAC in the regulation of anti-inflammatory signaling in the vascular endothelium, namely neg. regulation of pro-inflammatory cytokine signaling and pos. support of barrier function.  Further elucidation of these important signaling mechanisms will no doubt support the development of the next generation of anti-inflammatory drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmHu5l02mb9LVg90H21EOLACvtfcHk0ligNjJ-sxK5rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVKmu7bO&md5=0a73b19e1ba4ce3d7adbe130b26f99ff</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2008.00087.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2008.00087.x%26sid%3Dliteratum%253Aachs%26aulast%3DBorland%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DB.%2BO.%26aulast%3DYarwood%26aufirst%3DS.%2BJ.%26atitle%3DEPAC%2520proteins%2520transduce%2520diverse%2520cellular%2520actions%2520of%2520cAMP%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D158%26spage%3D70%26epage%3D86%26doi%3D10.1111%2Fj.1476-5381.2008.00087.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtiss, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinle, J. J.</span></span> <span> </span><span class="NLM_article-title">Epac1 blocks NLRP3 inflammasome to reduce IL-1beta in retinal endothelial cells and mouse retinal vasculature</span>. <i>Mediators Inflammation</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2017</i></span>,  <span class="NLM_fpage">2860956</span>, <span class="refDoi"> DOI: 10.1155/2017/2860956</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1155%2F2017%2F2860956" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=28348460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A280%3ADC%252BC1cvhslektw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2017&publication_year=2017&pages=2860956&author=Y.+Jiangauthor=L.+Liuauthor=E.+Curtissauthor=J.+J.+Steinle&title=Epac1+blocks+NLRP3+inflammasome+to+reduce+IL-1beta+in+retinal+endothelial+cells+and+mouse+retinal+vasculature&doi=10.1155%2F2017%2F2860956"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Epac1 Blocks NLRP3 Inflammasome to Reduce IL-1β in Retinal Endothelial Cells and Mouse Retinal Vasculature</span></div><div class="casAuthors">Jiang Youde; Liu Li; Curtiss Elizabeth; Steinle Jena J</div><div class="citationInfo"><span class="NLM_cas:title">Mediators of inflammation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2017</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2860956</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inflammation is an important component of diabetic retinal damage.  We previously reported that a novel β-adrenergic receptor agonist, Compound 49b, reduced Toll-like receptor 4 (TLR4) signaling in retinal endothelial cells (REC) grown in high glucose.  Others reported that TLR4 activates high-mobility group box 1 (HMGB1), which has been associated with the NOD-like receptor 3 (NLRP3) inflammasome.  Thus, we hypothesized that Epac1, a downstream mediator of β-adrenergic receptors, would block TLR4/HMGB1-mediated stimulation of the NLRP3 inflammasome, leading to reduced cleavage of caspase-1 and interleukin-1 beta (IL-1β).  We generated vascular specific conditional knockout mice for Epac1 and used REC grown in normal and high glucose treated with an Epac1 agonist and/or NLRP3 siRNA.  Protein analyses were done for Epac1, TLR4, HMGB1, NLRP3, cleaved caspase-1, and IL-1β.  Loss of Epac1 in the mouse retinal vasculature significantly increased all of the inflammatory proteins.  Epac1 effectively reduced high glucose-induced increases in TLR4, HMGB1, cleaved caspase-1, and IL-1β in REC.  Taken together, the data suggest that Epac1 reduces formation of the NLRP3 inflammasome to reduce inflammatory responses in the retinal vasculature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSGbu2tbuDrRXthwrmtH4OBfW6udTcc2eZW3YB689XOirntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cvhslektw%253D%253D&md5=fe24bf440d24895bf2367e48949a1b42</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1155%2F2017%2F2860956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2017%252F2860956%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DCurtiss%26aufirst%3DE.%26aulast%3DSteinle%26aufirst%3DJ.%2BJ.%26atitle%3DEpac1%2520blocks%2520NLRP3%2520inflammasome%2520to%2520reduce%2520IL-1beta%2520in%2520retinal%2520endothelial%2520cells%2520and%2520mouse%2520retinal%2520vasculature%26jtitle%3DMediators%2520Inflammation%26date%3D2017%26volume%3D2017%26spage%3D2860956%26doi%3D10.1155%2F2017%2F2860956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chahine, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtiss, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinle, J. J.</span></span> <span> </span><span class="NLM_article-title">Epac1 agonist decreased inflammatory proteins in retinal endothelial cells, and loss of Epac1 increased inflammatory proteins in the retinal vasculature of mice</span>. <i>Mol. Vision</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">7</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=28210097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsFens7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=1-7&author=L.+Liuauthor=Y.+Jiangauthor=A.+Chahineauthor=E.+Curtissauthor=J.+J.+Steinle&title=Epac1+agonist+decreased+inflammatory+proteins+in+retinal+endothelial+cells%2C+and+loss+of+Epac1+increased+inflammatory+proteins+in+the+retinal+vasculature+of+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Epac1 agonist decreased inflammatory proteins in retinal endothelial cells, and loss of Epac1 increased inflammatory proteins in the retinal vasculature of mice</span></div><div class="casAuthors">Liu, Li; Jiang, Youde; Chahine, Adam; Curtiss, Elizabeth; Steinle, Jena J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Vision</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">MVEPFB</span>;
        ISSN:<span class="NLM_cas:issn">1090-0535</span>.
    
            (<span class="NLM_cas:orgname">Molecular Vision</span>)
        </div><div class="casAbstract">Purpose: Increased inflammatory mediator levels are reported in diabetic retinopathy.  We previously reported that β-adrenergic receptor agonists reduced inflammatory mediators in the diabetic retina; however, these agents cannot be given systemically.  Here, we investigated whether Epac1 is key to the protective effects of β-adrenergic receptor agonists.  Methods: We cultured primary human retinal endothelial cells (RECs) in normal (5 mM) or high (25 mM) glucose and treated them with an Epac1-specific agonist.  Addnl., we generated Epac1 conditional vascular endothelial cell knockout mice by breeding Epac1 floxed mice with Cdh5 Cre mice to investigate the role of Epac1 in the retinal levels of tumor necrosis factor alpha (TNF-α), interleukin-1β (IL-1β), nuclear factor kappa beta (NFκB), and inhibitor of kappa beta (IκB).  Confocal microscopy was performed to localize Epac1 in the mouse retina.  Results: Data showed that high glucose increased the TNF-α and IL-1β levels in the RECs, which were reduced cells treated with the Epac1 agonist.  The loss of Epac1 in the retinas of the conditional knockout mice resulted in statistically significantly increased levels of TNF-α and IL-1β, as well as NFκB.  Conclusions: These data indicate that Epac1 may be protective to the retina through inhibition of key inflammatory mediators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAW6gmoJ8vn7Vg90H21EOLACvtfcHk0ligNjJ-sxK5rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsFens7s%253D&md5=2dab852cf76fc79ffe63b55bd3f6b029</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DChahine%26aufirst%3DA.%26aulast%3DCurtiss%26aufirst%3DE.%26aulast%3DSteinle%26aufirst%3DJ.%2BJ.%26atitle%3DEpac1%2520agonist%2520decreased%2520inflammatory%2520proteins%2520in%2520retinal%2520endothelial%2520cells%252C%2520and%2520loss%2520of%2520Epac1%2520increased%2520inflammatory%2520proteins%2520in%2520the%2520retinal%2520vasculature%2520of%2520mice%26jtitle%3DMol.%2520Vision%26date%3D2017%26volume%3D23%26spage%3D1%26epage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umemura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okumura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, Y.</span></span> <span> </span><span class="NLM_article-title">The role of Epac in the heart</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">591</span>– <span class="NLM_lpage">606</span>, <span class="refDoi"> DOI: 10.1007/s00018-016-2336-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1007%2Fs00018-016-2336-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=27549789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlyksbnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2017&pages=591-606&author=T.+Fujitaauthor=M.+Umemuraauthor=U.+Yokoyamaauthor=S.+Okumuraauthor=Y.+Ishikawa&title=The+role+of+Epac+in+the+heart&doi=10.1007%2Fs00018-016-2336-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The role of Epac in the heart</span></div><div class="casAuthors">Fujita, Takayuki; Umemura, Masanari; Yokoyama, Utako; Okumura, Satoshi; Ishikawa, Yoshihiro</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">591-606</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">As one of the most important second messengers, 3',5'-cyclic adenosine monophosphate (cAMP) mediates various extracellular signals including hormones and neurotransmitters, and induces appropriate responses in diverse types of cells.  Since cAMP was formerly believed to transmit signals through only two direct target mols., protein kinase A and the cyclic nucleotide-gated channel, the sensational discovery in 1998 of another novel direct effecter of cAMP [exchangeproteins directly activated by cAMP (Epac)] attracted a great deal of scientific interest in cAMP signaling.  Numerous studies on Epac have since disclosed its important functions in various tissues in the body.  Recently, observations of genetically manipulated mice in various pathogenic models have begun to reveal the in vivo significance of previous in vitro or cellular-level findings.  Here, we focused on the function of Epac in the heart.  Accumulating evidence has revealed that both Epac1 and Epac2 play important roles in the structure and function of the heart under physiol. and pathol. conditions.  Accordingly, developing the ability to regulate cAMP-mediated signaling through Epac may lead to remarkable new therapies for the treatment of cardiac diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTXwyuZJkZrrVg90H21EOLACvtfcHk0lj-nTVbNDTs8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlyksbnP&md5=2ca5c13557787b15009e3c74805102f5</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1007%2Fs00018-016-2336-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-016-2336-5%26sid%3Dliteratum%253Aachs%26aulast%3DFujita%26aufirst%3DT.%26aulast%3DUmemura%26aufirst%3DM.%26aulast%3DYokoyama%26aufirst%3DU.%26aulast%3DOkumura%26aufirst%3DS.%26aulast%3DIshikawa%26aufirst%3DY.%26atitle%3DThe%2520role%2520of%2520Epac%2520in%2520the%2520heart%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2017%26volume%3D74%26spage%3D591%26epage%3D606%26doi%3D10.1007%2Fs00018-016-2336-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laubner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakob, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seufert, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Preproinsulin Gene Expression by Leptin Induction of Suppressor of Cytokine Signaling 3 in Pancreatic -Cells</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">3410</span>– <span class="NLM_lpage">3417</span>, <span class="refDoi"> DOI: 10.2337/diabetes.54.12.3410</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.2337%2Fdiabetes.54.12.3410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=16306356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht12gs7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2005&pages=3410-3417&author=K.+Laubnerauthor=T.+J.+Kiefferauthor=N.+T.+Lamauthor=X.+Niuauthor=F.+Jakobauthor=J.+Seufert&title=Inhibition+of+Preproinsulin+Gene+Expression+by+Leptin+Induction+of+Suppressor+of+Cytokine+Signaling+3+in+Pancreatic+-Cells&doi=10.2337%2Fdiabetes.54.12.3410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of preproinsulin gene expression by leptin induction of suppressor of cytokine signaling 3 in pancreatic β-cells</span></div><div class="casAuthors">Laubner, Katharina; Kieffer, Timothy J.; Lam, Ni T.; Niu, Xinjie; Jakob, Franz; Seufert, Jochen</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3410-3417</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association</span>)
        </div><div class="casAbstract">Leptin inhibits insulin secretion and preproinsulin gene expression in pancreatic β-cells, but signal transduction pathways and mol. mechanisms underlying this effect are poorly characterized.  In this study, we analyzed leptin-mediated signal transduction and preproinsulin gene regulation at the mol. level in pancreatic β-cells.  Leptin stimulation led to janus kinase (JAK)2-dependent phosphorylation and nuclear translocation of the transcription factors signal transducer and activator of transcription (STAT)3 and STAT5b in INS-1 β-cells.  Leptin also induced mRNA expression of the JAK-STAT inhibitor suppressor of cytokine signaling (SOCS)3 in INS-1 β-cells and human pancreatic islets in vitro and in pancreatic islets of ob/ob mice in vivo.  Transcriptional activation of the rat SOCS3 promoter by leptin was obsd. with concomitant leptin-induced STAT3 and STAT5b DNA binding to specific promoter regions.  Unexpectedly, SOCS3 inhibited both basal and STAT3/5b-dependent rat preproinsulin 1 gene promoter activity in INS-1 cells.  These results suggest that SOCS3 represents a transcriptional inhibitor of preproinsulin gene expression, which is induced by leptin through JAK-STAT3/5b signaling in pancreatic β-cells.  In conclusion, although SOCS3 is believed to be a neg. feedback regulator of JAK-STAT signaling, our findings suggest involvement of SOCS3 in a direct gene regulatory pathway downstream of leptin-activated JAK-STAT signaling in pancreatic β-cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1DlLpn8X-JrVg90H21EOLACvtfcHk0lj-nTVbNDTs8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht12gs7fI&md5=4f285b1c78dd21f069b0cb0035f04073</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.2337%2Fdiabetes.54.12.3410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiabetes.54.12.3410%26sid%3Dliteratum%253Aachs%26aulast%3DLaubner%26aufirst%3DK.%26aulast%3DKieffer%26aufirst%3DT.%2BJ.%26aulast%3DLam%26aufirst%3DN.%2BT.%26aulast%3DNiu%26aufirst%3DX.%26aulast%3DJakob%26aufirst%3DF.%26aulast%3DSeufert%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520Preproinsulin%2520Gene%2520Expression%2520by%2520Leptin%2520Induction%2520of%2520Suppressor%2520of%2520Cytokine%2520Signaling%25203%2520in%2520Pancreatic%2520-Cells%26jtitle%3DDiabetes%26date%3D2005%26volume%3D54%26spage%3D3410%26epage%3D3417%26doi%3D10.2337%2Fdiabetes.54.12.3410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torregrossa, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nairn, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J. R.</span></span> <span> </span><span class="NLM_article-title">Activation of exchange protein activated by cAMP in the rat basolateral amygdala impairs reconsolidation of a memory associated with self-administered cocaine</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e107359</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0107359</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1371%2Fjournal.pone.0107359" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=25259911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslWls7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e107359&author=X.+Wanauthor=M.+M.+Torregrossaauthor=H.+Sanchezauthor=A.+C.+Nairnauthor=J.+R.+Taylor&title=Activation+of+exchange+protein+activated+by+cAMP+in+the+rat+basolateral+amygdala+impairs+reconsolidation+of+a+memory+associated+with+self-administered+cocaine&doi=10.1371%2Fjournal.pone.0107359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of exchange protein activated by cAMP in the rat basolateral amygdala impairs reconsolidation of a memory associated with self-administered cocaine</span></div><div class="casAuthors">Wan, Xun; Torregrossa, Mary M.; Sanchez, Hayde; Nairn, Angus C.; Taylor, Jane R.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e107359/1-e107359/10, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The intracellular mechanisms underlying memory reconsolidation critically involve cAMP signaling.  These events were originally attributed to PKA activation by cAMP, but the identification of Exchange Protein Activated by cAMP (Epac), as a distinct mediator of cAMP signaling, suggests that cAMP-regulated processes that subserve memory reconsolidation are more complex.  Here we investigated how activation of Epac with 8-pCPT-cAMP (8-CPT) impacts reconsolidation of a memory that had been assocd. with cocaine self-administration.  Rats were trained to lever press for cocaine on an FR-1 schedule, in which each cocaine delivery was paired with a tone+light cue.  Lever pressing was then extinguished in the absence of cue presentations and cocaine delivery.  Following the last day of extinction, rats were put in a novel context, in which the conditioned cue was presented to reactivate the cocaine-assocd. memory.  Immediate bilateral infusions of 8-CPT into the basolateral amygdala (BLA) following reactivation disrupted subsequent cue-induced reinstatement in a dose-dependent manner, and modestly reduced responding for conditioned reinforcement.  When 8-CPT infusions were delayed for 3 h after the cue reactivation session or were given after a cue extinction session, no effect on cue-induced reinstatement was obsd.  Co-administration of 8-CPT and the PKA activator 6-Bnz-cAMP (10 nmol/side) rescued memory reconsolidation while 6-Bnz alone had no effect, suggesting an antagonizing interaction between the two cAMP signaling substrates.  Taken together, these studies suggest that activation of Epac represents a parallel cAMP-dependent pathway that can inhibit reconsolidation of cocaine-cue memories and reduce the ability of the cue to produce reinstatement of cocaine-seeking behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoahRS0_hSCWrVg90H21EOLACvtfcHk0lj-nTVbNDTs8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslWls7bL&md5=0d6d24eeb7cd0c2c4d02f7cda9504255</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0107359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0107359%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DX.%26aulast%3DTorregrossa%26aufirst%3DM.%2BM.%26aulast%3DSanchez%26aufirst%3DH.%26aulast%3DNairn%26aufirst%3DA.%2BC.%26aulast%3DTaylor%26aufirst%3DJ.%2BR.%26atitle%3DActivation%2520of%2520exchange%2520protein%2520activated%2520by%2520cAMP%2520in%2520the%2520rat%2520basolateral%2520amygdala%2520impairs%2520reconsolidation%2520of%2520a%2520memory%2520associated%2520with%2520self-administered%2520cocaine%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De107359%26doi%3D10.1371%2Fjournal.pone.0107359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eijkelkamp, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garza-Carbajal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willemen, H. L. D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwartkruis, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dantzer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heijnen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kavelaars, A.</span></span> <span> </span><span class="NLM_article-title">Low nociceptor GRK2 prolongs prostaglandin E2 hyperalgesia via biased cAMP signaling to Epac/Rap1, protein kinase Cepsilon, and MEK/ERK</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">12806</span>– <span class="NLM_lpage">12815</span>, <span class="refDoi"> DOI: 10.1523/jneurosci.3142-10.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1523%2FJNEUROSCI.3142-10.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=20861385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1CmsbjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=12806-12815&author=N.+Eijkelkampauthor=H.+Wangauthor=A.+Garza-Carbajalauthor=H.+L.+D.+M.+Willemenauthor=F.+J.+Zwartkruisauthor=J.+N.+Woodauthor=R.+Dantzerauthor=K.+W.+Kelleyauthor=C.+J.+Heijnenauthor=A.+Kavelaars&title=Low+nociceptor+GRK2+prolongs+prostaglandin+E2+hyperalgesia+via+biased+cAMP+signaling+to+Epac%2FRap1%2C+protein+kinase+Cepsilon%2C+and+MEK%2FERK&doi=10.1523%2Fjneurosci.3142-10.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Low nociceptor GRK2 prolongs prostaglandin E2 hyperalgesia via biased cAMP signaling to Epac/Rap1, protein kinase Cε, and MEK/ERK</span></div><div class="casAuthors">Eijkelkamp, Niels; Wang, Huijing; Garza-Carbajal, Anibal; Willemen, Hanneke L. D. M.; Zwartkruis, Fried J.; Wood, John N.; Dantzer, Robert; Kelley, Keith W.; Heijnen, Cobi J.; Kavelaars, Annemieke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">12806-12815</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Hyperexcitability of peripheral nociceptive pathways is often assocd. with inflammation and is an important mechanism underlying inflammatory pain.  Here we describe a completely novel mechanism via which nociceptor G-protein-coupled receptor kinase 2 (GRK2) contributes to regulation of inflammatory hyperalgesia.  We show that nociceptor GRK2 is downregulated during inflammation.  In addn., we show for the first time that prostaglandin E2 (PGE2)-induced hyperalgesia is prolonged from <6 h in wild-type (WT) mice to 3 days in mice with low GRK2 in Nav1.8+ nociceptors (SNS-GRK2+/- mice).  This prolongation of PGE2 hyperalgesia in SNS-GRK2+/- mice does not depend on changes in the sensitivity of the prostaglandin receptors because prolonged hyperalgesia also developed in response to 8-Br-cAMP.  PGE2 or cAMP-induced hyperalgesia in WT mice is PKA dependent.  However, PKA activity is not required for hyperalgesia in SNS-GRK2+/- mice.  SNS-GRK2+/- mice developed prolonged hyperalgesia in response to the Exchange proteins directly activated by cAMP (Epac) activator 8-pCPT-2'-O-Me-cAMP (8-pCPT).  Coimmunopptn. expts. showed that GRK2 binds to Epac1.  In vitro, GRK2 deficiency increased 8-pCPT-induced activation of the downstream effector of Epac, Rap1, and extracellular signal-regulated kinase (ERK).  In vivo, inhibition of MEK1 or PKCε prevented prolonged PGE2, 8-Br-cAMP, and 8-pCPT hyperalgesia in SNS-GRK2+/- mice.  In conclusion, we discovered GRK2 as a novel Epac1-interacting protein.  A redn. in the cellular level of GRK2 enhances activation of the Epac-Rap1 pathway.  In vivo, low nociceptor GRK2 leads to prolonged inflammatory hyperalgesia via biased cAMP signaling from PKA to Epac-Rap1, ERK/PKCε pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp9wjd80ZUq7Vg90H21EOLACvtfcHk0lieRIJNqottNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1CmsbjI&md5=b474c6c01ee2ea9a159cec49680c5927</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3142-10.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3142-10.2010%26sid%3Dliteratum%253Aachs%26aulast%3DEijkelkamp%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DGarza-Carbajal%26aufirst%3DA.%26aulast%3DWillemen%26aufirst%3DH.%2BL.%2BD.%2BM.%26aulast%3DZwartkruis%26aufirst%3DF.%2BJ.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26aulast%3DDantzer%26aufirst%3DR.%26aulast%3DKelley%26aufirst%3DK.%2BW.%26aulast%3DHeijnen%26aufirst%3DC.%2BJ.%26aulast%3DKavelaars%26aufirst%3DA.%26atitle%3DLow%2520nociceptor%2520GRK2%2520prolongs%2520prostaglandin%2520E2%2520hyperalgesia%2520via%2520biased%2520cAMP%2520signaling%2520to%2520Epac%252FRap1%252C%2520protein%2520kinase%2520Cepsilon%252C%2520and%2520MEK%252FERK%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26spage%3D12806%26epage%3D12815%26doi%3D10.1523%2Fjneurosci.3142-10.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lezoualc’h, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazal, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laudette, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conte, C.</span></span> <span> </span><span class="NLM_article-title">Cyclic AMP sensor EPAC proteins and their role in cardiovascular function and disease</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">897</span>, <span class="refDoi"> DOI: 10.1161/CIRCRESAHA.115.306529</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1161%2FCIRCRESAHA.115.306529" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=26941424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1SqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2016&pages=881-897&author=F.+Lezoualc%E2%80%99hauthor=L.+Fazalauthor=M.+Laudetteauthor=C.+Conte&title=Cyclic+AMP+sensor+EPAC+proteins+and+their+role+in+cardiovascular+function+and+disease&doi=10.1161%2FCIRCRESAHA.115.306529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">CAMP sensor EPAC proteins and their role in cardiovascular function and disease</span></div><div class="casAuthors">Lezoualc'h, Frank; Fazal, Loubina; Laudette, Marion; Conte, Caroline</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">881-897</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">CAMP is a universal second messenger that plays central roles in cardiovascular regulation influencing gene expression, cell morphol., and function.  A crucial step toward a better understanding of cAMP signaling came 18 years ago with the discovery of the exchange protein directly activated by cAMP (EPAC).  The 2 EPAC isoforms, EPAC1 and EPAC2, are guanine-nucleotide exchange factors for the Ras-like GTPases, Rap1 and Rap2, which they activate independently of the classical effector of cAMP, protein kinase A.  With the development of EPAC pharmacol. modulators, many reports in the literature have demonstrated the crit. role of EPAC in the regulation of various cAMP-dependent cardiovascular functions, such as calcium handling and vascular tone.  EPAC proteins are coupled to a multitude of effectors into distinct subcellular compartments because of their multidomain architecture.  These novel cAMP sensors are not only at the crossroads of different physiol. processes but also may represent attractive therapeutic targets for the treatment of several cardiovascular disorders, including cardiac arrhythmia and heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIHsdKYqG57rVg90H21EOLACvtfcHk0lieRIJNqottNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1SqsLk%253D&md5=863c603e082b1bb2ec69635044a49919</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.115.306529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.115.306529%26sid%3Dliteratum%253Aachs%26aulast%3DLezoualc%25E2%2580%2599h%26aufirst%3DF.%26aulast%3DFazal%26aufirst%3DL.%26aulast%3DLaudette%26aufirst%3DM.%26aulast%3DConte%26aufirst%3DC.%26atitle%3DCyclic%2520AMP%2520sensor%2520EPAC%2520proteins%2520and%2520their%2520role%2520in%2520cardiovascular%2520function%2520and%2520disease%26jtitle%3DCirc.%2520Res.%26date%3D2016%26volume%3D118%26spage%3D881%26epage%3D897%26doi%3D10.1161%2FCIRCRESAHA.115.306529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barker, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parnell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Basten, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buist, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarwood, S.</span></span> <span> </span><span class="NLM_article-title">The potential of a novel class of EPAC-selective agonists to combat cardiovascular inflammation</span>. <i>J. Cardiovasc. Dev. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">22</span>, <span class="refDoi"> DOI: 10.3390/jcdd4040022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.3390%2Fjcdd4040022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC1MXislSksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2017&pages=22&author=G.+Barkerauthor=E.+Parnellauthor=B.+van+Bastenauthor=H.+Buistauthor=D.+Adamsauthor=S.+Yarwood&title=The+potential+of+a+novel+class+of+EPAC-selective+agonists+to+combat+cardiovascular+inflammation&doi=10.3390%2Fjcdd4040022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The potential of a novel class of EPAC-selective agonists to combat cardiovascular inflammation</span></div><div class="casAuthors">Barker, Graeme; Parnell, Euan; van Basten, Boy; Buist, Hanna; Adams, David R.; Yarwood, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cardiovascular Development and Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">22/1-22/16</span>CODEN:
                <span class="NLM_cas:coden">JCDDB4</span>;
        ISSN:<span class="NLM_cas:issn">2308-3425</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  The cyclic 3',5'-adenosine monophosphate (cAMP) sensor enzyme, EPAC1, is a candidate drug target in vascular endothelial cells (VECs) due to its ability to attenuate proinflammatory cytokine signalling normally assocd. with cardiovascular diseases (CVDs), including atherosclerosis.  This is through the EPAC1-dependent induction of the suppressor of cytokine signalling gene, SOCS3, which targets inflammatory signalling proteins for ubiquitinylation and destruction by the proteosome.  Given this important role for the EPAC1/SOCS3 signalling axis, we have used high throughput screening (HTS) to identify small mol. EPAC1 regulators and have recently isolated the first known non-cyclic nucleotide (NCN) EPAC1 agonist, I942.  I942 therefore represents the first in class, isoformselective EPAC1 activator, with the potential to suppress pro-inflammatory cytokine signalling with a reduced risk of side effects assocd. with general cAMP-elevating agents that activate multiple response pathways.  The development of augmented I942 analogs may therefore provide improved research tools to validate EPAC1 as a potential therapeutic target for the treatment of chronic inflammation assocd. with deadly CVDs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG_LSYtD4gJ7Vg90H21EOLACvtfcHk0lieRIJNqottNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXislSksL4%253D&md5=a120032b05a955839f40338425ae8915</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.3390%2Fjcdd4040022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fjcdd4040022%26sid%3Dliteratum%253Aachs%26aulast%3DBarker%26aufirst%3DG.%26aulast%3DParnell%26aufirst%3DE.%26aulast%3Dvan%2BBasten%26aufirst%3DB.%26aulast%3DBuist%26aufirst%3DH.%26aulast%3DAdams%26aufirst%3DD.%26aulast%3DYarwood%26aufirst%3DS.%26atitle%3DThe%2520potential%2520of%2520a%2520novel%2520class%2520of%2520EPAC-selective%2520agonists%2520to%2520combat%2520cardiovascular%2520inflammation%26jtitle%3DJ.%2520Cardiovasc.%2520Dev.%2520Dis.%26date%3D2017%26volume%3D4%26spage%3D22%26doi%3D10.3390%2Fjcdd4040022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Enserink, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Rooij, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Triest, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwede, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genieser, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Døskeland, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blank, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bos, J. L.</span></span> <span> </span><span class="NLM_article-title">A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">901</span>– <span class="NLM_lpage">906</span>, <span class="refDoi"> DOI: 10.1038/ncb874</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1038%2Fncb874" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=12402047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVKmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=901-906&author=J.+M.+Enserinkauthor=A.+E.+Christensenauthor=J.+de+Rooijauthor=M.+van+Triestauthor=F.+Schwedeauthor=H.+G.+Genieserauthor=S.+O.+D%C3%B8skelandauthor=J.+L.+Blankauthor=J.+L.+Bos&title=A+novel+Epac-specific+cAMP+analogue+demonstrates+independent+regulation+of+Rap1+and+ERK&doi=10.1038%2Fncb874"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK</span></div><div class="casAuthors">Enserink, Jorrit M.; Christensen, Anne E.; De Rooij, Johan; Van Triest, Miranda; Schwede, Frank; Genieser, Hans Gottfried; Doskeland, Stein O.; Blank, Jonathan L.; Bos, Johannes L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">901-906</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">CAMP is involved in a wide variety of cellular processes that were thought to be mediated by protein kinase A (PKA).  However, cAMP also directly regulates Epac1 and Epac2, guanine nucleotide-exchange factors (GEFs) for the small GTPases Rap1 and Rap2.  Unfortunately, there is an absence of tools to discriminate between PKA- and Epac-mediated effects.  Therefore, through rational drug design we have developed a novel cAMP analog, 8-(4-chloro-phenylthio)-2'-O-methyladenosine-3',5'-cyclic monophosphate (8CPT-2Me-cAMP), which activates Epac, but not PKA, both in vitro and in vivo.  Using this analog, we tested the widespread model that Rap1 mediates cAMP-induced regulation of the extracellular signal-regulated kinase (ERK).  However, both in cell lines in which cAMP inhibits growth-factor-induced ERK activation and in which cAMP activates ERK, 8CPT-2Me-cAMP did not affect ERK activity.  Moreover, in cell lines in which cAMP activates ERK, inhibition of PKA and Ras, but not Rap1, abolished cAMP-mediated ERK activation.  We conclude that cAMP-induced regulation of ERK and activation of Rap1 are independent processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAeWJEct8ivLVg90H21EOLACvtfcHk0lj7-eVCf2JWkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVKmug%253D%253D&md5=49434eb6f33a7ade23bc10556b9c2cc3</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fncb874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb874%26sid%3Dliteratum%253Aachs%26aulast%3DEnserink%26aufirst%3DJ.%2BM.%26aulast%3DChristensen%26aufirst%3DA.%2BE.%26aulast%3Dde%2BRooij%26aufirst%3DJ.%26aulast%3Dvan%2BTriest%26aufirst%3DM.%26aulast%3DSchwede%26aufirst%3DF.%26aulast%3DGenieser%26aufirst%3DH.%2BG.%26aulast%3DD%25C3%25B8skeland%26aufirst%3DS.%2BO.%26aulast%3DBlank%26aufirst%3DJ.%2BL.%26aulast%3DBos%26aufirst%3DJ.%2BL.%26atitle%3DA%2520novel%2520Epac-specific%2520cAMP%2520analogue%2520demonstrates%2520independent%2520regulation%2520of%2520Rap1%2520and%2520ERK%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2002%26volume%3D4%26spage%3D901%26epage%3D906%26doi%3D10.1038%2Fncb874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwede, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertinetti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langerijs, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadders, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wienk, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellenbroek, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Koning, E. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bos, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genieser, H.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssen, R. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehmann, H.</span></span> <span> </span><span class="NLM_article-title">Structure-guided design of selective Epac1 and Epac2 agonists</span>. <i>PLoS Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">e1002038</span>, <span class="refDoi"> DOI: 10.1371/journal.pbio.1002038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1371%2Fjournal.pbio.1002038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=25603503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC28XptVChsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=e1002038&author=F.+Schwedeauthor=D.+Bertinettiauthor=C.+N.+Langerijsauthor=M.+A.+Haddersauthor=H.+Wienkauthor=J.+H.+Ellenbroekauthor=E.+J.+P.+de+Koningauthor=J.+L.+Bosauthor=H.-G.+Genieserauthor=R.+A.+J.+Janssenauthor=H.+Rehmannauthor=H.+Rehmann&title=Structure-guided+design+of+selective+Epac1+and+Epac2+agonists&doi=10.1371%2Fjournal.pbio.1002038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided design of selective Epac1 and Epac2 agonists</span></div><div class="casAuthors">Schwede, Frank; Bertinetti, Daniela; Langerijs, Carianne N.; Hadders, Michael A.; Wienk, Hans; Ellenbroek, Johanne H.; de Koning, Eelco J. P.; Bos, Johannes L.; Herberg, Friedrich W.; Genieser, Hans-Gottfried; Janssen, Richard A. J.; Rehmann, Holger</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e1002038/1-e1002038/26</span>CODEN:
                <span class="NLM_cas:coden">PBLIBG</span>;
        ISSN:<span class="NLM_cas:issn">1545-7885</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The second messenger cAMP is known to augment glucose-induced insulin secretion.  However, its downstream targets in pancreatic β-cells have not been unequivocally detd.  Therefore, we designed cAMP analogs by a structure-guided approach that act as Epac2-selective agonists both in vitro and in vivo.  These analogs activate Epac2 about two orders of magnitude more potently than cAMP.  The high potency arises from increased affinity as well as increased maximal activation.  Crystallog. studies demonstrate that this is due to unique interactions.  At least one of the Epac2-specific agonists, Sp- 8-BnT-cAMPS (S-220), enhances glucose-induced insulin secretion in human pancreatic cells.  Selective targeting of Epac2 is thus proven possible and may be an option in diabetes treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI1ZifakFNi7Vg90H21EOLACvtfcHk0lj7-eVCf2JWkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptVChsg%253D%253D&md5=fa0ed8b2940432a3b6db006633ed4e4f</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pbio.1002038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pbio.1002038%26sid%3Dliteratum%253Aachs%26aulast%3DSchwede%26aufirst%3DF.%26aulast%3DBertinetti%26aufirst%3DD.%26aulast%3DLangerijs%26aufirst%3DC.%2BN.%26aulast%3DHadders%26aufirst%3DM.%2BA.%26aulast%3DWienk%26aufirst%3DH.%26aulast%3DEllenbroek%26aufirst%3DJ.%2BH.%26aulast%3Dde%2BKoning%26aufirst%3DE.%2BJ.%2BP.%26aulast%3DBos%26aufirst%3DJ.%2BL.%26aulast%3DGenieser%26aufirst%3DH.-G.%26aulast%3DJanssen%26aufirst%3DR.%2BA.%2BJ.%26aulast%3DRehmann%26aufirst%3DH.%26aulast%3DRehmann%26aufirst%3DH.%26atitle%3DStructure-guided%2520design%2520of%2520selective%2520Epac1%2520and%2520Epac2%2520agonists%26jtitle%3DPLoS%2520Biol.%26date%3D2015%26volume%3D13%26spage%3De1002038%26doi%3D10.1371%2Fjournal.pbio.1002038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsalkova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span> <span> </span><span class="NLM_article-title">A fluorescence-based high-throughput assay for the discovery of exchange protein directly activated by cyclic AMP (EPAC) antagonists</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e30441</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0030441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1371%2Fjournal.pone.0030441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=22276201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFyrsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e30441&author=T.+Tsalkovaauthor=F.+C.+Meiauthor=X.+Cheng&title=A+fluorescence-based+high-throughput+assay+for+the+discovery+of+exchange+protein+directly+activated+by+cyclic+AMP+%28EPAC%29+antagonists&doi=10.1371%2Fjournal.pone.0030441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">A fluorescence-based high-throughput assay for the discovery of exchange protein directly activated by cyclic AMP (EPAC) antagonists</span></div><div class="casAuthors">Tsalkova, Tamara; Mei, Fang C.; Cheng, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e30441</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: The discovery, more than ten years ago, of exchange proteins directly activated by cAMP (EPAC) as a new family of intracellular cAMP receptors revolutionized the cAMP signaling research field.  Extensive studies have revealed that the cAMP signaling network is much more complex and dynamic as many cAMP-related cellular processes, previously thought to be controlled by protein kinase A, are found to be also mediated by EPAC proteins.  Although there have been many important discoveries in the roles of EPACs greater understanding of their physiol. function in cAMP-mediated signaling is impeded by the absence of EPAC-specific antagonist.  Methodol./Principal Findings: To overcome this deficit, we have developed a fluorescence-based high throughput assay for screening EPAC specific antagonists.  Our assay is highly reproducible and simple to perform using the "mix and measure" format.  A pilot screening using the NCI-DTP diversity set library led to the identification of small chem. compds. capable of specifically inhibiting cAMP-induced EPAC activation while not affecting PKA activity.  Conclusions/Significance: Our study establishes a robust high throughput screening assay that can be effectively applied for the discovery of EPAC-specific antagonists, which may provide valuable pharmacol. tools for elucidating the biol. functions of EPAC and for promoting an understanding of disease mechanisms related to EPAC/cAMP signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-g9GuUaBUL7Vg90H21EOLACvtfcHk0lj7-eVCf2JWkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFyrsbo%253D&md5=7f24b489008acb4c3c7c3658bb1cbfe3</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0030441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0030441%26sid%3Dliteratum%253Aachs%26aulast%3DTsalkova%26aufirst%3DT.%26aulast%3DMei%26aufirst%3DF.%2BC.%26aulast%3DCheng%26aufirst%3DX.%26atitle%3DA%2520fluorescence-based%2520high-throughput%2520assay%2520for%2520the%2520discovery%2520of%2520exchange%2520protein%2520directly%2520activated%2520by%2520cyclic%2520AMP%2520%2528EPAC%2529%2520antagonists%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De30441%26doi%3D10.1371%2Fjournal.pone.0030441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parnell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McElroy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiejak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarwood, S. J.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel, small molecule partial agonist for the cyclic AMP sensor, EPAC1</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">294</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-00455-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1038%2Fs41598-017-00455-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=28331191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A280%3ADC%252BC1cvgtVWhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=294&author=E.+Parnellauthor=S.+P.+McElroyauthor=J.+Wiejakauthor=G.+L.+Baillieauthor=A.+Porterauthor=D.+R.+Adamsauthor=H.+Rehmannauthor=B.+O.+Smithauthor=S.+J.+Yarwood&title=Identification+of+a+novel%2C+small+molecule+partial+agonist+for+the+cyclic+AMP+sensor%2C+EPAC1&doi=10.1038%2Fs41598-017-00455-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Novel, Small Molecule Partial Agonist for the Cyclic AMP Sensor, EPAC1</span></div><div class="casAuthors">Parnell Euan; Smith Brian O; McElroy Stuart P; Baillie Gemma L; Porter Alison; Wiejak Jolanta; Yarwood Stephen J; Adams David R; Rehmann Holger</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">294</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Screening of a carefully selected library of 5,195 small molecules identified 34 hit compounds that interact with the regulatory cyclic nucleotide-binding domain (CNB) of the cAMP sensor, EPAC1.  Two of these hits (I942 and I178) were selected for their robust and reproducible inhibitory effects within the primary screening assay.  Follow-up characterisation by ligand observed nuclear magnetic resonance (NMR) revealed direct interaction of I942 and I178 with EPAC1 and EPAC2-CNBs in vitro.  Moreover, in vitro guanine nucleotide exchange factor (GEF) assays revealed that I942 and, to a lesser extent, I178 had partial agonist properties towards EPAC1, leading to activation of EPAC1, in the absence of cAMP, and inhibition of GEF activity in the presence of cAMP.  In contrast, there was very little agonist action of I942 towards EPAC2 or protein kinase A (PKA).  To our knowledge, this is the first observation of non-cyclic-nucleotide small molecules with agonist properties towards EPAC1.  Furthermore, the isoform selective agonist nature of these compounds highlights the potential for the development of small molecule tools that selectively up-regulate EPAC1 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQJz-Vtf3yjwmgRQsDqrjW_fW6udTcc2eZbH9aX0UeCirntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cvgtVWhtw%253D%253D&md5=c509f625dad046131bae78aa798f40db</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-00455-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-00455-7%26sid%3Dliteratum%253Aachs%26aulast%3DParnell%26aufirst%3DE.%26aulast%3DMcElroy%26aufirst%3DS.%2BP.%26aulast%3DWiejak%26aufirst%3DJ.%26aulast%3DBaillie%26aufirst%3DG.%2BL.%26aulast%3DPorter%26aufirst%3DA.%26aulast%3DAdams%26aufirst%3DD.%2BR.%26aulast%3DRehmann%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DB.%2BO.%26aulast%3DYarwood%26aufirst%3DS.%2BJ.%26atitle%3DIdentification%2520of%2520a%2520novel%252C%2520small%2520molecule%2520partial%2520agonist%2520for%2520the%2520cyclic%2520AMP%2520sensor%252C%2520EPAC1%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D294%26doi%3D10.1038%2Fs41598-017-00455-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wiejak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Basten, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luchowska-Stańska, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarwood, S. J.</span></span> <span> </span><span class="NLM_article-title">The novel exchange protein activated by cyclic AMP 1 (EPAC1) agonist, I942, regulates inflammatory gene expression in human umbilical vascular endothelial cells (HUVECs)</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1866</i></span>,  <span class="NLM_fpage">264</span>– <span class="NLM_lpage">276</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2018.11.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2Fj.bbamcr.2018.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=30414891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit12ltLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1866&publication_year=2019&pages=264-276&author=J.+Wiejakauthor=B.+van+Bastenauthor=U.+Luchowska-Sta%C5%84skaauthor=G.+Hamiltonauthor=S.+J.+Yarwood&title=The+novel+exchange+protein+activated+by+cyclic+AMP+1+%28EPAC1%29+agonist%2C+I942%2C+regulates+inflammatory+gene+expression+in+human+umbilical+vascular+endothelial+cells+%28HUVECs%29&doi=10.1016%2Fj.bbamcr.2018.11.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The novel exchange protein activated by cyclic AMP 1 (EPAC1) agonist, I942, regulates inflammatory gene expression in human umbilical vascular endothelial cells (HUVECs)</span></div><div class="casAuthors">Wiejak, Jolanta; van Basten, Boy; Luchowska-Stanska, Urszula; Hamilton, Graham; Yarwood, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1866</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">264-276</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Exchange protein activated by cAMP (EPAC1) suppresses multiple inflammatory actions in vascular endothelial cells (VECs), partly due to its ability to induce expression of the suppressor of cytokine signalling 3 (SOCS3) gene, the protein product of which inhibits interleukin 6 (IL6) signalling through the JAK/STAT3 pathway.  Here, for the first time, we use the non-cyclic nucleotide EPAC1 agonist, I942, to det. its actions on cellular EPAC1 activity and cAMP-regulated gene expression in VECs.  We demonstrate that I942 promotes EPAC1 and Rap1 activation in HEK293T cells and induces SOCS3 expression and suppresses IL6-stimulated JAK/STAT3 signalling in HUVECs.  SOCS3 induction by I942 in HUVECs was blocked by the EPAC1 antagonist, ESI-09, and EPAC1 siRNA, but not by the broad-spectrum protein kinase A (PKA) inhibitor, H89, indicating that I942 regulates SOCS3 gene expression through EPAC1.  RNA sequencing was carried out to further identify I942-regulated genes in HUVECs.  This identified 425 I942-regulated genes that were also regulated by the EPAC1-selective cAMP analog, 007, and the cAMP-elevating agents, forskolin and rolipram (F/R).  The majority of genes identified were suppressed by I942, 007 and F/R treatment and many were involved in the control of key vascular functions, including the gene for the cell adhesion mol., VCAM1.  I942 and 007 also inhibited IL6-induced expression of VCAM1 at the protein level and blocked VCAM1-dependent monocyte adhesion to HUVECs.  Overall, I942 represents the first non-cyclic nucleotide EPAC1 agonist in cells with the ability to suppress IL6 signalling and inflammatory gene expression in VECs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzsuIrKyPU2rVg90H21EOLACvtfcHk0lgA_qBChvD3lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit12ltLrM&md5=381e7a3893d3ca68af406c7823404371</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2018.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2018.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DWiejak%26aufirst%3DJ.%26aulast%3Dvan%2BBasten%26aufirst%3DB.%26aulast%3DLuchowska-Sta%25C5%2584ska%26aufirst%3DU.%26aulast%3DHamilton%26aufirst%3DG.%26aulast%3DYarwood%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520novel%2520exchange%2520protein%2520activated%2520by%2520cyclic%2520AMP%25201%2520%2528EPAC1%2529%2520agonist%252C%2520I942%252C%2520regulates%2520inflammatory%2520gene%2520expression%2520in%2520human%2520umbilical%2520vascular%2520endothelial%2520cells%2520%2528HUVECs%2529%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2019%26volume%3D1866%26spage%3D264%26epage%3D276%26doi%3D10.1016%2Fj.bbamcr.2018.11.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shao, H.</span>; <span class="NLM_string-name">Mohamed, H.</span>; <span class="NLM_string-name">Boulton, S.</span>; <span class="NLM_string-name">Huang, J.</span>; <span class="NLM_string-name">Wang, P.</span>; <span class="NLM_string-name">Chen, H.</span>; <span class="NLM_string-name">Zhou, J.</span>; <span class="NLM_string-name">Luchowska-Stańska, U.</span>; <span class="NLM_string-name">Jentsch, N. G.</span>; <span class="NLM_string-name">Armstrong, A. L.</span>; <span class="NLM_string-name">Magolan, J.</span>; <span class="NLM_string-name">Yarwood, S.</span>; <span class="NLM_string-name">Melacini, G.</span></span> <span> </span><span class="NLM_article-title">Mechanism of action of an EPAC1-selective competitive partial agonist</span>.  <i>J. Med. Chem.</i> <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b02151</span> , Published online: Apr 16, 2020. [Online early access].</span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b02151" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Shao%2C+H.%3B+Mohamed%2C+H.%3B+Boulton%2C+S.%3B+Huang%2C+J.%3B+Wang%2C+P.%3B+Chen%2C+H.%3B+Zhou%2C+J.%3B+Luchowska-Sta%C5%84ska%2C+U.%3B+Jentsch%2C+N.+G.%3B+Armstrong%2C+A.+L.%3B+Magolan%2C+J.%3B+Yarwood%2C+S.%3B+Melacini%2C+G.+Mechanism+of+action+of+an+EPAC1-selective+competitive+partial+agonist.+J.+Med.+Chem.+10.1021%2Facs.jmedchem.9b02151%2C+Published+online%3A+Apr+16%2C+2020.+%5BOnline+early+access%5D."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b02151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b02151%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DH.%26atitle%3DMechanism%2520of%2520action%2520of%2520an%2520EPAC1-selective%2520competitive%2520partial%2520agonist%26jtitle%3DJ.%2520Med.%2520Chem.%26doi%3D10.1021%2Facs.jmedchem.9b02151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsalkova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chepurny, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leech, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holz, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, V. L.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span> <span> </span><span class="NLM_article-title">Isoform-specific antagonists of exchange proteins directly activated by cAMP</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">18613</span>– <span class="NLM_lpage">18618</span>, <span class="refDoi"> DOI: 10.1073/pnas.1210209109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1073%2Fpnas.1210209109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=23091014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslymtbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=18613-18618&author=T.+Tsalkovaauthor=F.+C.+Meiauthor=S.+Liauthor=O.+G.+Chepurnyauthor=C.+A.+Leechauthor=T.+Liuauthor=G.+G.+Holzauthor=V.+L.+Woodsauthor=X.+Cheng&title=Isoform-specific+antagonists+of+exchange+proteins+directly+activated+by+cAMP&doi=10.1073%2Fpnas.1210209109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Isoform-specific antagonists of exchange proteins directly activated by cAMP</span></div><div class="casAuthors">Tsalkova, Tamara; Mei, Fang C.; Li, Sheng; Chepurny, Oleg G.; Leech, Colin A.; Liu, Tong; Holz, George G.; Woods, Virgil L., Jr.; Cheng, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">18613-18618, S18613/1-S18613/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The major physiol. effects of cAMP in mammalian cells are transduced by two ubiquitously expressed intracellular cAMP receptors, protein kinase A (PKA) and exchange protein directly activated by cAMP (EPAC), as well as cyclic nucleotide-gated ion channels in certain tissues.  Although a large no. of PKA inhibitors are available, there are no repotted EPAC-specific antagonists, despite extensive research efforts.  Here we report the identification and characterization of noncyclic nucleotide EPAC antagonists that are exclusively specific for the EPAC2 isoform.  These EAPC2-specific antagonists, designated as ESI-05 and ESI-07, inhibit Rap1 activation mediated by EAPC2, but not EPAC1, with high potency in vitro.  Moreover, ESI-05 and ESI-07 are capable of suppressing the cAMP-mediated activation of EPAC2, but not EPAC1 and PKA, as monitored in living cells through the use of EPAC- and PKA-based FRET reporters, or by the use of Rap1-GTP pull-down assays.  Deuterium exchange mass spectroscopy anal. further reveals that EPAC2-specific inhibitors exert their isoform selectivity through a unique mechanism by binding to a previously undescribed allosteric site: the interface of the two cAMP binding domains, which is not present in the EPAC1 isoform.  Isoform-specific EPAC pharmacol. probes are highly desired and will be valuable tools for dissecting the biol. functions of EPAC proteins and their roles in various disease states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCqe7G_IG8DLVg90H21EOLACvtfcHk0lguWWRGsgLiCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslymtbbF&md5=eb4d5d7299b3b7988fce7704f1cbdd5c</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1210209109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1210209109%26sid%3Dliteratum%253Aachs%26aulast%3DTsalkova%26aufirst%3DT.%26aulast%3DMei%26aufirst%3DF.%2BC.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DChepurny%26aufirst%3DO.%2BG.%26aulast%3DLeech%26aufirst%3DC.%2BA.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DHolz%26aufirst%3DG.%2BG.%26aulast%3DWoods%26aufirst%3DV.%2BL.%26aulast%3DCheng%26aufirst%3DX.%26atitle%3DIsoform-specific%2520antagonists%2520of%2520exchange%2520proteins%2520directly%2520activated%2520by%2520cAMP%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2012%26volume%3D109%26spage%3D18613%26epage%3D18618%26doi%3D10.1073%2Fpnas.1210209109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rehmann, H.</span></span> <span> </span><span class="NLM_article-title">Characterization of the activation of the Rap-specific exchange factor Epac by cyclic nucleotides</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>407</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.1016/s0076-6879(05)07014-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2FS0076-6879%2805%2907014-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=16757322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmt1Sgt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2006&pages=159-173&author=H.+Rehmann&title=Characterization+of+the+activation+of+the+Rap-specific+exchange+factor+Epac+by+cyclic+nucleotides&doi=10.1016%2Fs0076-6879%2805%2907014-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the activation of the Rap-specific exchange factor Epac by cyclic nucleotides</span></div><div class="casAuthors">Rehmann, Holger</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">407</span>
        (<span class="NLM_cas:issue">Regulators and Effectors of Small GTPases: Ras Family</span>),
    <span class="NLM_cas:pages">159-173</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Epac1 and Epac2 are cAMP-dependent guanine nucleotide exchange factors (GEF) for the small G-proteins Rap1 and Rap2.  Epac is inactive in the absence of cAMP, and binding of cAMP to a cyclic nucleotide-binding domain in the N-terminal regulatory region results in activation of the protein.  The cAMP-dependent activity of Epac proteins can be analyzed by a fluorescence-based assay in vitro.  These kinds of measurements can help to unravel the mol. mechanism by which cAMP binding is translated in activation of the protein.  For this purpose, Epac mutants can be analyzed.  In addn., the interaction of cAMP itself might be the focus of the research.  Thus, modified cAMP analogs can be characterized by their ability to activate Epac.  This is of particular interest for the development of Epac-specific analogs, which do not act on other cellular cAMP targets such as protein kinase A (PKA) or for the design of therapeutic agents targeting Epac.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK5RMLzhAabbVg90H21EOLACvtfcHk0lguWWRGsgLiCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmt1Sgt7c%253D&md5=6d45e1a211606622e4fc34268d61eb0e</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2805%2907014-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252805%252907014-X%26sid%3Dliteratum%253Aachs%26aulast%3DRehmann%26aufirst%3DH.%26atitle%3DCharacterization%2520of%2520the%2520activation%2520of%2520the%2520Rap-specific%2520exchange%2520factor%2520Epac%2520by%2520cyclic%2520nucleotides%26jtitle%3DMethods%2520Enzymol.%26date%3D2006%26volume%3D407%26spage%3D159%26epage%3D173%26doi%3D10.1016%2Fs0076-6879%2805%2907014-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Besnard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruda, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setola, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abecassis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguiz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norval, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeons, F. R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidah, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Constam, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bickerton, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetsel, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span> <span> </span><span class="NLM_article-title">Automated design of ligands to polypharmacological profiles</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>492</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1038/nature11691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1038%2Fnature11691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=23235874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=492&publication_year=2012&pages=215-220&author=J.+Besnardauthor=G.+F.+Rudaauthor=V.+Setolaauthor=K.+Abecassisauthor=R.+M.+Rodriguizauthor=X.-P.+Huangauthor=S.+Norvalauthor=M.+F.+Sassanoauthor=A.+I.+Shinauthor=L.+A.+Websterauthor=F.+R.+C.+Simeonsauthor=L.+Stojanovskiauthor=A.+Pratauthor=N.+G.+Seidahauthor=D.+B.+Constamauthor=G.+R.+Bickertonauthor=K.+D.+Readauthor=W.+C.+Wetselauthor=I.+H.+Gilbertauthor=B.+L.+Rothauthor=A.+L.+Hopkins&title=Automated+design+of+ligands+to+polypharmacological+profiles&doi=10.1038%2Fnature11691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Automated design of ligands to polypharmacological profiles</span></div><div class="casAuthors">Besnard, Jeremy; Ruda, Gian Filippo; Setola, Vincent; Abecassis, Keren; Rodriguiz, Ramona M.; Huang, Xi-Ping; Norval, Suzanne; Sassano, Maria F.; Shin, Antony I.; Webster, Lauren A.; Simeons, Frederick R. C.; Stojanovski, Laste; Prat, Annik; Seidah, Nabil G.; Constam, Daniel B.; Bickerton, G. Richard; Read, Kevin D.; Wetsel, William C.; Gilbert, Ian H.; Roth, Bryan L.; Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">492</span>
        (<span class="NLM_cas:issue">7428</span>),
    <span class="NLM_cas:pages">215-220</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The clin. efficacy and safety of a drug is detd. by its activity profile across many proteins in the proteome.  However, designing drugs with a specific multi-target profile is both complex and difficult.  Therefore methods to design drugs rationally a priori against profiles of several proteins would have immense value in drug discovery.  Here is described a new approach for the automated design of ligands against profiles of multiple drug targets.  The method is demonstrated by the evolution of an approved acetylcholinesterase inhibitor drug donepezil (I) into brain-penetrable ligands with either specific polypharmacol. or exquisite selectivity profiles for G-protein-coupled receptors.  Overall, 800 ligand-target predictions of prospectively designed ligands were tested exptl., of which 75% were confirmed to be correct.  Target engagement in vivo is also demonstrated.  The approach can be a useful source of drug leads when multi-target profiles are required to achieve either selectivity over other drug targets or a desired polypharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNu5bwrBD3tbVg90H21EOLACvtfcHk0ligZZcHhpCp6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN&md5=ace6cced250cf968d327b482a5bf1798</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1038%2Fnature11691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11691%26sid%3Dliteratum%253Aachs%26aulast%3DBesnard%26aufirst%3DJ.%26aulast%3DRuda%26aufirst%3DG.%2BF.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DAbecassis%26aufirst%3DK.%26aulast%3DRodriguiz%26aufirst%3DR.%2BM.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DShin%26aufirst%3DA.%2BI.%26aulast%3DWebster%26aufirst%3DL.%2BA.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%2BC.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DPrat%26aufirst%3DA.%26aulast%3DSeidah%26aufirst%3DN.%2BG.%26aulast%3DConstam%26aufirst%3DD.%2BB.%26aulast%3DBickerton%26aufirst%3DG.%2BR.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DAutomated%2520design%2520of%2520ligands%2520to%2520polypharmacological%2520profiles%26jtitle%3DNature%26date%3D2012%26volume%3D492%26spage%3D215%26epage%3D220%26doi%3D10.1038%2Fnature11691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokunaga, N.</span></span> <span> </span><span class="NLM_article-title">Asymmetric synthesis of diarylmethyl amines by rhodium-catalyzed asymmetric addition of aryl titanium reagents to imines</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">6125</span>– <span class="NLM_lpage">6128</span>, <span class="refDoi"> DOI: 10.1002/anie.200461338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1002%2Fanie.200461338" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKgsrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=6125-6128&author=T.+Hayashiauthor=M.+Kawaiauthor=N.+Tokunaga&title=Asymmetric+synthesis+of+diarylmethyl+amines+by+rhodium-catalyzed+asymmetric+addition+of+aryl+titanium+reagents+to+imines&doi=10.1002%2Fanie.200461338"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric synthesis of diarylmethyl amines by rhodium-catalyzed asymmetric addition of aryl titanium reagents to imines</span></div><div class="casAuthors">Hayashi, Tamio; Kawai, Masahiro; Tokunaga, Norihito</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">6125-6128</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Rhodium/chiral phosphine-catalyzed asym. addn. of aryltitanium triisopropoxides to N-arylidene sulfonamides (Ar1CH=NSO2Ar2) yielded diarylmethyl arylsulfonamides, e.g., I, enantioselectively.  A rational tuning of the arene sulfonamide moiety (by introducing iso-Pr groups onto the Ph ring) brought about high enantioselectivity in the reaction.  Desulfonylation of the diarylmethyl arylsulfonamides yielded chiral diarylmethyl amines, e.g., II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPhGlyFTlTWbVg90H21EOLACvtfcHk0ligZZcHhpCp6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKgsrvF&md5=aa5a24c4785413dffc0ba3fe208ebb89</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1002%2Fanie.200461338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200461338%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DKawai%26aufirst%3DM.%26aulast%3DTokunaga%26aufirst%3DN.%26atitle%3DAsymmetric%2520synthesis%2520of%2520diarylmethyl%2520amines%2520by%2520rhodium-catalyzed%2520asymmetric%2520addition%2520of%2520aryl%2520titanium%2520reagents%2520to%2520imines%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2004%26volume%3D43%26spage%3D6125%26epage%3D6128%26doi%3D10.1002%2Fanie.200461338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Das, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasetya, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K. H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woon, E. C. Y.</span></span> <span> </span><span class="NLM_article-title">Multiprotein dynamic combinatorial chemistry: a strategy for the simultaneous discovery of subfamily-selective inhibitors for nucleic acid demethylases FTO and ALKBH3</span>. <i>Chem.—Asian J.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2854</span>– <span class="NLM_lpage">2867</span>, <span class="refDoi"> DOI: 10.1002/asia.201800729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1002%2Fasia.201800729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=29917331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslaiu7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=2854-2867&author=M.+Dasauthor=T.+Yangauthor=J.+Dongauthor=F.+Prasetyaauthor=Y.+Xieauthor=K.+H.+Q.+Wongauthor=A.+Cheongauthor=E.+C.+Y.+Woon&title=Multiprotein+dynamic+combinatorial+chemistry%3A+a+strategy+for+the+simultaneous+discovery+of+subfamily-selective+inhibitors+for+nucleic+acid+demethylases+FTO+and+ALKBH3&doi=10.1002%2Fasia.201800729"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Multiprotein Dynamic Combinatorial Chemistry: A Strategy for the Simultaneous Discovery of Subfamily-Selective Inhibitors for Nucleic Acid Demethylases FTO and ALKBH3</span></div><div class="casAuthors">Das, Mohua; Yang, Tianming; Dong, Jinghua; Prasetya, Fransisca; Xie, Yiming; Wong, Kendra H. Q.; Cheong, Adeline; Woon, Esther C. Y.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - An Asian Journal</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2854-2867</span>CODEN:
                <span class="NLM_cas:coden">CAAJBI</span>;
        ISSN:<span class="NLM_cas:issn">1861-4728</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Dynamic combinatorial chem. (DCC) is a powerful supramol. approach for discovering ligands for biomols.  To date, most, if not all, biol. templated DCC systems employ only a single biomol. to direct the self-assembly process.  To expand the scope of DCC, herein, a novel multiprotein DCC strategy has been developed that combines the discriminatory power of a zwitterionic "thermal tag" with the sensitivity of differential scanning fluorimetry (DSF).  This strategy is highly sensitive and could differentiate the binding of ligands to structurally similar subfamily members.  Through this strategy, it was possible to simultaneously identify subfamily-selective probes against two clin. important epigenetic enzymes: FTO (7; IC50 = 2.6 μm) and ALKBH3 (8; IC50 = 3.7 μm).  To date, this is the first report of a subfamily-selective ALKBH3 inhibitor.  The developed strategy could, in principle, be adapted to a broad range of proteins; thus it is of broad scientific interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXwpH9yHmQ_LVg90H21EOLACvtfcHk0ljIfnnbK7NyCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslaiu7%252FK&md5=2e8dca74858c93f2cbf8f77b9cb5660d</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1002%2Fasia.201800729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fasia.201800729%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DPrasetya%26aufirst%3DF.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DWong%26aufirst%3DK.%2BH.%2BQ.%26aulast%3DCheong%26aufirst%3DA.%26aulast%3DWoon%26aufirst%3DE.%2BC.%2BY.%26atitle%3DMultiprotein%2520dynamic%2520combinatorial%2520chemistry%253A%2520a%2520strategy%2520for%2520the%2520simultaneous%2520discovery%2520of%2520subfamily-selective%2520inhibitors%2520for%2520nucleic%2520acid%2520demethylases%2520FTO%2520and%2520ALKBH3%26jtitle%3DChem.%25E2%2580%2594Asian%2520J.%26date%3D2018%26volume%3D13%26spage%3D2854%26epage%3D2867%26doi%3D10.1002%2Fasia.201800729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Charlton, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aleksis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saint-Leger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribas de Pouplana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaula, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustina, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madre, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lola, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaudzems, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmund, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randall, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kime, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goessens, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jirgensons, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finn, P. W.</span></span> <span> </span><span class="NLM_article-title">N-Leucinyl benzenesulfonamides as structurally simplified leucyl-tRNA synthetase inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">84</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00374</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00374" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Gnu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=84-88&author=M.+H.+Charltonauthor=R.+Aleksisauthor=A.+Saint-Legerauthor=A.+Guptaauthor=E.+Lozaauthor=L.+Ribas+de+Pouplanaauthor=I.+Kaulaauthor=D.+Gustinaauthor=M.+Madreauthor=D.+Lolaauthor=K.+Jaudzemsauthor=G.+Edmundauthor=C.+P.+Randallauthor=L.+Kimeauthor=A.+J.+O%E2%80%99Neillauthor=W.+Goessensauthor=A.+Jirgensonsauthor=P.+W.+Finn&title=N-Leucinyl+benzenesulfonamides+as+structurally+simplified+leucyl-tRNA+synthetase+inhibitors&doi=10.1021%2Facsmedchemlett.7b00374"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">N-Leucinyl Benzenesulfonamides as Structurally Simplified Leucyl-tRNA Synthetase Inhibitors</span></div><div class="casAuthors">Charlton, Michael H.; Aleksis, Rihards; Saint-Leger, Adelaide; Gupta, Arya; Loza, Einars; Ribas de Pouplana, Lluis; Kaula, Ilze; Gustina, Daina; Madre, Marina; Lola, Daina; Jaudzems, Kristaps; Edmund, Grace; Randall, Christopher P.; Kime, Louise; O'Neill, Alex J.; Goessens, Wil; Jirgensons, Aigars; Finn, Paul W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">84-88</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Leucinyl benzenesulfonamides have been discovered as a novel class of potent inhibitors of E. coli leucyl-tRNA synthetase.  The binding of inhibitors to the enzyme was measured by using isothermal titrn. calorimetry.  This provided information on enthalpy and entropy contributions to binding, which, together with docking studies, were used for structure-activity relationship anal.  Enzymic assays revealed that N-leucinyl benzenesulfonamides display remarkable selectivity for E. coli leucyl-tRNA synthetase compared to S. aureus and human orthologues.  The simplest analog of the series, N-leucinyl benzenesulfonamide (R = H), showed the highest affinity against E. coli leucyl-tRNA synthetase and also exhibited antibacterial activity against Gram-neg. pathogens (the best MIC = 8 μg/mL, E. coli ATCC 25922), which renders it as a promising template for antibacterial drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOX-ZtM7nuaLVg90H21EOLACvtfcHk0ljIfnnbK7NyCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Gnu74%253D&md5=6926e503dcad06b5217592977e297493</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00374%26sid%3Dliteratum%253Aachs%26aulast%3DCharlton%26aufirst%3DM.%2BH.%26aulast%3DAleksis%26aufirst%3DR.%26aulast%3DSaint-Leger%26aufirst%3DA.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DLoza%26aufirst%3DE.%26aulast%3DRibas%2Bde%2BPouplana%26aufirst%3DL.%26aulast%3DKaula%26aufirst%3DI.%26aulast%3DGustina%26aufirst%3DD.%26aulast%3DMadre%26aufirst%3DM.%26aulast%3DLola%26aufirst%3DD.%26aulast%3DJaudzems%26aufirst%3DK.%26aulast%3DEdmund%26aufirst%3DG.%26aulast%3DRandall%26aufirst%3DC.%2BP.%26aulast%3DKime%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DA.%2BJ.%26aulast%3DGoessens%26aufirst%3DW.%26aulast%3DJirgensons%26aufirst%3DA.%26aulast%3DFinn%26aufirst%3DP.%2BW.%26atitle%3DN-Leucinyl%2520benzenesulfonamides%2520as%2520structurally%2520simplified%2520leucyl-tRNA%2520synthetase%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D84%26epage%3D88%26doi%3D10.1021%2Facsmedchemlett.7b00374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lobb, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hipskind, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aikins, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Considine, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Dios, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durst, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferritto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossman, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giera, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollister, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iversen, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Law, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrejas, L. M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCann, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molero, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richett, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teicher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wikel, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mader, M. M.</span></span> <span> </span><span class="NLM_article-title">Acyl sulfonamide anti-proliferatives: benzene substituent structure-activity relationships for a novel class of antitumor agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">5367</span>– <span class="NLM_lpage">5380</span>, <span class="refDoi"> DOI: 10.1021/jm030594r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030594r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsleis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=5367-5380&author=K.+L.+Lobbauthor=P.+A.+Hipskindauthor=J.+A.+Aikinsauthor=E.+Alvarezauthor=Y.-Y.+Cheungauthor=E.+L.+Considineauthor=A.+De+Diosauthor=G.+L.+Durstauthor=R.+Ferrittoauthor=C.+S.+Grossmanauthor=D.+D.+Gieraauthor=B.+A.+Hollisterauthor=Z.+Huangauthor=P.+W.+Iversenauthor=K.+L.+Lawauthor=T.+Liauthor=H.-S.+Linauthor=B.+Lopezauthor=J.+E.+Lopezauthor=L.+M.+M.+Cabrejasauthor=D.+J.+McCannauthor=V.+Moleroauthor=J.+E.+Reillyauthor=M.+E.+Richettauthor=C.+Shihauthor=B.+Teicherauthor=J.+H.+Wikelauthor=W.+T.+Whiteauthor=M.+M.+Mader&title=Acyl+sulfonamide+anti-proliferatives%3A+benzene+substituent+structure-activity+relationships+for+a+novel+class+of+antitumor+agents&doi=10.1021%2Fjm030594r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Acyl Sulfonamide Anti-Proliferatives: Benzene Substituent Structure-Activity Relationships for a Novel Class of Antitumor Agents</span></div><div class="casAuthors">Lobb, Karen L.; Hipskind, Philip A.; Aikins, James A.; Alvarez, Enrique; Cheung, Yiu-Yin; Considine, Eileen L.; De Dios, Alfonso; Durst, Gregory L.; Ferritto, Rafael; Grossman, Cora Sue; Giera, Deborah D.; Hollister, Beth A.; Huang, Zhongping; Iversen, Philip W.; Law, Kevin L.; Li, Tiechao; Lin, Ho-Shen; Lopez, Beatriz; Lopez, Jose E.; Cabrejas, Luisa M. Martin; McCann, Denis J.; Molero, Victoriano; Reilly, John E.; Richett, Michael E.; Shih, Chuan; Teicher, Beverly; Wikel, James H.; White, Wesley T.; Mader, Mary M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5367-5380</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two closely related diaryl acylsulfonamides were recently reported as potent antitumor agents against a broad spectrum of human tumor xenografts (colon, lung, breast, ovary, and prostate) in nude mice.  Esp. intriguing was their activity against colorectal cancer xenografts.  In this paper, rapid parallel synthesis along with traditional medicinal chem. techniques were used to quickly delineate the structure-activity relationships of the substitution patterns in both Ph rings of the acylsufonamide anti-proliferative scaffold.  Although the mol. target of the compds. remains unclear, we detd. that the vascular endothelial growth factor-dependent human umbilical vein endothelial cells assay in combination with a soft agar disk diffusion assay allowed for optimization of potency in the series.  The pharmacokinetic properties and in vivo activity in an HCT116 xenograft model are reported for representative compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeCysoz5N61bVg90H21EOLACvtfcHk0lg3AW3JaE5a4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsleis7Y%253D&md5=e10193988e21a4cecf4040e5e8ad996e</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm030594r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030594r%26sid%3Dliteratum%253Aachs%26aulast%3DLobb%26aufirst%3DK.%2BL.%26aulast%3DHipskind%26aufirst%3DP.%2BA.%26aulast%3DAikins%26aufirst%3DJ.%2BA.%26aulast%3DAlvarez%26aufirst%3DE.%26aulast%3DCheung%26aufirst%3DY.-Y.%26aulast%3DConsidine%26aufirst%3DE.%2BL.%26aulast%3DDe%2BDios%26aufirst%3DA.%26aulast%3DDurst%26aufirst%3DG.%2BL.%26aulast%3DFerritto%26aufirst%3DR.%26aulast%3DGrossman%26aufirst%3DC.%2BS.%26aulast%3DGiera%26aufirst%3DD.%2BD.%26aulast%3DHollister%26aufirst%3DB.%2BA.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DIversen%26aufirst%3DP.%2BW.%26aulast%3DLaw%26aufirst%3DK.%2BL.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DH.-S.%26aulast%3DLopez%26aufirst%3DB.%26aulast%3DLopez%26aufirst%3DJ.%2BE.%26aulast%3DCabrejas%26aufirst%3DL.%2BM.%2BM.%26aulast%3DMcCann%26aufirst%3DD.%2BJ.%26aulast%3DMolero%26aufirst%3DV.%26aulast%3DReilly%26aufirst%3DJ.%2BE.%26aulast%3DRichett%26aufirst%3DM.%2BE.%26aulast%3DShih%26aufirst%3DC.%26aulast%3DTeicher%26aufirst%3DB.%26aulast%3DWikel%26aufirst%3DJ.%2BH.%26aulast%3DWhite%26aufirst%3DW.%2BT.%26aulast%3DMader%26aufirst%3DM.%2BM.%26atitle%3DAcyl%2520sulfonamide%2520anti-proliferatives%253A%2520benzene%2520substituent%2520structure-activity%2520relationships%2520for%2520a%2520novel%2520class%2520of%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D5367%26epage%3D5380%26doi%3D10.1021%2Fjm030594r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Egleton, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thinnes, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seden, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurieri, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadavizadeh, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Measures, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varney, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynne, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, A. J.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships and colorimetric properties of specific probes for the putative cancer biomarker human arylamine N-acetyltransferase 1</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3030</span>– <span class="NLM_lpage">3054</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.03.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2Fj.bmc.2014.03.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=24758871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFCls70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=3030-3054&author=J.+E.+Egletonauthor=C.+C.+Thinnesauthor=P.+T.+Sedenauthor=N.+Laurieriauthor=S.+P.+Leeauthor=K.+S.+Hadavizadehauthor=A.+R.+Measuresauthor=A.+M.+Jonesauthor=S.+Thompsonauthor=A.+Varneyauthor=G.+M.+Wynneauthor=A.+Ryanauthor=E.+Simauthor=A.+J.+Russell&title=Structure-activity+relationships+and+colorimetric+properties+of+specific+probes+for+the+putative+cancer+biomarker+human+arylamine+N-acetyltransferase+1&doi=10.1016%2Fj.bmc.2014.03.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships and colorimetric properties of specific probes for the putative cancer biomarker human arylamine N-acetyltransferase 1</span></div><div class="casAuthors">Egleton, James E.; Thinnes, Cyrille C.; Seden, Peter T.; Laurieri, Nicola; Lee, Siu Po; Hadavizadeh, Kate S.; Measures, Angelina R.; Jones, Alan M.; Thompson, Sam; Varney, Amy; Wynne, Graham M.; Ryan, Ali; Sim, Edith; Russell, Angela J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3030-3054</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A naphthoquinone inhibitor of human arylamine N-acetyltransferase 1 (hNAT1), a potential cancer biomarker and therapeutic target, has been reported which undergoes a distinctive concomitant color change from red to blue upon binding to the enzyme.  Here we describe the use of in silico modeling alongside structure-activity relationship studies to advance the hit compd. towards a potential probe to quantify hNAT1 levels in tissues.  Derivs. with both a fifty-fold higher potency against hNAT1 and a two-fold greater absorption coeff. compared to the initial hit have been synthesized; these compds. retain specificity for hNAT1 and its murine homolog mNat2 over the isoenzyme hNAT2.  A relationship between pKa, inhibitor potency and colorimetric properties has also been uncovered.  The high potency of representative examples against hNAT1 in ZR-75-1 cell exts. also paves the way for the development of inhibitors with improved intrinsic sensitivity which could enable detection of hNAT1 in tissue samples and potentially act as tools for elucidating the unknown role hNAT1 plays in ER+ breast cancer; this could in turn lead to a therapeutic use for such inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwKpsbUvNJa7Vg90H21EOLACvtfcHk0lg3AW3JaE5a4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFCls70%253D&md5=0fd8eaf791cc58361ca8e3f4f834a9af</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.03.015%26sid%3Dliteratum%253Aachs%26aulast%3DEgleton%26aufirst%3DJ.%2BE.%26aulast%3DThinnes%26aufirst%3DC.%2BC.%26aulast%3DSeden%26aufirst%3DP.%2BT.%26aulast%3DLaurieri%26aufirst%3DN.%26aulast%3DLee%26aufirst%3DS.%2BP.%26aulast%3DHadavizadeh%26aufirst%3DK.%2BS.%26aulast%3DMeasures%26aufirst%3DA.%2BR.%26aulast%3DJones%26aufirst%3DA.%2BM.%26aulast%3DThompson%26aufirst%3DS.%26aulast%3DVarney%26aufirst%3DA.%26aulast%3DWynne%26aufirst%3DG.%2BM.%26aulast%3DRyan%26aufirst%3DA.%26aulast%3DSim%26aufirst%3DE.%26aulast%3DRussell%26aufirst%3DA.%2BJ.%26atitle%3DStructure-activity%2520relationships%2520and%2520colorimetric%2520properties%2520of%2520specific%2520probes%2520for%2520the%2520putative%2520cancer%2520biomarker%2520human%2520arylamine%2520N-acetyltransferase%25201%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D3030%26epage%3D3054%26doi%3D10.1016%2Fj.bmc.2014.03.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span>; <span class="NLM_string-name">Lu, X.</span>; <span class="NLM_string-name">Li, Z.</span>; <span class="NLM_string-name">Xin, L.</span>; <span class="NLM_string-name">Zhu, J.</span>; <span class="NLM_string-name">Fu, C.</span></span> <span> </span><span class="NLM_article-title">Fused imidazole compound having indoleamine 2,3-dioxygenase inhibitory activity</span>. <span class="NLM_patent">WO 2018113624 A1</span>, June 28, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=J.+Yu&author=X.+Lu&author=Z.+Li&author=L.+Xin&author=J.+Zhu&author=C.+Fu&title=Fused+imidazole+compound+having+indoleamine+2%2C3-dioxygenase+inhibitory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DJ.%26atitle%3DFused%2520imidazole%2520compound%2520having%2520indoleamine%25202%252C3-dioxygenase%2520inhibitory%2520activity%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mattsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlström, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, S.</span></span> <span> </span><span class="NLM_article-title">A mild hydrolysis of esters mediated by lithium salts</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">2497</span>– <span class="NLM_lpage">2499</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2007.02.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2Fj.tetlet.2007.02.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis1Ohs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=2497-2499&author=S.+Mattssonauthor=M.+Dahlstr%C3%B6mauthor=S.+Karlsson&title=A+mild+hydrolysis+of+esters+mediated+by+lithium+salts&doi=10.1016%2Fj.tetlet.2007.02.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">A mild hydrolysis of esters mediated by lithium salts</span></div><div class="casAuthors">Mattsson, Sara; Dahlstroem, Mikael; Karlsson, Staffan</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2497-2499</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">When treated with amine bases such as triethylamine and various lithium salts in wet solvents, esters are efficiently hydrolyzed to the corresponding acids in good yields.  Esters incorporating an α- or β-heteroatom with respect to the ester carbonyl group are hydrolyzed rapidly even at room temp.  To further demonstrate the usefulness of this method, one example is provided where hydrolysis of acetylated camphorsultam is mediated by LiBr.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlkdhTIjsx0bVg90H21EOLACvtfcHk0lg3AW3JaE5a4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis1Ohs7w%253D&md5=7a88787176f93ccdd555a0ab411b0635</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2007.02.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2007.02.029%26sid%3Dliteratum%253Aachs%26aulast%3DMattsson%26aufirst%3DS.%26aulast%3DDahlstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DKarlsson%26aufirst%3DS.%26atitle%3DA%2520mild%2520hydrolysis%2520of%2520esters%2520mediated%2520by%2520lithium%2520salts%26jtitle%3DTetrahedron%2520Lett.%26date%3D2007%26volume%3D48%26spage%3D2497%26epage%3D2499%26doi%3D10.1016%2Fj.tetlet.2007.02.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lizarzaburu, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuttleworth, S. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of aryl ethers from amino alcohols using polymer-supported triphenylphosphine</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">2157</span>– <span class="NLM_lpage">2159</span>, <span class="refDoi"> DOI: 10.1016/s0040-4039(02)00222-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2FS0040-4039%2802%2900222-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD38XhslGlu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=2157-2159&author=M.+E.+Lizarzaburuauthor=S.+J.+Shuttleworth&title=Synthesis+of+aryl+ethers+from+amino+alcohols+using+polymer-supported+triphenylphosphine&doi=10.1016%2Fs0040-4039%2802%2900222-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of aryl ethers from amino alcohols using polymer-supported triphenylphosphine</span></div><div class="casAuthors">Lizarzaburu, Mike E.; Shuttleworth, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2157-2159</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Optimum conditions for the prepn. of aryl alkyl ethers from N-protected amino alcs. using polymer-supported triphenylphosphine have been developed.  In contrast to previous literature reports, it was discovered that the progress of this reaction is greatly improved when a tertiary amine base is employed along with minor modifications of the order of reagent addn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsEcjS7EClzLVg90H21EOLACvtfcHk0liU8aZkbHnS3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhslGlu78%253D&md5=3493534a2e43e37c6b7422474c298d97</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2802%2900222-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252802%252900222-8%26sid%3Dliteratum%253Aachs%26aulast%3DLizarzaburu%26aufirst%3DM.%2BE.%26aulast%3DShuttleworth%26aufirst%3DS.%2BJ.%26atitle%3DSynthesis%2520of%2520aryl%2520ethers%2520from%2520amino%2520alcohols%2520using%2520polymer-supported%2520triphenylphosphine%26jtitle%3DTetrahedron%2520Lett.%26date%3D2002%26volume%3D43%26spage%3D2157%26epage%3D2159%26doi%3D10.1016%2Fs0040-4039%2802%2900222-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I. S.</span></span> <span> </span><span class="NLM_article-title">One-pot synthesis of 2-naphthols from nitrones and MBH adducts via decarboxylative N–O bond cleavage</span>. <i>Org. Chem. Front.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">3210</span>– <span class="NLM_lpage">3218</span>, <span class="refDoi"> DOI: 10.1039/c8qo00988k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1039%2FC8QO00988K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVahur7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2018&pages=3210-3218&author=S.+H.+Hanauthor=A.+K.+Pandeyauthor=H.+Leeauthor=S.+Kimauthor=D.+Kangauthor=Y.+H.+Jungauthor=H.+S.+Kimauthor=S.+Hongauthor=I.+S.+Kim&title=One-pot+synthesis+of+2-naphthols+from+nitrones+and+MBH+adducts+via+decarboxylative+N%E2%80%93O+bond+cleavage&doi=10.1039%2Fc8qo00988k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">One-pot synthesis of 2-naphthols from nitrones and MBH adducts via decarboxylative N-O bond cleavage</span></div><div class="casAuthors">Han, Sang Hoon; Pandey, Ashok Kumar; Lee, Heeyoung; Kim, Saegun; Kang, Dahye; Jung, Young Hoon; Kim, Hyung Sik; Hong, Sungwoo; Kim, In Su</div><div class="citationInfo"><span class="NLM_cas:title">Organic Chemistry Frontiers</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3210-3218</span>CODEN:
                <span class="NLM_cas:coden">OCFRA8</span>;
        ISSN:<span class="NLM_cas:issn">2052-4129</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The unprecedented one-pot synthesis of 2-naphthols through an acid-mediated decarboxylative N-O bond cleavage of bridged benzoxazepine intermediates, which were in turn generated from aryl nitrones and Morita-Baylis-Hillman (MBH) adducts under cationic rhodium(III) catalysis was described.  A range of 2-naphthol derivs. including anthracen-2-ol, phenanthren-2-ol, and 11H-benzo[b]fluoren-7-ol were formed with excellent site selectivities and functional group compatibilities.  To gain mechanistic insight into this process, a series of mechanistic investigations and DFT calcns. were also performed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpXEbbnczpP7Vg90H21EOLACvtfcHk0liU8aZkbHnS3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVahur7P&md5=4fc69c52e752b00bcdefadfc099ed110</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1039%2FC8QO00988K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8QO00988K%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DS.%2BH.%26aulast%3DPandey%26aufirst%3DA.%2BK.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DD.%26aulast%3DJung%26aufirst%3DY.%2BH.%26aulast%3DKim%26aufirst%3DH.%2BS.%26aulast%3DHong%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DI.%2BS.%26atitle%3DOne-pot%2520synthesis%2520of%25202-naphthols%2520from%2520nitrones%2520and%2520MBH%2520adducts%2520via%2520decarboxylative%2520N%25E2%2580%2593O%2520bond%2520cleavage%26jtitle%3DOrg.%2520Chem.%2520Front.%26date%3D2018%26volume%3D5%26spage%3D3210%26epage%3D3218%26doi%3D10.1039%2Fc8qo00988k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arakawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shigeta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konishi, G.-i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of dinaphthylacetylene nematic liquid crystals for high-birefringence materials</span>. <i>Liq. Cryst.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1063</span>– <span class="NLM_lpage">1069</span>, <span class="refDoi"> DOI: 10.1080/02678292.2012.696730</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1080%2F02678292.2012.696730" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC38Xot1CntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2012&pages=1063-1069&author=Y.+Arakawaauthor=S.+Nakajimaauthor=S.+Kangauthor=M.+Shigetaauthor=G.-i.+Konishiauthor=J.+Watanabe&title=Synthesis+and+evaluation+of+dinaphthylacetylene+nematic+liquid+crystals+for+high-birefringence+materials&doi=10.1080%2F02678292.2012.696730"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of dinaphthylacetylene nematic liquid crystals for high-birefringence materials</span></div><div class="casAuthors">Arakawa, Yuki; Nakajima, Shunpei; Kang, Sungmin; Shigeta, Masayuki; Konishi, Gen-ichi; Watanabe, Junji</div><div class="citationInfo"><span class="NLM_cas:title">Liquid Crystals</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1063-1069</span>CODEN:
                <span class="NLM_cas:coden">LICRE6</span>;
        ISSN:<span class="NLM_cas:issn">0267-8292</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">We synthesized 1,2-bis(6-alkoxy-2-naphthyl)acetylene as a new dinaphthylacetylene liq. crystal (LC) compds. I [n = 1 - 10] with alkoxy tails of length m (DNA-OCm, m = 1 - 10) and characterized their phase behavior by polarizing optical microscopy and differential scanning calorimetry, where all compds. exhibited a nematic phase.  Also, we measured the actual, and not extrapolated, Δn values of this target compd., and our results show the birefringence potential of the pure LC compd.  They have high birefringence values, with the highest value of approx. 0.5 obtained for DNA-OC2 at 550 nm at 10°C above the nematic-crystal transition temp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzxrvO-MdLurVg90H21EOLACvtfcHk0lj0CFszJEQhbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xot1CntrY%253D&md5=c3491f0a41057945b654ac0c51ed94d9</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1080%2F02678292.2012.696730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F02678292.2012.696730%26sid%3Dliteratum%253Aachs%26aulast%3DArakawa%26aufirst%3DY.%26aulast%3DNakajima%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DShigeta%26aufirst%3DM.%26aulast%3DKonishi%26aufirst%3DG.-i.%26aulast%3DWatanabe%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520dinaphthylacetylene%2520nematic%2520liquid%2520crystals%2520for%2520high-birefringence%2520materials%26jtitle%3DLiq.%2520Cryst.%26date%3D2012%26volume%3D39%26spage%3D1063%26epage%3D1069%26doi%3D10.1080%2F02678292.2012.696730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Appel, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biedermann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauwald, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zayed, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherman, O. A.</span></span> <span> </span><span class="NLM_article-title">Supramolecular cross-linked networks via host-guest complexation with cucurbit[8]uril</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">14251</span>– <span class="NLM_lpage">14260</span>, <span class="refDoi"> DOI: 10.1021/ja106362w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja106362w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=14251-14260&author=E.+A.+Appelauthor=F.+Biedermannauthor=U.+Rauwaldauthor=S.+T.+Jonesauthor=J.+M.+Zayedauthor=O.+A.+Scherman&title=Supramolecular+cross-linked+networks+via+host-guest+complexation+with+cucurbit%5B8%5Duril&doi=10.1021%2Fja106362w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Supramolecular Cross-Linked Networks via Host-Guest Complexation with Cucurbit[8]uril</span></div><div class="casAuthors">Appel, Eric A.; Biedermann, Frank; Rauwald, Urs; Jones, Samuel T.; Zayed, Jameel M.; Scherman, Oren A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">14251-14260</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ability to finely tune the soln. viscosity of an aq. system is crit. in many applications ranging from large-scale fluid-based industrial processes to free-standing hydrogels important in regenerative medicine, controlled drug delivery, and green' self-healing materials.  Herein we demonstrate the use of the macrocyclic host mol. cucurbit[8]uril (CB[8]) to facilitate reversible crosslinking of multivalent copolymers with high binding consts. (Ka > 1011-1012 M-2) leading to a supramol. hydrogel.  Multivalent copolymers were prepd. by free radical polymn. techniques and contained either pendant Me viologen (a good first guest for CB[8]) or naphthoxy derivs. (good second guests for CB[8]).  A colorless soln. of the two multivalent copolymers bearing first and second guests, resp., can be transformed into a highly viscous, colored supramol. hydrogel with the crosslink d. being easily controlled through CB[8] addn.  Moreover, the crosslinks (1:1:1 supramol. ternary complexes of CB[8]/viologen/naphthoxy) are dynamic and stimuli-responsive, and the material properties can be modulated by temp. or other external stimuli.  Rheol. characterization of the bulk material properties of these dynamically crosslinked networks provided insight into the kinetics of CB[8] ternary complexation responsible for elastically active crosslinking with a second guest dissocn. rate const. (kd) of 1200 s-1 for the ternary complex.  These materials exhibited intermediate mech. properties at 5 wt.% in water (plateau modulus = 350-600 Pa and zero-shear viscosity = 5-55 Pa-s), which is complementary to existing supramol. hydrogels.  Addnl., these supramol. hydrogels exhibited thermal reversibility and subsequent facile modulation of microstructure upon further addn. of CB[8] and thermal treatment.  The fundamental knowledge gained from the study of these dynamic materials will facilitate progress in the field of smart, self-healing materials, self-assembled hydrogels, and controlled soln. viscosity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxasisFkLhs7Vg90H21EOLACvtfcHk0lj0CFszJEQhbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtLnO&md5=ac4e92f12feeeb23986486c4bb99481a</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fja106362w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja106362w%26sid%3Dliteratum%253Aachs%26aulast%3DAppel%26aufirst%3DE.%2BA.%26aulast%3DBiedermann%26aufirst%3DF.%26aulast%3DRauwald%26aufirst%3DU.%26aulast%3DJones%26aufirst%3DS.%2BT.%26aulast%3DZayed%26aufirst%3DJ.%2BM.%26aulast%3DScherman%26aufirst%3DO.%2BA.%26atitle%3DSupramolecular%2520cross-linked%2520networks%2520via%2520host-guest%2520complexation%2520with%2520cucurbit%255B8%255Duril%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D14251%26epage%3D14260%26doi%3D10.1021%2Fja106362w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zakrzewicz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Didiasova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krüger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giaimo, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borggrefe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mieth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocke, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zakrzewicz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaefer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preissner, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wygrecka, M.</span></span> <span> </span><span class="NLM_article-title">Protein arginine methyltransferase 5 mediates enolase-1 cell surface trafficking in human lung adenocarcinoma cells</span>. <i>Biochim. Biophys. Acta</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1864</i></span>,  <span class="NLM_fpage">1816</span>– <span class="NLM_lpage">1827</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2018.02.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2Fj.bbadis.2018.02.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktlGrs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1864&publication_year=2018&pages=1816-1827&author=D.+Zakrzewiczauthor=M.+Didiasovaauthor=M.+Kr%C3%BCgerauthor=B.+D.+Giaimoauthor=T.+Borggrefeauthor=M.+Miethauthor=A.+C.+Hockeauthor=A.+Zakrzewiczauthor=L.+Schaeferauthor=K.+T.+Preissnerauthor=M.+Wygrecka&title=Protein+arginine+methyltransferase+5+mediates+enolase-1+cell+surface+trafficking+in+human+lung+adenocarcinoma+cells&doi=10.1016%2Fj.bbadis.2018.02.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Protein arginine methyltransferase 5 mediates enolase-1 cell surface trafficking in human lung adenocarcinoma cells</span></div><div class="casAuthors">Zakrzewicz, Dariusz; Didiasova, Miroslava; Krueger, Marcus; Giaimo, Benedetto Daniele; Borggrefe, Tilman; Mieth, Maren; Hocke, Andreas C.; Zakrzewicz, Anna; Schaefer, Liliana; Preissner, Klaus T.; Wygrecka, Malgorzata</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">1864</span>
        (<span class="NLM_cas:issue">5_Part_A</span>),
    <span class="NLM_cas:pages">1816-1827</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Enolase-1-dependent cell surface proteolysis plays an important role in cell invasion.  Although enolase-1 (Eno-1), a glycolytic enzyme, has been found on the surface of various cells, the mechanism responsible for its exteriorization remains elusive.  Here, we investigated the involvement of post-translational modifications (PTMs) of Eno-1 in its lipopolysaccharide (LPS)-triggered trafficking to the cell surface.  We found that stimulation of human lung adenocarcinoma cells with LPS triggered the monomethylation of arginine 50 (R50me) within Eno-1.  The Eno-1R50me was confirmed by its interaction with the tudor domain (TD) from TD-contg. 3 (TDRD3) protein recognizing methylarginines.  Substitution of R50 with lysine (R50K) reduced Eno-1 assocn. with epithelial caveolar domains, thereby diminishing its exteriorization.  Similar effects were obsd. when pharmacol. inhibitors of arginine methyltransferases were applied.  Protein arginine methyltransferase 5 (PRMT5) was identified to be responsible for Eno-1 methylation.  Overexpression of PRMT5 and caveolin-1 enhanced levels of membrane-bound extracellular Eno-1 and, conversely, pharmacol. inhibition of PRMT5 attenuated Eno-1 cell-surface localization.  Importantly, Eno-1R50me was essential for cancer cell motility since the replacement of Eno-1 R50 by lysine or the suppression of PRMT 5 activity diminished Eno-1-triggered cell invasion.  LPS-triggered Eno-1R50me enhances Eno-1 cell surface levels and thus potentiates the invasive properties of cancer cells.  Strategies to target Eno-1R50me may offer novel therapeutic approaches to attenuate tumor metastasis in cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE5EyHucXpw7Vg90H21EOLACvtfcHk0lgvG75ZlHIHzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktlGrs7o%253D&md5=81e1ba2aa285978778e34e8abc9687ba</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2018.02.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2018.02.021%26sid%3Dliteratum%253Aachs%26aulast%3DZakrzewicz%26aufirst%3DD.%26aulast%3DDidiasova%26aufirst%3DM.%26aulast%3DKr%25C3%25BCger%26aufirst%3DM.%26aulast%3DGiaimo%26aufirst%3DB.%2BD.%26aulast%3DBorggrefe%26aufirst%3DT.%26aulast%3DMieth%26aufirst%3DM.%26aulast%3DHocke%26aufirst%3DA.%2BC.%26aulast%3DZakrzewicz%26aufirst%3DA.%26aulast%3DSchaefer%26aufirst%3DL.%26aulast%3DPreissner%26aufirst%3DK.%2BT.%26aulast%3DWygrecka%26aufirst%3DM.%26atitle%3DProtein%2520arginine%2520methyltransferase%25205%2520mediates%2520enolase-1%2520cell%2520surface%2520trafficking%2520in%2520human%2520lung%2520adenocarcinoma%2520cells%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2018%26volume%3D1864%26spage%3D1816%26epage%3D1827%26doi%3D10.1016%2Fj.bbadis.2018.02.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 3 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marion  Laudette</span>, <span class="hlFld-ContribAuthor ">Karina  Formoso</span>, <span class="hlFld-ContribAuthor ">Frank  Lezoualc’h</span>. </span><span class="cited-content_cbyCitation_article-title">GRKs and Epac1 Interaction in Cardiac Remodeling and Heart Failure. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2021,</strong> <em>10 </em>
                                    (1)
                                     , 154. <a href="https://doi.org/10.3390/cells10010154" title="DOI URL">https://doi.org/10.3390/cells10010154</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells10010154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells10010154%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DGRKs%252Band%252BEpac1%252BInteraction%252Bin%252BCardiac%252BRemodeling%252Band%252BHeart%252BFailure%26aulast%3DLaudette%26aufirst%3DMarion%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D1%26spage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen John  Yarwood</span>. </span><span class="cited-content_cbyCitation_article-title">Special Issue on “New Advances in Cyclic AMP Signalling”—An Editorial Overview. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2020,</strong> <em>9 </em>
                                    (10)
                                     , 2274. <a href="https://doi.org/10.3390/cells9102274" title="DOI URL">https://doi.org/10.3390/cells9102274</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells9102274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells9102274%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DSpecial%252BIssue%252Bon%252B%2525E2%252580%25259CNew%252BAdvances%252Bin%252BCyclic%252BAMP%252BSignalling%2525E2%252580%25259D%2525E2%252580%252594An%252BEditorial%252BOverview%26aulast%3DYarwood%26aufirst%3DStephen%2BJohn%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D10%26spage%3D2274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karina  Formoso</span>, <span class="hlFld-ContribAuthor ">Frank  Lezoualc’h</span>, <span class="hlFld-ContribAuthor ">Jeanne  Mialet-Perez</span>. </span><span class="cited-content_cbyCitation_article-title">Role of EPAC1 Signalosomes in Cell Fate: Friends or Foes?. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2020,</strong> <em>9 </em>
                                    (9)
                                     , 1954. <a href="https://doi.org/10.3390/cells9091954" title="DOI URL">https://doi.org/10.3390/cells9091954</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells9091954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells9091954%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DRole%252Bof%252BEPAC1%252BSignalosomes%252Bin%252BCell%252BFate%25253A%252BFriends%252Bor%252BFoes%25253F%26aulast%3DFormoso%26aufirst%3DKarina%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D9%26spage%3D1954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0026.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of cAMP and representative reported EPAC agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Proposed structural modifications on <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>9a–m</b> with Modification on the <b>P1</b> Moiety<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NH<sub>4</sub>OH<sub>(aq)</sub>, THF, 0 °C to rt, overnight, 94%; (b) 2-bromoacetyl bromide, toluene, reflux, 5 h, 67%; and (c) <b>8a–m</b>, K<sub>2</sub>CO<sub>3</sub>, dry DMF, rt, overnight, 48–81%.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>9n–s</b> with Modification on the <b>P1</b> Moiety<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaH, THF, rt, 0.5 h and then MOMCl, THF, rt, 2 h, 58–60%; (b) <i>n</i>-BuLi, THF, −78 °C, 0.5 h and then <i>N</i>-chlorosuccinimide, THF, −78 °C to rt, 16 h, 21–29%; (c) <i>n</i>-BuLi, THF, −78 °C, 0.5 h and then <i>N</i>-fluorobenzenesulfonimide, THF, −78 °C to rt, 16 h, 38%; (d) HCl<sub>(aq)</sub>, MeOH, 50 °C, 2 h, 86–95%; (e) <b>8n–s</b>, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 16 h and then NaOH<sub>(aq)</sub>, MeOH, rt, 3 h, 11–99%; (f) NH<sub>4</sub>OH<sub>(aq)</sub>, THF, rt, 16 h, 93%; and (g) EDCI, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 72 h, 16–88%.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>12a–g</b> with Modification on the <b>P2</b> Moiety<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaH, THF, 0 °C to rt, overnight, 40–76%; (b) <i>tert</i>-butyl (2-hydroxyethyl)carbamate or <i>tert</i>-butyl 4-hydroxypiperidine-1-carboxylate, PPh<sub>3</sub>, DEAD, THF, rt, overnight, 81–88%; (c) CF<sub>3</sub>COOH, CH<sub>2</sub>Cl<sub>2</sub>, rt, 5 h, quant; (d) <b>5</b>, NEt<sub>3</sub>, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 8 h, 91–92%; (e) ethyl 2-bromo-2-fluoroacetate, K<sub>2</sub>CO<sub>3</sub>, dry DMF, rt, overnight, 40%; (f) (i) LiOH, THF, H<sub>2</sub>O, rt, overnight; (ii) 4 N HCl, 76%; (g) <b>6</b>, EDCI, DAMP, DMF, rt, overnight, 86%; (h) 2-bromo-2-methylpropanoic acid, acetone, CHCl<sub>3</sub>, NaOH, reflux, 4 h, 22%; (i) EDCI, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 48 h, 8%; (j) 2-chloroethylamine hydrochloride, KOH, 3:1 PhMe/dioxane, reflux, 18 h, 57%; and (k) 2,4-dimethylbenzenesulfonyl chloride, CH<sub>2</sub>Cl<sub>2</sub>, rt, 20 min, 36%.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>25a–v</b> with Modification on the <b>P3</b> Moiety<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) methyl 2-bromoacetate, K<sub>2</sub>CO<sub>3</sub>, dry DMF, rt, overnight, 84–87%; (b) (i) LiOH, THF, H<sub>2</sub>O, rt, overnight; (ii) 4 N HCl, 86–88%; (c) substituted benzenesulfonamide, EDCI, DAMP, DMF, rt, overnight, 39–87%; (d) Pd/C, H<sub>2</sub>, MeOH, 50 °C, 3 h, 92–94%; and (e) for <b>25r–t</b>, R<sup>4</sup>B(OH)<sub>2</sub>, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, H<sub>2</sub>O, 110 °C, overnight, 63–79%; for <b>25u</b> and <b>25v</b>, R<sup>4</sup>H, Pd(OAc)<sub>2</sub>, XantPhos, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 100 °C, overnight, 50–72%.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compounds <b>25w–ad</b> with Modification on the <b>P3</b> Moiety<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NH<sub>4</sub>OH<sub>(aq)</sub>, THF, rt, 16 h, 51–96%; (b) PhB(OH)<sub>2</sub> or 3-furanylB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, reflux, 16 h, 81–93%; and (c) <b>23</b>, EDCI, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 48 h, 8–77%.</p></p></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0007.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Relative binding affinity of selected hit compounds, in comparison with hit <b>3</b>, was tested using the 8-NBD-cAMP competition assay. (A) Dose–response curves of the selected compounds (<b>3</b>, <b>25g</b>, <b>25q</b>, and <b>25n</b>) for EPAC1-CNBD binding affinity. (B) Dose–response curves of selected compounds (<b>3</b>, <b>25u</b>, <b>25e</b>, and <b>25f</b>) for EPAC1-CNBD binding affinity. (C) Representative dose–response curves for EPAC1-ΔDEP binding affinity. The data are the mean ± SEM of at least three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0008.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Ability of compounds <b>25g</b>, <b>25n</b>, and <b>25q</b> to promote EPAC1 GEF activity <i>in vitro</i>. The figure shows relative fluorescence from EPAC1 activation assays (on left) and rate constants (<i>k</i><sub>obs</sub>) as bar graphs (on right) with 500 μM cyclic AMP, in the presence or absence of 500 μM <b>25g</b> (A) or <b>25n</b> (B), respectively. (C) Dose dependency of EPAC1 <i>k</i><sub>obs</sub> on the concentration of <b>25n</b> (open circles), <b>25n</b> (closed triangles), or <b>25q</b> (closed squares).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0009.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Ability of compounds <b>25g</b>, <b>25q</b>, and <b>25n</b> to promote cellular EPAC1 activity in the presence of the EPAC1 agonist, compound <b>2</b>. U2OS cells stably transfected with EPAC1 were stimulated with the indicated compounds (as described in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>). Active, GTP-bound Rap1 was pulled down from cell lysates and its levels were visualized by western blotting and quantified densitometrically. Data from at least three independent experiments presented as mean ± SEM with significant increases in Rap1-GTP levels in comparison with cells treated with <b>2</b> being indicated; *<i>p</i> < 0.05 and **<i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0010.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. PKA activation results of representative newly discovered EPAC1 agonists. U2OS cells stably transfected with EPAC1 were treated with 100 μM test compounds, cyclic nucleotide EPAC1 agonist <b>2</b> or 10 μM forskolin and rolipram (F/R), cyclic AMP elevating agents, as a positive control. Active, phosphorylated VASP (P-VASP) was visualized using a phosphospecific, anti-VASP antibody. None of the tested compounds promoted VASP phosphorylation in cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0011.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Identification of compounds <b>25e</b>, <b>25f</b>, and <b>25u</b> as EPAC1 activators in an <i>in vitro</i> GEF screen. The figure demonstrates relative fluorescence from EPAC1 activation assays with 10 μM of all synthesized compounds. Selected compounds have been highlighted as indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0012.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Ability of compounds <b>25e</b>, <b>25f</b>, <b>25g</b>, <b>25q</b>, <b>25n</b>, and <b>25u</b> to promote EPAC1 and EPAC2 activity in cells. U2OS cells stably transfected with EPAC1 or EPAC2 were stimulated with the indicated compounds. Cyclic nucleotide EPAC1 and EPAC2 agonist 007 and S-220, respectively (<b>2</b> and <b>4</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), were used as positive controls. Active, GTP-bound Rap1 was pulled down from cell lysates and its levels were visualized by western blotting. Experiments were carried out on at least three separate occasions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0013.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Immunoblots in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a> were quantified densitometrically and the data from at least three independent experiments are presented here as mean ± SEM with significant increases in Rap1-GTP levels in EPAC1-expressing cells relative to EPAC2-expressing cells being indicated; **<i>p</i> < 0.01. Red bars indicate separate, not additive, percentages of Rap1 activation for EPAC2 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0002.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Effects of the selected compounds on IL-6-promoted signaling in HUVECs. HUVECs were preincubated with 100 μM of the indicated compounds for 30 min and then stimulated with IL-6 (5 ng/mL) plus sIL6Rα (25 ng/mL) for 5 h. Cell extracts were then prepared and immunoblotted with antibodies to phosphorylated and nonphosphorylated forms of STAT3, ERK, and AKT, as indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0003.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Compounds <b>3</b> and <b>25u</b> inhibit IL-6-promoted STAT3 and promote AKT signaling in HUVECs. Densitometric values from three separate immunoblots from <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a> are shown, with significant decreases in STAT3 phosphorylation being indicated; <sup>#</sup><i>p</i> < 0.05 and <sup>##</sup><i>p</i> < 0.01, relative to IL-6-stimulated cells. Significant increases in STAT3 and AKT activation, relative to vehicle-stimulated (veh.) cells, are also indicated; *<i>p</i> < 0.05, **<i>p</i> < 0.01, and ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0004.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Effects of the selected compounds on IL-6-promoted adhesion molecule expression in HUVECs. HUVECs were preincubated with 100 μM of the indicated compounds for 30 min and then further incubated with IL-6 (5 ng/mL) plus sIL6Rα (25 ng/mL) for 5 h. Cell extracts were then prepared and immunoblotted with antibodies to either VCAM1, ICAM1, or SELE, as indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/medium/jm9b02094_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0005.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Capability of the selected compounds to inhibit IL-6-promoted VCAM1 induction in HUVECs. Densitometric values from three separate immunoblots from <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a> are shown, with significant decreases in VCAM1 expression being indicated; <sup>#</sup><i>p</i> < 0.05, relative to IL-6-stimulated cells. Significant increases in VCAM1 expression, relative to vehicle-stimulated (veh.) cells, are also indicated; *<i>p</i> < 0.05. Changes that were not statistically significant are indicated (ns).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02094/20200520/images/large/jm9b02094_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02094&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i109">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17813" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17813" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 67 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robichaux, W. G.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span> <span> </span><span class="NLM_article-title">Intracellular cAMP sensor EPAC: physiology, pathophysiology, and therapeutics development</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">919</span>– <span class="NLM_lpage">1053</span>, <span class="refDoi"> DOI: 10.1152/physrev.00025.2017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1152%2Fphysrev.00025.2017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=29537337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvFeksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2018&pages=919-1053&author=W.+G.+Robichauxauthor=X.+Cheng&title=Intracellular+cAMP+sensor+EPAC%3A+physiology%2C+pathophysiology%2C+and+therapeutics+development&doi=10.1152%2Fphysrev.00025.2017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular cAMP sensor EPAC: physiology, pathophysiology, and therapeutics development</span></div><div class="casAuthors">Robichaux, William G., III; Cheng, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">919-1053</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">1522-1210</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">This review focuses on one family of the known cAMP receptors, the exchange proteins directly activated by cAMP (EPACs), also known as the cAMP-regulated guanine nucleotide exchange factors (cAMP-GEFs).  Although EPAC proteins are fairly new addns. to the growing list of cAMP effectors, and relatively "young" in the cAMP discovery timeline, the significance of an EPAC presence in different cell systems is extraordinary.  The study of EPACs has considerably expanded the diversity and adaptive nature of cAMP signaling assocd. with numerous physiol. and pathophysiol. responses.  This review comprehensively covers EPAC protein functions at the mol., cellular, physiol., and pathophysiol. levels; and in turn, the applications of employing EPAC-based biosensors as detection tools for dissecting cAMP signaling and the implications for targeting EPAC proteins for therapeutic development are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEXxHMBR_kU7Vg90H21EOLACvtfcHk0ljVwhel-ddvuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvFeksb4%253D&md5=fa74e7dabdae8d04288b9fe4a68b647a</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00025.2017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00025.2017%26sid%3Dliteratum%253Aachs%26aulast%3DRobichaux%26aufirst%3DW.%2BG.%26aulast%3DCheng%26aufirst%3DX.%26atitle%3DIntracellular%2520cAMP%2520sensor%2520EPAC%253A%2520physiology%252C%2520pathophysiology%252C%2520and%2520therapeutics%2520development%26jtitle%3DPhysiol.%2520Rev.%26date%3D2018%26volume%3D98%26spage%3D919%26epage%3D1053%26doi%3D10.1152%2Fphysrev.00025.2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span> <span> </span><span class="NLM_article-title">Protein kinases--the major drug targets of the twenty-first century?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1038/nrd773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1038%2Fnrd773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=12120282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD38XivVGmtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=309-315&author=P.+Cohen&title=Protein+kinases%2D%2Dthe+major+drug+targets+of+the+twenty-first+century%3F&doi=10.1038%2Fnrd773"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Timeline: Protein kinases - the major drug targets of the twenty-first century?</span></div><div class="casAuthors">Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">309-315</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein phosphorylation regulates most aspects of cell life, whereas abnormal phosphorylation is a cause or consequence of disease.  A growing interest in developing orally active protein-kinase inhibitors has recently culminated in the approval of the first of these drugs for clin. use.  Protein kinases have now become the second most important group of drug targets, after G-protein-coupled receptors.  Here, I give a personal view of some of the most important advances that have shaped this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRd_GqiGAWaLVg90H21EOLACvtfcHk0ljvAfLDrxQRbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XivVGmtr8%253D&md5=67d2fbc11a55b5980ee0692f7bc13cc9</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd773%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DProtein%2520kinases--the%2520major%2520drug%2520targets%2520of%2520the%2520twenty-first%2520century%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2002%26volume%3D1%26spage%3D309%26epage%3D315%26doi%3D10.1038%2Fnrd773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steichen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keshwani, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornev, A. P.</span></span> <span> </span><span class="NLM_article-title">PKA: lessons learned after twenty years</span>. <i>Biochim. Biophys. Acta</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1834</i></span>,  <span class="NLM_fpage">1271</span>– <span class="NLM_lpage">1278</span>, <span class="refDoi"> DOI: 10.1016/j.bbapap.2013.03.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2Fj.bbapap.2013.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=23535202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvVertL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1834&publication_year=2013&pages=1271-1278&author=S.+S.+Taylorauthor=P.+Zhangauthor=J.+M.+Steichenauthor=M.+M.+Keshwaniauthor=A.+P.+Kornev&title=PKA%3A+lessons+learned+after+twenty+years&doi=10.1016%2Fj.bbapap.2013.03.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">PKA: Lessons learned after twenty years</span></div><div class="casAuthors">Taylor, Susan S.; Zhang, Ping; Steichen, Jon M.; Keshwani, Malik M.; Kornev, Alexandr P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1834</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1271-1278</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  The first protein kinase structure, solved in 1991, revealed the fold that is shared by all members of the eukaryotic protein kinase superfamily and showed how the conserved sequence motifs cluster mostly around the active site.  This structure of the PKA catalytic (C) subunit showed also how a single phosphate integrated the entire mol.  Since then the EPKs have become a major drug target, second only to the G-protein coupled receptors.  Although PKA provided a mechanistic understanding of catalysis that continues to serve as a prototype for the family, by comparing many active and inactive kinases we subsequently discovered a hydrophobic spine architecture that is a characteristic feature of all active kinases.  The ways in which the regulatory spine is dynamically assembled is the defining feature of each protein kinase.  Protein kinases have thus evolved to be mol. switches, like the G-proteins, and unlike metabolic enzymes which have evolved to be efficient catalysis.  PKA also shows how the dynamic tails surround the core and serve as essential regulatory elements.  The phosphorylation sites in PKA, introduced both co- and post-translationally, are very stable.  The resulting C-subunit is then packaged as an inhibited holoenzyme with cAMP-binding regulatory (R) subunits so that PKA activity is regulated exclusively by cAMP, not by the dynamic turnover of an activation loop phosphate.  We could not understand activation and inhibition without seeing structures of R:C complexes; however, to appreciate the structural uniqueness of each R2:C2 holoenzyme required solving structures of tetrameric holoenzymes.  It is these tetrameric holoenzymes that are localized to discrete sites in the cell, typically by A Kinase Anchoring Proteins where they create discrete foci for PKA signaling.  Understanding these dynamic macromol. complexes is the challenge that we now face.  This article is part of a Special Issue entitled: Inhibitors of Protein Kinases (2012).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdclEBqYAub7Vg90H21EOLACvtfcHk0ljvAfLDrxQRbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvVertL0%253D&md5=9250d05df946ebf658ceda343a89bc28</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2013.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2013.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DSteichen%26aufirst%3DJ.%2BM.%26aulast%3DKeshwani%26aufirst%3DM.%2BM.%26aulast%3DKornev%26aufirst%3DA.%2BP.%26atitle%3DPKA%253A%2520lessons%2520learned%2520after%2520twenty%2520years%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2013%26volume%3D1834%26spage%3D1271%26epage%3D1278%26doi%3D10.1016%2Fj.bbapap.2013.03.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Torres-Quesada, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayrhofer, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefan, E.</span></span> <span> </span><span class="NLM_article-title">The many faces of compartmentalized PKA signalosomes</span>. <i>Cell. Signal.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2017.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2Fj.cellsig.2017.05.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=28528970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC2sXot1egurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=1-11&author=O.+Torres-Quesadaauthor=J.+E.+Mayrhoferauthor=E.+Stefan&title=The+many+faces+of+compartmentalized+PKA+signalosomes&doi=10.1016%2Fj.cellsig.2017.05.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The many faces of compartmentalized PKA signalosomes</span></div><div class="casAuthors">Torres-Quesada, Omar; Mayrhofer, Johanna E.; Stefan, Eduard</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Cellular signal transmission requires the dynamic formation of spatiotemporally controlled mol. interactions.  At the cell surface information is received by receptor complexes and relayed through intracellular signaling platforms which organize the actions of functionally interacting signaling enzymes and substrates.  The list of hormone or neurotransmitter pathways that utilize the ubiquitous cAMP-sensing protein kinase A (PKA) system is expansive.  This requires that the specificity, duration, and intensity of PKA responses are spatially and temporally restricted.  Hereby, scaffolding proteins take the center stage for ensuring proper signal transmission.  They unite second messenger sensors, activators, effectors, and kinase substrates within cellular micro-domains to precisely control and route signal propagation.  A-kinase anchoring proteins (AKAPs) organize such subcellular signalosomes by tethering the PKA holoenzyme to distinct cell compartments.  AKAPs differ in their modular organization showing pathway specific arrangements of interaction motifs or domains.  This enables the cell- and compartment- guided assembly of signalosomes with unique enzyme compn. and function.  The AKAP-mediated clustering of cAMP and other second messenger sensing and interacting signaling components along with functional successive enzymes facilitates the rapid and precise dissemination of incoming signals.  This review article delineates examples for different means of PKA regulation and for snapshots of compartmentalized PKA signalosomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG5NcBVwB2w7Vg90H21EOLACvtfcHk0lgU5lG6yTKjbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXot1egurk%253D&md5=3f2ebf4506b00487cbbf2dcb341af43c</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2017.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2017.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DTorres-Quesada%26aufirst%3DO.%26aulast%3DMayrhofer%26aufirst%3DJ.%2BE.%26aulast%3DStefan%26aufirst%3DE.%26atitle%3DThe%2520many%2520faces%2520of%2520compartmentalized%2520PKA%2520signalosomes%26jtitle%3DCell.%2520Signal.%26date%3D2017%26volume%3D37%26spage%3D1%26epage%3D11%26doi%3D10.1016%2Fj.cellsig.2017.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biel, M.</span></span> <span> </span><span class="NLM_article-title">Cyclic nucleotide-regulated cation channels</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">9017</span>– <span class="NLM_lpage">9021</span>, <span class="refDoi"> DOI: 10.1074/jbc.r800075200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1074%2Fjbc.R800075200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=19054768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjs1ynur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=9017-9021&author=M.+Biel&title=Cyclic+nucleotide-regulated+cation+channels&doi=10.1074%2Fjbc.r800075200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic Nucleotide-regulated Cation Channels</span></div><div class="casAuthors">Biel, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">9017-9021</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  Cyclic nucleotide-regulated cation channels are ion channels whose activation is regulated by the direct binding of cAMP or cGMP to the channel protein.  Two structurally related families of channels regulated by cyclic nucleotides have been identified, the cyclic nucleotide-gated channels and the hyperpolarization-activated cyclic nucleotide-gated channels.  Cyclic nucleotide-gated channels play a key role in visual and olfactory transduction.  Hyperpolarization-activated cyclic nucleotide-gated channels are present in the conduction system of the heart and are involved in the control of cardiac automaticity.  Moreover, these channels are widely expressed in central and peripheral neurons, where they control a variety of fundamental processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiWwEkcIv2MLVg90H21EOLACvtfcHk0lgU5lG6yTKjbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjs1ynur8%253D&md5=a4fa7ded9c03be2429a30d2fbf1e45fa</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R800075200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R800075200%26sid%3Dliteratum%253Aachs%26aulast%3DBiel%26aufirst%3DM.%26atitle%3DCyclic%2520nucleotide-regulated%2520cation%2520channels%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D9017%26epage%3D9021%26doi%3D10.1074%2Fjbc.r800075200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bos, J. L.</span></span> <span> </span><span class="NLM_article-title">Epac: a new cAMP target and new avenues in cAMP research</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">733</span>– <span class="NLM_lpage">738</span>, <span class="refDoi"> DOI: 10.1038/nrm1197</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1038%2Fnrm1197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=14506476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsVKqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=733-738&author=J.+L.+Bos&title=Epac%3A+a+new+cAMP+target+and+new+avenues+in+cAMP+research&doi=10.1038%2Fnrm1197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Opinion: Epac: a new cAMP target and new avenues in cAMP research</span></div><div class="casAuthors">Bos, Johannes L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">733-738</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Five years ago, Epac - a guanine nucleotide exchange factor for the Ras-like small GTPases Rap1 and Rap2 - was found to be a new target of cAMP, which opened up new avenues for cAMP research.  Structural anal. of the cAMP-binding domains of Epac2 has identified a unifying mechanism for how cAMP activates proteins, and the design and synthesis of an Epac-specific cAMP analog has paved the way for future discoveries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMTh0k8Iy-8LVg90H21EOLACvtfcHk0lgU5lG6yTKjbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsVKqsLw%253D&md5=14be0f1922a69532b14fe2b4d3b079c5</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrm1197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1197%26sid%3Dliteratum%253Aachs%26aulast%3DBos%26aufirst%3DJ.%2BL.%26atitle%3DEpac%253A%2520a%2520new%2520cAMP%2520target%2520and%2520new%2520avenues%2520in%2520cAMP%2520research%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2003%26volume%3D4%26spage%3D733%26epage%3D738%26doi%3D10.1038%2Fnrm1197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsalkova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, F.</span></span> <span> </span><span class="NLM_article-title">Epac and PKA: a tale of two intracellular cAMP receptors</span>. <i>Acta Biochim. Biophys. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">651</span>– <span class="NLM_lpage">662</span>, <span class="refDoi"> DOI: 10.1111/j.1745-7270.2008.00438.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1111%2Fj.1745-7270.2008.00438.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=18604457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpvF2qsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2008&pages=651-662&author=X.+Chengauthor=Z.+Jiauthor=T.+Tsalkovaauthor=F.+Mei&title=Epac+and+PKA%3A+a+tale+of+two+intracellular+cAMP+receptors&doi=10.1111%2Fj.1745-7270.2008.00438.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Epac and PKA: a tale of two intracellular cAMP receptors</span></div><div class="casAuthors">Cheng, Xiaodong; Ji, Zhenyu; Tsalkova, Tamara; Mei, Fang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Biochimica et Biophysica Sinica</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">651-662</span>CODEN:
                <span class="NLM_cas:coden">ABBSC2</span>;
        ISSN:<span class="NLM_cas:issn">1672-9145</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The cAMP-mediated signaling pathways regulate a multitude of important biol. processes under both physiol. and pathol. conditions, including diabetes, heart failure, and cancer.  In eukaryotic cells, the effects of cAMP are mediated by 2 ubiquitously expressed intracellular cAMP receptors, the classic cAMP-dependent protein kinase A (PKA) and the recently discovered exchange protein activated by cAMP (Epac), a cAMP-regulated guanine nucleotide exchange factor.  Like PKA, Epac contains an evolutionally conserved cAMP-binding domain that acts as a mol. switch for sensing intracellular 2nd messenger cAMP levels to control diverse biol. functions.  The existence of 2 families of cAMP effectors provides a mechanism for a more precise and integrated control of the cAMP signaling pathways in a spatial and temporal manner.  Depending upon the specific cellular environments as well as their relative abundance, distribution and localization, Epac and PKA may act independently, converge synergistically, or oppose each other in regulating a specific cellular function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBLmBPtSLObrVg90H21EOLACvtfcHk0lhPuXAIQzHKyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpvF2qsL0%253D&md5=e607e382cff805e63fa1556dc7604558</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fj.1745-7270.2008.00438.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1745-7270.2008.00438.x%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DJi%26aufirst%3DZ.%26aulast%3DTsalkova%26aufirst%3DT.%26aulast%3DMei%26aufirst%3DF.%26atitle%3DEpac%2520and%2520PKA%253A%2520a%2520tale%2520of%2520two%2520intracellular%2520cAMP%2520receptors%26jtitle%3DActa%2520Biochim.%2520Biophys.%2520Sin.%26date%3D2008%26volume%3D40%26spage%3D651%26epage%3D662%26doi%3D10.1111%2Fj.1745-7270.2008.00438.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wild, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the discovery of small molecules targeting exchange proteins directly activated by cAMP (EPAC)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">3651</span>– <span class="NLM_lpage">3665</span>, <span class="refDoi"> DOI: 10.1021/jm401425e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401425e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVShsL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3651-3665&author=H.+Chenauthor=C.+Wildauthor=X.+Zhouauthor=N.+Yeauthor=X.+Chengauthor=J.+Zhou&title=Recent+advances+in+the+discovery+of+small+molecules+targeting+exchange+proteins+directly+activated+by+cAMP+%28EPAC%29&doi=10.1021%2Fjm401425e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances in the Discovery of Small Molecules Targeting Exchange Proteins Directly Activated by cAMP (EPAC)</span></div><div class="casAuthors">Chen, Haijun; Wild, Christopher; Zhou, Xiaobin; Ye, Na; Cheng, Xiaodong; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3651-3665</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  3',5'-Cyclic adenosine monophosphate (cAMP) is a pivotal second messenger that regulates numerous biol. processes under physiol. and pathol. conditions, including cancer, diabetes, heart failure, inflammation, and neurol. disorders.  In the past, all effects of cAMP were initially believed to be mediated by protein kinase A (PKA) and cyclic nucleotide-regulated ion channels.  Since the discovery of exchange proteins directly activated by cAMP (EPACs) in 1998, accumulating evidence has demonstrated that the net cellular effects of cAMP are also regulated by EPAC.  The pursuit of the biol. functions of EPAC has benefited from the development and applications of a growing no. of pharmacol. probes targeting EPACs.  In this review, we seek to provide a concise update on recent advances in the development of chem. entities including various membrane-permeable analogs of cAMP and newly discovered EPAC-specific ligands from high throughput assays and hit-to-lead optimizations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ5iSmjJ-WXLVg90H21EOLACvtfcHk0lhPuXAIQzHKyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVShsL7K&md5=d95ba49c7415288ae57f49e5fc00041e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm401425e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401425e%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DWild%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DN.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DRecent%2520advances%2520in%2520the%2520discovery%2520of%2520small%2520molecules%2520targeting%2520exchange%2520proteins%2520directly%2520activated%2520by%2520cAMP%2520%2528EPAC%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3651%26epage%3D3665%26doi%3D10.1021%2Fjm401425e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parnell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarwood, S. J.</span></span> <span> </span><span class="NLM_article-title">The future of EPAC-targeted therapies: agonism versus antagonism</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">214</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2015.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2Fj.tips.2015.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=25744542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjt1ShsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=203-214&author=E.+Parnellauthor=T.+M.+Palmerauthor=S.+J.+Yarwood&title=The+future+of+EPAC-targeted+therapies%3A+agonism+versus+antagonism&doi=10.1016%2Fj.tips.2015.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The future of EPAC-targeted therapies: agonism versus antagonism</span></div><div class="casAuthors">Parnell, Euan; Palmer, Timothy M.; Yarwood, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">203-214</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Pharmaceutical manipulation of cAMP levels exerts beneficial effects through the regulation of the exchange protein activated by cAMP (EPAC) and protein kinase A (PKA) signaling routes.  Recent attention has turned to the specific regulation of EPAC isoforms (EPAC1 and EPAC2) as a more targeted approach to cAMP-based therapies.  For example, EPAC2-selective agonists could promote insulin secretion from pancreatic β cells, whereas EPAC1-selective agonists may be useful in the treatment of vascular inflammation.  By contrast, EPAC1 and EPAC2 antagonists could both be useful in the treatment of heart failure.  Here we discuss whether the best way forward is to design EPAC-selective agonists or antagonists and the current strategies being used to develop isoform-selective, small-mol. regulators of EPAC1 and EPAC2 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFYdzaBCR8SLVg90H21EOLACvtfcHk0lh8a60R7vMkWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjt1ShsL0%253D&md5=e130a5389a31f057585fb32456ddbcef</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2015.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2015.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DParnell%26aufirst%3DE.%26aulast%3DPalmer%26aufirst%3DT.%2BM.%26aulast%3DYarwood%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520future%2520of%2520EPAC-targeted%2520therapies%253A%2520agonism%2520versus%2520antagonism%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D36%26spage%3D203%26epage%3D214%26doi%3D10.1016%2Fj.tips.2015.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Exchange proteins directly activated by cAMP (EPACs): emerging therapeutic targets</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1633</span>– <span class="NLM_lpage">1639</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.02.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2Fj.bmcl.2017.02.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=28283242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktVCgu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=1633-1639&author=P.+Wangauthor=Z.+Liuauthor=H.+Chenauthor=N.+Yeauthor=X.+Chengauthor=J.+Zhou&title=Exchange+proteins+directly+activated+by+cAMP+%28EPACs%29%3A+emerging+therapeutic+targets&doi=10.1016%2Fj.bmcl.2017.02.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Exchange proteins directly activated by cAMP (EPACs): Emerging therapeutic targets</span></div><div class="casAuthors">Wang, Pingyuan; Liu, Zhiqing; Chen, Haiying; Ye, Na; Cheng, Xiaodong; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1633-1639</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Exchange proteins directly activated by cAMP (EPACs) are crit. cAMP-dependent signaling pathway mediators.  The discovery of EPAC proteins has significantly facilitated understanding on cAMP-dependent signaling pathway and efforts along this line open new avenues for developing novel therapeutics for cancer, diabetes, heart failure, inflammation, infections, neurol. disorders and other human diseases.  Over the past decade, important progress has been made in the identification of EPAC agonists, antagonists and their biol. and pharmacol. applications.  In this review, we briefly summarize recently reported novel functions of EPACs and the discovery of their small mol. modulators.  The challenges and future perspectives are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAQYamb6TbpLVg90H21EOLACvtfcHk0lh8a60R7vMkWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktVCgu7Y%253D&md5=0eb3514d37d9fe2813f16e03d1a528f2</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.02.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.02.065%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DYe%26aufirst%3DN.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DExchange%2520proteins%2520directly%2520activated%2520by%2520cAMP%2520%2528EPACs%2529%253A%2520emerging%2520therapeutic%2520targets%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D1633%26epage%3D1639%26doi%3D10.1016%2Fj.bmcl.2017.02.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Rooij, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwartkruis, F. J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verheijen, M. H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cool, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nijman, S. M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittinghofer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bos, J. L.</span></span> <span> </span><span class="NLM_article-title">Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>396</i></span>,  <span class="NLM_fpage">474</span>– <span class="NLM_lpage">477</span>, <span class="refDoi"> DOI: 10.1038/24884</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1038%2F24884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=9853756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADyaK1cXotVSitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=396&publication_year=1998&pages=474-477&author=J.+de%0ARooijauthor=F.+J.+T.+Zwartkruisauthor=M.+H.+G.+Verheijenauthor=R.+H.+Coolauthor=S.+M.+B.+Nijmanauthor=A.+Wittinghoferauthor=J.+L.+Bos&title=Epac+is+a+Rap1+guanine-nucleotide-exchange+factor+directly+activated+by+cyclic+AMP&doi=10.1038%2F24884"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP</span></div><div class="casAuthors">De Rooij, Johan; Zwartkruis, Fried J. T.; Verhaijen, Mark H. G.; Cool, Robbert H.; Nijman, Sebastian M. B.; Wittinghofer, Alfred; Bos, Johannes L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">396</span>
        (<span class="NLM_cas:issue">6710</span>),
    <span class="NLM_cas:pages">474-477</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Rap1 is a small, Ras-like GTPase that was first identified as a protein that could suppress the oncogenic transformation of cells by Ras.  Rap1 is activated by several extracellular stimuli and may be involved in cellular processes such as cell proliferation, cell differentiation, T-cell anergy and platelet activation.  At least three different second messengers, namely diacylglycerol, calcium and cAMP, are able to activate Rap1 by promoting its release of the guanine nucleotide GDP and its binding to GTP.  Here we report that activation of Rap1 by forskolin and cAMP occurs independently of protein kinase A (also known as cAMP-activated protein kinase).  We have cloned the gene encoding a guanine-nucleotide-exchange factor (GEF) which we have named Epac (exchange protein directly activated by cAMP).  This protein contains a cAMP-binding site and a domain that is homologous to domains of known GEFs for Ras and Rap1.  Epac binds cAMP in vitro and exhibits in vivo and in vitro GEF activity towards Rap1.  CAMP strongly induces the GEF activity of Epac towards Rap1 both in vivo and in vitro.  We conclude that Epac is a GEF for Rap1 that is regulated directly by cAMP and that Epac is a new target protein for cAMP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ96rDUUrIc7Vg90H21EOLACvtfcHk0liG7tmwzs5r3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXotVSitbs%253D&md5=8f4a50b23d8bfc344c0c9947175b89a5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2F24884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F24884%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BRooij%26aufirst%3DJ.%26aulast%3DZwartkruis%26aufirst%3DF.%2BJ.%2BT.%26aulast%3DVerheijen%26aufirst%3DM.%2BH.%2BG.%26aulast%3DCool%26aufirst%3DR.%2BH.%26aulast%3DNijman%26aufirst%3DS.%2BM.%2BB.%26aulast%3DWittinghofer%26aufirst%3DA.%26aulast%3DBos%26aufirst%3DJ.%2BL.%26atitle%3DEpac%2520is%2520a%2520Rap1%2520guanine-nucleotide-exchange%2520factor%2520directly%2520activated%2520by%2520cyclic%2520AMP%26jtitle%3DNature%26date%3D1998%26volume%3D396%26spage%3D474%26epage%3D477%26doi%3D10.1038%2F24884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springett, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mochizuki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakaya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Housman, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graybiel, A. M.</span></span> <span> </span><span class="NLM_article-title">A family of cAMP-binding proteins that directly activate Rap1</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">2275</span>– <span class="NLM_lpage">2279</span>, <span class="refDoi"> DOI: 10.1126/science.282.5397.2275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1126%2Fscience.282.5397.2275" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=9856955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADyaK1cXotFGjt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=1998&pages=2275-2279&author=H.+Kawasakiauthor=G.+M.+Springettauthor=N.+Mochizukiauthor=S.+Tokiauthor=M.+Nakayaauthor=M.+Matsudaauthor=D.+E.+Housmanauthor=A.+M.+Graybiel&title=A+family+of+cAMP-binding+proteins+that+directly+activate+Rap1&doi=10.1126%2Fscience.282.5397.2275"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A family of cAMP-binding proteins that directly activate Rap1</span></div><div class="casAuthors">Kawasaki, Hiroaki; Springett, Gregory M.; Mochizuki, Naoki; Toki, Shinichiro; Nakaya, Mie; Matsuda, Michiyuki; Housman, David E.; Graybiel, Ann M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">5397</span>),
    <span class="NLM_cas:pages">2275-2279</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">CAMP (3',5' cAMP) is a second messenger that in eukaryotic cells induces physiol. responses ranging from growth, differentiation, and gene expression to secretion and neurotransmission.  Most of these effects have been attributed to the binding of cAMP to cAMP-dependent protein kinase A (PKA).  Here, a family of cAMP-binding proteins that are differentially distributed in the mammalian brain and body organs and that exhibit both cAMP-binding and guanine nucleotide exchange factor (GEF) domains is reported.  These cAMP-regulated GEFs (cAMP-GEFs) bind cAMP and selectively activate the Ras superfamily guanine nucleotide binding protein Rap1A in a cAMP-dependent but PKA-independent manner.  Our findings suggest the need to reformulate concepts of cAMP-mediated signaling to include direct coupling to Ras superfamily signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-_6RlErjnO7Vg90H21EOLACvtfcHk0liG7tmwzs5r3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXotFGjt7c%253D&md5=405913633acf0d725dce8ff974a99a07</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.282.5397.2275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.282.5397.2275%26sid%3Dliteratum%253Aachs%26aulast%3DKawasaki%26aufirst%3DH.%26aulast%3DSpringett%26aufirst%3DG.%2BM.%26aulast%3DMochizuki%26aufirst%3DN.%26aulast%3DToki%26aufirst%3DS.%26aulast%3DNakaya%26aufirst%3DM.%26aulast%3DMatsuda%26aufirst%3DM.%26aulast%3DHousman%26aufirst%3DD.%2BE.%26aulast%3DGraybiel%26aufirst%3DA.%2BM.%26atitle%3DA%2520family%2520of%2520cAMP-binding%2520proteins%2520that%2520directly%2520activate%2520Rap1%26jtitle%3DScience%26date%3D1998%26volume%3D282%26spage%3D2275%26epage%3D2279%26doi%3D10.1126%2Fscience.282.5397.2275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span> <span> </span><span class="NLM_article-title">Exchange protein directly activated by cAMP encoded by the mammalian rapgef3 gene: structure, function and therapeutics</span>. <i>Gene</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>570</i></span>,  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">167</span>, <span class="refDoi"> DOI: 10.1016/j.gene.2015.06.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2Fj.gene.2015.06.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=26119090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVOlsbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=570&publication_year=2015&pages=157-167&author=U.+Banerjeeauthor=X.+Cheng&title=Exchange+protein+directly+activated+by+cAMP+encoded+by+the+mammalian+rapgef3+gene%3A+structure%2C+function+and+therapeutics&doi=10.1016%2Fj.gene.2015.06.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Exchange protein directly activated by cAMP encoded by the mammalian rapgef3 gene: Structure, function and therapeutics</span></div><div class="casAuthors">Banerjee, Upasana; Cheng, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Gene</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">570</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-167</span>CODEN:
                <span class="NLM_cas:coden">GENED6</span>;
        ISSN:<span class="NLM_cas:issn">0378-1119</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Mammalian exchange protein directly activated by cAMP isoform 1 (EPAC1), encoded by the RAPGEF3 gene, is one of the two-membered family of cAMP sensors that mediate the intracellular functions of cAMP by acting as guanine nucleotide exchange factors for the Ras-like Rap small GTPases.  Extensive studies have revealed that EPAC1-mediated cAMP signaling is highly coordinated spatiotemporally through the formation of dynamic signalosomes by interacting with a diverse array of cellular partners.  Recent functional analyses of genetically engineered mouse models further suggest that EPAC1 functions as an important stress response switch and is involved in pathophysiol. conditions of cardiac stresses, chronic pain, cancer and infectious diseases.  These findings, coupled with the development of EPAC specific small mol. modulators, validate EPAC1 as a promising target for therapeutic interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9EhUcwEva9rVg90H21EOLACvtfcHk0liG7tmwzs5r3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOlsbjE&md5=3eb0d8b5cb162a14b317b57fab891f31</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.gene.2015.06.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gene.2015.06.063%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DU.%26aulast%3DCheng%26aufirst%3DX.%26atitle%3DExchange%2520protein%2520directly%2520activated%2520by%2520cAMP%2520encoded%2520by%2520the%2520mammalian%2520rapgef3%2520gene%253A%2520structure%252C%2520function%2520and%2520therapeutics%26jtitle%3DGene%26date%3D2015%26volume%3D570%26spage%3D157%26epage%3D167%26doi%3D10.1016%2Fj.gene.2015.06.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rehmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knipscheer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittinghofer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bos, J. L.</span></span> <span> </span><span class="NLM_article-title">Structure of the cyclic-AMP-responsive exchange factor Epac2 in its auto-inhibited state</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>439</i></span>,  <span class="NLM_fpage">625</span>– <span class="NLM_lpage">628</span>, <span class="refDoi"> DOI: 10.1038/nature04468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1038%2Fnature04468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=16452984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsVCgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=439&publication_year=2006&pages=625-628&author=H.+Rehmannauthor=J.+Dasauthor=P.+Knipscheerauthor=A.+Wittinghoferauthor=J.+L.+Bos&title=Structure+of+the+cyclic-AMP-responsive+exchange+factor+Epac2+in+its+auto-inhibited+state&doi=10.1038%2Fnature04468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the cyclic-AMP-responsive exchange factor Epac2 in its auto-inhibited state</span></div><div class="casAuthors">Rehmann, Holger; Das, Joost; Knipscheer, Puck; Wittinghofer, Alfred; Bos, Johannes L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">439</span>
        (<span class="NLM_cas:issue">7076</span>),
    <span class="NLM_cas:pages">625-628</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Epac proteins (exchange proteins directly activated by cAMP) are guanine-nucleotide-exchange factors (GEFs) for the small GTP-binding proteins Rap1 and Rap2 that are directly regulated by the second messenger cAMP and function in the control of diverse cellular processes, including cell adhesion and insulin secretion.  Here we report the three-dimensional structure of full-length Epac2, a 110-kDa protein that contains an amino-terminal regulatory region with two cyclic-nucleotide-binding domains and a carboxy-terminal catalytic region.  The structure was solved in the absence of cAMP and shows the auto-inhibited state of Epac.  The regulatory region is positioned with respect to the catalytic region by a rigid, tripartite β-sheet-like structure we refer to as the 'switchboard' and an ionic interaction we call the 'ionic latch'.  As a consequence of this arrangement, the access of Rap to the catalytic site is sterically blocked.  Mutational anal. suggests a model for cAMP-induced Epac activation with rigid body movement of the regulatory region, the features of which are universally conserved in cAMP-regulated proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK0sBmjrW9krVg90H21EOLACvtfcHk0ljlOeotK3R0KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsVCgsQ%253D%253D&md5=1b021d7751d7add16f50026dfe7cecc8</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnature04468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04468%26sid%3Dliteratum%253Aachs%26aulast%3DRehmann%26aufirst%3DH.%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DKnipscheer%26aufirst%3DP.%26aulast%3DWittinghofer%26aufirst%3DA.%26aulast%3DBos%26aufirst%3DJ.%2BL.%26atitle%3DStructure%2520of%2520the%2520cyclic-AMP-responsive%2520exchange%2520factor%2520Epac2%2520in%2520its%2520auto-inhibited%2520state%26jtitle%3DNature%26date%3D2006%26volume%3D439%26spage%3D625%26epage%3D628%26doi%3D10.1038%2Fnature04468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rehmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arias-Palomo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadders, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwede, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llorca, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bos, J. L.</span></span> <span> </span><span class="NLM_article-title">Structure of Epac2 in complex with a cyclic AMP analogue and RAP1B</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>455</i></span>,  <span class="NLM_fpage">124</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.1038/nature07187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1038%2Fnature07187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=18660803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVKrsbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2008&pages=124-127&author=H.+Rehmannauthor=E.+Arias-Palomoauthor=M.+A.+Haddersauthor=F.+Schwedeauthor=O.+Llorcaauthor=J.+L.+Bos&title=Structure+of+Epac2+in+complex+with+a+cyclic+AMP+analogue+and+RAP1B&doi=10.1038%2Fnature07187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of Epac2 in complex with a cyclic AMP analogue and RAP1B</span></div><div class="casAuthors">Rehmann, Holger; Arias-Palomo, Ernesto; Hadders, Michael A.; Schwede, Frank; Llorca, Oscar; Bos, Johannes L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">455</span>
        (<span class="NLM_cas:issue">7209</span>),
    <span class="NLM_cas:pages">124-127</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Epac proteins are activated by binding of the second messenger cAMP and then act as guanine nucleotide exchange factors for Rap proteins.  The Epac proteins are involved in the regulation of cell adhesion and insulin secretion.  Here we have detd. the structure of Epac2 in complex with a cAMP analog (Sp-cAMPS) and RAP1B by X-ray crystallog. and single particle electron microscopy.  The structure represents the cAMP activated state of the Epac2 protein with the RAP1B protein trapped in the course of the exchange reaction.  Comparison with the inactive conformation reveals that cAMP binding causes conformational changes that allow the cyclic nucleotide binding domain to swing from a position blocking the Rap binding site towards a docking site at the Ras exchange motif domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcepqP8Xn6hbVg90H21EOLACvtfcHk0ljlOeotK3R0KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVKrsbvF&md5=b950409923a86ea5df583065a2dd3dc9</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnature07187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07187%26sid%3Dliteratum%253Aachs%26aulast%3DRehmann%26aufirst%3DH.%26aulast%3DArias-Palomo%26aufirst%3DE.%26aulast%3DHadders%26aufirst%3DM.%2BA.%26aulast%3DSchwede%26aufirst%3DF.%26aulast%3DLlorca%26aufirst%3DO.%26aulast%3DBos%26aufirst%3DJ.%2BL.%26atitle%3DStructure%2520of%2520Epac2%2520in%2520complex%2520with%2520a%2520cyclic%2520AMP%2520analogue%2520and%2520RAP1B%26jtitle%3DNature%26date%3D2008%26volume%3D455%26spage%3D124%26epage%3D127%26doi%3D10.1038%2Fnature07187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laudette, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lezoualc’h, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, M.</span></span> <span> </span><span class="NLM_article-title">Epac function and cAMP scaffolds in the heart and lung</span>. <i>J. Cardiovasc. Dev. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">9</span>, <span class="refDoi"> DOI: 10.3390/jcdd5010009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.3390%2Fjcdd5010009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2018&pages=9&author=M.+Laudetteauthor=H.+Zuoauthor=F.+Lezoualc%E2%80%99hauthor=M.+Schmidt&title=Epac+function+and+cAMP+scaffolds+in+the+heart+and+lung&doi=10.3390%2Fjcdd5010009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.3390%2Fjcdd5010009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fjcdd5010009%26sid%3Dliteratum%253Aachs%26aulast%3DLaudette%26aufirst%3DM.%26aulast%3DZuo%26aufirst%3DH.%26aulast%3DLezoualc%25E2%2580%2599h%26aufirst%3DF.%26aulast%3DSchmidt%26aufirst%3DM.%26atitle%3DEpac%2520function%2520and%2520cAMP%2520scaffolds%2520in%2520the%2520heart%2520and%2520lung%26jtitle%3DJ.%2520Cardiovasc.%2520Dev.%2520Dis.%26date%3D2018%26volume%3D5%26spage%3D9%26doi%3D10.3390%2Fjcdd5010009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Identification of novel 2-(benzo[d]isoxazol-3-yl)-2-oxo-N-phenylacetohydrazonoyl cyanide analoguesas potent EPAC antagonists</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">62</span>– <span class="NLM_lpage">71</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2Fj.ejmech.2017.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=28399451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFWnt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2017&pages=62-71&author=N.+Yeauthor=Y.+Zhuauthor=Z.+Liuauthor=F.+C.+Meiauthor=H.+Chenauthor=P.+Wangauthor=X.+Chengauthor=J.+Zhou&title=Identification+of+novel+2-%28benzo%5Bd%5Disoxazol-3-yl%29-2-oxo-N-phenylacetohydrazonoyl+cyanide+analoguesas+potent+EPAC+antagonists&doi=10.1016%2Fj.ejmech.2017.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel 2-(benzo[d]isoxazol-3-yl)-2-oxo-N-phenylacetohydrazonoyl cyanide analogues as potent EPAC antagonists</span></div><div class="casAuthors">Ye, Na; Zhu, Yingmin; Liu, Zhiqing; Mei, Fang C.; Chen, Haiying; Wang, Pingyuan; Cheng, Xiaodong; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">62-71</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Two series of novel EPAC antagonists are designed, synthesized and evaluated in an effort to develop diversified analogs based on the scaffold of the previously identified high-throughput (HTS) hit (1, ESI-09).  Further SAR studies reveal that the isoxazole ring A of ESI-09 can tolerate chem. modifications with either introduction of flexible electron-donating substitutions or structurally restrictedly fusing with a Ph ring, leading to identification of several more potent and diversified EPAC antagonists (e.g., 10 (NY0617), 14 (NY0460), 26 (NY0725), 32 (NY0561), and 33 (NY0562)), I-V resp., with low micromolar inhibitory activities.  Mol. docking studies on compds. I and V indicate that these two series of compds. bind at a similar site with substantially different interactions with the EPAC proteins.  The findings may serve as good starting points for the development of more potent EPAC antagonists as valuable pharmacol. probes or potential drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4LT4pJFMIhLVg90H21EOLACvtfcHk0ljnXUxqqnYiGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFWnt7c%253D&md5=845a7194ecb3ae6a54f3bcc80d310fba</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DN.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DMei%26aufirst%3DF.%2BC.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520novel%25202-%2528benzo%255Bd%255Disoxazol-3-yl%2529-2-oxo-N-phenylacetohydrazonoyl%2520cyanide%2520analoguesas%2520potent%2520EPAC%2520antagonists%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D134%26spage%3D62%26epage%3D71%26doi%3D10.1016%2Fj.ejmech.2017.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of 2-substituted phenyl-N-phenyl-2-oxoacetohydrazonoyl cyanides as novel antagonists of exchange proteins directly activated by cAMP (EPACs)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">5163</span>– <span class="NLM_lpage">5166</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.10.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2Fj.bmcl.2017.10.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=29100797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslKnsrzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=5163-5166&author=Z.+Liuauthor=Y.+Zhuauthor=H.+Chenauthor=P.+Wangauthor=F.+C.+Meiauthor=N.+Yeauthor=X.+Chengauthor=J.+Zhou&title=Structure-activity+relationships+of+2-substituted+phenyl-N-phenyl-2-oxoacetohydrazonoyl+cyanides+as+novel+antagonists+of+exchange+proteins+directly+activated+by+cAMP+%28EPACs%29&doi=10.1016%2Fj.bmcl.2017.10.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of 2-substituted phenyl-N-phenyl-2-oxoacetohydrazonoyl cyanides as novel antagonists of exchange proteins directly activated by cAMP (EPACs)</span></div><div class="casAuthors">Liu, Zhiqing; Zhu, Yingmin; Chen, Haiying; Wang, Pingyuan; Mei, Fang C.; Ye, Na; Cheng, Xiaodong; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5163-5166</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Exchange proteins directly activated by cAMP (EPACs) are crit. cAMP-dependent signaling pathway mediators that play important roles in cancer, diabetes, heart failure, inflammations, infections, neurol. disorders and other human diseases.  EPAC specific modulators are urgently needed to explore EPAC's physiol. function, mechanism of action and therapeutic applications.  On the basis of a previously identified EPAC specific inhibitor hit ESI-09, herein we have designed and synthesized a novel series of 2-substituted phenyl-N-phenyl-2-oxoacetohydrazonoyl cyanides as potent EPAC inhibitors.  Compd. 31 (ZL0524) has been discovered as the most potent EPAC inhibitor with IC50 values of 3.6 μM and 1.2 μM against EPAC1 and EPAC2, resp.  Mol. docking of 31 onto an active EPAC2 structure predicts that 31 occupies the hydrophobic pocket in cAMP binding domain (CBD) and also opens up new space leading to the solvent region.  These findings provide inspirations for discovering next generation of EPAC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRFzj5oCxdF7Vg90H21EOLACvtfcHk0ljnXUxqqnYiGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslKnsrzK&md5=73b37d93a7a5473b909c776f5bc04807</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.10.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.10.056%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DMei%26aufirst%3DF.%2BC.%26aulast%3DYe%26aufirst%3DN.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DStructure-activity%2520relationships%2520of%25202-substituted%2520phenyl-N-phenyl-2-oxoacetohydrazonoyl%2520cyanides%2520as%2520novel%2520antagonists%2520of%2520exchange%2520proteins%2520directly%2520activated%2520by%2520cAMP%2520%2528EPACs%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D5163%26epage%3D5166%26doi%3D10.1016%2Fj.bmcl.2017.10.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wild, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Na, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ynalvez, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Functionalized N,N-diphenylamines as potent and selective EPAC2 inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">460</span>– <span class="NLM_lpage">464</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00477</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00477" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvFClsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=460-464&author=C.+T.+Wildauthor=Y.+Zhuauthor=Y.+Naauthor=F.+Meiauthor=M.+A.+Ynalvezauthor=H.+Chenauthor=X.+Chengauthor=J.+Zhou&title=Functionalized+N%2CN-diphenylamines+as+potent+and+selective+EPAC2+inhibitors&doi=10.1021%2Facsmedchemlett.5b00477"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Functionalized N,N-Diphenylamines as Potent and Selective EPAC2 Inhibitors</span></div><div class="casAuthors">Wild, Christopher T.; Zhu, Yingmin; Na, Ye; Mei, Fang; Ynalvez, Marcus A.; Chen, Haiying; Cheng, Xiaodong; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">460-464</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N,N-Diphenylamines were discovered as potent and selective EPAC2 inhibitors.  A study was conducted to det. the structure-activity relationships in a series of inhibitors of which several compds. displayed submicromolar potencies.  Selectivity over the related EPAC1 protein was also demonstrated.  Computational modeling reveals an allosteric site that is distinct from the cAMP binding domain shared by both EPAC isoforms, providing a theory with regards to subtype selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7mW7XnsgOf7Vg90H21EOLACvtfcHk0lj5IT4QoNsHwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvFClsLk%253D&md5=8452ff014caf43ddb96b908b5ba2b3bf</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00477%26sid%3Dliteratum%253Aachs%26aulast%3DWild%26aufirst%3DC.%2BT.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DNa%26aufirst%3DY.%26aulast%3DMei%26aufirst%3DF.%26aulast%3DYnalvez%26aufirst%3DM.%2BA.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DFunctionalized%2520N%252CN-diphenylamines%2520as%2520potent%2520and%2520selective%2520EPAC2%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D460%26epage%3D464%26doi%3D10.1021%2Facsmedchemlett.5b00477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boulton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melacini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span> <span> </span><span class="NLM_article-title">Biochemical and pharmacological characterizations of ESI-09 based EPAC inhibitors: defining the ESI-09 “therapeutic window”</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">9344</span>, <span class="refDoi"> DOI: 10.1038/srep09344</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1038%2Fsrep09344" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=25791905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFKkurnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=9344&author=Y.+Zhuauthor=H.+Chenauthor=S.+Boultonauthor=F.+Meiauthor=N.+Yeauthor=G.+Melaciniauthor=J.+Zhouauthor=X.+Cheng&title=Biochemical+and+pharmacological+characterizations+of+ESI-09+based+EPAC+inhibitors%3A+defining+the+ESI-09+%E2%80%9Ctherapeutic+window%E2%80%9D&doi=10.1038%2Fsrep09344"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and Pharmacological Characterizations of ESI-09 Based EPAC Inhibitors: Defining the ESI-09 "Therapeutic Window"</span></div><div class="casAuthors">Zhu, Yingmin; Chen, Haijun; Boulton, Stephen; Mei, Fang; Ye, Na; Melacini, Giuseppe; Zhou, Jia; Cheng, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9344</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The cAMP signaling cascade is one of the most frequently targeted pathways for the development of pharmaceutics.  A plethora of recent genetic and pharmacol. studies suggest that exchange proteins directly activated by cAMP (EPACs) are implicated in multiple pathologies.  Selective EPAC inhibitors have been recently developed.  One specific inhibitor, ESI-09, has been shown to block EPAC activity and functions, as well as to recapitulate genetic phenotypes of EPAC knockout mice when applied in vivo.  However, a recent study raised concern that ESI-09 might act as a non-specific protein denaturant.  Herein, we present a detailed biochem. and pharmacol. characterization, as well as a structure-activity relationship (SAR) anal. of ESI-09.  Our studies show that ESI-09 dose-dependently inhibits activity of both EPAC1 and EPAC2 with apparent IC50 values well below the concns. shown to induce "protein denaturation".  Moreover, the ESI-09's action towards EPAC proteins is highly sensitive to minor modifications of the 3-chlorophenyl moiety.  Taken together, these results demonstrate that ESI-09 indeed acts as an EPAC specific antagonist and does not significantly destabilize/denature proteins at pharmacol. effective concns.  This conclusion is further supported by NMR data showing that ESI-09 induces residue-dependent chem. shift changes at low concns., while preserving well dispersed peaks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOTzhJMkgGxLVg90H21EOLACvtfcHk0lj5IT4QoNsHwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFKkurnF&md5=2890d652223a1f96411a11dd4d11ddc8</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fsrep09344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep09344%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DBoulton%26aufirst%3DS.%26aulast%3DMei%26aufirst%3DF.%26aulast%3DYe%26aufirst%3DN.%26aulast%3DMelacini%26aufirst%3DG.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DX.%26atitle%3DBiochemical%2520and%2520pharmacological%2520characterizations%2520of%2520ESI-09%2520based%2520EPAC%2520inhibitors%253A%2520defining%2520the%2520ESI-09%2520%25E2%2580%259Ctherapeutic%2520window%25E2%2580%259D%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D9344%26doi%3D10.1038%2Fsrep09344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wild, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship studies of substituted 2-(isoxazol-3-yl)-2-oxo-N′-phenyl-acetohydrazonoyl cyanide analogues: identification of potent exchange proteins directly activated by cAMP (EPAC) antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6033</span>– <span class="NLM_lpage">6047</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00635</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00635" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFejtb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6033-6047&author=N.+Yeauthor=Y.+Zhuauthor=H.+Chenauthor=Z.+Liuauthor=F.+C.+Meiauthor=C.+Wildauthor=H.+Chenauthor=X.+Chengauthor=J.+Zhou&title=Structure-activity+relationship+studies+of+substituted+2-%28isoxazol-3-yl%29-2-oxo-N%E2%80%B2-phenyl-acetohydrazonoyl+cyanide+analogues%3A+identification+of+potent+exchange+proteins+directly+activated+by+cAMP+%28EPAC%29+antagonists&doi=10.1021%2Facs.jmedchem.5b00635"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship Studies of Substituted 2-(Isoxazol-3-yl)-2-oxo-N'-phenyl-acetohydrazonoyl Cyanide Analogues: Identification of Potent Exchange Proteins Directly Activated by cAMP (EPAC) Antagonists</span></div><div class="casAuthors">Ye, Na; Zhu, Yingmin; Chen, Haijun; Liu, Zhiqing; Mei, Fang C.; Wild, Christopher; Chen, Haiying; Cheng, Xiaodong; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6033-6047</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Exchange proteins directly activated by cAMP (EPAC) as guanine nucleotide exchange factors mediate the effects of the pivotal second messenger cAMP, thereby regulating a wide variety of intracellular physiol. and pathophysiol. processes.  A series of novel 2-(isoxazol-3-yl)-2-oxo-N'-phenyl-acetohydrazonoyl cyanide EPAC antagonists was synthesized and evaluated in an effort to optimize properties of the previously identified high-throughput (HTS) hit 1 (I, ESI-09).  Structure-activity relationship (SAR) anal. led to the discovery of several more active EPAC antagonists [e.g., 22 (HJC0726), 35 (NY0123), and 47 (NY0173); II, III and IV, resp.] with low micromolar inhibitory activity.  These inhibitors may serve as valuable pharmacol. probes to facilitate our efforts in elucidating the biol. functions of EPAC and developing potential novel therapeutics against human diseases.  Our SAR results have also revealed that further modification at the 3-, 4-, and 5-positions of the Ph ring as well as the 5-position of the isoxazole moiety may allow for the development of more potent EPAC antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjca_eNfQUiLVg90H21EOLACvtfcHk0ljvD8lP2pT79w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFejtb7M&md5=a78aa852f1a4cc206a83fe5c72cdeca8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00635%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DN.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DMei%26aufirst%3DF.%2BC.%26aulast%3DWild%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DStructure-activity%2520relationship%2520studies%2520of%2520substituted%25202-%2528isoxazol-3-yl%2529-2-oxo-N%25E2%2580%25B2-phenyl-acetohydrazonoyl%2520cyanide%2520analogues%253A%2520identification%2520of%2520potent%2520exchange%2520proteins%2520directly%2520activated%2520by%2520cAMP%2520%2528EPAC%2529%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6033%26epage%3D6047%26doi%3D10.1021%2Facs.jmedchem.5b00635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsalkova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chepurny, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holz, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of small molecules as potent and specific EPAC2 antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">952</span>– <span class="NLM_lpage">962</span>, <span class="refDoi"> DOI: 10.1021/jm3014162</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3014162" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVartA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=952-962&author=H.+Chenauthor=T.+Tsalkovaauthor=O.+G.+Chepurnyauthor=F.+C.+Meiauthor=G.+G.+Holzauthor=X.+Chengauthor=J.+Zhou&title=Identification+and+characterization+of+small+molecules+as+potent+and+specific+EPAC2+antagonists&doi=10.1021%2Fjm3014162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Characterization of Small Molecules as Potent and Specific EPAC2 Antagonists</span></div><div class="casAuthors">Chen, Haijun; Tsalkova, Tamara; Chepurny, Oleg G.; Mei, Fang C.; Holz, George G.; Cheng, Xiaodong; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">952-962</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">EPAC1 and EPAC2, two isoforms of exchange proteins directly activated by cAMP (EPAC), respond to the second messenger cAMP and regulate a wide variety of intracellular processes under physiol. and pathophysiol. circumstances.  Herein, we report the chem. design, synthesis, and pharmacol. characterization of three different scaffolds (diarylsulfones, N,N-diarylamines, and arylsulfonamides) as highly potent and selective antagonists of EPAC2.  Several selective EPAC2 antagonists have been identified including 20i (HJC0350, I), which has an apparent IC50 of 0.3 μM for competing with 8-NBD-cAMP binding of EPAC2 and is about 133-fold more potent than cAMP.  Compds. 1 (ESI-05), 14c (HJC0338), and 20i, selected from each series, have exhibited no inhibition of EPAC1-mediated Rap1-GDP exchange activity at 25 μM, indicating that they are EPAC2-specific antagonists.  Moreover, live-cell imaging studies using EPAC1, EPAC2, or PKA FRET sensor also demonstrate that 20i functions as an EPAC2 specific antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrumM4DblVhxLVg90H21EOLACvtfcHk0ljvD8lP2pT79w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVartA%253D%253D&md5=5f100066fb30778ba2793a8543d4b89a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm3014162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3014162%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DTsalkova%26aufirst%3DT.%26aulast%3DChepurny%26aufirst%3DO.%2BG.%26aulast%3DMei%26aufirst%3DF.%2BC.%26aulast%3DHolz%26aufirst%3DG.%2BG.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520small%2520molecules%2520as%2520potent%2520and%2520specific%2520EPAC2%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D952%26epage%3D962%26doi%3D10.1021%2Fjm3014162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wild, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Efficient synthesis of ESI-09, a novel non-cyclic nucleotide EPAC antagonist</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1546</span>– <span class="NLM_lpage">1549</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2013.01.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2Fj.tetlet.2013.01.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=23459418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFSms7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=1546-1549&author=H.+Chenauthor=C.+Dingauthor=C.+Wildauthor=H.+Liuauthor=T.+Wangauthor=M.+A.+Whiteauthor=X.+Chengauthor=J.+Zhou&title=Efficient+synthesis+of+ESI-09%2C+a+novel+non-cyclic+nucleotide+EPAC+antagonist&doi=10.1016%2Fj.tetlet.2013.01.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient synthesis of ESI-09, a novel non-cyclic nucleotide EPAC antagonist</span></div><div class="casAuthors">Chen, Haijun; Ding, Chunyong; Wild, Christopher; Liu, Huiling; Wang, Tianzhi; White, Mark A.; Cheng, Xiaodong; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1546-1549</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A concise and efficient synthetic approach to producing a novel non-cyclic nucleotide EPAC antagonist ESI-09 I and its new analogs is reported.  Key features of the synthesis include a mild and reliable one-pot procedure for an isoxazole synthon, as well as a modified one-pot protocol for the cyanomethyl ketone key intermediate.  The synthesis requires inexpensive starting materials and only three linear steps for the completion in a total yield of 53%.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqanZAe4EAqgbVg90H21EOLACvtfcHk0ljvD8lP2pT79w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFSms7o%253D&md5=07ac251997639c928670452ce05f3fa5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2013.01.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2013.01.024%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DDing%26aufirst%3DC.%26aulast%3DWild%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DWhite%26aufirst%3DM.%2BA.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DEfficient%2520synthesis%2520of%2520ESI-09%252C%2520a%2520novel%2520non-cyclic%2520nucleotide%2520EPAC%2520antagonist%26jtitle%3DTetrahedron%2520Lett.%26date%3D2013%26volume%3D54%26spage%3D1546%26epage%3D1549%26doi%3D10.1016%2Fj.tetlet.2013.01.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsalkova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">5-Cyano-6-oxo-1,6-dihydro-pyrimidines as potent antagonists targeting exchange proteins directly activated by cAMP</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">4038</span>– <span class="NLM_lpage">4043</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.04.082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2Fj.bmcl.2012.04.082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=22607683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC38XntlWitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=4038-4043&author=H.+Chenauthor=T.+Tsalkovaauthor=F.+C.+Meiauthor=Y.+Huauthor=X.+Chengauthor=J.+Zhou&title=5-Cyano-6-oxo-1%2C6-dihydro-pyrimidines+as+potent+antagonists+targeting+exchange+proteins+directly+activated+by+cAMP&doi=10.1016%2Fj.bmcl.2012.04.082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">5-Cyano-6-oxo-1,6-dihydropyrimidines as potent antagonists targeting exchange proteins directly activated by cAMP</span></div><div class="casAuthors">Chen, Haijun; Tsalkova, Tamara; Mei, Fang C.; Hu, Yaohua; Cheng, Xiaodong; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4038-4043</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Exchange proteins directly activated by cAMP (Epac) are a family of guanine nucleotide exchange factors that regulate a wide variety of intracellular processes in response to second messenger cAMP.  To explore the structural determinants for Epac antagonist properties of high throughput screening hit ESI-08 [I, R1 = cyclohexyl, R2 = 2-Me], a series of 5-cyano-6-oxo-1,6-dihydropyrimidine analogs have been synthesized and evaluated for their activities for Epac inhibition.  Structure-activity relationship anal. led to the identification of three more potent Epac antagonists I [R1 = cyclohexyl, R2 = 3-Me; R1 = cyclopropyl, cyclopentyl, R2 = 2-Me].  These inhibitors may serve as valuable pharmacol. probes for further elucidation of the physiol. functions and mechanisms of Epac regulation.  The SAR results and mol. docking studies have also revealed that further optimization of the moieties at the C-6 position of pyrimidine scaffold may allow us to discover more potent Epac-specific antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDSgY2kI6j37Vg90H21EOLACvtfcHk0lhD9pRWmrgMBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntlWitLs%253D&md5=fca04e55dfa3e5ea2068a686594a2b21</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.04.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.04.082%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DTsalkova%26aufirst%3DT.%26aulast%3DMei%26aufirst%3DF.%2BC.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3D5-Cyano-6-oxo-1%252C6-dihydro-pyrimidines%2520as%2520potent%2520antagonists%2520targeting%2520exchange%2520proteins%2520directly%2520activated%2520by%2520cAMP%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D4038%26epage%3D4043%26doi%3D10.1016%2Fj.bmcl.2012.04.082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jash, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Husain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehrawat, S.</span></span> <span> </span><span class="NLM_article-title">Insights into exchange factor directly activated by cAMP (EPAC) as potential target for cancer treatment</span>. <i>Mol. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>447</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1007/s11010-018-3294-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1007%2Fs11010-018-3294-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=29417338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVKjtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=447&publication_year=2018&pages=77-92&author=N.+Kumarauthor=P.+Prasadauthor=E.+Jashauthor=M.+Sainiauthor=A.+Husainauthor=A.+Goldmanauthor=S.+Sehrawat&title=Insights+into+exchange+factor+directly+activated+by+cAMP+%28EPAC%29+as+potential+target+for+cancer+treatment&doi=10.1007%2Fs11010-018-3294-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into exchange factor directly activated by cAMP (EPAC) as potential target for cancer treatment</span></div><div class="casAuthors">Kumar, Naveen; Prasad, Peeyush; Jash, Eshna; Saini, Megha; Husain, Amjad; Goldman, Aaron; Sehrawat, Seema</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">447</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">77-92</span>CODEN:
                <span class="NLM_cas:coden">MCBIB8</span>;
        ISSN:<span class="NLM_cas:issn">0300-8177</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Cancer remains a global health problem and approx. 1.7 million new cancer cases are diagnosed every year worldwide.  Although diverse mols. are currently being explored as targets for cancer therapy the tumor treatment and therapy is highly tricky.  Secondary messengers are important for hormone-mediated signaling pathway.  CAMP (cAMP), a secondary messenger responsible for various physiol. processes regulates cell metab. by activating Protein kinase A (PKA) and by targeting exchange protein directly activated by cAMP (EPAC).  EPAC is present in two isoforms EPAC1 and EPAC2, which exhibit different tissue distribution and is involved in GDP/GTP exchange along with activating Rap1- and Rap2-mediated signaling pathways.  EPAC is also known for its dual role in cancer as pro- and anti-proliferative in addn. to metastasis.  Results after perturbing EPAC activity suggests its involvement in cancer cell migration, proliferation, and cytoskeleton remodeling which makes it a potential therapeutic target for cancer treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6OYVC-iV_EbVg90H21EOLACvtfcHk0lhD9pRWmrgMBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVKjtLc%253D&md5=7e4452e324d5dd9ab3b6ff26cba30f08</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs11010-018-3294-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11010-018-3294-z%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DN.%26aulast%3DPrasad%26aufirst%3DP.%26aulast%3DJash%26aufirst%3DE.%26aulast%3DSaini%26aufirst%3DM.%26aulast%3DHusain%26aufirst%3DA.%26aulast%3DGoldman%26aufirst%3DA.%26aulast%3DSehrawat%26aufirst%3DS.%26atitle%3DInsights%2520into%2520exchange%2520factor%2520directly%2520activated%2520by%2520cAMP%2520%2528EPAC%2529%2520as%2520potential%2520target%2520for%2520cancer%2520treatment%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2018%26volume%3D447%26spage%3D77%26epage%3D92%26doi%3D10.1007%2Fs11010-018-3294-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelite, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakamiya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ksiazek, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boor, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouyer, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popov, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span> <span> </span><span class="NLM_article-title">Exchange protein directly activated by cAMP plays a critical role in bacterial invasion during fatal rickettsioses</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">19615</span>– <span class="NLM_lpage">19620</span>, <span class="refDoi"> DOI: 10.1073/pnas.1314400110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1073%2Fpnas.1314400110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=24218580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFemurbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=19615-19620&author=B.+Gongauthor=T.+Sheliteauthor=F.+C.+Meiauthor=T.+Haauthor=Y.+Huauthor=G.+Xuauthor=Q.+Changauthor=M.+Wakamiyaauthor=T.+G.+Ksiazekauthor=P.+J.+Boorauthor=D.+H.+Bouyerauthor=V.+L.+Popovauthor=J.+Chenauthor=D.+H.+Walkerauthor=X.+Cheng&title=Exchange+protein+directly+activated+by+cAMP+plays+a+critical+role+in+bacterial+invasion+during+fatal+rickettsioses&doi=10.1073%2Fpnas.1314400110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Exchange protein directly activated by cAMP plays a critical role in bacterial invasion during fatal rickettsioses</span></div><div class="casAuthors">Gong, Bin; Shelite, Thomas; Mei, Fang C.; Ha, Tuha; Hu, Yaohua; Xu, Guang; Chang, Qing; Wakamiya, Maki; Ksiazek, Thomas G.; Boor, Paul J.; Bouyer, Donald H.; Popov, Vsevolod L.; Chen, Ju; Walker, David H.; Cheng, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">19615-19620,S19615/1-S19615/2</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Rickettsiae are responsible for some of the most devastating human infections.  A high infectivity and severe illness after inhalation make some rickettsiae bioterrorism threats.  We report that deletion of the exchange protein directly activated by cAMP (Epac) gene, Epac1, in mice protects them from an ordinarily LD of rickettsiae.  Inhibition of Epac1 suppresses bacterial adhesion and invasion.  Most importantly, pharmacol. inhibition of Epac1 in vivo using an Epac-specific small-mol. inhibitor, ESI-09, completely recapitulates the Epac1 knockout phenotype.  ESI-09 treatment dramatically decreases the morbidity and mortality assocd. with fatal spotted fever rickettsiosis.  Our results demonstrate that Epac1-mediated signaling represents a mechanism for host-pathogen interactions and that Epac1 is a potential target for the prevention and treatment of fatal rickettsioses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPljIAdEy6oLVg90H21EOLACvtfcHk0lhD9pRWmrgMBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFemurbE&md5=3e248192593f73aa2b2536787e1a6f09</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1314400110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1314400110%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DB.%26aulast%3DShelite%26aufirst%3DT.%26aulast%3DMei%26aufirst%3DF.%2BC.%26aulast%3DHa%26aufirst%3DT.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DChang%26aufirst%3DQ.%26aulast%3DWakamiya%26aufirst%3DM.%26aulast%3DKsiazek%26aufirst%3DT.%2BG.%26aulast%3DBoor%26aufirst%3DP.%2BJ.%26aulast%3DBouyer%26aufirst%3DD.%2BH.%26aulast%3DPopov%26aufirst%3DV.%2BL.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWalker%26aufirst%3DD.%2BH.%26aulast%3DCheng%26aufirst%3DX.%26atitle%3DExchange%2520protein%2520directly%2520activated%2520by%2520cAMP%2520plays%2520a%2520critical%2520role%2520in%2520bacterial%2520invasion%2520during%2520fatal%2520rickettsioses%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2013%26volume%3D110%26spage%3D19615%26epage%3D19620%26doi%3D10.1073%2Fpnas.1314400110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, E.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garofalo, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, X.</span></span> <span> </span><span class="NLM_article-title">Exchange proteins directly activated by cAMP and their roles in respiratory syncytial virus infection</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">e01200</span>– <span class="NLM_lpage">e01218</span>, <span class="refDoi"> DOI: 10.1128/jvi.01200-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1128%2FJVI.01200-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=30185593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvFemsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2018&pages=e01200-e01218&author=E.-J.+Choiauthor=Y.+Renauthor=Y.+Chenauthor=S.+Liuauthor=W.+Wuauthor=J.+Renauthor=P.+Wangauthor=R.+P.+Garofaloauthor=J.+Zhouauthor=X.+Bao&title=Exchange+proteins+directly+activated+by+cAMP+and+their+roles+in+respiratory+syncytial+virus+infection&doi=10.1128%2Fjvi.01200-18"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Exchange proteins directly activated by cAMP and their roles in respiratory syncytial virus infection</span></div><div class="casAuthors">Choi, Eun-Jin; Ren, Yuping; Chen, Yu; Liu, Shengxuan; Wu, Wenzhe; Ren, Junping; Wang, Pingyuan; Garofalo, Roberto P.; Zhou, Jia; Bao, Xiaoyong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">e01200-18/1-e01200-18/17</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">1098-5514</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Respiratory syncytial virus (RSV) is the leading cause of respiratory infection in young children and high-risk adults.  However, a specific treatment for this viral infection is not currently available.  In this study, we discovered that an exchange protein directly activated by cAMP (EPAC) can serve as a potential therapeutic target for RSV.  In both lower and upper epithelial cells, treatment with EPAC inhibitor (ESI-09), but not protein kinase A inhibitor (H89), significantly inhibits RSV replication and proinflammatory cytokine/chemokine induction.  In addn., RSV-activated transcriptional factors belonging to the NF-κB and IRF families are also suppressed by ESI-09.  Through isoform-specific gene knockdown, we found that EPAC2, but not EPAC1, plays a dominant role in controlling RSV replication and virus-induced host responses.  Expts. using both EPAC2 knockout and EPAC2-specific inhibitor support such roles of EPAC2.  Therefore, EPAC2 is a promising therapeutic target to regulate RSV replication and assocd. inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMrHTgdhc0orVg90H21EOLACvtfcHk0li6wWIVmswRoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvFemsbk%253D&md5=7566d42c9692310026ff73dcd2104505</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1128%2FJVI.01200-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01200-18%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DE.-J.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DGarofalo%26aufirst%3DR.%2BP.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DBao%26aufirst%3DX.%26atitle%3DExchange%2520proteins%2520directly%2520activated%2520by%2520cAMP%2520and%2520their%2520roles%2520in%2520respiratory%2520syncytial%2520virus%2520infection%26jtitle%3DJ.%2520Virol.%26date%3D2018%26volume%3D92%26spage%3De01200%26epage%3De01218%26doi%3D10.1128%2Fjvi.01200-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lao, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrikeev, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutz, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineley, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motamedi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hommel, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span> <span> </span><span class="NLM_article-title">Enhanced leptin sensitivity, reduced adiposity, and improved glucose homeostasis in mice lacking exchange protein directly activated by cyclic AMP isoform 1</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">918</span>– <span class="NLM_lpage">926</span>, <span class="refDoi"> DOI: 10.1128/mcb.01227-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1128%2FMCB.01227-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=23263987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltV2hsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=918-926&author=J.+Yanauthor=F.+C.+Meiauthor=H.+Chengauthor=D.+H.+Laoauthor=Y.+Huauthor=J.+Weiauthor=I.+Patrikeevauthor=D.+Haoauthor=S.+J.+Stutzauthor=K.+T.+Dineleyauthor=M.+Motamediauthor=J.+D.+Hommelauthor=K.+A.+Cunninghamauthor=J.+Chenauthor=X.+Cheng&title=Enhanced+leptin+sensitivity%2C+reduced+adiposity%2C+and+improved+glucose+homeostasis+in+mice+lacking+exchange+protein+directly+activated+by+cyclic+AMP+isoform+1&doi=10.1128%2Fmcb.01227-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced leptin sensitivity, reduced adiposity, and improved glucose homeostasis in mice lacking exchange protein directly activated by cyclic AMP isoform 1</span></div><div class="casAuthors">Yan, Jingbo; Mei, Fang C.; Cheng, Hongqiang; Lao, Dieu Hung; Hu, Yaohua; Wei, Jingna; Patrikeev, Igor; Hao, Dapeng; Stutz, Sonja J.; Dineley, Kelly T.; Motamedi, Massoud; Hommel, Jonathan D.; Cunningham, Kathryn A.; Chen, Ju; Cheng, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">918-926</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The prototypic second messenger cAMP (cAMP) is essential for controlling cellular metab., including glucose and lipid homeostasis.  In mammals, the majority of cAMP functions are mediated by cAMP-dependent protein kinase (PKA) and exchange proteins directly activated by cAMP (Epacs).  To explore the physiol. functions of Epac1, we generated Epac1 knockout mice.  Here we report that Epac1 null mutants have reduced white adipose tissue and reduced plasma leptin levels but display heightened leptin sensitivity.  Epac1-deficient mice are more resistant to high-fat diet-induced obesity, hyperleptinemia, and glucose intolerance.  Furthermore, pharmacol. inhibition of Epac by use of an Epac-specific inhibitor reduces plasma leptin levels in vivo and enhances leptin signaling in organotypic hypothalamic slices.  Taken together, our results demonstrate that Epac1 plays an important role in regulating adiposity and energy balance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLNMbsPjnHWrVg90H21EOLACvtfcHk0li6wWIVmswRoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltV2hsrY%253D&md5=14e0b6ce132544c477773ba6fb29f4eb</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1128%2FMCB.01227-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01227-12%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DMei%26aufirst%3DF.%2BC.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DLao%26aufirst%3DD.%2BH.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DPatrikeev%26aufirst%3DI.%26aulast%3DHao%26aufirst%3DD.%26aulast%3DStutz%26aufirst%3DS.%2BJ.%26aulast%3DDineley%26aufirst%3DK.%2BT.%26aulast%3DMotamedi%26aufirst%3DM.%26aulast%3DHommel%26aufirst%3DJ.%2BD.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DX.%26atitle%3DEnhanced%2520leptin%2520sensitivity%252C%2520reduced%2520adiposity%252C%2520and%2520improved%2520glucose%2520homeostasis%2520in%2520mice%2520lacking%2520exchange%2520protein%2520directly%2520activated%2520by%2520cyclic%2520AMP%2520isoform%25201%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2013%26volume%3D33%26spage%3D918%26epage%3D926%26doi%3D10.1128%2Fmcb.01227-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heijnen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Velthoven, C. T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willemen, H. L. D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sood, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vroon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eijkelkamp, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kavelaars, A.</span></span> <span> </span><span class="NLM_article-title">Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">5023</span>– <span class="NLM_lpage">5034</span>, <span class="refDoi"> DOI: 10.1172/jci66241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1172%2FJCI66241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=24231349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFSqtbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2013&pages=5023-5034&author=H.+Wangauthor=C.+J.+Heijnenauthor=C.+T.+J.+van+Velthovenauthor=H.+L.+D.+M.+Willemenauthor=Y.+Ishikawaauthor=X.+Zhangauthor=A.+K.+Soodauthor=A.+Vroonauthor=N.+Eijkelkampauthor=A.+Kavelaars&title=Balancing+GRK2+and+EPAC1+levels+prevents+and+relieves+chronic+pain&doi=10.1172%2Fjci66241"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain</span></div><div class="casAuthors">Wang, Huijing; Heijnen, Cobi J.; van Velthoven, Cindy T. J.; Willemen, Hanneke L. D. M.; Ishikawa, Yoshihiro; Zhang, Xinna; Sood, Anil K.; Vroon, Anne; Eijkelkamp, Niels; Kavelaars, Annemieke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5023-5034</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Chronic pain is a major clin. problem, yet the mechanisms underlying the transition from acute to chronic pain remain poorly understood.  In mice, reduced expression of GPCR kinase 2 (GRK2) in nociceptors promotes cAMP signaling to the guanine nucleotide exchange factor EPAC1 and prolongs the PGE2-induced increase in pain sensitivity (hyperalgesia).  Here we hypothesized that redn. of GRK2 or increased EPAC1 in dorsal root ganglion (DRG) neurons would promote the transition to chronic pain.  We used 2 mouse models of hyperalgesic priming in which the transition from acute to chronic PGE2-induced hyperalgesia occurs.  Hyperalgesic priming with carrageenan induced a sustained decrease in nociceptor GRK2, whereas priming with the PKCε agonist ΨεRACK increased DRG EPAC1.  When either GRK2 was increased in vivo by viral-based gene transfer or EPAC1 was decreased in vivo, as was the case for mice heterozygous for Epac1 or mice treated with Epac1 antisense oligodeoxynucleotides, chronic PGE2-induced hyperalgesia development was prevented in the 2 priming models.  Using the CFA model of chronic inflammatory pain, we found that increasing GRK2 or decreasing EPAC1 inhibited chronic hyperalgesia.  Our data suggest that therapies targeted at balancing nociceptor GRK2 and EPAC1 levels have promise for the prevention and treatment of chronic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6YyieKoSJGrVg90H21EOLACvtfcHk0lga-pisXAPQ5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFSqtbbL&md5=5945273ca2a1efe39d5360f26a6a64d0</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1172%2FJCI66241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI66241%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DHeijnen%26aufirst%3DC.%2BJ.%26aulast%3Dvan%2BVelthoven%26aufirst%3DC.%2BT.%2BJ.%26aulast%3DWillemen%26aufirst%3DH.%2BL.%2BD.%2BM.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DSood%26aufirst%3DA.%2BK.%26aulast%3DVroon%26aufirst%3DA.%26aulast%3DEijkelkamp%26aufirst%3DN.%26aulast%3DKavelaars%26aufirst%3DA.%26atitle%3DBalancing%2520GRK2%2520and%2520EPAC1%2520levels%2520prevents%2520and%2520relieves%2520chronic%2520pain%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2013%26volume%3D123%26spage%3D5023%26epage%3D5034%26doi%3D10.1172%2Fjci66241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, P. K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsim, K. W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">So, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, L. C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, S. K.</span></span> <span> </span><span class="NLM_article-title">Anxiety and depression with neurogenesis defects in exchange protein directly activated by cAMP 2-deficient mice are ameliorated by a selective serotonin reuptake inhibitor, Prozac</span>. <i>Transl. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e881</span>, <span class="refDoi"> DOI: 10.1038/tp.2016.129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1038%2Ftp.2016.129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=27598965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOht7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=e881&author=L.+Zhouauthor=S.+L.+Maauthor=P.+K.+K.+Yeungauthor=Y.+H.+Wongauthor=K.+W.+K.+Tsimauthor=K.+F.+Soauthor=L.+C.+W.+Lamauthor=S.+K.+Chung&title=Anxiety+and+depression+with+neurogenesis+defects+in+exchange+protein+directly+activated+by+cAMP+2-deficient+mice+are+ameliorated+by+a+selective+serotonin+reuptake+inhibitor%2C+Prozac&doi=10.1038%2Ftp.2016.129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Anxiety and depression with neurogenesis defects in exchange protein directly activated by cAMP 2-deficient mice are ameliorated by a selective serotonin reuptake inhibitor, Prozac</span></div><div class="casAuthors">Zhou, L.; Ma, S. L.; Yeung, P. K. K.; Wong, Y. H.; Tsim, K. W. K.; So, K. F.; Lam, L. C. W.; Chung, S. K.</div><div class="citationInfo"><span class="NLM_cas:title">Translational Psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e881</span>CODEN:
                <span class="NLM_cas:coden">TPRSCF</span>;
        ISSN:<span class="NLM_cas:issn">2158-3188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Intracellular cAMP and serotonin are important modulators of anxiety and depression.  Fluoxetine, a selective serotonin reuptake inhibitor (SSRI) also known as Prozac, is widely used against depression, potentially by activating cAMP response element-binding protein (CREB) and increasing brain-derived neurotrophic factor (BDNF) through protein kinase A (PKA).  However, the role of Epac1 and Epac2 (Rap guanine nucleotide exchange factors, RAPGEF3 and RAPGEF4, resp.) as potential downstream targets of SSRI/cAMP in mood regulations is not yet clear.  Here, we investigated the phenotypes of Epac1 (Epac1-/-) or Epac2 (Epac2-/-) knockout mice by comparing them with their wild-type counterparts.  Surprisingly, Epac2-/- mice exhibited a wide range of mood disorders, including anxiety and depression with learning and memory deficits in contextual and cued fear-conditioning tests without affecting Epac1 expression or PKA activity.  Interestingly, rs17746510, one of the three single-nucleotide polymorphisms (SNPs) in RAPGEF4 assocd. with cognitive decline in Chinese Alzheimer's disease (AD) patients, was significantly correlated with apathy and mood disturbance, whereas no significant assocn. was obsd. between RAPGEF3 SNPs and the risk of AD or neuropsychiatric inventory scores.  To further det. the detailed role of Epac2 in SSRI/serotonin/cAMP-involved mood disorders, we treated Epac2-/- mice with a SSRI, Prozac.  The alteration in open field behavior and impaired hippocampal cell proliferation in Epac2-/- mice were alleviated by Prozac.  Taken together, Epac2 gene polymorphism is a putative risk factor for mood disorders in AD patients in part by affecting the hippocampal neurogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR4XSTp0T6-bVg90H21EOLACvtfcHk0lga-pisXAPQ5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOht7jO&md5=2a9e4565d993f4cf617b66db8e2417bb</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Ftp.2016.129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Ftp.2016.129%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DMa%26aufirst%3DS.%2BL.%26aulast%3DYeung%26aufirst%3DP.%2BK.%2BK.%26aulast%3DWong%26aufirst%3DY.%2BH.%26aulast%3DTsim%26aufirst%3DK.%2BW.%2BK.%26aulast%3DSo%26aufirst%3DK.%2BF.%26aulast%3DLam%26aufirst%3DL.%2BC.%2BW.%26aulast%3DChung%26aufirst%3DS.%2BK.%26atitle%3DAnxiety%2520and%2520depression%2520with%2520neurogenesis%2520defects%2520in%2520exchange%2520protein%2520directly%2520activated%2520by%2520cAMP%25202-deficient%2520mice%2520are%2520ameliorated%2520by%2520a%2520selective%2520serotonin%2520reuptake%2520inhibitor%252C%2520Prozac%26jtitle%3DTransl.%2520Psychiatry%26date%3D2016%26volume%3D6%26spage%3De881%26doi%3D10.1038%2Ftp.2016.129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinle, J. J.</span></span> <span> </span><span class="NLM_article-title">Epac1 and glycyrrhizin both inhibit HMGB1 levels to reduce diabetes-induced neuronal and vascular damage in the mouse retina</span>. <i>J. Clin. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">772</span>, <span class="refDoi"> DOI: 10.3390/jcm8060772</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.3390%2Fjcm8060772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjslGntL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=772&author=L.+Liuauthor=Y.+Jiangauthor=J.+J.+Steinle&title=Epac1+and+glycyrrhizin+both+inhibit+HMGB1+levels+to+reduce+diabetes-induced+neuronal+and+vascular+damage+in+the+mouse+retina&doi=10.3390%2Fjcm8060772"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Epac1 and glycyrrhizin both inhibit HMGB1 levels to reduce diabetes-induced neuronal and vascular damage in the mouse retina</span></div><div class="casAuthors">Liu, Li; Jiang, Youde; Steinle, Jena J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">772</span>CODEN:
                <span class="NLM_cas:coden">JCMOHK</span>;
        ISSN:<span class="NLM_cas:issn">2077-0383</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The role of high mobility group box 1 (HMGB1) in acute diabetic retinal damage has been demonstrated.  We recently reported that glycyrrhizin, a HMGB1 inhibitor, protected the diabetic retina against neuronal, vascular, and permeability changes.  In this study, we wanted to investigate the role of exchange protein for cAMP 1 (Epac1) on HMGB1 and the actions of glycyrrhizin.  Using endothelial cell specific knockout mice for Epac1, we made some mice diabetic using streptozotocin, and treated some with glycyrrhizin for up to 6 mo.  We measured permeability, neuronal, and vascular changes in the Epac1 floxed and knockout mice.  We also investigated whether Epac1 and glycyrrhizin work synergistically to reduce the retinal inflammatory mediators, tumor necrosis factor alpha (TNFα) and interleukin-1-beta (IL1β), as well as sirtuin 1 (SIRT1) levels.  Epac1 and glycyrrhizin reduced inflammatory mediators with synergistic actions.  Glycyrrhizin also increased SIRT1 levels in the Epac1 mice.  Overall, these studies demonstrate that glycyrrhizin and Epac1 can work together to protect the retina.  Finally, glycyrrhizin may regulate HMGB1 through increased SIRT1 actions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMmb-6C3qNprVg90H21EOLACvtfcHk0lga-pisXAPQ5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjslGntL0%253D&md5=69a8f9c59e1a8c9f17d417a097ca34bf</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.3390%2Fjcm8060772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fjcm8060772%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DSteinle%26aufirst%3DJ.%2BJ.%26atitle%3DEpac1%2520and%2520glycyrrhizin%2520both%2520inhibit%2520HMGB1%2520levels%2520to%2520reduce%2520diabetes-induced%2520neuronal%2520and%2520vascular%2520damage%2520in%2520the%2520mouse%2520retina%26jtitle%3DJ.%2520Clin.%2520Med.%26date%3D2019%26volume%3D8%26spage%3D772%26doi%3D10.3390%2Fjcm8060772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selheim, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Rooij, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dremier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwede, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dao, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maenhaut, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bos, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genieser, H.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Døskeland, S. O.</span></span> <span> </span><span class="NLM_article-title">cAMP Analog Mapping of Epac1 and cAMP Kinase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">35394</span>– <span class="NLM_lpage">35402</span>, <span class="refDoi"> DOI: 10.1074/jbc.m302179200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1074%2Fjbc.M302179200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=12819211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVWqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=35394-35402&author=A.+E.+Christensenauthor=F.+Selheimauthor=J.+de+Rooijauthor=S.+Dremierauthor=F.+Schwedeauthor=K.+K.+Daoauthor=A.+Martinezauthor=C.+Maenhautauthor=J.+L.+Bosauthor=H.-G.+Genieserauthor=S.+O.+D%C3%B8skeland&title=cAMP+Analog+Mapping+of+Epac1+and+cAMP+Kinase&doi=10.1074%2Fjbc.m302179200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">cAMP analog mapping of Epac1 and cAMP kinase: discriminating analogs demonstrate that Epac and camp kinase act synergistically to promote PC-12 cell neurite extension</span></div><div class="casAuthors">Christensen, Anne E.; Selheim, Frode; de Rooij, Johan; Dremier, Sarah; Schwede, Frank; Dao, Khanh K.; Martinez, Aurora; Maenhaut, Carine; Bos, Johannes L.; Genieser, H.-G.; Doskeland, Stein O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">35394-35402</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Little is known about the relative role of cAMP-dependent protein kinase (cAPK) and guanine exchange factor directly activated by cAMP (Epac) as mediators of cAMP action.  The authors tested cAMP analogs for ability to selectively activate Epac1 or cAPK and discriminate between the binding sites of Epac and of cAPKI and cAPKII.  The authors found that commonly used cAMP analogs, like 8-Br-cAMP and 8-pCPT-cAMP, activate Epac and cAPK equally as well as cAMP, i.e., were full agonists.  In contrast, 6-modified cAMP analogs, like N6-benzoyl-cAMP, were inefficient Epac activators and full cAPK activators.  Analogs modified in the 2'-position of the ribose induced stronger Epac1 activation than cAMP but were only partial agonists for cAPK.  2'-O-Alkyl substitution of cAMP improved Epac/cAPK binding selectivity 10-100-fold.  Phenylthio substituents in position 8, particularly with MeO- or Cl- in p-position, enhanced the Epac/cAPK selectivity even more.  The combination of 8-pCPT- and 2'-O-Me substitutions improved the Epac/cAPK binding selectivity about three orders of magnitude.  The cAPK selectivity of 6-substituted cAMP analogs, the preferential inhibition of cAPK by moderate concns. of Rp-cAMPS analogs, and the Epac selectivity of 8-pCPT-2'-O-methyl-cAMP was also demonstrated in intact cells.  Using these compds. to selectively modulate Epac and cAPK in PC-12 cells, the authors obsd. that analogs selectively activating Epac synergized strongly with cAPK specific analogs to induce neurite outgrowth.  The authors therefore conclude that cAMP-induced neurite outgrowth is mediated by both Epac and cAPK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHPaVWQFVD0LVg90H21EOLACvtfcHk0ljdMVDeDOV0Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVWqu7s%253D&md5=faa0d4654ad4b49892fd373ba1543aa4</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M302179200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M302179200%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DA.%2BE.%26aulast%3DSelheim%26aufirst%3DF.%26aulast%3Dde%2BRooij%26aufirst%3DJ.%26aulast%3DDremier%26aufirst%3DS.%26aulast%3DSchwede%26aufirst%3DF.%26aulast%3DDao%26aufirst%3DK.%2BK.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DMaenhaut%26aufirst%3DC.%26aulast%3DBos%26aufirst%3DJ.%2BL.%26aulast%3DGenieser%26aufirst%3DH.-G.%26aulast%3DD%25C3%25B8skeland%26aufirst%3DS.%2BO.%26atitle%3DcAMP%2520Analog%2520Mapping%2520of%2520Epac1%2520and%2520cAMP%2520Kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D35394%26epage%3D35402%26doi%3D10.1074%2Fjbc.m302179200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kiermayer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biondi, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plotz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haupenthal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeuzem, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piiper, A.</span></span> <span> </span><span class="NLM_article-title">Epac activation converts cAMP from a proliferative into a differentiation signal in PC12 cells</span>. <i>Mol. Biol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">5639</span>– <span class="NLM_lpage">5648</span>, <span class="refDoi"> DOI: 10.1091/mbc.e05-05-0432</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1091%2Fmbc.e05-05-0432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=16207818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht12gsLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=5639-5648&author=S.+Kiermayerauthor=R.+M.+Biondiauthor=J.+Imigauthor=G.+Plotzauthor=J.+Haupenthalauthor=S.+Zeuzemauthor=A.+Piiper&title=Epac+activation+converts+cAMP+from+a+proliferative+into+a+differentiation+signal+in+PC12+cells&doi=10.1091%2Fmbc.e05-05-0432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Epac activation converts cAMP from a proliferative into a differentiation signal in PC12 cells</span></div><div class="casAuthors">Kiermayer, Simone; Biondi, Ricardo M.; Imig, Jochen; Plotz, Guido; Haupenthal, Joerg; Zeuzem, Stefan; Piiper, Albrecht</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5639-5648</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1059-1524</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">Elevation of the intracellular cAMP concn. ([cAMP]i) regulates metab., cell proliferation, and differentiation and plays roles in memory formation and neoplastic growth.  CAMP mediates its effects mainly through activation of protein kinase A (PKA) as well as Epac1 and Epac2, exchange factors activating the small GTPases Rap1 and Rap2.  However, how cAMP utilizes these effectors to induce distinct biol. responses is unknown.  We here studied the specific roles of PKA and Epac in neuroendocrine PC12 cells.  In these cells, elevation of [cAMP]i activates extracellular signal-regulated kinase (ERK) 1/2 and induces low-degree neurite outgrowth.  The present study showed that specific stimulation of PKA triggered ERK1/2 activation that was considerably more transient than that obsd. upon simultaneous activation of both PKA and Epac.  Unexpectedly, the PKA-specific cAMP analog induced cell proliferation rather than neurite outgrowth.  The proliferative signaling pathway activated by the PKA-specific cAMP analog involved activation of the epidermal growth factor receptor and ERK1/2.  Activation of Epac appeared to extend the duration of PKA-dependent ERK1/2 activation and converted cAMP from a proliferative into an anti-proliferative, neurite outgrowth-promoting signal.  Thus, the present study showed that the outcome of cAMP signaling can depend heavily on the set of cAMP effectors activated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9sMlx_okjoLVg90H21EOLACvtfcHk0ljdMVDeDOV0Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht12gsLnL&md5=197efc52d627e9dae346c719836535b2</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1091%2Fmbc.e05-05-0432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.e05-05-0432%26sid%3Dliteratum%253Aachs%26aulast%3DKiermayer%26aufirst%3DS.%26aulast%3DBiondi%26aufirst%3DR.%2BM.%26aulast%3DImig%26aufirst%3DJ.%26aulast%3DPlotz%26aufirst%3DG.%26aulast%3DHaupenthal%26aufirst%3DJ.%26aulast%3DZeuzem%26aufirst%3DS.%26aulast%3DPiiper%26aufirst%3DA.%26atitle%3DEpac%2520activation%2520converts%2520cAMP%2520from%2520a%2520proliferative%2520into%2520a%2520differentiation%2520signal%2520in%2520PC12%2520cells%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2005%26volume%3D16%26spage%3D5639%26epage%3D5648%26doi%3D10.1091%2Fmbc.e05-05-0432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emery, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiden, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiden, L. E.</span></span> <span> </span><span class="NLM_article-title">Separate cyclic AMP sensors for neuritogenesis, growth arrest, and survival of neuroendocrine cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">10126</span>– <span class="NLM_lpage">10139</span>, <span class="refDoi"> DOI: 10.1074/jbc.m113.529321</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1074%2Fjbc.M113.529321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=24567337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1ajtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=10126-10139&author=A.+C.+Emeryauthor=M.+V.+Eidenauthor=L.+E.+Eiden&title=Separate+cyclic+AMP+sensors+for+neuritogenesis%2C+growth+arrest%2C+and+survival+of+neuroendocrine+cells&doi=10.1074%2Fjbc.m113.529321"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Separate Cyclic AMP Sensors for Neuritogenesis, Growth Arrest, and Survival of Neuroendocrine Cells</span></div><div class="casAuthors">Emery, Andrew C.; Eiden, Maribeth V.; Eiden, Lee E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">10126-10139</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Dividing neuroendocrine cells differentiate into a neuronal-like phenotype in response to ligands activating G protein-coupled receptors, leading to the elevation of the second messenger cAMP.  Growth factors that act at receptor tyrosine kinases, such as nerve growth factor, also cause differentiation.  We report here that two aspects of cAMP-induced differentiation, neurite extension and growth arrest, are dissociable at the level of the sensors conveying the cAMP signal in PC12 and NS-1 cells.  Following cAMP elevation, neuritogenic cAMP sensor/Rapgef2 is activated for signaling to ERK to mediate neuritogenesis, whereas Epac2 is activated for signaling to the MAP kinase p38 to mediate growth arrest.  Neither action of cAMP requires transactivation of TrkA, the receptor for NGF.  In fact, the differentiating effects of NGF do not require activation of any of the cAMP sensors protein kinase A, Epac, or neuritogenic cAMP sensor/Rapgef2 but, rather, depend on ERK and p38 activation via completely independent signaling pathways.  Hence, cAMP- and NGF-dependent signaling for differentiation are also completely insulated from each other.  CAMP and NGF also protect NS-1 cells from serum withdrawal-induced cell death, again by two wholly sep. signaling mechanisms, PKA-dependent for cAMP and PKA-independent for NGF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa0ljabRDxHbVg90H21EOLACvtfcHk0ljdMVDeDOV0Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1ajtrg%253D&md5=be4c801691d66374fc0c44b9af510b30</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.529321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.529321%26sid%3Dliteratum%253Aachs%26aulast%3DEmery%26aufirst%3DA.%2BC.%26aulast%3DEiden%26aufirst%3DM.%2BV.%26aulast%3DEiden%26aufirst%3DL.%2BE.%26atitle%3DSeparate%2520cyclic%2520AMP%2520sensors%2520for%2520neuritogenesis%252C%2520growth%2520arrest%252C%2520and%2520survival%2520of%2520neuroendocrine%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D10126%26epage%3D10139%26doi%3D10.1074%2Fjbc.m113.529321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petralia, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span> <span> </span><span class="NLM_article-title">EPAC null mutation impairs learning and social interactions via aberrant regulation of miR-124 and Zif268 translation</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">774</span>– <span class="NLM_lpage">788</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2012.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2Fj.neuron.2012.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=22365550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtV2ktLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2012&pages=774-788&author=Y.+Yangauthor=X.+Shuauthor=D.+Liuauthor=Y.+Shangauthor=Y.+Wuauthor=L.+Peiauthor=X.+Xuauthor=Q.+Tianauthor=J.+Zhangauthor=K.+Qianauthor=Y.-X.+Wangauthor=R.+S.+Petraliaauthor=W.+Tuauthor=L.-Q.+Zhuauthor=J.-Z.+Wangauthor=Y.+Lu&title=EPAC+null+mutation+impairs+learning+and+social+interactions+via+aberrant+regulation+of+miR-124+and+Zif268+translation&doi=10.1016%2Fj.neuron.2012.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">EPAC Null Mutation Impairs Learning and Social Interactions via Aberrant Regulation of miR-124 and Zif268 Translation</span></div><div class="casAuthors">Yang, Ying; Shu, Xiaogang; Liu, Dan; Shang, You; Wu, Yan; Pei, Lei; Xu, Xin; Tian, Qing; Zhang, Jian; Qian, Kun; Wang, Ya-Xian; Petralia, Ronald S.; Tu, Weihong; Zhu, Ling-Qiang; Wang, Jian-Zhi; Lu, Youming</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">774-788</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">EPAC proteins are the guanine nucleotide exchange factors that act as the intracellular receptors for cAMP.  Two variants of EPAC genes including EPAC1 and EPAC2 are cloned and are widely expressed throughout the brain.  But, their functions in the brain remain unknown.  Here, we genetically delete EPAC1 (EPAC1-/-), EPAC2 (EPAC2-/-), or both EPAC1 and EPAC2 genes (EPAC-/-) in the forebrain of mice.  We show that EPAC null mutation impairs long-term potentiation (LTP) and that this impairment is paralleled with the severe deficits in spatial learning and social interactions and is mediated in a direct manner by miR-124 transcription and Zif268 translation.  Knockdown of miR-124 restores Zif268 and hence reverses all aspects of the EPAC-/- phenotypes, whereas expression of miR-124 or knockdown of Zif268 reproduces the effects of EPAC null mutation.  Thus, EPAC proteins control miR-124 transcription in the brain for processing spatial learning and social interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS3xT7TZPA37Vg90H21EOLACvtfcHk0lhWu2bK-ZIKWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtV2ktLw%253D&md5=03fd3bd2a6401a5f3c6e36916d9b3a4b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2012.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2012.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DShu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DShang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DPei%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DTian%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DY.-X.%26aulast%3DPetralia%26aufirst%3DR.%2BS.%26aulast%3DTu%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DL.-Q.%26aulast%3DWang%26aufirst%3DJ.-Z.%26aulast%3DLu%26aufirst%3DY.%26atitle%3DEPAC%2520null%2520mutation%2520impairs%2520learning%2520and%2520social%2520interactions%2520via%2520aberrant%2520regulation%2520of%2520miR-124%2520and%2520Zif268%2520translation%26jtitle%3DNeuron%26date%3D2012%26volume%3D73%26spage%3D774%26epage%3D788%26doi%3D10.1016%2Fj.neuron.2012.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yarwood, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borland, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sands, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, T. M.</span></span> <span> </span><span class="NLM_article-title">Identification of CCAAT/enhancer-binding proteins as exchange protein activated by cAMP-activated transcription factors that mediate the induction of the SOCS-3 gene</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">6843</span>– <span class="NLM_lpage">6853</span>, <span class="refDoi"> DOI: 10.1074/jbc.m710342200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1074%2Fjbc.M710342200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=18195020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivFyjtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=6843-6853&author=S.+J.+Yarwoodauthor=G.+Borlandauthor=W.+A.+Sandsauthor=T.+M.+Palmer&title=Identification+of+CCAAT%2Fenhancer-binding+proteins+as+exchange+protein+activated+by+cAMP-activated+transcription+factors+that+mediate+the+induction+of+the+SOCS-3+gene&doi=10.1074%2Fjbc.m710342200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of CCAAT/Enhancer-binding Proteins as Exchange Protein Activated by cAMP-activated Transcription Factors That Mediate the Induction of the SOCS-3 Gene</span></div><div class="casAuthors">Yarwood, Stephen J.; Borland, Gillian; Sands, William A.; Palmer, Timothy M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6843-6853</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The prototypical second messenger cAMP is a key regulator of immune and inflammatory responses.  Its ability to inhibit interleukin (IL)-6 responses is due to induction of suppressor of cytokine signaling-3 (SOCS-3), a neg. regulator of IL-6 receptor signaling.  We have detd. previously that SOCS-3 induction by cAMP occurs independently of cAMP-dependent protein kinase, instead requiring the recently identified cAMP sensor exchange protein activated by cAMP 1 (EPAC1).  Here we present evidence to suggest that the C/EBP family of transcription factors link EPAC1 activation to SOCS-3 induction.  Firstly, selective activation of EPAC in human umbilical vein endothelial cells increased C/EBP DNA binding activity and recruitment of C/EBPβ to the SOCS-3 promoter.  Secondly, knockdown of C/EBPβ and -δ isoforms abolished both SOCS-3 induction and inhibition of IL-6 signaling in response to cAMP.  Thirdly, overexpression of C/EBPα, -β, or -δ potentiated EPAC-mediated accumulation of SOCS-3.  Finally, these effects were not restricted to human umbilical vein endothelial cells, because similar phenomena were obsd. in murine embryonic fibroblasts in which C/EBPβ or δ had been deleted.  In summary, our findings constitute the first description of an EPAC-C/EBP pathway that can control cAMP-mediated changes in gene expression independently of protein kinase A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp938IwfsNVkLVg90H21EOLACvtfcHk0lhWu2bK-ZIKWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivFyjtrk%253D&md5=1afd4aaeea00999b360628a06e16bf54</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M710342200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M710342200%26sid%3Dliteratum%253Aachs%26aulast%3DYarwood%26aufirst%3DS.%2BJ.%26aulast%3DBorland%26aufirst%3DG.%26aulast%3DSands%26aufirst%3DW.%2BA.%26aulast%3DPalmer%26aufirst%3DT.%2BM.%26atitle%3DIdentification%2520of%2520CCAAT%252Fenhancer-binding%2520proteins%2520as%2520exchange%2520protein%2520activated%2520by%2520cAMP-activated%2520transcription%2520factors%2520that%2520mediate%2520the%2520induction%2520of%2520the%2520SOCS-3%2520gene%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D6843%26epage%3D6853%26doi%3D10.1074%2Fjbc.m710342200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parnell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terrin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaccolo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarwood, S. J.</span></span> <span> </span><span class="NLM_article-title">Regulation of the inflammatory response of vascular endothelial cells by EPAC1</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>166</i></span>,  <span class="NLM_fpage">434</span>– <span class="NLM_lpage">446</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2011.01808.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1111%2Fj.1476-5381.2011.01808.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=22145651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVaqtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2012&pages=434-446&author=E.+Parnellauthor=B.+O.+Smithauthor=T.+M.+Palmerauthor=A.+Terrinauthor=M.+Zaccoloauthor=S.+J.+Yarwood&title=Regulation+of+the+inflammatory+response+of+vascular+endothelial+cells+by+EPAC1&doi=10.1111%2Fj.1476-5381.2011.01808.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of the inflammatory response of vascular endothelial cells by EPAC1</span></div><div class="casAuthors">Parnell, Euan; Smith, Brian O.; Palmer, Timothy M.; Terrin, Anna; Zaccolo, Manuela; Yarwood, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">434-446</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Life-threatening diseases of the cardiovascular system, like atherosclerosis, are exacerbated by unwanted inflammation within the structures of large blood vessels.  This inflammation involves increased permeability of the vascular endothelial cells (VECs) that form the lining of blood vessels, leading to exaggerated extravasation of blood components and accumulation of fluid in the extravascular space.  This results in tissue dysfunction and increased secretion of chemokines that attract leukocytes and monocytes to the inflamed endothelium.  CAMP is synthesized in VECs in response to endogenous Gs-coupled receptors and is known to limit cytokine action and reduce endothelial hyperpermeability induced by multiple pro-inflammatory stimuli.  The mechanisms underlying this anti-inflammatory action of cAMP are now being elucidated and it is becoming clear that the cAMP sensor, exchange protein activated by cAMP (EPAC1), appears to play a key role in suppressing unwanted inflammation.  EPAC1 mediates at least three anti-inflammatory pathways in VECs by down-regulating inflammatory signalling through the induction of the suppressors of cytokine signalling 3 (SOCS-3) gene, limiting integrin-dependent vascular permeability and enhancing endothelial barrier function through the stabilization of VE-cadherin junctions.  Given that manipulation of cellular cAMP levels currently forms the basis of many effective pharmaceuticals and that EPAC1 is involved in multiple anti-inflammatory protective processes in VECs, does this make EPAC1 an attractive target for the development of activators capable of eliciting a coordinated program of "protection" against the development of endothelial dysfunction.  Here we discuss whether EPAC1 represents an attractive therapeutic target for limiting endothelial dysfunction assocd. with cardiovascular diseases like atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn3b9FSN5J0bVg90H21EOLACvtfcHk0lhWu2bK-ZIKWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVaqtL8%253D&md5=dd51d27c2c5ff3f0e7316b1d7fcb2df6</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01808.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01808.x%26sid%3Dliteratum%253Aachs%26aulast%3DParnell%26aufirst%3DE.%26aulast%3DSmith%26aufirst%3DB.%2BO.%26aulast%3DPalmer%26aufirst%3DT.%2BM.%26aulast%3DTerrin%26aufirst%3DA.%26aulast%3DZaccolo%26aufirst%3DM.%26aulast%3DYarwood%26aufirst%3DS.%2BJ.%26atitle%3DRegulation%2520of%2520the%2520inflammatory%2520response%2520of%2520vascular%2520endothelial%2520cells%2520by%2520EPAC1%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D166%26spage%3D434%26epage%3D446%26doi%3D10.1111%2Fj.1476-5381.2011.01808.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borland, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarwood, S. J.</span></span> <span> </span><span class="NLM_article-title">EPAC proteins transduce diverse cellular actions of cAMP</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>158</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2008.00087.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1111%2Fj.1476-5381.2008.00087.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=19210747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVKmu7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2009&pages=70-86&author=G.+Borlandauthor=B.+O.+Smithauthor=S.+J.+Yarwood&title=EPAC+proteins+transduce+diverse+cellular+actions+of+cAMP&doi=10.1111%2Fj.1476-5381.2008.00087.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">EPAC Proteins Transduce Diverse Cellular Actions of cAMP</span></div><div class="casAuthors">Borland, Gillian; Smith, Brian O.; Yarwood, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">70-86</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  It has now been over 10 years since efforts to completely understand the signaling actions of cAMP (3'-5'-cAMP) led to the discovery of exchange protein directly activated by cAMP (EPAC) proteins.  In the current review the authors will highlight important advances in the understanding of EPAC structure and function and demonstrate that EPAC proteins mediate multiple actions of cAMP in cells, revealing future targets for pharmaceutical intervention.  It has been known for some time that drugs that elevate intracellular cAMP levels have proven therapeutic benefit for diseases ranging from depression to inflammation.  The challenge now is to det. which of these pos. actions of cAMP involve activation of EPAC-regulated signal transduction pathways.  EPACs are specific guanine nucleotide exchange factors for the Ras GTPase homologs, Rap1 and Rap2, which they activate independently of the classical routes for cAMP signaling, cyclic nucleotide-gated ion channels and protein kinase A.  Rather, EPAC activation is triggered by internal conformational changes induced by direct interaction with cAMP.  Leading from this has been the development of EPAC-specific agonists, which has helped to delineate numerous cellular actions of cAMP that rely on subsequent activation of EPAC.  These include regulation of exocytosis and the control of cell adhesion, growth, division and differentiation.  Recent work also implicates EPAC in the regulation of anti-inflammatory signaling in the vascular endothelium, namely neg. regulation of pro-inflammatory cytokine signaling and pos. support of barrier function.  Further elucidation of these important signaling mechanisms will no doubt support the development of the next generation of anti-inflammatory drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmHu5l02mb9LVg90H21EOLACvtfcHk0lh8Q2uFt1zjbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVKmu7bO&md5=0a73b19e1ba4ce3d7adbe130b26f99ff</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2008.00087.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2008.00087.x%26sid%3Dliteratum%253Aachs%26aulast%3DBorland%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DB.%2BO.%26aulast%3DYarwood%26aufirst%3DS.%2BJ.%26atitle%3DEPAC%2520proteins%2520transduce%2520diverse%2520cellular%2520actions%2520of%2520cAMP%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D158%26spage%3D70%26epage%3D86%26doi%3D10.1111%2Fj.1476-5381.2008.00087.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtiss, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinle, J. J.</span></span> <span> </span><span class="NLM_article-title">Epac1 blocks NLRP3 inflammasome to reduce IL-1beta in retinal endothelial cells and mouse retinal vasculature</span>. <i>Mediators Inflammation</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2017</i></span>,  <span class="NLM_fpage">2860956</span>, <span class="refDoi"> DOI: 10.1155/2017/2860956</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1155%2F2017%2F2860956" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=28348460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A280%3ADC%252BC1cvhslektw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2017&publication_year=2017&pages=2860956&author=Y.+Jiangauthor=L.+Liuauthor=E.+Curtissauthor=J.+J.+Steinle&title=Epac1+blocks+NLRP3+inflammasome+to+reduce+IL-1beta+in+retinal+endothelial+cells+and+mouse+retinal+vasculature&doi=10.1155%2F2017%2F2860956"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Epac1 Blocks NLRP3 Inflammasome to Reduce IL-1β in Retinal Endothelial Cells and Mouse Retinal Vasculature</span></div><div class="casAuthors">Jiang Youde; Liu Li; Curtiss Elizabeth; Steinle Jena J</div><div class="citationInfo"><span class="NLM_cas:title">Mediators of inflammation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2017</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2860956</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inflammation is an important component of diabetic retinal damage.  We previously reported that a novel β-adrenergic receptor agonist, Compound 49b, reduced Toll-like receptor 4 (TLR4) signaling in retinal endothelial cells (REC) grown in high glucose.  Others reported that TLR4 activates high-mobility group box 1 (HMGB1), which has been associated with the NOD-like receptor 3 (NLRP3) inflammasome.  Thus, we hypothesized that Epac1, a downstream mediator of β-adrenergic receptors, would block TLR4/HMGB1-mediated stimulation of the NLRP3 inflammasome, leading to reduced cleavage of caspase-1 and interleukin-1 beta (IL-1β).  We generated vascular specific conditional knockout mice for Epac1 and used REC grown in normal and high glucose treated with an Epac1 agonist and/or NLRP3 siRNA.  Protein analyses were done for Epac1, TLR4, HMGB1, NLRP3, cleaved caspase-1, and IL-1β.  Loss of Epac1 in the mouse retinal vasculature significantly increased all of the inflammatory proteins.  Epac1 effectively reduced high glucose-induced increases in TLR4, HMGB1, cleaved caspase-1, and IL-1β in REC.  Taken together, the data suggest that Epac1 reduces formation of the NLRP3 inflammasome to reduce inflammatory responses in the retinal vasculature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSGbu2tbuDrRXthwrmtH4OBfW6udTcc2eZERNgKEqvvYbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cvhslektw%253D%253D&md5=fe24bf440d24895bf2367e48949a1b42</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1155%2F2017%2F2860956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2017%252F2860956%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DCurtiss%26aufirst%3DE.%26aulast%3DSteinle%26aufirst%3DJ.%2BJ.%26atitle%3DEpac1%2520blocks%2520NLRP3%2520inflammasome%2520to%2520reduce%2520IL-1beta%2520in%2520retinal%2520endothelial%2520cells%2520and%2520mouse%2520retinal%2520vasculature%26jtitle%3DMediators%2520Inflammation%26date%3D2017%26volume%3D2017%26spage%3D2860956%26doi%3D10.1155%2F2017%2F2860956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chahine, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtiss, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinle, J. J.</span></span> <span> </span><span class="NLM_article-title">Epac1 agonist decreased inflammatory proteins in retinal endothelial cells, and loss of Epac1 increased inflammatory proteins in the retinal vasculature of mice</span>. <i>Mol. Vision</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">7</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=28210097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsFens7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=1-7&author=L.+Liuauthor=Y.+Jiangauthor=A.+Chahineauthor=E.+Curtissauthor=J.+J.+Steinle&title=Epac1+agonist+decreased+inflammatory+proteins+in+retinal+endothelial+cells%2C+and+loss+of+Epac1+increased+inflammatory+proteins+in+the+retinal+vasculature+of+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Epac1 agonist decreased inflammatory proteins in retinal endothelial cells, and loss of Epac1 increased inflammatory proteins in the retinal vasculature of mice</span></div><div class="casAuthors">Liu, Li; Jiang, Youde; Chahine, Adam; Curtiss, Elizabeth; Steinle, Jena J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Vision</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">MVEPFB</span>;
        ISSN:<span class="NLM_cas:issn">1090-0535</span>.
    
            (<span class="NLM_cas:orgname">Molecular Vision</span>)
        </div><div class="casAbstract">Purpose: Increased inflammatory mediator levels are reported in diabetic retinopathy.  We previously reported that β-adrenergic receptor agonists reduced inflammatory mediators in the diabetic retina; however, these agents cannot be given systemically.  Here, we investigated whether Epac1 is key to the protective effects of β-adrenergic receptor agonists.  Methods: We cultured primary human retinal endothelial cells (RECs) in normal (5 mM) or high (25 mM) glucose and treated them with an Epac1-specific agonist.  Addnl., we generated Epac1 conditional vascular endothelial cell knockout mice by breeding Epac1 floxed mice with Cdh5 Cre mice to investigate the role of Epac1 in the retinal levels of tumor necrosis factor alpha (TNF-α), interleukin-1β (IL-1β), nuclear factor kappa beta (NFκB), and inhibitor of kappa beta (IκB).  Confocal microscopy was performed to localize Epac1 in the mouse retina.  Results: Data showed that high glucose increased the TNF-α and IL-1β levels in the RECs, which were reduced cells treated with the Epac1 agonist.  The loss of Epac1 in the retinas of the conditional knockout mice resulted in statistically significantly increased levels of TNF-α and IL-1β, as well as NFκB.  Conclusions: These data indicate that Epac1 may be protective to the retina through inhibition of key inflammatory mediators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAW6gmoJ8vn7Vg90H21EOLACvtfcHk0lh8Q2uFt1zjbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsFens7s%253D&md5=2dab852cf76fc79ffe63b55bd3f6b029</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DChahine%26aufirst%3DA.%26aulast%3DCurtiss%26aufirst%3DE.%26aulast%3DSteinle%26aufirst%3DJ.%2BJ.%26atitle%3DEpac1%2520agonist%2520decreased%2520inflammatory%2520proteins%2520in%2520retinal%2520endothelial%2520cells%252C%2520and%2520loss%2520of%2520Epac1%2520increased%2520inflammatory%2520proteins%2520in%2520the%2520retinal%2520vasculature%2520of%2520mice%26jtitle%3DMol.%2520Vision%26date%3D2017%26volume%3D23%26spage%3D1%26epage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umemura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okumura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, Y.</span></span> <span> </span><span class="NLM_article-title">The role of Epac in the heart</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">591</span>– <span class="NLM_lpage">606</span>, <span class="refDoi"> DOI: 10.1007/s00018-016-2336-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1007%2Fs00018-016-2336-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=27549789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlyksbnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2017&pages=591-606&author=T.+Fujitaauthor=M.+Umemuraauthor=U.+Yokoyamaauthor=S.+Okumuraauthor=Y.+Ishikawa&title=The+role+of+Epac+in+the+heart&doi=10.1007%2Fs00018-016-2336-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The role of Epac in the heart</span></div><div class="casAuthors">Fujita, Takayuki; Umemura, Masanari; Yokoyama, Utako; Okumura, Satoshi; Ishikawa, Yoshihiro</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">591-606</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">As one of the most important second messengers, 3',5'-cyclic adenosine monophosphate (cAMP) mediates various extracellular signals including hormones and neurotransmitters, and induces appropriate responses in diverse types of cells.  Since cAMP was formerly believed to transmit signals through only two direct target mols., protein kinase A and the cyclic nucleotide-gated channel, the sensational discovery in 1998 of another novel direct effecter of cAMP [exchangeproteins directly activated by cAMP (Epac)] attracted a great deal of scientific interest in cAMP signaling.  Numerous studies on Epac have since disclosed its important functions in various tissues in the body.  Recently, observations of genetically manipulated mice in various pathogenic models have begun to reveal the in vivo significance of previous in vitro or cellular-level findings.  Here, we focused on the function of Epac in the heart.  Accumulating evidence has revealed that both Epac1 and Epac2 play important roles in the structure and function of the heart under physiol. and pathol. conditions.  Accordingly, developing the ability to regulate cAMP-mediated signaling through Epac may lead to remarkable new therapies for the treatment of cardiac diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTXwyuZJkZrrVg90H21EOLACvtfcHk0lh8Q2uFt1zjbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlyksbnP&md5=2ca5c13557787b15009e3c74805102f5</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1007%2Fs00018-016-2336-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-016-2336-5%26sid%3Dliteratum%253Aachs%26aulast%3DFujita%26aufirst%3DT.%26aulast%3DUmemura%26aufirst%3DM.%26aulast%3DYokoyama%26aufirst%3DU.%26aulast%3DOkumura%26aufirst%3DS.%26aulast%3DIshikawa%26aufirst%3DY.%26atitle%3DThe%2520role%2520of%2520Epac%2520in%2520the%2520heart%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2017%26volume%3D74%26spage%3D591%26epage%3D606%26doi%3D10.1007%2Fs00018-016-2336-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laubner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakob, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seufert, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Preproinsulin Gene Expression by Leptin Induction of Suppressor of Cytokine Signaling 3 in Pancreatic -Cells</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">3410</span>– <span class="NLM_lpage">3417</span>, <span class="refDoi"> DOI: 10.2337/diabetes.54.12.3410</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.2337%2Fdiabetes.54.12.3410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=16306356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht12gs7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2005&pages=3410-3417&author=K.+Laubnerauthor=T.+J.+Kiefferauthor=N.+T.+Lamauthor=X.+Niuauthor=F.+Jakobauthor=J.+Seufert&title=Inhibition+of+Preproinsulin+Gene+Expression+by+Leptin+Induction+of+Suppressor+of+Cytokine+Signaling+3+in+Pancreatic+-Cells&doi=10.2337%2Fdiabetes.54.12.3410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of preproinsulin gene expression by leptin induction of suppressor of cytokine signaling 3 in pancreatic β-cells</span></div><div class="casAuthors">Laubner, Katharina; Kieffer, Timothy J.; Lam, Ni T.; Niu, Xinjie; Jakob, Franz; Seufert, Jochen</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3410-3417</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association</span>)
        </div><div class="casAbstract">Leptin inhibits insulin secretion and preproinsulin gene expression in pancreatic β-cells, but signal transduction pathways and mol. mechanisms underlying this effect are poorly characterized.  In this study, we analyzed leptin-mediated signal transduction and preproinsulin gene regulation at the mol. level in pancreatic β-cells.  Leptin stimulation led to janus kinase (JAK)2-dependent phosphorylation and nuclear translocation of the transcription factors signal transducer and activator of transcription (STAT)3 and STAT5b in INS-1 β-cells.  Leptin also induced mRNA expression of the JAK-STAT inhibitor suppressor of cytokine signaling (SOCS)3 in INS-1 β-cells and human pancreatic islets in vitro and in pancreatic islets of ob/ob mice in vivo.  Transcriptional activation of the rat SOCS3 promoter by leptin was obsd. with concomitant leptin-induced STAT3 and STAT5b DNA binding to specific promoter regions.  Unexpectedly, SOCS3 inhibited both basal and STAT3/5b-dependent rat preproinsulin 1 gene promoter activity in INS-1 cells.  These results suggest that SOCS3 represents a transcriptional inhibitor of preproinsulin gene expression, which is induced by leptin through JAK-STAT3/5b signaling in pancreatic β-cells.  In conclusion, although SOCS3 is believed to be a neg. feedback regulator of JAK-STAT signaling, our findings suggest involvement of SOCS3 in a direct gene regulatory pathway downstream of leptin-activated JAK-STAT signaling in pancreatic β-cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1DlLpn8X-JrVg90H21EOLACvtfcHk0ljN7z5ieo9jsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht12gs7fI&md5=4f285b1c78dd21f069b0cb0035f04073</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.2337%2Fdiabetes.54.12.3410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiabetes.54.12.3410%26sid%3Dliteratum%253Aachs%26aulast%3DLaubner%26aufirst%3DK.%26aulast%3DKieffer%26aufirst%3DT.%2BJ.%26aulast%3DLam%26aufirst%3DN.%2BT.%26aulast%3DNiu%26aufirst%3DX.%26aulast%3DJakob%26aufirst%3DF.%26aulast%3DSeufert%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520Preproinsulin%2520Gene%2520Expression%2520by%2520Leptin%2520Induction%2520of%2520Suppressor%2520of%2520Cytokine%2520Signaling%25203%2520in%2520Pancreatic%2520-Cells%26jtitle%3DDiabetes%26date%3D2005%26volume%3D54%26spage%3D3410%26epage%3D3417%26doi%3D10.2337%2Fdiabetes.54.12.3410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torregrossa, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nairn, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J. R.</span></span> <span> </span><span class="NLM_article-title">Activation of exchange protein activated by cAMP in the rat basolateral amygdala impairs reconsolidation of a memory associated with self-administered cocaine</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e107359</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0107359</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1371%2Fjournal.pone.0107359" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=25259911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslWls7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e107359&author=X.+Wanauthor=M.+M.+Torregrossaauthor=H.+Sanchezauthor=A.+C.+Nairnauthor=J.+R.+Taylor&title=Activation+of+exchange+protein+activated+by+cAMP+in+the+rat+basolateral+amygdala+impairs+reconsolidation+of+a+memory+associated+with+self-administered+cocaine&doi=10.1371%2Fjournal.pone.0107359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of exchange protein activated by cAMP in the rat basolateral amygdala impairs reconsolidation of a memory associated with self-administered cocaine</span></div><div class="casAuthors">Wan, Xun; Torregrossa, Mary M.; Sanchez, Hayde; Nairn, Angus C.; Taylor, Jane R.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e107359/1-e107359/10, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The intracellular mechanisms underlying memory reconsolidation critically involve cAMP signaling.  These events were originally attributed to PKA activation by cAMP, but the identification of Exchange Protein Activated by cAMP (Epac), as a distinct mediator of cAMP signaling, suggests that cAMP-regulated processes that subserve memory reconsolidation are more complex.  Here we investigated how activation of Epac with 8-pCPT-cAMP (8-CPT) impacts reconsolidation of a memory that had been assocd. with cocaine self-administration.  Rats were trained to lever press for cocaine on an FR-1 schedule, in which each cocaine delivery was paired with a tone+light cue.  Lever pressing was then extinguished in the absence of cue presentations and cocaine delivery.  Following the last day of extinction, rats were put in a novel context, in which the conditioned cue was presented to reactivate the cocaine-assocd. memory.  Immediate bilateral infusions of 8-CPT into the basolateral amygdala (BLA) following reactivation disrupted subsequent cue-induced reinstatement in a dose-dependent manner, and modestly reduced responding for conditioned reinforcement.  When 8-CPT infusions were delayed for 3 h after the cue reactivation session or were given after a cue extinction session, no effect on cue-induced reinstatement was obsd.  Co-administration of 8-CPT and the PKA activator 6-Bnz-cAMP (10 nmol/side) rescued memory reconsolidation while 6-Bnz alone had no effect, suggesting an antagonizing interaction between the two cAMP signaling substrates.  Taken together, these studies suggest that activation of Epac represents a parallel cAMP-dependent pathway that can inhibit reconsolidation of cocaine-cue memories and reduce the ability of the cue to produce reinstatement of cocaine-seeking behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoahRS0_hSCWrVg90H21EOLACvtfcHk0ljN7z5ieo9jsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslWls7bL&md5=0d6d24eeb7cd0c2c4d02f7cda9504255</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0107359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0107359%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DX.%26aulast%3DTorregrossa%26aufirst%3DM.%2BM.%26aulast%3DSanchez%26aufirst%3DH.%26aulast%3DNairn%26aufirst%3DA.%2BC.%26aulast%3DTaylor%26aufirst%3DJ.%2BR.%26atitle%3DActivation%2520of%2520exchange%2520protein%2520activated%2520by%2520cAMP%2520in%2520the%2520rat%2520basolateral%2520amygdala%2520impairs%2520reconsolidation%2520of%2520a%2520memory%2520associated%2520with%2520self-administered%2520cocaine%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De107359%26doi%3D10.1371%2Fjournal.pone.0107359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eijkelkamp, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garza-Carbajal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willemen, H. L. D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwartkruis, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dantzer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heijnen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kavelaars, A.</span></span> <span> </span><span class="NLM_article-title">Low nociceptor GRK2 prolongs prostaglandin E2 hyperalgesia via biased cAMP signaling to Epac/Rap1, protein kinase Cepsilon, and MEK/ERK</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">12806</span>– <span class="NLM_lpage">12815</span>, <span class="refDoi"> DOI: 10.1523/jneurosci.3142-10.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1523%2FJNEUROSCI.3142-10.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=20861385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1CmsbjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=12806-12815&author=N.+Eijkelkampauthor=H.+Wangauthor=A.+Garza-Carbajalauthor=H.+L.+D.+M.+Willemenauthor=F.+J.+Zwartkruisauthor=J.+N.+Woodauthor=R.+Dantzerauthor=K.+W.+Kelleyauthor=C.+J.+Heijnenauthor=A.+Kavelaars&title=Low+nociceptor+GRK2+prolongs+prostaglandin+E2+hyperalgesia+via+biased+cAMP+signaling+to+Epac%2FRap1%2C+protein+kinase+Cepsilon%2C+and+MEK%2FERK&doi=10.1523%2Fjneurosci.3142-10.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Low nociceptor GRK2 prolongs prostaglandin E2 hyperalgesia via biased cAMP signaling to Epac/Rap1, protein kinase Cε, and MEK/ERK</span></div><div class="casAuthors">Eijkelkamp, Niels; Wang, Huijing; Garza-Carbajal, Anibal; Willemen, Hanneke L. D. M.; Zwartkruis, Fried J.; Wood, John N.; Dantzer, Robert; Kelley, Keith W.; Heijnen, Cobi J.; Kavelaars, Annemieke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">12806-12815</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Hyperexcitability of peripheral nociceptive pathways is often assocd. with inflammation and is an important mechanism underlying inflammatory pain.  Here we describe a completely novel mechanism via which nociceptor G-protein-coupled receptor kinase 2 (GRK2) contributes to regulation of inflammatory hyperalgesia.  We show that nociceptor GRK2 is downregulated during inflammation.  In addn., we show for the first time that prostaglandin E2 (PGE2)-induced hyperalgesia is prolonged from <6 h in wild-type (WT) mice to 3 days in mice with low GRK2 in Nav1.8+ nociceptors (SNS-GRK2+/- mice).  This prolongation of PGE2 hyperalgesia in SNS-GRK2+/- mice does not depend on changes in the sensitivity of the prostaglandin receptors because prolonged hyperalgesia also developed in response to 8-Br-cAMP.  PGE2 or cAMP-induced hyperalgesia in WT mice is PKA dependent.  However, PKA activity is not required for hyperalgesia in SNS-GRK2+/- mice.  SNS-GRK2+/- mice developed prolonged hyperalgesia in response to the Exchange proteins directly activated by cAMP (Epac) activator 8-pCPT-2'-O-Me-cAMP (8-pCPT).  Coimmunopptn. expts. showed that GRK2 binds to Epac1.  In vitro, GRK2 deficiency increased 8-pCPT-induced activation of the downstream effector of Epac, Rap1, and extracellular signal-regulated kinase (ERK).  In vivo, inhibition of MEK1 or PKCε prevented prolonged PGE2, 8-Br-cAMP, and 8-pCPT hyperalgesia in SNS-GRK2+/- mice.  In conclusion, we discovered GRK2 as a novel Epac1-interacting protein.  A redn. in the cellular level of GRK2 enhances activation of the Epac-Rap1 pathway.  In vivo, low nociceptor GRK2 leads to prolonged inflammatory hyperalgesia via biased cAMP signaling from PKA to Epac-Rap1, ERK/PKCε pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp9wjd80ZUq7Vg90H21EOLACvtfcHk0lhCTca20DMdiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1CmsbjI&md5=b474c6c01ee2ea9a159cec49680c5927</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3142-10.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3142-10.2010%26sid%3Dliteratum%253Aachs%26aulast%3DEijkelkamp%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DGarza-Carbajal%26aufirst%3DA.%26aulast%3DWillemen%26aufirst%3DH.%2BL.%2BD.%2BM.%26aulast%3DZwartkruis%26aufirst%3DF.%2BJ.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26aulast%3DDantzer%26aufirst%3DR.%26aulast%3DKelley%26aufirst%3DK.%2BW.%26aulast%3DHeijnen%26aufirst%3DC.%2BJ.%26aulast%3DKavelaars%26aufirst%3DA.%26atitle%3DLow%2520nociceptor%2520GRK2%2520prolongs%2520prostaglandin%2520E2%2520hyperalgesia%2520via%2520biased%2520cAMP%2520signaling%2520to%2520Epac%252FRap1%252C%2520protein%2520kinase%2520Cepsilon%252C%2520and%2520MEK%252FERK%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26spage%3D12806%26epage%3D12815%26doi%3D10.1523%2Fjneurosci.3142-10.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lezoualc’h, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazal, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laudette, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conte, C.</span></span> <span> </span><span class="NLM_article-title">Cyclic AMP sensor EPAC proteins and their role in cardiovascular function and disease</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">897</span>, <span class="refDoi"> DOI: 10.1161/CIRCRESAHA.115.306529</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1161%2FCIRCRESAHA.115.306529" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=26941424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1SqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2016&pages=881-897&author=F.+Lezoualc%E2%80%99hauthor=L.+Fazalauthor=M.+Laudetteauthor=C.+Conte&title=Cyclic+AMP+sensor+EPAC+proteins+and+their+role+in+cardiovascular+function+and+disease&doi=10.1161%2FCIRCRESAHA.115.306529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">CAMP sensor EPAC proteins and their role in cardiovascular function and disease</span></div><div class="casAuthors">Lezoualc'h, Frank; Fazal, Loubina; Laudette, Marion; Conte, Caroline</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">881-897</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">CAMP is a universal second messenger that plays central roles in cardiovascular regulation influencing gene expression, cell morphol., and function.  A crucial step toward a better understanding of cAMP signaling came 18 years ago with the discovery of the exchange protein directly activated by cAMP (EPAC).  The 2 EPAC isoforms, EPAC1 and EPAC2, are guanine-nucleotide exchange factors for the Ras-like GTPases, Rap1 and Rap2, which they activate independently of the classical effector of cAMP, protein kinase A.  With the development of EPAC pharmacol. modulators, many reports in the literature have demonstrated the crit. role of EPAC in the regulation of various cAMP-dependent cardiovascular functions, such as calcium handling and vascular tone.  EPAC proteins are coupled to a multitude of effectors into distinct subcellular compartments because of their multidomain architecture.  These novel cAMP sensors are not only at the crossroads of different physiol. processes but also may represent attractive therapeutic targets for the treatment of several cardiovascular disorders, including cardiac arrhythmia and heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIHsdKYqG57rVg90H21EOLACvtfcHk0lhCTca20DMdiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1SqsLk%253D&md5=863c603e082b1bb2ec69635044a49919</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.115.306529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.115.306529%26sid%3Dliteratum%253Aachs%26aulast%3DLezoualc%25E2%2580%2599h%26aufirst%3DF.%26aulast%3DFazal%26aufirst%3DL.%26aulast%3DLaudette%26aufirst%3DM.%26aulast%3DConte%26aufirst%3DC.%26atitle%3DCyclic%2520AMP%2520sensor%2520EPAC%2520proteins%2520and%2520their%2520role%2520in%2520cardiovascular%2520function%2520and%2520disease%26jtitle%3DCirc.%2520Res.%26date%3D2016%26volume%3D118%26spage%3D881%26epage%3D897%26doi%3D10.1161%2FCIRCRESAHA.115.306529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barker, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parnell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Basten, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buist, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarwood, S.</span></span> <span> </span><span class="NLM_article-title">The potential of a novel class of EPAC-selective agonists to combat cardiovascular inflammation</span>. <i>J. Cardiovasc. Dev. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">22</span>, <span class="refDoi"> DOI: 10.3390/jcdd4040022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.3390%2Fjcdd4040022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC1MXislSksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2017&pages=22&author=G.+Barkerauthor=E.+Parnellauthor=B.+van+Bastenauthor=H.+Buistauthor=D.+Adamsauthor=S.+Yarwood&title=The+potential+of+a+novel+class+of+EPAC-selective+agonists+to+combat+cardiovascular+inflammation&doi=10.3390%2Fjcdd4040022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The potential of a novel class of EPAC-selective agonists to combat cardiovascular inflammation</span></div><div class="casAuthors">Barker, Graeme; Parnell, Euan; van Basten, Boy; Buist, Hanna; Adams, David R.; Yarwood, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cardiovascular Development and Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">22/1-22/16</span>CODEN:
                <span class="NLM_cas:coden">JCDDB4</span>;
        ISSN:<span class="NLM_cas:issn">2308-3425</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  The cyclic 3',5'-adenosine monophosphate (cAMP) sensor enzyme, EPAC1, is a candidate drug target in vascular endothelial cells (VECs) due to its ability to attenuate proinflammatory cytokine signalling normally assocd. with cardiovascular diseases (CVDs), including atherosclerosis.  This is through the EPAC1-dependent induction of the suppressor of cytokine signalling gene, SOCS3, which targets inflammatory signalling proteins for ubiquitinylation and destruction by the proteosome.  Given this important role for the EPAC1/SOCS3 signalling axis, we have used high throughput screening (HTS) to identify small mol. EPAC1 regulators and have recently isolated the first known non-cyclic nucleotide (NCN) EPAC1 agonist, I942.  I942 therefore represents the first in class, isoformselective EPAC1 activator, with the potential to suppress pro-inflammatory cytokine signalling with a reduced risk of side effects assocd. with general cAMP-elevating agents that activate multiple response pathways.  The development of augmented I942 analogs may therefore provide improved research tools to validate EPAC1 as a potential therapeutic target for the treatment of chronic inflammation assocd. with deadly CVDs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG_LSYtD4gJ7Vg90H21EOLACvtfcHk0liNLl4DY9l-og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXislSksL4%253D&md5=a120032b05a955839f40338425ae8915</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.3390%2Fjcdd4040022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fjcdd4040022%26sid%3Dliteratum%253Aachs%26aulast%3DBarker%26aufirst%3DG.%26aulast%3DParnell%26aufirst%3DE.%26aulast%3Dvan%2BBasten%26aufirst%3DB.%26aulast%3DBuist%26aufirst%3DH.%26aulast%3DAdams%26aufirst%3DD.%26aulast%3DYarwood%26aufirst%3DS.%26atitle%3DThe%2520potential%2520of%2520a%2520novel%2520class%2520of%2520EPAC-selective%2520agonists%2520to%2520combat%2520cardiovascular%2520inflammation%26jtitle%3DJ.%2520Cardiovasc.%2520Dev.%2520Dis.%26date%3D2017%26volume%3D4%26spage%3D22%26doi%3D10.3390%2Fjcdd4040022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Enserink, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Rooij, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Triest, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwede, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genieser, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Døskeland, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blank, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bos, J. L.</span></span> <span> </span><span class="NLM_article-title">A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">901</span>– <span class="NLM_lpage">906</span>, <span class="refDoi"> DOI: 10.1038/ncb874</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1038%2Fncb874" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=12402047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVKmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=901-906&author=J.+M.+Enserinkauthor=A.+E.+Christensenauthor=J.+de+Rooijauthor=M.+van+Triestauthor=F.+Schwedeauthor=H.+G.+Genieserauthor=S.+O.+D%C3%B8skelandauthor=J.+L.+Blankauthor=J.+L.+Bos&title=A+novel+Epac-specific+cAMP+analogue+demonstrates+independent+regulation+of+Rap1+and+ERK&doi=10.1038%2Fncb874"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK</span></div><div class="casAuthors">Enserink, Jorrit M.; Christensen, Anne E.; De Rooij, Johan; Van Triest, Miranda; Schwede, Frank; Genieser, Hans Gottfried; Doskeland, Stein O.; Blank, Jonathan L.; Bos, Johannes L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">901-906</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">CAMP is involved in a wide variety of cellular processes that were thought to be mediated by protein kinase A (PKA).  However, cAMP also directly regulates Epac1 and Epac2, guanine nucleotide-exchange factors (GEFs) for the small GTPases Rap1 and Rap2.  Unfortunately, there is an absence of tools to discriminate between PKA- and Epac-mediated effects.  Therefore, through rational drug design we have developed a novel cAMP analog, 8-(4-chloro-phenylthio)-2'-O-methyladenosine-3',5'-cyclic monophosphate (8CPT-2Me-cAMP), which activates Epac, but not PKA, both in vitro and in vivo.  Using this analog, we tested the widespread model that Rap1 mediates cAMP-induced regulation of the extracellular signal-regulated kinase (ERK).  However, both in cell lines in which cAMP inhibits growth-factor-induced ERK activation and in which cAMP activates ERK, 8CPT-2Me-cAMP did not affect ERK activity.  Moreover, in cell lines in which cAMP activates ERK, inhibition of PKA and Ras, but not Rap1, abolished cAMP-mediated ERK activation.  We conclude that cAMP-induced regulation of ERK and activation of Rap1 are independent processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAeWJEct8ivLVg90H21EOLACvtfcHk0liNLl4DY9l-og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVKmug%253D%253D&md5=49434eb6f33a7ade23bc10556b9c2cc3</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fncb874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb874%26sid%3Dliteratum%253Aachs%26aulast%3DEnserink%26aufirst%3DJ.%2BM.%26aulast%3DChristensen%26aufirst%3DA.%2BE.%26aulast%3Dde%2BRooij%26aufirst%3DJ.%26aulast%3Dvan%2BTriest%26aufirst%3DM.%26aulast%3DSchwede%26aufirst%3DF.%26aulast%3DGenieser%26aufirst%3DH.%2BG.%26aulast%3DD%25C3%25B8skeland%26aufirst%3DS.%2BO.%26aulast%3DBlank%26aufirst%3DJ.%2BL.%26aulast%3DBos%26aufirst%3DJ.%2BL.%26atitle%3DA%2520novel%2520Epac-specific%2520cAMP%2520analogue%2520demonstrates%2520independent%2520regulation%2520of%2520Rap1%2520and%2520ERK%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2002%26volume%3D4%26spage%3D901%26epage%3D906%26doi%3D10.1038%2Fncb874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwede, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertinetti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langerijs, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadders, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wienk, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellenbroek, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Koning, E. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bos, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genieser, H.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssen, R. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehmann, H.</span></span> <span> </span><span class="NLM_article-title">Structure-guided design of selective Epac1 and Epac2 agonists</span>. <i>PLoS Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">e1002038</span>, <span class="refDoi"> DOI: 10.1371/journal.pbio.1002038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1371%2Fjournal.pbio.1002038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=25603503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC28XptVChsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=e1002038&author=F.+Schwedeauthor=D.+Bertinettiauthor=C.+N.+Langerijsauthor=M.+A.+Haddersauthor=H.+Wienkauthor=J.+H.+Ellenbroekauthor=E.+J.+P.+de+Koningauthor=J.+L.+Bosauthor=H.-G.+Genieserauthor=R.+A.+J.+Janssenauthor=H.+Rehmannauthor=H.+Rehmann&title=Structure-guided+design+of+selective+Epac1+and+Epac2+agonists&doi=10.1371%2Fjournal.pbio.1002038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided design of selective Epac1 and Epac2 agonists</span></div><div class="casAuthors">Schwede, Frank; Bertinetti, Daniela; Langerijs, Carianne N.; Hadders, Michael A.; Wienk, Hans; Ellenbroek, Johanne H.; de Koning, Eelco J. P.; Bos, Johannes L.; Herberg, Friedrich W.; Genieser, Hans-Gottfried; Janssen, Richard A. J.; Rehmann, Holger</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e1002038/1-e1002038/26</span>CODEN:
                <span class="NLM_cas:coden">PBLIBG</span>;
        ISSN:<span class="NLM_cas:issn">1545-7885</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The second messenger cAMP is known to augment glucose-induced insulin secretion.  However, its downstream targets in pancreatic β-cells have not been unequivocally detd.  Therefore, we designed cAMP analogs by a structure-guided approach that act as Epac2-selective agonists both in vitro and in vivo.  These analogs activate Epac2 about two orders of magnitude more potently than cAMP.  The high potency arises from increased affinity as well as increased maximal activation.  Crystallog. studies demonstrate that this is due to unique interactions.  At least one of the Epac2-specific agonists, Sp- 8-BnT-cAMPS (S-220), enhances glucose-induced insulin secretion in human pancreatic cells.  Selective targeting of Epac2 is thus proven possible and may be an option in diabetes treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI1ZifakFNi7Vg90H21EOLACvtfcHk0ljX7MEytxrajw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptVChsg%253D%253D&md5=fa0ed8b2940432a3b6db006633ed4e4f</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pbio.1002038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pbio.1002038%26sid%3Dliteratum%253Aachs%26aulast%3DSchwede%26aufirst%3DF.%26aulast%3DBertinetti%26aufirst%3DD.%26aulast%3DLangerijs%26aufirst%3DC.%2BN.%26aulast%3DHadders%26aufirst%3DM.%2BA.%26aulast%3DWienk%26aufirst%3DH.%26aulast%3DEllenbroek%26aufirst%3DJ.%2BH.%26aulast%3Dde%2BKoning%26aufirst%3DE.%2BJ.%2BP.%26aulast%3DBos%26aufirst%3DJ.%2BL.%26aulast%3DGenieser%26aufirst%3DH.-G.%26aulast%3DJanssen%26aufirst%3DR.%2BA.%2BJ.%26aulast%3DRehmann%26aufirst%3DH.%26aulast%3DRehmann%26aufirst%3DH.%26atitle%3DStructure-guided%2520design%2520of%2520selective%2520Epac1%2520and%2520Epac2%2520agonists%26jtitle%3DPLoS%2520Biol.%26date%3D2015%26volume%3D13%26spage%3De1002038%26doi%3D10.1371%2Fjournal.pbio.1002038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsalkova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span> <span> </span><span class="NLM_article-title">A fluorescence-based high-throughput assay for the discovery of exchange protein directly activated by cyclic AMP (EPAC) antagonists</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e30441</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0030441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1371%2Fjournal.pone.0030441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=22276201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFyrsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e30441&author=T.+Tsalkovaauthor=F.+C.+Meiauthor=X.+Cheng&title=A+fluorescence-based+high-throughput+assay+for+the+discovery+of+exchange+protein+directly+activated+by+cyclic+AMP+%28EPAC%29+antagonists&doi=10.1371%2Fjournal.pone.0030441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">A fluorescence-based high-throughput assay for the discovery of exchange protein directly activated by cyclic AMP (EPAC) antagonists</span></div><div class="casAuthors">Tsalkova, Tamara; Mei, Fang C.; Cheng, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e30441</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: The discovery, more than ten years ago, of exchange proteins directly activated by cAMP (EPAC) as a new family of intracellular cAMP receptors revolutionized the cAMP signaling research field.  Extensive studies have revealed that the cAMP signaling network is much more complex and dynamic as many cAMP-related cellular processes, previously thought to be controlled by protein kinase A, are found to be also mediated by EPAC proteins.  Although there have been many important discoveries in the roles of EPACs greater understanding of their physiol. function in cAMP-mediated signaling is impeded by the absence of EPAC-specific antagonist.  Methodol./Principal Findings: To overcome this deficit, we have developed a fluorescence-based high throughput assay for screening EPAC specific antagonists.  Our assay is highly reproducible and simple to perform using the "mix and measure" format.  A pilot screening using the NCI-DTP diversity set library led to the identification of small chem. compds. capable of specifically inhibiting cAMP-induced EPAC activation while not affecting PKA activity.  Conclusions/Significance: Our study establishes a robust high throughput screening assay that can be effectively applied for the discovery of EPAC-specific antagonists, which may provide valuable pharmacol. tools for elucidating the biol. functions of EPAC and for promoting an understanding of disease mechanisms related to EPAC/cAMP signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-g9GuUaBUL7Vg90H21EOLACvtfcHk0ljX7MEytxrajw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFyrsbo%253D&md5=7f24b489008acb4c3c7c3658bb1cbfe3</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0030441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0030441%26sid%3Dliteratum%253Aachs%26aulast%3DTsalkova%26aufirst%3DT.%26aulast%3DMei%26aufirst%3DF.%2BC.%26aulast%3DCheng%26aufirst%3DX.%26atitle%3DA%2520fluorescence-based%2520high-throughput%2520assay%2520for%2520the%2520discovery%2520of%2520exchange%2520protein%2520directly%2520activated%2520by%2520cyclic%2520AMP%2520%2528EPAC%2529%2520antagonists%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De30441%26doi%3D10.1371%2Fjournal.pone.0030441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parnell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McElroy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiejak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarwood, S. J.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel, small molecule partial agonist for the cyclic AMP sensor, EPAC1</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">294</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-00455-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1038%2Fs41598-017-00455-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=28331191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A280%3ADC%252BC1cvgtVWhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=294&author=E.+Parnellauthor=S.+P.+McElroyauthor=J.+Wiejakauthor=G.+L.+Baillieauthor=A.+Porterauthor=D.+R.+Adamsauthor=H.+Rehmannauthor=B.+O.+Smithauthor=S.+J.+Yarwood&title=Identification+of+a+novel%2C+small+molecule+partial+agonist+for+the+cyclic+AMP+sensor%2C+EPAC1&doi=10.1038%2Fs41598-017-00455-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Novel, Small Molecule Partial Agonist for the Cyclic AMP Sensor, EPAC1</span></div><div class="casAuthors">Parnell Euan; Smith Brian O; McElroy Stuart P; Baillie Gemma L; Porter Alison; Wiejak Jolanta; Yarwood Stephen J; Adams David R; Rehmann Holger</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">294</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Screening of a carefully selected library of 5,195 small molecules identified 34 hit compounds that interact with the regulatory cyclic nucleotide-binding domain (CNB) of the cAMP sensor, EPAC1.  Two of these hits (I942 and I178) were selected for their robust and reproducible inhibitory effects within the primary screening assay.  Follow-up characterisation by ligand observed nuclear magnetic resonance (NMR) revealed direct interaction of I942 and I178 with EPAC1 and EPAC2-CNBs in vitro.  Moreover, in vitro guanine nucleotide exchange factor (GEF) assays revealed that I942 and, to a lesser extent, I178 had partial agonist properties towards EPAC1, leading to activation of EPAC1, in the absence of cAMP, and inhibition of GEF activity in the presence of cAMP.  In contrast, there was very little agonist action of I942 towards EPAC2 or protein kinase A (PKA).  To our knowledge, this is the first observation of non-cyclic-nucleotide small molecules with agonist properties towards EPAC1.  Furthermore, the isoform selective agonist nature of these compounds highlights the potential for the development of small molecule tools that selectively up-regulate EPAC1 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQJz-Vtf3yjwmgRQsDqrjW_fW6udTcc2ea4EbjNXQZkJrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cvgtVWhtw%253D%253D&md5=c509f625dad046131bae78aa798f40db</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-00455-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-00455-7%26sid%3Dliteratum%253Aachs%26aulast%3DParnell%26aufirst%3DE.%26aulast%3DMcElroy%26aufirst%3DS.%2BP.%26aulast%3DWiejak%26aufirst%3DJ.%26aulast%3DBaillie%26aufirst%3DG.%2BL.%26aulast%3DPorter%26aufirst%3DA.%26aulast%3DAdams%26aufirst%3DD.%2BR.%26aulast%3DRehmann%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DB.%2BO.%26aulast%3DYarwood%26aufirst%3DS.%2BJ.%26atitle%3DIdentification%2520of%2520a%2520novel%252C%2520small%2520molecule%2520partial%2520agonist%2520for%2520the%2520cyclic%2520AMP%2520sensor%252C%2520EPAC1%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D294%26doi%3D10.1038%2Fs41598-017-00455-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wiejak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Basten, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luchowska-Stańska, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarwood, S. J.</span></span> <span> </span><span class="NLM_article-title">The novel exchange protein activated by cyclic AMP 1 (EPAC1) agonist, I942, regulates inflammatory gene expression in human umbilical vascular endothelial cells (HUVECs)</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1866</i></span>,  <span class="NLM_fpage">264</span>– <span class="NLM_lpage">276</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2018.11.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2Fj.bbamcr.2018.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=30414891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit12ltLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1866&publication_year=2019&pages=264-276&author=J.+Wiejakauthor=B.+van+Bastenauthor=U.+Luchowska-Sta%C5%84skaauthor=G.+Hamiltonauthor=S.+J.+Yarwood&title=The+novel+exchange+protein+activated+by+cyclic+AMP+1+%28EPAC1%29+agonist%2C+I942%2C+regulates+inflammatory+gene+expression+in+human+umbilical+vascular+endothelial+cells+%28HUVECs%29&doi=10.1016%2Fj.bbamcr.2018.11.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The novel exchange protein activated by cyclic AMP 1 (EPAC1) agonist, I942, regulates inflammatory gene expression in human umbilical vascular endothelial cells (HUVECs)</span></div><div class="casAuthors">Wiejak, Jolanta; van Basten, Boy; Luchowska-Stanska, Urszula; Hamilton, Graham; Yarwood, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1866</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">264-276</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Exchange protein activated by cAMP (EPAC1) suppresses multiple inflammatory actions in vascular endothelial cells (VECs), partly due to its ability to induce expression of the suppressor of cytokine signalling 3 (SOCS3) gene, the protein product of which inhibits interleukin 6 (IL6) signalling through the JAK/STAT3 pathway.  Here, for the first time, we use the non-cyclic nucleotide EPAC1 agonist, I942, to det. its actions on cellular EPAC1 activity and cAMP-regulated gene expression in VECs.  We demonstrate that I942 promotes EPAC1 and Rap1 activation in HEK293T cells and induces SOCS3 expression and suppresses IL6-stimulated JAK/STAT3 signalling in HUVECs.  SOCS3 induction by I942 in HUVECs was blocked by the EPAC1 antagonist, ESI-09, and EPAC1 siRNA, but not by the broad-spectrum protein kinase A (PKA) inhibitor, H89, indicating that I942 regulates SOCS3 gene expression through EPAC1.  RNA sequencing was carried out to further identify I942-regulated genes in HUVECs.  This identified 425 I942-regulated genes that were also regulated by the EPAC1-selective cAMP analog, 007, and the cAMP-elevating agents, forskolin and rolipram (F/R).  The majority of genes identified were suppressed by I942, 007 and F/R treatment and many were involved in the control of key vascular functions, including the gene for the cell adhesion mol., VCAM1.  I942 and 007 also inhibited IL6-induced expression of VCAM1 at the protein level and blocked VCAM1-dependent monocyte adhesion to HUVECs.  Overall, I942 represents the first non-cyclic nucleotide EPAC1 agonist in cells with the ability to suppress IL6 signalling and inflammatory gene expression in VECs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzsuIrKyPU2rVg90H21EOLACvtfcHk0li0fpgiRYmFAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit12ltLrM&md5=381e7a3893d3ca68af406c7823404371</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2018.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2018.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DWiejak%26aufirst%3DJ.%26aulast%3Dvan%2BBasten%26aufirst%3DB.%26aulast%3DLuchowska-Sta%25C5%2584ska%26aufirst%3DU.%26aulast%3DHamilton%26aufirst%3DG.%26aulast%3DYarwood%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520novel%2520exchange%2520protein%2520activated%2520by%2520cyclic%2520AMP%25201%2520%2528EPAC1%2529%2520agonist%252C%2520I942%252C%2520regulates%2520inflammatory%2520gene%2520expression%2520in%2520human%2520umbilical%2520vascular%2520endothelial%2520cells%2520%2528HUVECs%2529%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2019%26volume%3D1866%26spage%3D264%26epage%3D276%26doi%3D10.1016%2Fj.bbamcr.2018.11.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shao, H.</span>; <span class="NLM_string-name">Mohamed, H.</span>; <span class="NLM_string-name">Boulton, S.</span>; <span class="NLM_string-name">Huang, J.</span>; <span class="NLM_string-name">Wang, P.</span>; <span class="NLM_string-name">Chen, H.</span>; <span class="NLM_string-name">Zhou, J.</span>; <span class="NLM_string-name">Luchowska-Stańska, U.</span>; <span class="NLM_string-name">Jentsch, N. G.</span>; <span class="NLM_string-name">Armstrong, A. L.</span>; <span class="NLM_string-name">Magolan, J.</span>; <span class="NLM_string-name">Yarwood, S.</span>; <span class="NLM_string-name">Melacini, G.</span></span> <span> </span><span class="NLM_article-title">Mechanism of action of an EPAC1-selective competitive partial agonist</span>.  <i>J. Med. Chem.</i> <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b02151</span> , Published online: Apr 16, 2020. [Online early access].</span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b02151" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Shao%2C+H.%3B+Mohamed%2C+H.%3B+Boulton%2C+S.%3B+Huang%2C+J.%3B+Wang%2C+P.%3B+Chen%2C+H.%3B+Zhou%2C+J.%3B+Luchowska-Sta%C5%84ska%2C+U.%3B+Jentsch%2C+N.+G.%3B+Armstrong%2C+A.+L.%3B+Magolan%2C+J.%3B+Yarwood%2C+S.%3B+Melacini%2C+G.+Mechanism+of+action+of+an+EPAC1-selective+competitive+partial+agonist.+J.+Med.+Chem.+10.1021%2Facs.jmedchem.9b02151%2C+Published+online%3A+Apr+16%2C+2020.+%5BOnline+early+access%5D."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b02151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b02151%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DH.%26atitle%3DMechanism%2520of%2520action%2520of%2520an%2520EPAC1-selective%2520competitive%2520partial%2520agonist%26jtitle%3DJ.%2520Med.%2520Chem.%26doi%3D10.1021%2Facs.jmedchem.9b02151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsalkova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chepurny, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leech, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holz, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, V. L.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span> <span> </span><span class="NLM_article-title">Isoform-specific antagonists of exchange proteins directly activated by cAMP</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">18613</span>– <span class="NLM_lpage">18618</span>, <span class="refDoi"> DOI: 10.1073/pnas.1210209109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1073%2Fpnas.1210209109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=23091014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslymtbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=18613-18618&author=T.+Tsalkovaauthor=F.+C.+Meiauthor=S.+Liauthor=O.+G.+Chepurnyauthor=C.+A.+Leechauthor=T.+Liuauthor=G.+G.+Holzauthor=V.+L.+Woodsauthor=X.+Cheng&title=Isoform-specific+antagonists+of+exchange+proteins+directly+activated+by+cAMP&doi=10.1073%2Fpnas.1210209109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Isoform-specific antagonists of exchange proteins directly activated by cAMP</span></div><div class="casAuthors">Tsalkova, Tamara; Mei, Fang C.; Li, Sheng; Chepurny, Oleg G.; Leech, Colin A.; Liu, Tong; Holz, George G.; Woods, Virgil L., Jr.; Cheng, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">18613-18618, S18613/1-S18613/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The major physiol. effects of cAMP in mammalian cells are transduced by two ubiquitously expressed intracellular cAMP receptors, protein kinase A (PKA) and exchange protein directly activated by cAMP (EPAC), as well as cyclic nucleotide-gated ion channels in certain tissues.  Although a large no. of PKA inhibitors are available, there are no repotted EPAC-specific antagonists, despite extensive research efforts.  Here we report the identification and characterization of noncyclic nucleotide EPAC antagonists that are exclusively specific for the EPAC2 isoform.  These EAPC2-specific antagonists, designated as ESI-05 and ESI-07, inhibit Rap1 activation mediated by EAPC2, but not EPAC1, with high potency in vitro.  Moreover, ESI-05 and ESI-07 are capable of suppressing the cAMP-mediated activation of EPAC2, but not EPAC1 and PKA, as monitored in living cells through the use of EPAC- and PKA-based FRET reporters, or by the use of Rap1-GTP pull-down assays.  Deuterium exchange mass spectroscopy anal. further reveals that EPAC2-specific inhibitors exert their isoform selectivity through a unique mechanism by binding to a previously undescribed allosteric site: the interface of the two cAMP binding domains, which is not present in the EPAC1 isoform.  Isoform-specific EPAC pharmacol. probes are highly desired and will be valuable tools for dissecting the biol. functions of EPAC proteins and their roles in various disease states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCqe7G_IG8DLVg90H21EOLACvtfcHk0lgcDX6IBmbE0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslymtbbF&md5=eb4d5d7299b3b7988fce7704f1cbdd5c</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1210209109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1210209109%26sid%3Dliteratum%253Aachs%26aulast%3DTsalkova%26aufirst%3DT.%26aulast%3DMei%26aufirst%3DF.%2BC.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DChepurny%26aufirst%3DO.%2BG.%26aulast%3DLeech%26aufirst%3DC.%2BA.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DHolz%26aufirst%3DG.%2BG.%26aulast%3DWoods%26aufirst%3DV.%2BL.%26aulast%3DCheng%26aufirst%3DX.%26atitle%3DIsoform-specific%2520antagonists%2520of%2520exchange%2520proteins%2520directly%2520activated%2520by%2520cAMP%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2012%26volume%3D109%26spage%3D18613%26epage%3D18618%26doi%3D10.1073%2Fpnas.1210209109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rehmann, H.</span></span> <span> </span><span class="NLM_article-title">Characterization of the activation of the Rap-specific exchange factor Epac by cyclic nucleotides</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>407</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.1016/s0076-6879(05)07014-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2FS0076-6879%2805%2907014-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=16757322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmt1Sgt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2006&pages=159-173&author=H.+Rehmann&title=Characterization+of+the+activation+of+the+Rap-specific+exchange+factor+Epac+by+cyclic+nucleotides&doi=10.1016%2Fs0076-6879%2805%2907014-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the activation of the Rap-specific exchange factor Epac by cyclic nucleotides</span></div><div class="casAuthors">Rehmann, Holger</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">407</span>
        (<span class="NLM_cas:issue">Regulators and Effectors of Small GTPases: Ras Family</span>),
    <span class="NLM_cas:pages">159-173</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Epac1 and Epac2 are cAMP-dependent guanine nucleotide exchange factors (GEF) for the small G-proteins Rap1 and Rap2.  Epac is inactive in the absence of cAMP, and binding of cAMP to a cyclic nucleotide-binding domain in the N-terminal regulatory region results in activation of the protein.  The cAMP-dependent activity of Epac proteins can be analyzed by a fluorescence-based assay in vitro.  These kinds of measurements can help to unravel the mol. mechanism by which cAMP binding is translated in activation of the protein.  For this purpose, Epac mutants can be analyzed.  In addn., the interaction of cAMP itself might be the focus of the research.  Thus, modified cAMP analogs can be characterized by their ability to activate Epac.  This is of particular interest for the development of Epac-specific analogs, which do not act on other cellular cAMP targets such as protein kinase A (PKA) or for the design of therapeutic agents targeting Epac.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK5RMLzhAabbVg90H21EOLACvtfcHk0lgcDX6IBmbE0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmt1Sgt7c%253D&md5=6d45e1a211606622e4fc34268d61eb0e</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2805%2907014-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252805%252907014-X%26sid%3Dliteratum%253Aachs%26aulast%3DRehmann%26aufirst%3DH.%26atitle%3DCharacterization%2520of%2520the%2520activation%2520of%2520the%2520Rap-specific%2520exchange%2520factor%2520Epac%2520by%2520cyclic%2520nucleotides%26jtitle%3DMethods%2520Enzymol.%26date%3D2006%26volume%3D407%26spage%3D159%26epage%3D173%26doi%3D10.1016%2Fs0076-6879%2805%2907014-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Besnard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruda, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setola, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abecassis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguiz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norval, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeons, F. R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidah, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Constam, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bickerton, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetsel, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span> <span> </span><span class="NLM_article-title">Automated design of ligands to polypharmacological profiles</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>492</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1038/nature11691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1038%2Fnature11691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=23235874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=492&publication_year=2012&pages=215-220&author=J.+Besnardauthor=G.+F.+Rudaauthor=V.+Setolaauthor=K.+Abecassisauthor=R.+M.+Rodriguizauthor=X.-P.+Huangauthor=S.+Norvalauthor=M.+F.+Sassanoauthor=A.+I.+Shinauthor=L.+A.+Websterauthor=F.+R.+C.+Simeonsauthor=L.+Stojanovskiauthor=A.+Pratauthor=N.+G.+Seidahauthor=D.+B.+Constamauthor=G.+R.+Bickertonauthor=K.+D.+Readauthor=W.+C.+Wetselauthor=I.+H.+Gilbertauthor=B.+L.+Rothauthor=A.+L.+Hopkins&title=Automated+design+of+ligands+to+polypharmacological+profiles&doi=10.1038%2Fnature11691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Automated design of ligands to polypharmacological profiles</span></div><div class="casAuthors">Besnard, Jeremy; Ruda, Gian Filippo; Setola, Vincent; Abecassis, Keren; Rodriguiz, Ramona M.; Huang, Xi-Ping; Norval, Suzanne; Sassano, Maria F.; Shin, Antony I.; Webster, Lauren A.; Simeons, Frederick R. C.; Stojanovski, Laste; Prat, Annik; Seidah, Nabil G.; Constam, Daniel B.; Bickerton, G. Richard; Read, Kevin D.; Wetsel, William C.; Gilbert, Ian H.; Roth, Bryan L.; Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">492</span>
        (<span class="NLM_cas:issue">7428</span>),
    <span class="NLM_cas:pages">215-220</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The clin. efficacy and safety of a drug is detd. by its activity profile across many proteins in the proteome.  However, designing drugs with a specific multi-target profile is both complex and difficult.  Therefore methods to design drugs rationally a priori against profiles of several proteins would have immense value in drug discovery.  Here is described a new approach for the automated design of ligands against profiles of multiple drug targets.  The method is demonstrated by the evolution of an approved acetylcholinesterase inhibitor drug donepezil (I) into brain-penetrable ligands with either specific polypharmacol. or exquisite selectivity profiles for G-protein-coupled receptors.  Overall, 800 ligand-target predictions of prospectively designed ligands were tested exptl., of which 75% were confirmed to be correct.  Target engagement in vivo is also demonstrated.  The approach can be a useful source of drug leads when multi-target profiles are required to achieve either selectivity over other drug targets or a desired polypharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNu5bwrBD3tbVg90H21EOLACvtfcHk0lglOb18kOAYGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN&md5=ace6cced250cf968d327b482a5bf1798</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1038%2Fnature11691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11691%26sid%3Dliteratum%253Aachs%26aulast%3DBesnard%26aufirst%3DJ.%26aulast%3DRuda%26aufirst%3DG.%2BF.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DAbecassis%26aufirst%3DK.%26aulast%3DRodriguiz%26aufirst%3DR.%2BM.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DShin%26aufirst%3DA.%2BI.%26aulast%3DWebster%26aufirst%3DL.%2BA.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%2BC.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DPrat%26aufirst%3DA.%26aulast%3DSeidah%26aufirst%3DN.%2BG.%26aulast%3DConstam%26aufirst%3DD.%2BB.%26aulast%3DBickerton%26aufirst%3DG.%2BR.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DAutomated%2520design%2520of%2520ligands%2520to%2520polypharmacological%2520profiles%26jtitle%3DNature%26date%3D2012%26volume%3D492%26spage%3D215%26epage%3D220%26doi%3D10.1038%2Fnature11691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokunaga, N.</span></span> <span> </span><span class="NLM_article-title">Asymmetric synthesis of diarylmethyl amines by rhodium-catalyzed asymmetric addition of aryl titanium reagents to imines</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">6125</span>– <span class="NLM_lpage">6128</span>, <span class="refDoi"> DOI: 10.1002/anie.200461338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1002%2Fanie.200461338" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKgsrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=6125-6128&author=T.+Hayashiauthor=M.+Kawaiauthor=N.+Tokunaga&title=Asymmetric+synthesis+of+diarylmethyl+amines+by+rhodium-catalyzed+asymmetric+addition+of+aryl+titanium+reagents+to+imines&doi=10.1002%2Fanie.200461338"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric synthesis of diarylmethyl amines by rhodium-catalyzed asymmetric addition of aryl titanium reagents to imines</span></div><div class="casAuthors">Hayashi, Tamio; Kawai, Masahiro; Tokunaga, Norihito</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">6125-6128</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Rhodium/chiral phosphine-catalyzed asym. addn. of aryltitanium triisopropoxides to N-arylidene sulfonamides (Ar1CH=NSO2Ar2) yielded diarylmethyl arylsulfonamides, e.g., I, enantioselectively.  A rational tuning of the arene sulfonamide moiety (by introducing iso-Pr groups onto the Ph ring) brought about high enantioselectivity in the reaction.  Desulfonylation of the diarylmethyl arylsulfonamides yielded chiral diarylmethyl amines, e.g., II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPhGlyFTlTWbVg90H21EOLACvtfcHk0lglOb18kOAYGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKgsrvF&md5=aa5a24c4785413dffc0ba3fe208ebb89</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1002%2Fanie.200461338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200461338%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DKawai%26aufirst%3DM.%26aulast%3DTokunaga%26aufirst%3DN.%26atitle%3DAsymmetric%2520synthesis%2520of%2520diarylmethyl%2520amines%2520by%2520rhodium-catalyzed%2520asymmetric%2520addition%2520of%2520aryl%2520titanium%2520reagents%2520to%2520imines%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2004%26volume%3D43%26spage%3D6125%26epage%3D6128%26doi%3D10.1002%2Fanie.200461338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Das, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasetya, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K. H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woon, E. C. Y.</span></span> <span> </span><span class="NLM_article-title">Multiprotein dynamic combinatorial chemistry: a strategy for the simultaneous discovery of subfamily-selective inhibitors for nucleic acid demethylases FTO and ALKBH3</span>. <i>Chem.—Asian J.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2854</span>– <span class="NLM_lpage">2867</span>, <span class="refDoi"> DOI: 10.1002/asia.201800729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1002%2Fasia.201800729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=29917331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslaiu7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=2854-2867&author=M.+Dasauthor=T.+Yangauthor=J.+Dongauthor=F.+Prasetyaauthor=Y.+Xieauthor=K.+H.+Q.+Wongauthor=A.+Cheongauthor=E.+C.+Y.+Woon&title=Multiprotein+dynamic+combinatorial+chemistry%3A+a+strategy+for+the+simultaneous+discovery+of+subfamily-selective+inhibitors+for+nucleic+acid+demethylases+FTO+and+ALKBH3&doi=10.1002%2Fasia.201800729"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Multiprotein Dynamic Combinatorial Chemistry: A Strategy for the Simultaneous Discovery of Subfamily-Selective Inhibitors for Nucleic Acid Demethylases FTO and ALKBH3</span></div><div class="casAuthors">Das, Mohua; Yang, Tianming; Dong, Jinghua; Prasetya, Fransisca; Xie, Yiming; Wong, Kendra H. Q.; Cheong, Adeline; Woon, Esther C. Y.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - An Asian Journal</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2854-2867</span>CODEN:
                <span class="NLM_cas:coden">CAAJBI</span>;
        ISSN:<span class="NLM_cas:issn">1861-4728</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Dynamic combinatorial chem. (DCC) is a powerful supramol. approach for discovering ligands for biomols.  To date, most, if not all, biol. templated DCC systems employ only a single biomol. to direct the self-assembly process.  To expand the scope of DCC, herein, a novel multiprotein DCC strategy has been developed that combines the discriminatory power of a zwitterionic "thermal tag" with the sensitivity of differential scanning fluorimetry (DSF).  This strategy is highly sensitive and could differentiate the binding of ligands to structurally similar subfamily members.  Through this strategy, it was possible to simultaneously identify subfamily-selective probes against two clin. important epigenetic enzymes: FTO (7; IC50 = 2.6 μm) and ALKBH3 (8; IC50 = 3.7 μm).  To date, this is the first report of a subfamily-selective ALKBH3 inhibitor.  The developed strategy could, in principle, be adapted to a broad range of proteins; thus it is of broad scientific interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXwpH9yHmQ_LVg90H21EOLACvtfcHk0ljAnwOOVEcfOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslaiu7%252FK&md5=2e8dca74858c93f2cbf8f77b9cb5660d</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1002%2Fasia.201800729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fasia.201800729%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DPrasetya%26aufirst%3DF.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DWong%26aufirst%3DK.%2BH.%2BQ.%26aulast%3DCheong%26aufirst%3DA.%26aulast%3DWoon%26aufirst%3DE.%2BC.%2BY.%26atitle%3DMultiprotein%2520dynamic%2520combinatorial%2520chemistry%253A%2520a%2520strategy%2520for%2520the%2520simultaneous%2520discovery%2520of%2520subfamily-selective%2520inhibitors%2520for%2520nucleic%2520acid%2520demethylases%2520FTO%2520and%2520ALKBH3%26jtitle%3DChem.%25E2%2580%2594Asian%2520J.%26date%3D2018%26volume%3D13%26spage%3D2854%26epage%3D2867%26doi%3D10.1002%2Fasia.201800729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Charlton, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aleksis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saint-Leger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribas de Pouplana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaula, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustina, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madre, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lola, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaudzems, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmund, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randall, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kime, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goessens, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jirgensons, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finn, P. W.</span></span> <span> </span><span class="NLM_article-title">N-Leucinyl benzenesulfonamides as structurally simplified leucyl-tRNA synthetase inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">84</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00374</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00374" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Gnu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=84-88&author=M.+H.+Charltonauthor=R.+Aleksisauthor=A.+Saint-Legerauthor=A.+Guptaauthor=E.+Lozaauthor=L.+Ribas+de+Pouplanaauthor=I.+Kaulaauthor=D.+Gustinaauthor=M.+Madreauthor=D.+Lolaauthor=K.+Jaudzemsauthor=G.+Edmundauthor=C.+P.+Randallauthor=L.+Kimeauthor=A.+J.+O%E2%80%99Neillauthor=W.+Goessensauthor=A.+Jirgensonsauthor=P.+W.+Finn&title=N-Leucinyl+benzenesulfonamides+as+structurally+simplified+leucyl-tRNA+synthetase+inhibitors&doi=10.1021%2Facsmedchemlett.7b00374"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">N-Leucinyl Benzenesulfonamides as Structurally Simplified Leucyl-tRNA Synthetase Inhibitors</span></div><div class="casAuthors">Charlton, Michael H.; Aleksis, Rihards; Saint-Leger, Adelaide; Gupta, Arya; Loza, Einars; Ribas de Pouplana, Lluis; Kaula, Ilze; Gustina, Daina; Madre, Marina; Lola, Daina; Jaudzems, Kristaps; Edmund, Grace; Randall, Christopher P.; Kime, Louise; O'Neill, Alex J.; Goessens, Wil; Jirgensons, Aigars; Finn, Paul W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">84-88</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Leucinyl benzenesulfonamides have been discovered as a novel class of potent inhibitors of E. coli leucyl-tRNA synthetase.  The binding of inhibitors to the enzyme was measured by using isothermal titrn. calorimetry.  This provided information on enthalpy and entropy contributions to binding, which, together with docking studies, were used for structure-activity relationship anal.  Enzymic assays revealed that N-leucinyl benzenesulfonamides display remarkable selectivity for E. coli leucyl-tRNA synthetase compared to S. aureus and human orthologues.  The simplest analog of the series, N-leucinyl benzenesulfonamide (R = H), showed the highest affinity against E. coli leucyl-tRNA synthetase and also exhibited antibacterial activity against Gram-neg. pathogens (the best MIC = 8 μg/mL, E. coli ATCC 25922), which renders it as a promising template for antibacterial drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOX-ZtM7nuaLVg90H21EOLACvtfcHk0lgrcQOo9K8YpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Gnu74%253D&md5=6926e503dcad06b5217592977e297493</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00374%26sid%3Dliteratum%253Aachs%26aulast%3DCharlton%26aufirst%3DM.%2BH.%26aulast%3DAleksis%26aufirst%3DR.%26aulast%3DSaint-Leger%26aufirst%3DA.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DLoza%26aufirst%3DE.%26aulast%3DRibas%2Bde%2BPouplana%26aufirst%3DL.%26aulast%3DKaula%26aufirst%3DI.%26aulast%3DGustina%26aufirst%3DD.%26aulast%3DMadre%26aufirst%3DM.%26aulast%3DLola%26aufirst%3DD.%26aulast%3DJaudzems%26aufirst%3DK.%26aulast%3DEdmund%26aufirst%3DG.%26aulast%3DRandall%26aufirst%3DC.%2BP.%26aulast%3DKime%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DA.%2BJ.%26aulast%3DGoessens%26aufirst%3DW.%26aulast%3DJirgensons%26aufirst%3DA.%26aulast%3DFinn%26aufirst%3DP.%2BW.%26atitle%3DN-Leucinyl%2520benzenesulfonamides%2520as%2520structurally%2520simplified%2520leucyl-tRNA%2520synthetase%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D84%26epage%3D88%26doi%3D10.1021%2Facsmedchemlett.7b00374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lobb, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hipskind, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aikins, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Considine, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Dios, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durst, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferritto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossman, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giera, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollister, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iversen, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Law, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrejas, L. M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCann, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molero, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richett, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teicher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wikel, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mader, M. M.</span></span> <span> </span><span class="NLM_article-title">Acyl sulfonamide anti-proliferatives: benzene substituent structure-activity relationships for a novel class of antitumor agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">5367</span>– <span class="NLM_lpage">5380</span>, <span class="refDoi"> DOI: 10.1021/jm030594r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030594r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsleis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=5367-5380&author=K.+L.+Lobbauthor=P.+A.+Hipskindauthor=J.+A.+Aikinsauthor=E.+Alvarezauthor=Y.-Y.+Cheungauthor=E.+L.+Considineauthor=A.+De+Diosauthor=G.+L.+Durstauthor=R.+Ferrittoauthor=C.+S.+Grossmanauthor=D.+D.+Gieraauthor=B.+A.+Hollisterauthor=Z.+Huangauthor=P.+W.+Iversenauthor=K.+L.+Lawauthor=T.+Liauthor=H.-S.+Linauthor=B.+Lopezauthor=J.+E.+Lopezauthor=L.+M.+M.+Cabrejasauthor=D.+J.+McCannauthor=V.+Moleroauthor=J.+E.+Reillyauthor=M.+E.+Richettauthor=C.+Shihauthor=B.+Teicherauthor=J.+H.+Wikelauthor=W.+T.+Whiteauthor=M.+M.+Mader&title=Acyl+sulfonamide+anti-proliferatives%3A+benzene+substituent+structure-activity+relationships+for+a+novel+class+of+antitumor+agents&doi=10.1021%2Fjm030594r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Acyl Sulfonamide Anti-Proliferatives: Benzene Substituent Structure-Activity Relationships for a Novel Class of Antitumor Agents</span></div><div class="casAuthors">Lobb, Karen L.; Hipskind, Philip A.; Aikins, James A.; Alvarez, Enrique; Cheung, Yiu-Yin; Considine, Eileen L.; De Dios, Alfonso; Durst, Gregory L.; Ferritto, Rafael; Grossman, Cora Sue; Giera, Deborah D.; Hollister, Beth A.; Huang, Zhongping; Iversen, Philip W.; Law, Kevin L.; Li, Tiechao; Lin, Ho-Shen; Lopez, Beatriz; Lopez, Jose E.; Cabrejas, Luisa M. Martin; McCann, Denis J.; Molero, Victoriano; Reilly, John E.; Richett, Michael E.; Shih, Chuan; Teicher, Beverly; Wikel, James H.; White, Wesley T.; Mader, Mary M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5367-5380</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two closely related diaryl acylsulfonamides were recently reported as potent antitumor agents against a broad spectrum of human tumor xenografts (colon, lung, breast, ovary, and prostate) in nude mice.  Esp. intriguing was their activity against colorectal cancer xenografts.  In this paper, rapid parallel synthesis along with traditional medicinal chem. techniques were used to quickly delineate the structure-activity relationships of the substitution patterns in both Ph rings of the acylsufonamide anti-proliferative scaffold.  Although the mol. target of the compds. remains unclear, we detd. that the vascular endothelial growth factor-dependent human umbilical vein endothelial cells assay in combination with a soft agar disk diffusion assay allowed for optimization of potency in the series.  The pharmacokinetic properties and in vivo activity in an HCT116 xenograft model are reported for representative compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeCysoz5N61bVg90H21EOLACvtfcHk0lgrcQOo9K8YpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsleis7Y%253D&md5=e10193988e21a4cecf4040e5e8ad996e</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm030594r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030594r%26sid%3Dliteratum%253Aachs%26aulast%3DLobb%26aufirst%3DK.%2BL.%26aulast%3DHipskind%26aufirst%3DP.%2BA.%26aulast%3DAikins%26aufirst%3DJ.%2BA.%26aulast%3DAlvarez%26aufirst%3DE.%26aulast%3DCheung%26aufirst%3DY.-Y.%26aulast%3DConsidine%26aufirst%3DE.%2BL.%26aulast%3DDe%2BDios%26aufirst%3DA.%26aulast%3DDurst%26aufirst%3DG.%2BL.%26aulast%3DFerritto%26aufirst%3DR.%26aulast%3DGrossman%26aufirst%3DC.%2BS.%26aulast%3DGiera%26aufirst%3DD.%2BD.%26aulast%3DHollister%26aufirst%3DB.%2BA.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DIversen%26aufirst%3DP.%2BW.%26aulast%3DLaw%26aufirst%3DK.%2BL.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DH.-S.%26aulast%3DLopez%26aufirst%3DB.%26aulast%3DLopez%26aufirst%3DJ.%2BE.%26aulast%3DCabrejas%26aufirst%3DL.%2BM.%2BM.%26aulast%3DMcCann%26aufirst%3DD.%2BJ.%26aulast%3DMolero%26aufirst%3DV.%26aulast%3DReilly%26aufirst%3DJ.%2BE.%26aulast%3DRichett%26aufirst%3DM.%2BE.%26aulast%3DShih%26aufirst%3DC.%26aulast%3DTeicher%26aufirst%3DB.%26aulast%3DWikel%26aufirst%3DJ.%2BH.%26aulast%3DWhite%26aufirst%3DW.%2BT.%26aulast%3DMader%26aufirst%3DM.%2BM.%26atitle%3DAcyl%2520sulfonamide%2520anti-proliferatives%253A%2520benzene%2520substituent%2520structure-activity%2520relationships%2520for%2520a%2520novel%2520class%2520of%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D5367%26epage%3D5380%26doi%3D10.1021%2Fjm030594r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Egleton, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thinnes, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seden, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurieri, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadavizadeh, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Measures, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varney, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynne, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, A. J.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships and colorimetric properties of specific probes for the putative cancer biomarker human arylamine N-acetyltransferase 1</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3030</span>– <span class="NLM_lpage">3054</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.03.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2Fj.bmc.2014.03.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=24758871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFCls70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=3030-3054&author=J.+E.+Egletonauthor=C.+C.+Thinnesauthor=P.+T.+Sedenauthor=N.+Laurieriauthor=S.+P.+Leeauthor=K.+S.+Hadavizadehauthor=A.+R.+Measuresauthor=A.+M.+Jonesauthor=S.+Thompsonauthor=A.+Varneyauthor=G.+M.+Wynneauthor=A.+Ryanauthor=E.+Simauthor=A.+J.+Russell&title=Structure-activity+relationships+and+colorimetric+properties+of+specific+probes+for+the+putative+cancer+biomarker+human+arylamine+N-acetyltransferase+1&doi=10.1016%2Fj.bmc.2014.03.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships and colorimetric properties of specific probes for the putative cancer biomarker human arylamine N-acetyltransferase 1</span></div><div class="casAuthors">Egleton, James E.; Thinnes, Cyrille C.; Seden, Peter T.; Laurieri, Nicola; Lee, Siu Po; Hadavizadeh, Kate S.; Measures, Angelina R.; Jones, Alan M.; Thompson, Sam; Varney, Amy; Wynne, Graham M.; Ryan, Ali; Sim, Edith; Russell, Angela J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3030-3054</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A naphthoquinone inhibitor of human arylamine N-acetyltransferase 1 (hNAT1), a potential cancer biomarker and therapeutic target, has been reported which undergoes a distinctive concomitant color change from red to blue upon binding to the enzyme.  Here we describe the use of in silico modeling alongside structure-activity relationship studies to advance the hit compd. towards a potential probe to quantify hNAT1 levels in tissues.  Derivs. with both a fifty-fold higher potency against hNAT1 and a two-fold greater absorption coeff. compared to the initial hit have been synthesized; these compds. retain specificity for hNAT1 and its murine homolog mNat2 over the isoenzyme hNAT2.  A relationship between pKa, inhibitor potency and colorimetric properties has also been uncovered.  The high potency of representative examples against hNAT1 in ZR-75-1 cell exts. also paves the way for the development of inhibitors with improved intrinsic sensitivity which could enable detection of hNAT1 in tissue samples and potentially act as tools for elucidating the unknown role hNAT1 plays in ER+ breast cancer; this could in turn lead to a therapeutic use for such inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwKpsbUvNJa7Vg90H21EOLACvtfcHk0lhHTokuLgoEYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFCls70%253D&md5=0fd8eaf791cc58361ca8e3f4f834a9af</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.03.015%26sid%3Dliteratum%253Aachs%26aulast%3DEgleton%26aufirst%3DJ.%2BE.%26aulast%3DThinnes%26aufirst%3DC.%2BC.%26aulast%3DSeden%26aufirst%3DP.%2BT.%26aulast%3DLaurieri%26aufirst%3DN.%26aulast%3DLee%26aufirst%3DS.%2BP.%26aulast%3DHadavizadeh%26aufirst%3DK.%2BS.%26aulast%3DMeasures%26aufirst%3DA.%2BR.%26aulast%3DJones%26aufirst%3DA.%2BM.%26aulast%3DThompson%26aufirst%3DS.%26aulast%3DVarney%26aufirst%3DA.%26aulast%3DWynne%26aufirst%3DG.%2BM.%26aulast%3DRyan%26aufirst%3DA.%26aulast%3DSim%26aufirst%3DE.%26aulast%3DRussell%26aufirst%3DA.%2BJ.%26atitle%3DStructure-activity%2520relationships%2520and%2520colorimetric%2520properties%2520of%2520specific%2520probes%2520for%2520the%2520putative%2520cancer%2520biomarker%2520human%2520arylamine%2520N-acetyltransferase%25201%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D3030%26epage%3D3054%26doi%3D10.1016%2Fj.bmc.2014.03.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span>; <span class="NLM_string-name">Lu, X.</span>; <span class="NLM_string-name">Li, Z.</span>; <span class="NLM_string-name">Xin, L.</span>; <span class="NLM_string-name">Zhu, J.</span>; <span class="NLM_string-name">Fu, C.</span></span> <span> </span><span class="NLM_article-title">Fused imidazole compound having indoleamine 2,3-dioxygenase inhibitory activity</span>. <span class="NLM_patent">WO 2018113624 A1</span>, June 28, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=J.+Yu&author=X.+Lu&author=Z.+Li&author=L.+Xin&author=J.+Zhu&author=C.+Fu&title=Fused+imidazole+compound+having+indoleamine+2%2C3-dioxygenase+inhibitory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DJ.%26atitle%3DFused%2520imidazole%2520compound%2520having%2520indoleamine%25202%252C3-dioxygenase%2520inhibitory%2520activity%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mattsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlström, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, S.</span></span> <span> </span><span class="NLM_article-title">A mild hydrolysis of esters mediated by lithium salts</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">2497</span>– <span class="NLM_lpage">2499</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2007.02.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2Fj.tetlet.2007.02.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis1Ohs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=2497-2499&author=S.+Mattssonauthor=M.+Dahlstr%C3%B6mauthor=S.+Karlsson&title=A+mild+hydrolysis+of+esters+mediated+by+lithium+salts&doi=10.1016%2Fj.tetlet.2007.02.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">A mild hydrolysis of esters mediated by lithium salts</span></div><div class="casAuthors">Mattsson, Sara; Dahlstroem, Mikael; Karlsson, Staffan</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2497-2499</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">When treated with amine bases such as triethylamine and various lithium salts in wet solvents, esters are efficiently hydrolyzed to the corresponding acids in good yields.  Esters incorporating an α- or β-heteroatom with respect to the ester carbonyl group are hydrolyzed rapidly even at room temp.  To further demonstrate the usefulness of this method, one example is provided where hydrolysis of acetylated camphorsultam is mediated by LiBr.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlkdhTIjsx0bVg90H21EOLACvtfcHk0lhHTokuLgoEYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis1Ohs7w%253D&md5=7a88787176f93ccdd555a0ab411b0635</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2007.02.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2007.02.029%26sid%3Dliteratum%253Aachs%26aulast%3DMattsson%26aufirst%3DS.%26aulast%3DDahlstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DKarlsson%26aufirst%3DS.%26atitle%3DA%2520mild%2520hydrolysis%2520of%2520esters%2520mediated%2520by%2520lithium%2520salts%26jtitle%3DTetrahedron%2520Lett.%26date%3D2007%26volume%3D48%26spage%3D2497%26epage%3D2499%26doi%3D10.1016%2Fj.tetlet.2007.02.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lizarzaburu, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuttleworth, S. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of aryl ethers from amino alcohols using polymer-supported triphenylphosphine</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">2157</span>– <span class="NLM_lpage">2159</span>, <span class="refDoi"> DOI: 10.1016/s0040-4039(02)00222-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2FS0040-4039%2802%2900222-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BD38XhslGlu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=2157-2159&author=M.+E.+Lizarzaburuauthor=S.+J.+Shuttleworth&title=Synthesis+of+aryl+ethers+from+amino+alcohols+using+polymer-supported+triphenylphosphine&doi=10.1016%2Fs0040-4039%2802%2900222-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of aryl ethers from amino alcohols using polymer-supported triphenylphosphine</span></div><div class="casAuthors">Lizarzaburu, Mike E.; Shuttleworth, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2157-2159</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Optimum conditions for the prepn. of aryl alkyl ethers from N-protected amino alcs. using polymer-supported triphenylphosphine have been developed.  In contrast to previous literature reports, it was discovered that the progress of this reaction is greatly improved when a tertiary amine base is employed along with minor modifications of the order of reagent addn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsEcjS7EClzLVg90H21EOLACvtfcHk0lgqsHpJi5lOUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhslGlu78%253D&md5=3493534a2e43e37c6b7422474c298d97</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2802%2900222-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252802%252900222-8%26sid%3Dliteratum%253Aachs%26aulast%3DLizarzaburu%26aufirst%3DM.%2BE.%26aulast%3DShuttleworth%26aufirst%3DS.%2BJ.%26atitle%3DSynthesis%2520of%2520aryl%2520ethers%2520from%2520amino%2520alcohols%2520using%2520polymer-supported%2520triphenylphosphine%26jtitle%3DTetrahedron%2520Lett.%26date%3D2002%26volume%3D43%26spage%3D2157%26epage%3D2159%26doi%3D10.1016%2Fs0040-4039%2802%2900222-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I. S.</span></span> <span> </span><span class="NLM_article-title">One-pot synthesis of 2-naphthols from nitrones and MBH adducts via decarboxylative N–O bond cleavage</span>. <i>Org. Chem. Front.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">3210</span>– <span class="NLM_lpage">3218</span>, <span class="refDoi"> DOI: 10.1039/c8qo00988k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1039%2FC8QO00988K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVahur7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2018&pages=3210-3218&author=S.+H.+Hanauthor=A.+K.+Pandeyauthor=H.+Leeauthor=S.+Kimauthor=D.+Kangauthor=Y.+H.+Jungauthor=H.+S.+Kimauthor=S.+Hongauthor=I.+S.+Kim&title=One-pot+synthesis+of+2-naphthols+from+nitrones+and+MBH+adducts+via+decarboxylative+N%E2%80%93O+bond+cleavage&doi=10.1039%2Fc8qo00988k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">One-pot synthesis of 2-naphthols from nitrones and MBH adducts via decarboxylative N-O bond cleavage</span></div><div class="casAuthors">Han, Sang Hoon; Pandey, Ashok Kumar; Lee, Heeyoung; Kim, Saegun; Kang, Dahye; Jung, Young Hoon; Kim, Hyung Sik; Hong, Sungwoo; Kim, In Su</div><div class="citationInfo"><span class="NLM_cas:title">Organic Chemistry Frontiers</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3210-3218</span>CODEN:
                <span class="NLM_cas:coden">OCFRA8</span>;
        ISSN:<span class="NLM_cas:issn">2052-4129</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The unprecedented one-pot synthesis of 2-naphthols through an acid-mediated decarboxylative N-O bond cleavage of bridged benzoxazepine intermediates, which were in turn generated from aryl nitrones and Morita-Baylis-Hillman (MBH) adducts under cationic rhodium(III) catalysis was described.  A range of 2-naphthol derivs. including anthracen-2-ol, phenanthren-2-ol, and 11H-benzo[b]fluoren-7-ol were formed with excellent site selectivities and functional group compatibilities.  To gain mechanistic insight into this process, a series of mechanistic investigations and DFT calcns. were also performed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpXEbbnczpP7Vg90H21EOLACvtfcHk0lgqsHpJi5lOUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVahur7P&md5=4fc69c52e752b00bcdefadfc099ed110</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1039%2FC8QO00988K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8QO00988K%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DS.%2BH.%26aulast%3DPandey%26aufirst%3DA.%2BK.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DD.%26aulast%3DJung%26aufirst%3DY.%2BH.%26aulast%3DKim%26aufirst%3DH.%2BS.%26aulast%3DHong%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DI.%2BS.%26atitle%3DOne-pot%2520synthesis%2520of%25202-naphthols%2520from%2520nitrones%2520and%2520MBH%2520adducts%2520via%2520decarboxylative%2520N%25E2%2580%2593O%2520bond%2520cleavage%26jtitle%3DOrg.%2520Chem.%2520Front.%26date%3D2018%26volume%3D5%26spage%3D3210%26epage%3D3218%26doi%3D10.1039%2Fc8qo00988k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arakawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shigeta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konishi, G.-i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of dinaphthylacetylene nematic liquid crystals for high-birefringence materials</span>. <i>Liq. Cryst.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1063</span>– <span class="NLM_lpage">1069</span>, <span class="refDoi"> DOI: 10.1080/02678292.2012.696730</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1080%2F02678292.2012.696730" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC38Xot1CntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2012&pages=1063-1069&author=Y.+Arakawaauthor=S.+Nakajimaauthor=S.+Kangauthor=M.+Shigetaauthor=G.-i.+Konishiauthor=J.+Watanabe&title=Synthesis+and+evaluation+of+dinaphthylacetylene+nematic+liquid+crystals+for+high-birefringence+materials&doi=10.1080%2F02678292.2012.696730"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of dinaphthylacetylene nematic liquid crystals for high-birefringence materials</span></div><div class="casAuthors">Arakawa, Yuki; Nakajima, Shunpei; Kang, Sungmin; Shigeta, Masayuki; Konishi, Gen-ichi; Watanabe, Junji</div><div class="citationInfo"><span class="NLM_cas:title">Liquid Crystals</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1063-1069</span>CODEN:
                <span class="NLM_cas:coden">LICRE6</span>;
        ISSN:<span class="NLM_cas:issn">0267-8292</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">We synthesized 1,2-bis(6-alkoxy-2-naphthyl)acetylene as a new dinaphthylacetylene liq. crystal (LC) compds. I [n = 1 - 10] with alkoxy tails of length m (DNA-OCm, m = 1 - 10) and characterized their phase behavior by polarizing optical microscopy and differential scanning calorimetry, where all compds. exhibited a nematic phase.  Also, we measured the actual, and not extrapolated, Δn values of this target compd., and our results show the birefringence potential of the pure LC compd.  They have high birefringence values, with the highest value of approx. 0.5 obtained for DNA-OC2 at 550 nm at 10°C above the nematic-crystal transition temp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzxrvO-MdLurVg90H21EOLACvtfcHk0lgqsHpJi5lOUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xot1CntrY%253D&md5=c3491f0a41057945b654ac0c51ed94d9</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1080%2F02678292.2012.696730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F02678292.2012.696730%26sid%3Dliteratum%253Aachs%26aulast%3DArakawa%26aufirst%3DY.%26aulast%3DNakajima%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DShigeta%26aufirst%3DM.%26aulast%3DKonishi%26aufirst%3DG.-i.%26aulast%3DWatanabe%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520dinaphthylacetylene%2520nematic%2520liquid%2520crystals%2520for%2520high-birefringence%2520materials%26jtitle%3DLiq.%2520Cryst.%26date%3D2012%26volume%3D39%26spage%3D1063%26epage%3D1069%26doi%3D10.1080%2F02678292.2012.696730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Appel, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biedermann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauwald, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zayed, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherman, O. A.</span></span> <span> </span><span class="NLM_article-title">Supramolecular cross-linked networks via host-guest complexation with cucurbit[8]uril</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">14251</span>– <span class="NLM_lpage">14260</span>, <span class="refDoi"> DOI: 10.1021/ja106362w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja106362w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=14251-14260&author=E.+A.+Appelauthor=F.+Biedermannauthor=U.+Rauwaldauthor=S.+T.+Jonesauthor=J.+M.+Zayedauthor=O.+A.+Scherman&title=Supramolecular+cross-linked+networks+via+host-guest+complexation+with+cucurbit%5B8%5Duril&doi=10.1021%2Fja106362w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Supramolecular Cross-Linked Networks via Host-Guest Complexation with Cucurbit[8]uril</span></div><div class="casAuthors">Appel, Eric A.; Biedermann, Frank; Rauwald, Urs; Jones, Samuel T.; Zayed, Jameel M.; Scherman, Oren A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">14251-14260</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ability to finely tune the soln. viscosity of an aq. system is crit. in many applications ranging from large-scale fluid-based industrial processes to free-standing hydrogels important in regenerative medicine, controlled drug delivery, and green' self-healing materials.  Herein we demonstrate the use of the macrocyclic host mol. cucurbit[8]uril (CB[8]) to facilitate reversible crosslinking of multivalent copolymers with high binding consts. (Ka > 1011-1012 M-2) leading to a supramol. hydrogel.  Multivalent copolymers were prepd. by free radical polymn. techniques and contained either pendant Me viologen (a good first guest for CB[8]) or naphthoxy derivs. (good second guests for CB[8]).  A colorless soln. of the two multivalent copolymers bearing first and second guests, resp., can be transformed into a highly viscous, colored supramol. hydrogel with the crosslink d. being easily controlled through CB[8] addn.  Moreover, the crosslinks (1:1:1 supramol. ternary complexes of CB[8]/viologen/naphthoxy) are dynamic and stimuli-responsive, and the material properties can be modulated by temp. or other external stimuli.  Rheol. characterization of the bulk material properties of these dynamically crosslinked networks provided insight into the kinetics of CB[8] ternary complexation responsible for elastically active crosslinking with a second guest dissocn. rate const. (kd) of 1200 s-1 for the ternary complex.  These materials exhibited intermediate mech. properties at 5 wt.% in water (plateau modulus = 350-600 Pa and zero-shear viscosity = 5-55 Pa-s), which is complementary to existing supramol. hydrogels.  Addnl., these supramol. hydrogels exhibited thermal reversibility and subsequent facile modulation of microstructure upon further addn. of CB[8] and thermal treatment.  The fundamental knowledge gained from the study of these dynamic materials will facilitate progress in the field of smart, self-healing materials, self-assembled hydrogels, and controlled soln. viscosity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxasisFkLhs7Vg90H21EOLACvtfcHk0lgqsHpJi5lOUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtLnO&md5=ac4e92f12feeeb23986486c4bb99481a</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fja106362w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja106362w%26sid%3Dliteratum%253Aachs%26aulast%3DAppel%26aufirst%3DE.%2BA.%26aulast%3DBiedermann%26aufirst%3DF.%26aulast%3DRauwald%26aufirst%3DU.%26aulast%3DJones%26aufirst%3DS.%2BT.%26aulast%3DZayed%26aufirst%3DJ.%2BM.%26aulast%3DScherman%26aufirst%3DO.%2BA.%26atitle%3DSupramolecular%2520cross-linked%2520networks%2520via%2520host-guest%2520complexation%2520with%2520cucurbit%255B8%255Duril%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D14251%26epage%3D14260%26doi%3D10.1021%2Fja106362w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zakrzewicz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Didiasova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krüger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giaimo, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borggrefe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mieth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocke, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zakrzewicz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaefer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preissner, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wygrecka, M.</span></span> <span> </span><span class="NLM_article-title">Protein arginine methyltransferase 5 mediates enolase-1 cell surface trafficking in human lung adenocarcinoma cells</span>. <i>Biochim. Biophys. Acta</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1864</i></span>,  <span class="NLM_fpage">1816</span>– <span class="NLM_lpage">1827</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2018.02.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=10.1016%2Fj.bbadis.2018.02.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktlGrs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1864&publication_year=2018&pages=1816-1827&author=D.+Zakrzewiczauthor=M.+Didiasovaauthor=M.+Kr%C3%BCgerauthor=B.+D.+Giaimoauthor=T.+Borggrefeauthor=M.+Miethauthor=A.+C.+Hockeauthor=A.+Zakrzewiczauthor=L.+Schaeferauthor=K.+T.+Preissnerauthor=M.+Wygrecka&title=Protein+arginine+methyltransferase+5+mediates+enolase-1+cell+surface+trafficking+in+human+lung+adenocarcinoma+cells&doi=10.1016%2Fj.bbadis.2018.02.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Protein arginine methyltransferase 5 mediates enolase-1 cell surface trafficking in human lung adenocarcinoma cells</span></div><div class="casAuthors">Zakrzewicz, Dariusz; Didiasova, Miroslava; Krueger, Marcus; Giaimo, Benedetto Daniele; Borggrefe, Tilman; Mieth, Maren; Hocke, Andreas C.; Zakrzewicz, Anna; Schaefer, Liliana; Preissner, Klaus T.; Wygrecka, Malgorzata</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">1864</span>
        (<span class="NLM_cas:issue">5_Part_A</span>),
    <span class="NLM_cas:pages">1816-1827</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Enolase-1-dependent cell surface proteolysis plays an important role in cell invasion.  Although enolase-1 (Eno-1), a glycolytic enzyme, has been found on the surface of various cells, the mechanism responsible for its exteriorization remains elusive.  Here, we investigated the involvement of post-translational modifications (PTMs) of Eno-1 in its lipopolysaccharide (LPS)-triggered trafficking to the cell surface.  We found that stimulation of human lung adenocarcinoma cells with LPS triggered the monomethylation of arginine 50 (R50me) within Eno-1.  The Eno-1R50me was confirmed by its interaction with the tudor domain (TD) from TD-contg. 3 (TDRD3) protein recognizing methylarginines.  Substitution of R50 with lysine (R50K) reduced Eno-1 assocn. with epithelial caveolar domains, thereby diminishing its exteriorization.  Similar effects were obsd. when pharmacol. inhibitors of arginine methyltransferases were applied.  Protein arginine methyltransferase 5 (PRMT5) was identified to be responsible for Eno-1 methylation.  Overexpression of PRMT5 and caveolin-1 enhanced levels of membrane-bound extracellular Eno-1 and, conversely, pharmacol. inhibition of PRMT5 attenuated Eno-1 cell-surface localization.  Importantly, Eno-1R50me was essential for cancer cell motility since the replacement of Eno-1 R50 by lysine or the suppression of PRMT 5 activity diminished Eno-1-triggered cell invasion.  LPS-triggered Eno-1R50me enhances Eno-1 cell surface levels and thus potentiates the invasive properties of cancer cells.  Strategies to target Eno-1R50me may offer novel therapeutic approaches to attenuate tumor metastasis in cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE5EyHucXpw7Vg90H21EOLACvtfcHk0lgfiVUmU8OrnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktlGrs7o%253D&md5=81e1ba2aa285978778e34e8abc9687ba</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2018.02.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2018.02.021%26sid%3Dliteratum%253Aachs%26aulast%3DZakrzewicz%26aufirst%3DD.%26aulast%3DDidiasova%26aufirst%3DM.%26aulast%3DKr%25C3%25BCger%26aufirst%3DM.%26aulast%3DGiaimo%26aufirst%3DB.%2BD.%26aulast%3DBorggrefe%26aufirst%3DT.%26aulast%3DMieth%26aufirst%3DM.%26aulast%3DHocke%26aufirst%3DA.%2BC.%26aulast%3DZakrzewicz%26aufirst%3DA.%26aulast%3DSchaefer%26aufirst%3DL.%26aulast%3DPreissner%26aufirst%3DK.%2BT.%26aulast%3DWygrecka%26aufirst%3DM.%26atitle%3DProtein%2520arginine%2520methyltransferase%25205%2520mediates%2520enolase-1%2520cell%2520surface%2520trafficking%2520in%2520human%2520lung%2520adenocarcinoma%2520cells%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2018%26volume%3D1864%26spage%3D1816%26epage%3D1827%26doi%3D10.1016%2Fj.bbadis.2018.02.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i105"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02094">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_35177"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b02094?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02094</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Chemical structure of 8-NBD-cAMP; ability of the selected compounds to promote EPAC1 activity by EPAC1 IP in cells; summary results of compounds <b>25n</b> and <b>25q</b> counter screening study of over 40 GPCR targets; HPLC copies of example compounds; and <sup>1</sup>H and <sup>13</sup>C NMR spectra copies of all the biologically tested compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02094/suppl_file/jm9b02094_si_001.pdf">PDF</a>)</p></li><li><p class="inline">CSV file containing SMILES and binding and cellular data for final target compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02094/suppl_file/jm9b02094_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02094/suppl_file/jm9b02094_si_001.pdf">jm9b02094_si_001.pdf (6.64 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02094/suppl_file/jm9b02094_si_002.csv">jm9b02094_si_002.csv (4.01 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b02094&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b02094%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-10" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b02094" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"667981465d53247f","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
